data_2cbh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cbh _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.89 173.98 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.304 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.644 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.0 t-160 -47.84 158.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.695 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.5 m-85 46.91 23.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.341 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.06 135.12 11.96 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.308 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -65.16 100.98 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.36 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -89.86 -16.6 29.76 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.612 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.6 -179.79 31.85 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 118.514 -1.803 . . . . 0.0 111.537 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.66 131.69 3.33 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.3 mt -48.25 148.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.604 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.14 -14.46 14.89 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.611 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -79.39 138.64 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.022 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.8 p -137.71 63.12 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.6 178.99 21.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.91 166.11 7.35 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -135.15 0.43 2.84 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.83 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -80.68 112.42 18.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.495 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.8 m -71.21 147.02 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.353 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 142.19 49.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.163 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -44.95 146.22 0.84 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.55 -25.76 27.0 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.33 163.0 17.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.476 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.4 OUTLIER -126.64 169.71 12.84 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.812 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.7 t -95.34 120.56 35.79 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.038 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.488 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 22.5 mp0 -110.72 113.78 26.65 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.746 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.27 106.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.312 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.97 -54.06 14.98 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.034 -1.067 . . . . 0.0 109.184 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 m-80 -150.2 174.59 3.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.534 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.59 24.36 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 120.837 1.024 . . . . 0.0 112.208 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.29 17.56 0.48 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.452 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.455 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 42.8 t80 -170.21 131.97 1.02 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.975 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 m -142.66 110.82 6.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.16 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.455 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -99.2 145.28 27.4 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.099 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.0 m -84.43 118.72 24.44 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.559 -179.189 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -172.29 2.22 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.193 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.7 t-160 -67.24 149.68 50.09 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 44.9 m-85 54.28 25.79 6.21 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.913 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.9 150.21 18.66 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.737 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.5 109.64 10.39 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.612 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -25.46 15.7 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.694 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.44 -153.27 6.31 Favored Glycine 0 N--CA 1.48 1.597 0 C-N-CA 118.279 -1.915 . . . . 0.0 112.131 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.31 132.47 7.5 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -48.0 149.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.756 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.31 -0.4 87.76 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.056 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.62 139.19 33.07 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -131.07 31.2 4.47 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.585 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.18 175.82 16.9 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.51 160.58 23.5 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.515 1.477 . . . . 0.0 110.333 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.4 p -124.59 22.15 8.37 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.586 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.93 108.61 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.718 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -75.71 147.2 39.56 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.43 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.26 152.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.726 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 m -56.51 139.54 49.09 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.927 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.18 32.49 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.527 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -105.13 161.57 14.14 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.881 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -129.18 162.86 26.82 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.29 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.4 t -90.76 116.91 28.98 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.04 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 22.0 mp0 -107.39 107.74 18.77 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.463 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.63 120.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 118.719 -1.193 . . . . 0.0 108.666 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -81.14 -62.11 1.76 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -178.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.9 m-80 -141.04 175.32 3.15 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 Cg_exo -69.03 23.51 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.1 0.714 . . . . 0.0 111.712 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.55 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.1 m-85 -155.26 21.64 0.42 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.987 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 16.5 t80 -173.68 130.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.099 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.9 m -134.07 116.26 15.26 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.471 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.494 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tt0 -98.75 154.38 18.03 Favored 'General case' 0 N--CA 1.513 2.69 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.636 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.37 120.44 32.89 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.602 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.482 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 90.5 mt . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.197 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.68 HE22 ' N ' ' A' ' 7' ' ' GLN . 3.2 tt0 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -179.15 4.23 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.817 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.8 t-160 -54.83 150.97 9.1 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 19.6 m-85 52.89 17.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.351 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -81.35 134.18 12.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.696 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.68 ' N ' HE22 ' A' ' 2' ' ' GLN . 30.6 tt0 -69.99 101.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.31 -18.37 28.65 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.026 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.37 -172.04 22.57 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.445 -1.836 . . . . 0.0 112.314 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.96 126.48 4.55 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.9 mt -44.51 153.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.978 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 -12.84 52.03 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.701 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -90.14 146.94 23.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.049 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 p -140.27 22.78 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.808 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.39 177.36 24.86 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.84 159.8 16.74 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.485 1.457 . . . . 0.0 110.447 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.3 p -124.56 26.09 7.36 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.16 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.92 114.8 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.081 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -79.27 133.98 36.65 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.326 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.42 159.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.323 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.52 155.67 9.23 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.923 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.28 -15.68 32.96 Favored Glycine 0 N--CA 1.482 1.728 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.522 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 167.03 14.37 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.27 164.97 25.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.727 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.98 113.29 24.93 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.27 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -104.13 126.1 50.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.73 140.9 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.902 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.456 ' CD2' HD22 ' A' ' 29' ' ' ASN . 10.5 tp -108.14 -60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.858 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -149.15 175.89 2.53 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.8 24.4 0.15 Allowed 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 120.902 1.068 . . . . 0.0 111.67 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 29' ' ' ASN . 96.2 m-85 -147.39 9.99 0.96 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.074 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 75.3 t80 -169.96 138.96 1.81 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.413 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -150.03 113.24 4.89 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.1 tt0 -95.98 150.53 20.36 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.156 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.7 m -89.36 115.96 27.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.479 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.501 -179.398 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 7.0 tp60 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -178.66 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.599 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.646 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.8 t-160 -59.73 150.4 27.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 82.2 m-85 56.96 9.75 0.67 Allowed 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.856 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.33 155.29 24.14 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.176 -1.488 . . . . 0.0 112.116 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.489 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 39.9 tt0 -76.63 122.28 24.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.78 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -108.71 -23.48 11.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.57 -157.56 8.06 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 117.866 -2.111 . . . . 0.0 112.735 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 146.63 13.12 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.51 154.65 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.131 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.77 -5.92 21.45 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.762 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -94.0 112.97 24.87 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.735 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -110.6 55.36 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.283 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.35 -179.64 16.42 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.64 154.09 67.59 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.365 1.377 . . . . 0.0 110.409 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 p -127.5 28.1 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.207 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.03 109.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.803 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.9 m -78.76 137.59 37.82 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.324 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.42 150.04 1.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.74 154.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.314 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.1 -15.71 58.93 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.585 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.64 176.24 7.94 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.528 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 163.16 33.65 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.49 116.55 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.131 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.56 140.41 41.95 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.846 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.47 117.67 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.551 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -62.54 1.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -144.63 176.07 2.44 Favored Pre-proline 0 N--CA 1.501 2.076 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.0 Cg_exo -69.21 23.63 0.16 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 120.674 0.916 . . . . 0.0 111.841 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASN . 80.0 m-85 -155.39 19.89 0.41 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.873 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -173.0 117.83 0.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.452 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -119.91 111.83 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.525 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.96 157.93 17.01 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.349 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.5 m -100.77 121.77 42.25 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.887 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.12 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.71 HE22 ' HH ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.106 0.479 . . . . 0.0 110.425 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.47 177.9 7.97 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.874 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 10.7 t-160 -60.04 133.08 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 4' ' ' HIS . 27.5 m-85 66.77 22.84 10.23 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.32 155.37 19.87 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.222 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 54.0 tt0 -79.81 120.75 24.49 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -108.97 -27.33 9.73 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.613 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.46 -151.57 5.53 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.347 -1.882 . . . . 0.0 112.328 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 141.85 12.61 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.69 151.62 5.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.716 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.75 -15.06 44.38 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.25 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.71 ' HH ' HE22 ' A' ' 2' ' ' GLN . 45.2 t80 -82.87 138.64 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.471 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -131.22 27.17 4.83 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.25 -176.79 21.42 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.91 155.61 68.55 Favored 'Trans proline' 0 C--O 1.211 -0.842 0 C-N-CA 121.699 1.599 . . . . 0.0 110.865 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 p -117.29 7.55 12.92 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.34 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -90.19 113.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.335 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 m -82.59 148.41 28.03 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.945 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.25 139.83 8.14 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.014 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -47.21 141.83 4.25 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.88 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.77 -27.25 21.29 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.607 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -112.87 158.96 19.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 157.99 36.89 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.454 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.7 t -87.77 111.42 21.34 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.132 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -107.33 117.79 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.116 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -53.08 132.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.333 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.51 -51.32 4.81 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.341 -1.344 . . . . 0.0 107.797 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.0 p30 -161.52 172.98 5.05 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.3 Cg_exo -66.94 24.93 0.11 Allowed 'Trans proline' 0 C--O 1.214 -0.706 0 CA-C-N 119.366 0.809 . . . . 0.0 112.533 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.72 14.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.176 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 30.6 t80 -172.47 130.16 0.56 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.906 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -130.17 116.23 18.15 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.468 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.458 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tp-100 -100.09 150.16 22.76 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.452 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.9 m -97.19 116.59 29.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.784 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 116.306 -1.807 . . . . 0.0 109.982 -179.456 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.28 177.77 7.58 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.001 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.9 t-160 -59.94 132.32 53.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 26.5 m-85 67.98 26.38 7.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.69 153.65 17.88 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.13 108.22 13.55 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -97.53 -21.7 16.95 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.864 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.44 -155.09 6.61 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 118.544 -1.788 . . . . 0.0 111.831 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 144.77 12.58 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.57 148.51 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.995 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.9 -12.23 30.82 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.627 -1.273 . . . . 0.0 111.042 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -78.16 120.87 23.58 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.4 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 14' ' ' SER . 48.0 p -114.51 58.18 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.367 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.13 170.55 25.91 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.777 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.25 153.62 38.95 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.339 1.359 . . . . 0.0 110.052 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -119.56 33.3 5.68 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.609 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.9 107.15 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.116 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.7 m -74.94 143.61 43.62 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.769 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.69 148.22 0.78 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.683 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -53.08 160.5 1.01 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.121 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.29 -18.45 23.24 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -124.18 163.63 21.16 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.092 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.01 160.73 31.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.339 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -88.13 117.85 27.3 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.422 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -115.27 116.11 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.422 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.23 129.01 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.372 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -87.3 -51.36 6.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.37 176.08 2.84 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.2 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.429 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.0 Cg_exo -68.27 24.62 0.14 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.601 0.867 . . . . 0.0 111.459 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.578 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.0 m-85 -150.52 10.34 0.65 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.739 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -173.65 127.73 0.41 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.594 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 21.7 m -125.32 115.67 20.71 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.884 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -100.32 158.4 15.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.95 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 61.1 m -98.28 123.24 42.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 116.361 -1.781 . . . . 0.0 110.289 -178.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' SER . 5.6 tp60 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.73 -172.58 2.41 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.647 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.61 149.94 46.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 67.5 m-85 53.59 18.05 1.34 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.681 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 152.78 21.53 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.806 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -81.65 119.43 23.81 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.55 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -107.73 -21.96 12.66 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -169.43 15.83 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.211 -1.947 . . . . 0.0 112.427 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 143.28 9.03 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.9 mt -54.64 154.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.998 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.31 -11.7 48.89 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -95.56 129.56 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.304 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.5 p -137.92 57.94 1.7 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.662 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.32 -177.28 15.4 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.43 157.6 14.46 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.797 0.998 . . . . 0.0 109.664 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.4 p -131.83 26.47 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.487 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.97 115.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.484 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.71 161.26 30.44 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.788 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.9 171.18 0.98 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.294 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -63.77 141.57 58.72 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.11 -5.72 84.64 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.584 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -124.05 165.09 18.09 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.15 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -140.37 162.1 36.12 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.014 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.6 t -90.27 113.32 25.14 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 29.1 mp0 -105.46 125.61 51.18 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.952 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.31 126.21 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.553 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -89.13 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.706 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.0 p30 -155.61 178.59 1.6 Allowed Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.804 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 5.4 Cg_exo -67.6 23.4 0.12 Allowed 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 120.989 1.126 . . . . 0.0 113.116 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 29' ' ' ASN . 81.6 m-85 -154.62 16.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.072 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -174.69 133.72 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.541 -1.264 . . . . 0.0 111.767 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m -136.06 113.17 10.47 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.385 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 5' ' ' TYR . 5.0 tp60 -89.56 153.71 20.56 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 20.4 m -106.69 114.14 28.07 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.168 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.449 -1.739 . . . . 0.0 109.821 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.02 -170.58 2.14 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.171 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.62 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.4 t-160 -61.16 135.03 57.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.466 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 68.8 m-85 70.17 24.01 5.04 Favored 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.22 153.85 23.86 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.741 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 60.8 tt0 -90.19 111.13 22.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.691 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -97.95 -21.14 17.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.603 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 -156.32 7.38 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 117.938 -2.077 . . . . 0.0 112.526 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.1 131.1 6.86 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.517 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -46.58 145.95 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.79 9.66 84.23 Favored Glycine 0 C--N 1.292 -1.889 0 C-N-CA 119.582 -1.295 . . . . 0.0 111.202 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 80.6 t80 -110.8 126.28 54.45 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.6 p -120.5 11.02 11.28 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.43 -176.41 50.47 Favored Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -69.54 161.16 46.99 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.575 1.517 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 p -120.54 38.02 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.06 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.1 110.98 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -75.17 157.69 34.2 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.097 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -72.59 149.96 43.51 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.842 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -44.49 142.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.712 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -24.45 32.15 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.348 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -116.16 176.68 4.99 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.139 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.19 152.61 39.5 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.626 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.1 t -80.37 127.99 33.03 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.606 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -136.97 126.84 25.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.63 134.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.217 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.23 -47.67 5.37 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.9 p30 -162.64 171.81 6.06 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.308 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -67.75 24.56 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 CA-C-N 119.624 0.902 . . . . 0.0 112.26 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' H ' ' C ' ' A' ' 29' ' ' ASN . 57.5 m-85 -153.39 16.13 0.53 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.28 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -174.8 125.47 0.28 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.837 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -127.06 113.23 16.16 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.123 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -93.09 149.77 20.99 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.192 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 32.1 m -102.95 110.04 21.81 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.646 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.505 2.322 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.165 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.487 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 2.4 tp-100 . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -168.11 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.186 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.645 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.2 t-160 -73.99 132.28 42.24 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.145 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 60.5 m-85 70.43 20.12 6.11 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.447 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.88 154.9 19.26 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.491 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -75.99 119.34 19.82 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.885 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -103.2 -29.7 11.13 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.554 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.71 -163.5 10.91 Favored Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.002 -1.57 . . . . 0.0 111.611 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 142.71 10.54 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 13' ' ' TYR . 87.8 mt -50.17 156.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.618 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.55 -15.69 9.16 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.542 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 46.2 t80 -89.41 131.36 35.51 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.334 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 p -126.26 18.25 7.66 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.03 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.93 -178.35 33.39 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.768 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.04 153.09 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.591 1.527 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 p -117.5 27.37 9.11 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.467 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.36 122.23 54.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.931 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.98 163.72 18.73 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.843 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -68.28 154.59 41.45 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.67 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 m -45.1 141.35 2.36 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.035 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.82 -8.72 76.34 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.527 -1.32 . . . . 0.0 112.254 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -133.58 169.75 16.54 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.907 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.497 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.5 OUTLIER -145.16 171.81 14.0 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.491 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -92.23 144.94 24.9 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.263 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.497 HE22 ' C ' ' A' ' 24' ' ' THR . 28.9 mp0 -139.86 116.55 10.83 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.3 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.73 103.08 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.764 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.22 -52.03 65.39 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.827 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.92 174.52 3.72 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.179 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.421 ' O ' ' CD1' ' A' ' 11' ' ' ILE . 4.9 Cg_exo -66.97 24.65 0.11 Allowed 'Trans proline' 0 C--O 1.211 -0.839 0 C-N-CA 120.628 0.885 . . . . 0.0 112.84 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.6 m-85 -149.51 12.53 0.81 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.28 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -170.59 134.67 1.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.496 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -135.98 110.53 8.58 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.584 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -87.48 154.42 20.65 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.598 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.85 109.98 21.43 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.012 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.027 -179.016 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 11.7 pm0 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.93 -174.78 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.845 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.593 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.1 t-160 -57.38 140.66 49.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 52.4 m-85 65.64 18.18 11.13 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.01 157.03 34.9 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.82 116.34 27.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB3' HE21 ' A' ' 2' ' ' GLN . 1.1 p -105.06 -21.69 13.23 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.747 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.83 -166.06 13.02 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 118.329 -1.891 . . . . 0.0 113.163 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.28 144.81 13.62 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.424 HG21 ' H ' ' A' ' 12' ' ' GLY . 35.1 mt -61.63 156.49 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.333 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.424 ' H ' HG21 ' A' ' 11' ' ' ILE . . . 75.62 -2.12 55.08 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.485 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.614 ' HH ' ' N ' ' A' ' 16' ' ' PRO . 29.5 t80 -86.26 132.46 33.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.976 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 p -129.91 36.38 4.05 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.524 ' C ' ' HH ' ' A' ' 13' ' ' TYR . . . -121.34 -174.22 14.79 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.212 -0.994 . . . . 0.0 110.771 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.614 ' N ' ' HH ' ' A' ' 13' ' ' TYR . 1.6 Cg_endo -66.93 153.96 76.18 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.754 1.636 . . . . 0.0 111.211 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.512 ' H ' ' HG1' ' A' ' 17' ' ' THR . 7.7 p -104.34 -6.08 21.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.745 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.35 122.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.609 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 20' ' ' ALA . 92.2 m -84.13 148.46 26.78 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.618 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -39.96 140.14 0.59 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.583 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -49.9 140.0 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.93 13.71 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.5 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -102.69 -170.73 1.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.888 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.43 173.15 12.54 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.4 t -100.12 116.58 32.48 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.868 HE22 ' H ' ' A' ' 36' ' ' LEU . 3.6 mp0 -107.41 110.07 21.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.6 t -53.77 125.65 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.179 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -56.93 2.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.27 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.2 p30 -162.71 172.81 4.98 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 2.9 Cg_exo -66.07 25.37 0.1 OUTLIER 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.84 1.027 . . . . 0.0 113.124 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 29' ' ' ASN . 91.4 m-85 -153.72 13.53 0.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.16 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -175.31 137.57 0.39 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.793 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -136.41 114.4 11.37 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 40.6 tt0 -86.42 165.64 16.17 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.794 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 64.2 m -113.24 128.38 56.46 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.679 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.868 ' H ' HE22 ' A' ' 26' ' ' GLN . 93.8 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.48 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.704 0.288 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -162.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.444 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 19.6 t-160 -72.94 134.74 44.87 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.051 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 36.3 m-85 69.04 16.84 8.65 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.29 155.73 30.04 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.417 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -86.93 110.04 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -93.0 -17.98 23.24 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.939 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.62 -165.69 12.35 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 118.529 -1.796 . . . . 0.0 111.504 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.27 130.53 5.25 Favored Glycine 0 C--N 1.301 -1.415 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.9 mt -51.9 144.14 3.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.799 -1.161 . . . . 0.0 110.757 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.43 65.14 Favored Glycine 0 CA--C 1.548 2.095 0 C-N-CA 119.869 -1.158 . . . . 0.0 111.876 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 71.2 t80 -83.93 113.19 20.8 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.606 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -106.75 55.41 0.66 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.711 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.13 172.98 22.13 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.62 145.31 82.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.136 1.224 . . . . 0.0 110.832 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 p -107.18 30.49 6.16 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.03 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -116.06 119.7 62.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.661 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.1 m -79.63 164.64 23.64 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.64 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -65.68 168.08 8.2 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.979 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.02 147.94 52.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.777 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.05 26.61 Favored Glycine 0 C--N 1.297 -1.634 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -107.99 178.73 4.43 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.504 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.83 162.45 41.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.89 127.35 39.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.093 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.27 112.63 15.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.146 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.67 130.63 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.623 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -92.91 -54.98 3.52 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -154.53 175.34 3.14 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.416 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 4.7 Cg_exo -70.24 24.09 0.19 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.439 0.759 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.58 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.7 m-85 -149.55 10.82 0.76 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.131 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 22.4 t80 -174.74 128.81 0.32 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.806 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 70.4 m -131.68 113.56 13.73 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.505 ' NE2' ' OH ' ' A' ' 32' ' ' TYR . 1.2 tt0 -89.61 151.01 22.13 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 124.67 1.231 . . . . 0.0 112.693 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.8 m -105.72 111.34 23.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.555 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 116.386 -1.769 . . . . 0.0 109.95 179.74 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 3' ' ' SER . 10.4 tp60 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.411 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -132.3 163.92 27.59 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.754 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -53.33 141.71 23.45 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 58.34 22.88 9.87 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.729 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 153.48 19.69 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -81.7 115.58 21.01 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -94.67 -31.05 13.99 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.882 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.36 -174.32 22.8 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.47 -1.824 . . . . 0.0 112.377 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 117.81 129.08 4.08 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 10' ' ' GLY . 90.7 mt -40.55 154.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.457 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.7 31.29 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.661 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -87.45 141.78 28.37 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.318 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 14' ' ' SER . 54.2 p -138.62 56.29 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.0 177.32 23.53 Favored Glycine 0 N--CA 1.479 1.502 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.706 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.72 157.38 42.79 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.125 1.216 . . . . 0.0 109.747 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.1 p -118.99 2.79 11.52 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.015 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.09 108.59 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.596 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.9 156.93 37.62 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.871 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.83 170.19 2.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.188 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.35 155.43 37.37 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.821 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.03 37.11 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.296 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.11 169.33 12.9 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.42 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.47 154.71 42.53 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.459 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -80.18 141.76 35.37 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.544 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -137.17 107.5 6.44 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.59 115.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.432 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -52.3 8.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -153.43 176.12 2.62 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.424 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.5 Cg_exo -69.0 24.25 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.771 0.981 . . . . 0.0 112.007 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.7 m-85 -149.65 14.75 0.85 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.08 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -173.13 130.76 0.48 Allowed 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.399 -1.32 . . . . 0.0 111.748 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -136.89 111.62 8.76 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -96.53 147.79 23.49 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.847 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 70.8 m -101.63 111.53 23.81 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.413 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 116.381 -1.771 . . . . 0.0 109.772 -179.469 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 172.53 6.76 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.431 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 15.7 t-160 -55.75 128.04 32.94 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.548 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.7 m-85 75.93 23.89 1.28 Allowed 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.975 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.02 140.32 14.81 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.042 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.3 114.89 5.7 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.667 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.6 p -101.57 -24.69 14.09 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.22 16.58 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.592 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.58 130.66 5.43 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.7 mt -44.87 154.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.333 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.77 -16.16 21.85 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.634 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -91.19 131.17 36.9 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.397 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 p -127.02 51.49 1.87 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.089 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.56 174.15 20.85 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.95 156.62 23.15 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.217 1.278 . . . . 0.0 110.415 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 62.4 p -121.66 15.26 11.05 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.845 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -80.44 119.27 29.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.4 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 24' ' ' THR . 8.0 m -83.17 141.57 31.84 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.9 149.02 1.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.965 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -51.69 143.18 13.2 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.522 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.57 -20.09 46.65 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.004 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -121.15 167.14 12.99 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.982 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -135.77 166.76 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.594 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -85.43 124.91 32.56 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.729 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -115.4 109.96 18.65 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.8 110.43 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.817 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 29' ' ' ASN . 6.1 tp -72.12 -59.37 2.77 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.009 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -141.79 175.6 2.9 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.87 24.38 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.59 0.86 . . . . 0.0 111.415 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.5 m-85 -148.4 11.82 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.493 ' C ' ' HG ' ' A' ' 33' ' ' SER . 50.3 t80 -169.83 136.26 1.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.078 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.493 ' HG ' ' C ' ' A' ' 32' ' ' TYR . 16.3 m -143.26 113.34 7.2 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.154 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -98.4 149.0 23.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.879 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.1 m -84.58 115.56 22.69 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.919 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 116.321 -1.8 . . . . 0.0 110.269 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' ALA . 8.9 tp60 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.777 0.322 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.73 170.28 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.576 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.65 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.8 t-160 -52.25 150.15 4.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.362 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.65 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 56.6 m-85 56.99 11.94 1.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.71 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.55 156.37 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.469 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.49 109.78 10.49 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.04 -22.89 16.54 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.248 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.0 -179.91 25.28 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 118.932 -1.604 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 127.74 2.86 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.355 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.4 mt -48.9 148.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.486 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.54 54.75 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.998 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -79.64 147.45 32.03 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.308 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -137.24 44.13 2.3 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.77 175.24 20.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.18 160.7 25.5 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.176 1.251 . . . . 0.0 110.573 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -121.12 21.91 11.1 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.699 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.43 113.51 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.885 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.66 150.05 46.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.339 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -54.05 141.38 28.61 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.105 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ALA . 4.5 m -42.33 139.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 -25.13 29.01 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.09 167.24 11.65 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.374 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.472 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.7 OUTLIER -131.04 -177.59 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.542 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -102.14 125.85 48.95 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.022 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.472 HE22 ' CB ' ' A' ' 24' ' ' THR . 24.4 mp0 -124.68 121.89 35.96 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.492 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.22 146.67 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.16 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -56.38 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -153.68 177.47 1.96 Allowed Pre-proline 0 N--CA 1.508 2.455 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 Cg_exo -68.43 23.5 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.88 1.053 . . . . 0.0 112.066 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.5 m-85 -153.73 14.08 0.48 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.101 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -172.53 127.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.812 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.1 m -127.17 114.16 17.32 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.04 159.85 20.13 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.699 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -100.58 125.85 47.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.86 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.157 -178.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.545 ' H ' ' HG ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -94.27 -166.69 1.53 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.612 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.651 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.2 t-160 -73.5 139.47 45.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.217 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.4 m-85 66.51 20.81 10.85 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.65 155.46 20.5 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.42 102.66 6.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.615 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.09 -10.12 34.39 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.599 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.26 179.23 38.55 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 117.867 -2.111 . . . . 0.0 111.947 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.06 153.72 8.04 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.7 mt -67.39 151.95 10.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.282 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.04 -5.18 20.02 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.775 -1.202 . . . . 0.0 111.516 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.6 126.27 37.61 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.605 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.4 p -120.27 36.22 4.62 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.34 -178.18 21.93 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.739 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.36 162.15 15.26 Favored 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.375 1.384 . . . . 0.0 109.69 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 p -132.38 5.67 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.044 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 124.48 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.764 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 24' ' ' THR . 61.8 m -77.53 156.28 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -62.8 165.37 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -56.17 150.22 14.57 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.925 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.58 -22.57 2.67 Favored Glycine 0 N--CA 1.48 1.624 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.986 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -105.64 158.48 16.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.956 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.431 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -131.58 174.22 10.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.535 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -100.41 127.07 46.83 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.392 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.875 HE22 ' H ' ' A' ' 36' ' ' LEU . 4.1 mp0 -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.41 108.49 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.06 -46.74 67.07 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.284 -1.366 . . . . 0.0 107.508 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -163.56 173.75 3.95 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.457 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.88 24.64 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.817 0 C-N-CA 121.238 1.292 . . . . 0.0 113.199 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.3 m-85 -152.39 18.35 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.459 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.466 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 43.9 t80 -175.51 135.2 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.574 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -138.42 112.4 8.49 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.049 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.466 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -92.14 146.29 23.84 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.608 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.7 m -85.48 116.53 23.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.145 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.875 ' H ' HE22 ' A' ' 26' ' ' GLN . 70.8 mt . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.633 HE22 ' N ' ' A' ' 8' ' ' CYS . 1.2 tt0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.17 176.46 5.24 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.699 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -61.46 140.37 58.08 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.8 m-85 69.88 11.62 7.78 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.98 155.5 34.98 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.528 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.588 ' C ' HE22 ' A' ' 2' ' ' GLN . 42.1 tt0 -78.06 104.97 8.97 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.66 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.633 ' N ' HE22 ' A' ' 2' ' ' GLN . 1.6 p -89.79 -16.23 30.67 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.53 -156.74 9.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 117.862 -2.114 . . . . 0.0 112.425 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.27 144.46 16.94 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.196 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.16 153.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.292 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.38 79.79 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.087 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.12 109.64 13.72 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.886 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.5 p -109.05 21.23 17.45 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.275 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.27 178.99 42.03 Favored Glycine 0 N--CA 1.483 1.789 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.691 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.31 157.17 51.54 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.347 1.365 . . . . 0.0 109.79 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.4 p -119.79 8.46 11.15 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.804 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.62 109.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.224 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.9 m -69.11 168.62 13.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.69 174.86 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -68.4 140.92 55.83 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -11.36 52.22 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.575 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -107.23 169.12 8.76 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.179 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.5 177.37 7.98 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -100.32 147.84 25.35 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.539 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' OE1' ' N ' ' A' ' 36' ' ' LEU . 24.9 mp0 -145.2 125.38 13.74 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.035 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.23 110.28 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.572 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.98 -58.31 3.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.105 -1.438 . . . . 0.0 108.248 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.7 p30 -151.22 174.37 3.62 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.919 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 6.8 Cg_exo -64.73 24.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 120.952 1.101 . . . . 0.0 113.509 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.8 m-85 -153.95 20.48 0.51 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.02 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -175.24 131.24 0.29 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.318 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.9 m -131.57 106.75 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.957 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -86.25 153.25 22.14 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.775 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.46 128.19 43.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.629 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 75.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.079 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.49 174.02 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.811 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.64 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.8 t-160 -53.77 135.11 41.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 61.7 m-85 69.53 18.73 7.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.98 142.07 18.9 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.85 120.27 19.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.6 -15.53 14.4 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.922 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 -155.91 7.4 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 118.095 -2.003 . . . . 0.0 112.151 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.46 128.21 3.74 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.9 mt -46.67 152.25 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.699 -1.2 . . . . 0.0 110.506 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.25 -7.36 78.75 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.61 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -97.11 130.65 44.36 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.755 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 14' ' ' SER . 54.4 p -124.86 61.09 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.88 177.97 23.0 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.02 155.22 45.93 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.105 1.203 . . . . 0.0 110.414 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.7 p -118.34 32.66 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.73 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -105.07 123.52 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.943 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 24' ' ' THR . 58.8 m -88.24 143.25 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.847 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 168.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.765 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 p -59.13 144.7 44.91 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.064 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.22 -15.42 53.92 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.907 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.0 166.27 11.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.681 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.408 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -136.55 175.25 9.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.97 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -96.73 121.1 38.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.606 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -121.39 132.6 54.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.37 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -85.95 143.02 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.578 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.462 HD21 HD22 ' A' ' 29' ' ' ASN . 6.1 tp -107.86 -59.91 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -139.44 175.14 3.44 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.97 24.65 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.538 0.825 . . . . 0.0 111.073 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' ASN . 82.9 m-85 -150.6 10.16 0.64 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -163.67 122.06 1.93 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.537 -1.265 . . . . 0.0 112.229 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -131.29 112.64 12.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.099 -1.04 . . . . 0.0 109.466 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -91.09 153.41 20.11 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.662 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -92.9 112.56 24.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.157 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.355 -179.165 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 163.87 31.71 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.01 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.6 t-160 -47.08 137.37 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.472 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 49.3 m-85 62.47 34.23 15.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.9 150.03 18.19 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.364 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.69 102.55 10.79 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.285 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -89.9 -25.14 21.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.298 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.78 -176.27 25.16 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.363 -1.875 . . . . 0.0 112.305 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.95 133.74 4.05 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.5 mt -44.92 148.11 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.336 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.02 -17.4 22.64 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.775 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -80.37 139.43 36.54 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.422 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -131.5 10.13 4.76 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.998 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 177.9 46.76 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.779 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.52 155.29 69.67 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.488 1.459 . . . . 0.0 110.807 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.4 p -111.62 30.15 7.22 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.887 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.93 111.47 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.434 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -77.47 145.87 36.79 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -44.52 144.17 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.891 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -48.86 141.02 7.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.131 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -27.11 22.12 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.967 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -110.21 169.86 8.45 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.424 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 154.78 47.77 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.603 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.8 t -75.24 143.2 43.2 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.091 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -143.06 106.72 4.63 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.117 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.39 131.29 5.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.954 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -101.2 -48.95 4.23 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.8 p30 -162.18 170.4 7.96 Favored Pre-proline 0 CA--C 1.565 1.556 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.666 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.9 Cg_exo -67.72 25.06 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.708 0.939 . . . . 0.0 112.798 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 71.0 m-85 -155.27 16.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.506 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 54.9 t80 -175.18 132.39 0.31 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.689 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -135.8 113.94 11.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.894 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.6 tp-100 -94.69 149.04 21.65 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.396 1.06 . . . . 0.0 112.072 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.3 m -104.89 122.62 46.18 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.88 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 116.351 -1.785 . . . . 0.0 109.988 -179.242 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 3' ' ' SER . 0.3 OUTLIER -99.33 171.84 7.72 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.774 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -56.65 158.18 4.76 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 78.1 m-85 48.89 18.21 0.19 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.466 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -89.64 153.73 23.47 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.863 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -80.22 110.7 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.011 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.65 -15.57 23.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.57 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 -176.46 26.53 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 118.429 -1.843 . . . . 0.0 112.14 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.25 143.21 5.33 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.88 142.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.117 -1.433 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.51 -5.84 63.01 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.497 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.39 108.3 17.78 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 p -101.88 46.68 0.92 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.009 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.84 166.01 15.37 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.568 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.39 162.81 0.78 Allowed 'Trans proline' 0 C--O 1.207 -1.067 0 C-N-CA 121.265 1.31 . . . . 0.0 110.206 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 p -125.61 -3.72 7.22 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.683 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 t -78.57 122.89 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.208 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -77.2 154.91 32.63 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.077 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.9 163.48 3.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.916 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -60.27 155.74 17.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.605 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -6.86 24.73 Favored Glycine 0 N--CA 1.481 1.679 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.452 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -129.43 163.79 25.07 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.666 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.63 176.74 8.19 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.788 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.43 141.65 29.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.931 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.85 112.21 9.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.671 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.91 113.05 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.057 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 tp -78.21 -56.74 4.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.302 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.4 m-80 -150.09 174.19 3.69 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.2 23.63 0.22 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.493 0.795 . . . . 0.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -144.62 8.03 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.528 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -169.51 132.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.104 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -141.16 108.96 5.66 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.028 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -85.27 157.94 20.45 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.731 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 6' ' ' GLY . 1.5 m -101.53 115.43 30.49 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.375 -1.774 . . . . 0.0 109.344 179.556 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.9 -176.55 3.21 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.647 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.9 t-160 -60.75 136.11 57.97 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.222 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 35.4 m-85 68.67 13.0 8.86 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 123.39 0.431 . . . . 0.0 110.127 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 154.95 34.9 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.435 -1.364 . . . . 0.0 111.797 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -82.28 118.95 23.51 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.878 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -111.05 -16.14 13.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.484 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.69 -162.15 10.87 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.156 -1.973 . . . . 0.0 112.315 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.23 138.54 10.16 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.452 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.8 mt -49.61 146.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.884 -1.127 . . . . 0.0 110.027 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.86 14.45 64.94 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.009 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -121.19 119.76 33.27 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.021 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.2 p -117.42 57.9 0.8 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.594 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.36 174.76 22.73 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.514 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.0 154.67 49.28 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.244 1.296 . . . . 0.0 110.137 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.1 p -112.64 5.23 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.709 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.69 116.29 20.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.989 -1.085 . . . . 0.0 109.323 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -83.31 164.57 19.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.327 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.57 156.6 10.39 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.8 m -58.62 144.45 43.04 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.781 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.03 -15.21 63.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.928 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -117.84 -177.86 3.35 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.682 -179.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.57 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -146.17 171.29 15.15 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.855 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -100.61 114.15 27.58 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.094 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.57 HE22 ' C ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -105.58 118.36 36.39 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.862 178.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.66 130.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.566 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.37 -56.43 2.94 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.146 -1.422 . . . . 0.0 109.144 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.2 p30 -154.39 176.53 2.44 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.131 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.98 25.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.958 1.106 . . . . 0.0 112.812 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -152.68 15.85 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.642 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -175.27 135.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.599 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.6 m -136.51 113.68 10.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -82.6 164.05 21.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.368 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 21.3 m -111.26 112.94 25.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.714 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 116.472 -1.728 . . . . 0.0 110.189 -179.927 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.61 174.68 8.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.9 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.636 ' ND1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -50.91 144.18 9.0 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.178 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CE2' ' ND1' ' A' ' 4' ' ' HIS . 25.7 m-85 62.65 15.41 7.99 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.177 -177.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.4 150.6 31.85 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.737 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -85.3 103.8 14.57 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.05 -16.79 29.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.255 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.93 -176.34 29.87 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.305 -1.902 . . . . 0.0 112.359 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.54 130.57 3.31 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 120.056 -1.068 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mt -46.9 148.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.252 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.2 -9.16 27.9 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.369 -1.396 . . . . 0.0 111.05 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -88.78 130.32 35.39 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 p -130.19 62.35 1.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.38 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.3 173.41 23.04 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.79 154.55 12.38 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 N-CA-C 109.473 -1.01 . . . . 0.0 109.473 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.0 p -122.06 18.14 10.84 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.817 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -91.82 125.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.424 -0.91 . . . . 0.0 108.904 178.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 67.2 m -80.87 157.14 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.392 -179.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.98 151.97 11.0 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 m -56.93 139.68 51.0 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.031 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.29 -20.1 39.29 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.28 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -112.21 161.59 16.4 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.35 30.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 t -80.74 107.39 13.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.164 -179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -106.84 108.88 20.6 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.274 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -49.65 141.37 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.458 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -106.05 -57.82 1.99 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.49 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.4 p30 -155.76 172.32 6.16 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.121 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.94 23.76 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 120.972 1.115 . . . . 0.0 113.127 -176.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 29' ' ' ASN . 66.4 m-85 -154.16 18.07 0.49 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.183 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 40.8 t80 -174.45 128.24 0.34 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.399 -177.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m -125.59 115.74 20.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.4 tp60 -93.32 150.62 20.34 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.198 0.937 . . . . 0.0 112.691 -177.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 m -102.24 116.26 32.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.133 -178.651 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -136.26 171.59 14.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.044 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -57.15 149.37 19.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 50.0 m-85 53.72 26.74 6.19 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.221 -178.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.67 149.8 17.39 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.824 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.7 117.61 18.5 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -105.81 -24.98 12.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.763 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.77 -154.09 6.56 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.592 -1.766 . . . . 0.0 112.23 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 151.6 23.2 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -178.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -61.83 153.37 5.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.945 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.54 35.27 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.801 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -88.58 135.64 33.39 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -133.96 41.24 3.02 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.47 173.69 16.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.37 158.33 23.19 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.379 1.386 . . . . 0.0 110.095 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -127.36 29.4 5.55 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.976 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.46 109.45 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.194 178.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' C ' ' A' ' 24' ' ' THR . 52.4 m -70.87 157.01 38.87 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.085 -178.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.56 169.49 0.2 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.5 m -63.64 143.24 57.99 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.923 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.51 -15.47 40.75 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.429 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.34 169.27 8.99 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.709 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.446 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.591 179.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 t -92.75 142.87 26.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.292 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -139.31 123.98 18.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.906 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.79 131.59 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.988 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.96 -57.26 2.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.7 m-80 -143.1 173.54 4.44 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.454 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 5.0 Cg_exo -70.1 25.11 0.18 Allowed 'Trans proline' 0 C--O 1.212 -0.787 0 CA-C-N 119.319 0.792 . . . . 0.0 111.107 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.56 ' H ' ' C ' ' A' ' 29' ' ' ASN . 72.0 m-85 -152.06 20.87 0.67 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.206 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 62.3 t80 -175.46 125.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.71 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 m -130.92 113.96 14.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.175 177.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 9.2 tt0 -101.36 159.53 15.19 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.914 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -97.03 128.63 44.18 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.051 179.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.109 -178.501 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 162.77 25.93 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.484 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 11.5 t-160 -51.3 128.69 22.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.371 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.485 ' C ' HE21 ' A' ' 34' ' ' GLN . 54.8 m-85 72.22 20.31 4.21 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 123.912 0.758 . . . . 0.0 109.78 -178.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.55 154.98 22.45 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.92 117.13 21.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.125 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -107.91 -15.91 14.43 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.96 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.27 -178.6 24.42 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 118.0 -2.047 . . . . 0.0 111.729 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.78 154.01 7.81 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.84 137.67 22.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.045 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.86 -20.6 11.77 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.572 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 16' ' ' PRO . 53.2 t80 -69.26 100.37 1.31 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.6 p -92.01 16.04 12.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.592 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.41 177.46 50.28 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.729 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.7 Cg_endo -61.41 153.98 62.14 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.578 1.519 . . . . 0.0 110.243 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -119.89 20.03 12.28 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.31 -177.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.51 112.22 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.352 178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.92 175.31 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -75.27 173.72 10.48 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.115 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.4 m -66.52 143.74 56.89 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.917 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.09 -15.81 19.88 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.972 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -106.32 162.43 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.494 -179.846 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 166.81 22.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.867 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.1 127.01 43.8 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.264 -179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -126.74 117.32 22.45 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.753 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.27 136.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.164 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -53.46 3.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.566 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -153.42 177.07 2.1 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.44 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.53 24.17 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.534 0.822 . . . . 0.0 111.156 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.566 ' H ' ' C ' ' A' ' 29' ' ' ASN . 37.1 m-85 -151.0 0.15 0.39 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.756 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -159.83 138.21 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.426 -178.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 m -135.7 118.71 16.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.227 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.485 HE21 ' C ' ' A' ' 5' ' ' TYR . 1.2 tt0 -96.16 146.12 24.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.497 1.123 . . . . 0.0 113.16 -177.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 8.8 m -95.52 116.49 28.9 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 116.413 -1.756 . . . . 0.0 110.055 -179.922 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.58 -179.61 3.73 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.426 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.637 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.3 t-160 -66.99 142.37 57.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 72.9 m-85 59.65 27.84 17.15 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.345 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.62 156.37 20.64 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.999 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -86.87 117.09 25.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.157 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -102.32 -21.87 14.23 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.776 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.37 -169.13 15.51 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.473 -179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.76 132.47 5.52 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 13' ' ' TYR . 97.7 mt -50.23 155.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.45 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.17 -18.45 13.51 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.191 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 11' ' ' ILE . 44.9 t80 -82.7 148.11 28.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.978 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 p -141.1 11.07 2.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.514 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.66 -175.81 49.46 Favored Glycine 0 N--CA 1.478 1.473 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.16 154.2 70.46 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.525 1.483 . . . . 0.0 109.866 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -115.9 15.44 16.27 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.53 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.41 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.679 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -73.62 149.58 41.94 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.547 -179.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.5 165.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.306 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.5 m -62.08 141.23 58.23 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.75 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.86 72.91 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.724 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.37 178.51 6.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.368 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.63 173.98 11.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.754 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 t -100.08 129.91 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.194 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.41 117.4 22.09 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.816 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.19 142.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.079 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.5 -56.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.209 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.3 m-80 -144.01 175.41 2.84 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.36 24.64 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 CA-C-N 119.126 0.723 . . . . 0.0 111.356 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.7 m-85 -148.24 6.15 0.76 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -162.85 139.64 7.58 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.218 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -143.97 114.39 7.53 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.474 176.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -88.07 164.07 15.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.101 -178.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -108.48 118.23 36.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.416 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 116.325 -1.798 . . . . 0.0 109.641 -179.889 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 4.1 tp60 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.491 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -141.66 174.1 10.88 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.713 -179.735 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 20.4 t-160 -53.83 135.32 42.02 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.109 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.457 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 52.1 m-85 60.22 23.83 13.2 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.441 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.17 143.47 16.17 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 22.7 tt0 -67.43 111.62 4.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.347 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.92 -21.84 18.38 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.488 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.06 -175.14 24.17 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 118.321 -1.895 . . . . 0.0 112.342 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.21 137.69 4.81 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -47.9 151.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.167 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.08 7.36 66.68 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.957 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.54 128.0 44.7 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -119.87 56.56 0.95 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.015 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.81 179.96 18.35 Favored Glycine 0 N--CA 1.487 2.081 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.969 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.34 158.4 55.3 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.69 1.593 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -121.96 11.75 10.35 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.555 -178.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.27 117.2 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.107 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 24' ' ' THR . 97.6 m -77.24 145.06 37.78 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.492 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.84 163.2 5.93 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.841 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 m -54.44 147.28 14.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.25 -18.8 38.92 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.069 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -122.3 172.44 8.31 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.493 0.663 . . . . 0.0 111.218 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.46 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -149.22 162.4 40.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.378 179.718 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.67 136.2 33.12 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.448 -178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -130.22 116.54 18.55 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.172 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.23 118.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.561 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.6 -57.66 3.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.16 178.37 1.64 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.476 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -69.76 24.01 0.17 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.734 0.956 . . . . 0.0 111.132 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.582 ' H ' ' C ' ' A' ' 29' ' ' ASN . 76.7 m-85 -152.16 11.35 0.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 33' ' ' SER . 4.7 t80 -173.15 138.56 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.682 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 66.9 m -139.71 115.9 10.46 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.239 178.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 1.7 tt0 -90.77 152.5 20.77 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.916 -176.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.21 103.17 14.62 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.31 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.364 -1.779 . . . . 0.0 109.562 179.301 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 -179.48 5.11 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 19.0 t-160 -67.64 136.24 54.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 45.1 m-85 65.81 20.54 11.45 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.37 148.85 19.1 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.44 115.28 16.03 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 17' ' ' THR . 5.8 p -95.5 -19.06 20.14 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.379 179.127 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.55 -170.26 27.12 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.237 -1.935 . . . . 0.0 112.656 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.66 134.41 4.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mt -43.88 142.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.667 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.42 -17.54 53.69 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.687 -1.244 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.7 159.82 22.51 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.636 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 p -144.33 3.57 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.949 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.0 173.34 39.5 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.624 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.51 165.1 8.18 Favored 'Trans proline' 0 C--O 1.209 -0.959 0 C-N-CA 121.596 1.531 . . . . 0.0 110.215 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -128.17 14.45 6.73 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.14 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.8 114.73 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.662 178.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 24' ' ' THR . 64.2 m -77.28 147.43 36.29 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.329 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.23 170.34 0.22 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -60.53 148.18 38.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.614 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.97 44.49 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.379 179.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.19 165.45 17.57 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.458 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.443 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -143.49 165.91 26.26 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.608 179.825 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.2 t -82.28 128.06 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.75 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -120.72 115.51 23.46 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.094 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.93 121.41 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.599 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tp -90.22 -57.35 2.87 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.753 -1.179 . . . . 0.0 109.427 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.8 p30 -157.49 176.84 2.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.032 -178.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 4.1 Cg_exo -66.58 27.6 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 120.958 1.106 . . . . 0.0 112.989 -177.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.8 m-85 -154.75 14.84 0.42 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.947 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -174.87 140.7 0.57 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.661 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -143.9 113.25 6.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.11 158.27 17.37 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.794 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -99.77 112.82 25.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.007 178.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.236 179.669 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.01 -174.92 3.1 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.743 -178.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.657 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 21.5 t-160 -61.65 158.07 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.079 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.0 m-85 48.7 21.53 0.43 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.561 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 155.46 19.12 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.598 -1.287 . . . . 0.0 111.962 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -83.66 121.02 26.7 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.163 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -107.46 -27.96 10.11 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.656 179.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.38 -148.97 4.87 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.222 -1.942 . . . . 0.0 112.872 -178.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.04 134.25 7.58 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -178.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.1 mt -51.37 152.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.976 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -11.29 47.87 Favored Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.346 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -86.26 130.5 34.5 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.6 p -121.09 62.32 0.89 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.624 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.84 -175.74 19.16 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.642 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.69 159.2 53.75 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.493 1.462 . . . . 0.0 109.909 179.05 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -122.66 30.94 6.26 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.581 -178.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.42 116.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.394 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.2 m -82.01 155.79 24.98 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.09 151.66 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.341 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -49.56 141.77 9.02 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.077 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 -26.44 21.1 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.093 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.51 165.81 12.36 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.102 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.91 160.16 39.45 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.764 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.42 102.31 5.92 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.229 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -95.48 108.99 21.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.606 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.7 135.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.412 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.19 -55.5 2.46 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.8 p30 -154.14 173.42 4.73 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.436 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -66.87 24.99 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.504 0.859 . . . . 0.0 112.035 -177.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.577 ' H ' ' C ' ' A' ' 29' ' ' ASN . 47.4 m-85 -150.38 -5.65 0.32 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.611 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -152.54 132.41 13.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.409 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -127.79 112.28 14.6 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.925 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -89.83 155.33 19.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.121 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -99.83 113.2 25.56 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.533 178.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 116.385 -1.769 . . . . 0.0 109.934 179.206 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -177.42 3.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.88 -179.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 14.0 t-160 -70.27 127.93 34.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.606 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 68.5 m-85 79.87 18.32 0.7 Allowed 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.052 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.1 154.46 20.5 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.869 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.85 114.33 17.7 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.453 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -99.26 -19.25 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.98 -167.02 13.51 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.276 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.95 146.91 10.38 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.6 mt -59.34 153.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.094 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -12.81 39.87 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.101 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -88.19 152.97 21.6 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.642 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.4 p -148.59 13.32 0.93 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.944 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.81 -172.73 43.97 Favored Glycine 0 N--CA 1.483 1.783 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.76 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.76 160.44 32.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.306 1.337 . . . . 0.0 110.252 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -128.96 27.62 5.41 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.059 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -105.7 120.42 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.99 178.684 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.4 m -80.27 145.48 32.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.986 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -50.1 145.24 6.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.74 178.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -50.01 141.67 10.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.007 -179.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.45 -26.89 22.62 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.339 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.1 p -105.92 -173.46 2.3 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.28 157.37 43.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.724 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.79 136.25 33.06 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.428 -1.309 . . . . 0.0 109.301 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -136.53 120.62 17.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.392 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.24 118.46 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.639 178.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.411 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -84.28 -56.82 3.44 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.674 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.3 p30 -149.06 171.59 6.13 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.08 26.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 119.41 0.825 . . . . 0.0 111.95 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 83.3 m-85 -154.39 14.97 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -173.8 126.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.403 -177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -126.85 111.49 14.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.665 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.767 1.292 . . . . 0.0 112.561 -176.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.9 m -99.66 105.94 17.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.998 179.331 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 116.269 -1.824 . . . . 0.0 109.823 179.705 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.416 ' H ' ' HG ' ' A' ' 3' ' ' SER . 0.3 OUTLIER -109.69 170.45 8.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.694 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.5 t-160 -40.98 130.29 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 42.8 m-85 68.53 40.75 1.85 Allowed 'General case' 0 N--CA 1.511 2.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.26 -178.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.12 152.62 17.3 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.78 100.85 11.19 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.161 179.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.85 -17.51 27.96 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.802 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.43 -159.21 8.75 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.944 -2.074 . . . . 0.0 112.675 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 106.09 124.57 5.33 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -178.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 10' ' ' GLY . 96.4 mt -41.67 147.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.966 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.52 31.6 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.879 -1.153 . . . . 0.0 111.411 -179.247 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.32 114.11 21.63 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 p -108.11 17.47 22.27 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.78 176.73 42.96 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.594 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.64 158.65 44.96 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.453 1.435 . . . . 0.0 110.234 179.389 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -119.22 16.4 13.16 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.582 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -95.03 118.78 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.459 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 m -84.99 152.93 23.1 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.076 -1.049 . . . . 0.0 109.949 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.7 137.0 58.17 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ALA . 3.3 m -41.36 145.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.39 -24.02 30.06 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -120.98 -171.63 2.23 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.558 0.694 . . . . 0.0 110.473 179.69 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.88 162.12 41.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.92 136.53 34.05 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.904 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -132.64 139.07 47.57 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.499 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.98 123.29 35.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -88.1 -56.39 3.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.87 174.78 3.57 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.04 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.4 Cg_exo -64.78 24.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.211 -0.825 0 C-N-CA 121.005 1.137 . . . . 0.0 112.769 -179.138 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.2 m-85 -154.9 14.03 0.4 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.204 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HH ' ' CD ' ' A' ' 34' ' ' GLN . 24.7 t80 -172.43 125.79 0.51 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.701 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 72.2 m -126.84 115.43 19.31 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.342 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' CD ' ' HH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -93.92 149.32 21.34 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.669 -177.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.0 m -103.42 117.2 33.91 Favored 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.066 179.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 36' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 116.308 -1.805 . . . . 0.0 110.173 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.696 HE22 ' N ' ' A' ' 8' ' ' CYS . 3.1 tt0 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 160.28 32.86 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.956 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.654 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 18.7 t-160 -46.62 132.67 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.37 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 25.2 m-85 72.58 24.62 2.8 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 2' ' ' GLN . . . -92.44 144.54 17.16 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.111 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.512 ' C ' HE22 ' A' ' 2' ' ' GLN . 38.1 tt0 -76.13 96.37 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.614 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.696 ' N ' HE22 ' A' ' 2' ' ' GLN . 1.8 p -88.56 -12.0 44.0 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.663 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.53 -160.96 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.047 -2.025 . . . . 0.0 112.181 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.26 149.64 23.11 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.489 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 12' ' ' GLY . 81.9 mt -69.73 157.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.455 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 11' ' ' ILE . . . 73.74 -3.29 35.91 Favored Glycine 0 N--CA 1.484 1.89 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.338 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 16.7 t80 -85.1 154.24 22.18 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -146.8 57.26 1.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.463 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.64 177.26 24.15 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.331 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.48 164.64 6.92 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.13 1.22 . . . . 0.0 109.799 179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 29.8 p -127.15 29.33 5.61 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.326 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.89 120.9 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.913 179.131 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 24' ' ' THR . 10.3 m -77.67 142.33 38.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.6 168.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.04 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.11 149.99 46.49 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.512 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.1 -15.14 57.07 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.497 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.545 ' H ' ' HG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -114.9 -175.2 2.64 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.032 -179.715 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.653 ' HG1' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -150.96 162.46 40.77 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.53 179.631 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.2 t -92.37 124.61 36.55 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.494 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.653 ' NE2' ' HG1' ' A' ' 24' ' ' THR . 28.9 mp0 -125.42 128.52 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.787 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.59 142.12 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -56.72 2.22 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 10.3 p30 -161.36 171.87 6.39 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -67.25 24.24 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.601 0.867 . . . . 0.0 112.817 -176.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 62.3 m-85 -150.54 14.21 0.76 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.502 ' HH ' ' CG ' ' A' ' 34' ' ' GLN . 6.0 t80 -175.34 134.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 -179.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -132.74 114.33 14.02 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.502 ' CG ' ' HH ' ' A' ' 32' ' ' TYR . 49.9 tt0 -90.62 156.08 18.38 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.986 -176.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.2 m -104.04 131.03 51.71 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.048 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 70.6 mt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 116.404 -1.76 . . . . 0.0 109.875 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.46 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -175.71 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.123 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.635 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 23.1 t-160 -68.06 147.51 52.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 54.4 m-85 55.52 26.13 8.67 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.444 -177.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.93 145.92 18.07 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -77.05 116.94 18.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -17.37 14.49 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.816 179.715 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.48 -168.54 15.51 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 118.641 -1.743 . . . . 0.0 111.873 -179.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.81 133.91 5.59 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.0 mt -46.55 147.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.01 -179.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.41 -11.42 24.71 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.816 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -82.37 110.65 17.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 p -111.43 59.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.432 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.81 179.46 18.2 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.713 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.18 149.06 91.96 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.432 1.421 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.2 p -110.61 -12.6 14.32 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.536 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 t -76.77 108.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.43 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.65 156.86 38.93 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.664 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -52.92 152.3 4.06 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.224 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.11 152.24 4.38 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.94 -17.04 55.36 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.745 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -120.77 -179.94 4.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.227 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 163.25 37.4 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.085 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -89.72 138.37 31.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.534 -179.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -130.96 106.08 8.17 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.074 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.36 114.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -79.09 -51.82 9.04 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.51 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 p30 -158.68 174.78 3.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.202 -179.051 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.57 24.87 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.01 1.14 . . . . 0.0 113.213 -176.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' ASN . 93.5 m-85 -152.33 10.2 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.703 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -169.67 134.4 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.053 -178.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -138.07 113.73 9.7 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.452 177.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.61 163.54 15.78 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.862 -178.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.1 m -107.35 115.02 29.43 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.363 179.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.198 -179.804 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.4 tp60 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 179.07 5.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.6 t-160 -55.42 145.47 22.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.336 -0.946 . . . . 0.0 108.8 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 48.7 m-85 60.46 29.59 19.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.61 155.11 20.46 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.81 -179.064 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 57.5 tt0 -89.82 104.54 17.1 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.357 179.455 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.11 -22.67 21.66 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.132 179.557 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.65 19.19 Favored Glycine 0 N--CA 1.486 1.984 0 C-N-CA 118.241 -1.933 . . . . 0.0 112.323 -178.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.52 136.49 4.64 Favored Glycine 0 C--O 1.211 -1.313 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mt -48.06 142.03 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.554 -179.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.2 65.5 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.844 179.606 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 87.9 t80 -95.97 100.45 12.12 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.531 179.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -97.43 40.75 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.254 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.03 169.88 13.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.27 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -51.05 149.78 14.71 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.199 1.266 . . . . 0.0 109.899 179.482 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -111.84 -12.13 13.84 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -82.28 125.72 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.776 -1.169 . . . . 0.0 109.666 179.161 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.7 m -80.34 160.49 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.076 179.611 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -62.09 175.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.508 -179.926 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.6 m -62.63 144.79 55.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.251 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.27 60.03 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.667 -1.254 . . . . 0.0 112.435 178.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.35 166.47 13.49 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.603 -179.655 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.36 158.52 44.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -82.14 132.16 35.24 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.274 -179.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -127.57 119.25 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.104 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.67 122.3 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.595 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -53.28 4.13 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.459 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -154.23 175.02 3.3 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.754 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -72.75 23.27 0.29 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 120.512 0.808 . . . . 0.0 110.716 -179.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.1 m-85 -150.63 13.09 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.867 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -174.16 126.65 0.35 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.836 -178.84 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -128.68 112.66 14.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.103 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.13 149.82 22.3 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.597 -176.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.7 m -105.51 110.59 22.98 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.409 179.566 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.388 -1.768 . . . . 0.0 109.857 -179.359 . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 033 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.53 175.95 5.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.662 -178.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.579 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.7 t-160 -52.01 136.12 29.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.464 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.9 m-85 70.53 25.03 4.33 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.885 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.51 149.13 19.06 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.821 -1.181 . . . . 0.0 111.441 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.62 111.27 17.76 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.629 179.698 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.4 p -103.45 -12.76 16.95 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.08 -163.55 14.31 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 118.451 -1.833 . . . . 0.0 112.083 -179.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.0 133.35 8.04 Favored Glycine 0 N--CA 1.48 1.628 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.54 -179.634 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -50.6 154.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.014 -1.074 . . . . 0.0 109.696 -179.765 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.04 81.34 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.148 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CZ ' ' CA ' ' A' ' 15' ' ' GLY . 21.2 t80 -105.63 153.29 22.01 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.148 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 p -136.42 2.06 2.69 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.479 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' CZ ' ' A' ' 13' ' ' TYR . . . -93.97 178.59 37.67 Favored Glycine 0 CA--C 1.551 2.294 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.584 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.41 161.78 29.84 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.189 1.926 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 33.7 p -116.44 25.46 10.6 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.846 -178.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.07 116.63 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.875 179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.22 149.44 25.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.56 150.51 12.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.013 179.58 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -53.46 160.24 1.26 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.481 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.7 -20.15 9.93 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.069 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.83 163.43 23.61 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.668 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -135.84 173.82 11.29 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.821 179.214 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -87.09 148.81 25.08 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.371 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . 0.448 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 29.5 mp0 -143.64 124.54 14.3 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.558 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.56 113.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.167 179.04 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.406 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -81.97 -57.05 3.58 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.797 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -150.69 171.86 5.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.346 179.579 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -66.07 24.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.739 0.959 . . . . 0.0 113.123 -177.028 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.3 m-85 -155.58 16.63 0.39 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.903 178.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.443 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 52.9 t80 -171.65 121.8 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.571 -176.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -118.44 111.81 19.15 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.656 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.443 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 6.0 tp60 -90.51 144.02 26.19 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.448 -177.559 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.6 m -87.85 115.13 25.09 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 116.391 -1.766 . . . . 0.0 110.197 -178.356 . . . . . . . . 0 0 . 1 . 034 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -93.46 -167.43 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.153 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.636 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -66.71 132.12 47.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.649 -179.466 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.5 m-85 71.35 29.35 2.77 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.518 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.01 154.62 20.25 Favored Glycine 0 N--CA 1.481 1.693 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.54 117.3 25.23 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.2 p -102.7 -33.16 9.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.624 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 33' ' ' SER . . . -152.42 -178.75 27.4 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 117.433 -2.318 . . . . 0.0 113.828 -177.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.81 151.57 8.23 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.32 149.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.07 8.13 Favored Glycine 0 C--N 1.296 -1.663 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.211 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -82.38 138.17 34.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.561 179.578 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -136.53 40.13 2.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.462 -179.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.44 176.3 16.27 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.9 155.95 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 N-CA-C 109.407 -1.036 . . . . 0.0 109.407 179.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 38.8 p -117.89 32.64 6.04 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.869 -178.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.96 119.13 60.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.843 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.7 m -80.02 171.31 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.641 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -74.16 147.32 42.72 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.236 179.345 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 m -43.05 139.26 1.82 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.677 -179.579 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.43 -26.8 22.92 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.248 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -114.01 171.46 7.59 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.183 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 161.57 37.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.973 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.0 t -85.69 140.39 30.56 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.864 -179.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -137.19 117.47 13.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.56 126.33 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.568 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -57.64 2.3 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.03 177.03 2.05 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.065 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -67.43 24.08 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.774 0.983 . . . . 0.0 111.716 -178.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.568 ' H ' ' C ' ' A' ' 29' ' ' ASN . 98.3 m-85 -154.38 12.82 0.42 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.034 179.522 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -171.98 137.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.435 -178.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLY . 50.8 m -136.88 115.98 12.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.402 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 4.8 tp60 -89.64 155.69 19.07 Favored 'General case' 0 N--CA 1.51 2.563 0 O-C-N 124.119 0.887 . . . . 0.0 113.062 -176.795 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 8.6 m -105.85 106.09 16.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.459 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.502 2.155 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.705 179.918 . . . . . . . . 0 0 . 1 . 035 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.771 HE22 ' HH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.67 179.87 4.53 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.756 -179.706 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.7 t-160 -57.85 147.5 28.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 86.8 m-85 58.12 23.75 10.5 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.007 -178.884 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' CYS . . . -99.67 156.11 19.77 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.898 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.51 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 58.3 tt0 -83.85 110.06 18.06 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.416 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' O ' ' CG2' ' A' ' 17' ' ' THR . 3.4 p -96.24 -19.61 19.18 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.207 179.046 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.84 -149.96 5.28 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.47 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.11 126.09 5.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.3 mt -48.61 149.6 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.526 -179.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.28 -13.55 20.38 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.771 ' HH ' HE22 ' A' ' 2' ' ' GLN . 49.4 t80 -70.46 153.5 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.231 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -143.47 52.89 1.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.687 -179.573 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.01 174.3 23.72 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.442 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.12 163.64 5.92 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.072 1.181 . . . . 0.0 109.795 179.073 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 74.9 p -127.4 15.65 7.14 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.971 -178.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.21 115.61 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.926 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ALA . 54.0 m -79.99 130.13 35.03 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.537 -179.217 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' SER . . . -41.12 132.01 2.54 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.978 179.625 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -40.07 144.85 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.57 -179.683 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.88 30.78 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.72 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.82 176.96 5.69 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.2 167.84 20.52 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.675 179.209 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.65 106.32 18.3 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.653 -179.117 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -106.77 136.68 46.18 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.264 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.77 104.2 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.926 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.06 -57.86 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -146.03 173.42 4.27 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.073 178.31 . . . . . . . . 3 3 . 1 . 035 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.405 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.41 23.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.413 0.742 . . . . 0.0 111.99 -177.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 29' ' ' ASN . 34.2 m-85 -147.56 7.62 0.87 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.239 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.569 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 73.2 t80 -163.62 112.76 1.26 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.163 -178.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -115.87 114.29 24.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.982 177.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.569 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 18.0 tt0 -94.65 166.95 11.76 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.488 -177.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 6' ' ' GLY . 13.9 m -100.44 108.31 20.27 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.826 179.722 . . . . . . . . 2 2 . 1 . 035 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.229 -1.844 . . . . 0.0 109.951 -179.634 . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 036 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.69 -175.42 3.89 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.408 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.631 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.5 t-160 -71.39 154.38 41.61 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.056 179.725 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 63.4 m-85 51.18 18.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.697 -178.338 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.66 155.67 22.21 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.165 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -83.27 110.86 18.44 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.644 179.666 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.78 -26.23 17.06 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.868 179.495 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.14 -151.36 5.62 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.343 -1.884 . . . . 0.0 112.601 -178.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 150.42 18.78 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.16 149.73 9.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.33 -179.439 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.18 -4.09 42.41 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.676 -1.249 . . . . 0.0 111.313 -179.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -80.44 125.56 30.09 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.1 p -117.53 58.91 0.79 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.149 179.678 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.03 21.42 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.322 -179.562 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -68.44 159.77 51.99 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.758 1.638 . . . . 0.0 110.506 179.458 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -120.23 12.63 11.83 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.569 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.62 116.54 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.116 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -79.11 149.41 32.07 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.199 -179.765 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.0 146.69 41.71 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.09 179.757 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -43.09 149.66 0.21 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.599 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.89 68.46 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.298 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -134.04 178.83 6.65 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.095 -179.971 . . . . . . . . 3 3 . 1 . 036 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.63 168.69 19.55 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.677 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -89.87 136.44 33.04 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.914 -179.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -128.27 133.1 48.71 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.147 -179.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.11 108.32 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.633 179.041 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.69 -51.03 38.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.557 -179.359 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.4 p30 -159.54 173.87 4.52 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.843 -179.122 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.444 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.1 Cg_exo -66.34 24.93 0.1 OUTLIER 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 120.909 1.073 . . . . 0.0 113.106 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 29' ' ' ASN . 99.3 m-85 -152.75 19.37 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.468 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -175.99 130.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.094 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.1 m -132.57 112.04 11.74 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.834 177.166 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -93.73 157.77 15.99 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.071 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.3 m -102.39 121.14 41.73 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.145 179.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 116.132 -1.89 . . . . 0.0 109.567 -179.949 . . . . . . . . 0 0 . 1 . 037 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 7' ' ' GLN . 11.7 tp60 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 164.71 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.937 -178.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.621 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -44.73 159.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.159 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.621 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 67.3 m-85 47.57 19.37 0.14 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.727 -179.511 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.25 154.39 20.44 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.736 -178.707 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 39.7 tt0 -78.17 108.49 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.367 179.755 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -92.61 -24.72 18.6 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.794 179.386 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.26 -157.03 7.66 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.253 -178.763 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 113.94 126.38 4.35 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.876 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 10' ' ' GLY . 17.4 mt -40.41 145.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.62 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.9 -1.04 56.29 Favored Glycine 0 CA--C 1.544 1.903 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.795 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -91.43 101.3 13.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.424 179.693 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.6 p -95.1 55.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.07 171.76 22.0 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.228 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.68 161.9 13.97 Favored 'Trans proline' 0 C--O 1.205 -1.162 0 C-N-CA 121.756 1.637 . . . . 0.0 110.415 179.593 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -131.33 20.14 4.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.712 -178.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.21 116.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.379 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.06 144.07 29.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.149 -179.529 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.34 169.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.5 p -67.07 143.45 56.7 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.474 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.79 -17.36 45.83 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.39 169.9 8.7 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.515 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.53 160.03 41.8 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.223 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.3 t -79.97 116.73 20.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.114 -179.269 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -113.99 136.16 53.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.394 179.19 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -83.43 132.09 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.2 m-80 -149.74 173.33 4.36 Favored Pre-proline 0 N--CA 1.495 1.811 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.876 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 3.7 Cg_exo -70.42 23.88 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.539 0.826 . . . . 0.0 111.39 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.547 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.0 m-85 -152.88 20.17 0.59 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.661 179.305 . . . . . . . . 2 2 . 1 . 037 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -173.96 129.76 0.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.6 m -136.79 119.45 16.07 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.549 177.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -99.81 158.28 15.91 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.431 -178.464 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 m -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 116.415 -1.755 . . . . 0.0 110.066 -178.681 . . . . . . . . 0 0 . 1 . 038 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 3.7 tp60 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.42 174.77 8.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.415 -179.87 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.615 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.3 t-160 -55.17 134.08 49.37 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.801 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.2 m-85 69.23 -3.48 1.54 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -61.45 152.75 41.02 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.765 179.715 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -84.61 111.93 19.98 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.72 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.416 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.7 p -89.69 -34.42 16.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.937 179.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.8 -155.54 6.75 Favored Glycine 0 N--CA 1.48 1.569 0 C-N-CA 118.303 -1.903 . . . . 0.0 112.395 -178.797 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.31 152.52 14.67 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.456 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 11.0 mt -60.87 146.9 10.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.917 -179.309 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.48 -8.76 52.85 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.736 -179.909 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.479 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 52.2 t80 -82.64 119.21 23.99 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.865 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -113.04 57.62 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.329 179.791 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.27 21.6 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -69.19 157.14 62.62 Favored 'Trans proline' 0 C--O 1.21 -0.907 0 C-N-CA 121.818 1.679 . . . . 0.0 110.596 179.55 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 47.7 p -115.87 13.31 16.01 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.716 -178.281 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.31 110.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.663 179.322 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -77.01 149.56 35.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.877 -179.067 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 155.98 0.34 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.239 179.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -52.64 144.8 13.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.428 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.06 -25.15 10.52 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.673 178.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.46 173.86 6.14 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.726 -179.462 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.64 170.14 17.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.65 140.99 28.96 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -141.9 113.88 8.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.43 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.86 111.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.87 -48.97 50.96 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.021 -1.471 . . . . 0.0 107.651 179.299 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.6 p30 -163.27 175.09 3.0 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.655 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 6.3 Cg_exo -65.93 28.9 0.1 OUTLIER 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 121.001 1.134 . . . . 0.0 113.6 -177.278 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' ASN . 70.7 m-85 -154.48 13.78 0.43 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.144 178.425 . . . . . . . . 2 2 . 1 . 038 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -175.35 133.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.747 -178.544 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -131.54 109.07 9.99 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.487 177.286 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -86.82 153.18 21.85 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.72 -177.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 m -97.4 115.33 27.54 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.847 178.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 116.403 -1.76 . . . . 0.0 110.329 -179.879 . . . . . . . . 0 0 . 1 . 039 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 1.3 tp60 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.37 166.34 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.405 -179.214 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.0 t-160 -48.56 139.67 9.02 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.56 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 79.8 m-85 58.21 30.13 18.98 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.297 -178.491 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.59 148.34 18.59 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.976 -178.98 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -75.81 102.39 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.694 179.643 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -91.21 -14.25 31.34 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.054 179.389 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.08 -154.29 6.92 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.423 -1.846 . . . . 0.0 112.378 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 137.23 8.69 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.813 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.04 145.21 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.79 4.72 89.52 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.594 -179.575 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 87.4 t80 -100.25 113.64 26.49 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.222 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 p -111.05 46.5 1.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.718 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.79 172.89 16.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.31 155.89 54.36 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.837 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -117.01 20.34 13.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.647 -178.536 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.46 120.82 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.305 178.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.0 m -83.19 156.47 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.774 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.47 152.95 20.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.706 179.395 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.72 144.98 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.72 -12.02 69.97 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.373 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -127.03 163.68 23.21 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.722 -179.699 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.22 158.92 39.27 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.179 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -89.53 131.87 35.35 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.775 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -131.48 119.05 21.03 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.159 179.663 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -54.29 117.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.664 179.668 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -82.3 -58.01 3.12 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -179.923 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.16 176.75 2.2 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.327 . . . . . . . . 3 3 . 1 . 039 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -67.99 24.56 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.056 1.171 . . . . 0.0 112.047 -178.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 29' ' ' ASN . 88.9 m-85 -155.01 15.03 0.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.043 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' OH ' ' CD ' ' A' ' 34' ' ' GLN . 21.2 t80 -174.17 124.42 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.062 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 22.3 m -124.98 115.44 20.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.948 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 5.4 tp60 -94.34 151.69 19.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.733 -176.251 . . . . . . . . 2 2 . 1 . 039 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.3 m -100.98 107.21 18.62 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.515 179.061 . . . . . . . . 1 1 . 1 . 039 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.413 -1.755 . . . . 0.0 109.943 -179.615 . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 040 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.457 ' H ' ' HG ' ' A' ' 3' ' ' SER . 2.6 p -99.73 -172.95 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.867 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.61 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 22.8 t-160 -61.8 160.71 11.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.312 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.61 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 81.9 m-85 47.09 19.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.631 -1.227 . . . . 0.0 109.125 -178.046 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.486 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -87.09 154.06 26.11 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.62 -178.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -89.13 114.72 26.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.381 179.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -103.05 -21.51 13.91 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.093 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.32 -153.32 6.49 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 118.175 -1.964 . . . . 0.0 112.765 -179.145 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 139.3 10.41 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 12' ' ' GLY . 90.9 mt -51.32 151.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.069 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 11' ' ' ILE . . . 80.68 -15.98 16.97 Favored Glycine 0 C--N 1.296 -1.676 0 C-N-CA 119.508 -1.329 . . . . 0.0 111.032 -179.701 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -82.06 124.5 29.88 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.394 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -120.55 37.29 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.12 -175.5 17.94 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.133 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.28 158.71 56.38 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 121.798 1.665 . . . . 0.0 110.493 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 p -122.23 31.09 6.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.544 -0.863 . . . . 0.0 112.012 -178.184 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -111.52 117.07 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.733 178.707 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 4.3 m -85.32 142.17 29.53 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -49.13 146.93 3.22 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.358 179.851 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -47.3 153.84 0.46 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.733 -179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.3 -26.11 12.77 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -119.59 171.97 7.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.129 179.779 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 155.91 43.31 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.88 179.265 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 14.8 t -70.71 130.33 41.46 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.733 -178.801 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.43 103.07 6.93 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.228 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.02 128.14 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.673 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.78 -56.45 3.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.337 . . . . . . . . 3 3 . 1 . 040 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.28 171.44 6.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.256 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 3.4 Cg_exo -67.81 24.79 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.36 0.807 . . . . 0.0 112.26 -177.341 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' ASN . 84.9 m-85 -151.27 11.91 0.63 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.87 178.861 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -171.88 131.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.649 -178.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.0 m -131.7 113.49 13.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.656 178.153 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -98.45 161.07 13.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.482 1.113 . . . . 0.0 111.464 -178.001 . . . . . . . . 1 1 . 1 . 040 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.3 m -111.94 121.54 45.3 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.073 179.311 . . . . . . . . 2 2 . 1 . 040 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 116.236 -1.84 . . . . 0.0 109.872 -179.684 . . . . . . . . 0 0 . 1 . 041 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -171.32 1.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.905 -179.45 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 4' ' ' HIS . . . . . 0.678 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 23.0 t-160 -59.11 164.87 2.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.553 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.678 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 30.7 m-85 47.82 23.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.538 -178.272 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -86.01 157.58 30.95 Favored Glycine 0 N--CA 1.484 1.874 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.069 -179.06 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 2' ' ' GLN . 50.8 tt0 -93.69 106.07 18.06 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.147 -179.049 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -91.9 -19.04 22.9 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.735 -1.186 . . . . 0.0 110.777 179.997 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.45 -161.63 10.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.174 -1.965 . . . . 0.0 112.288 -179.381 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 110.35 127.32 5.24 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' GLY . 78.5 mt -44.96 154.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.028 -179.379 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 -12.84 25.17 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.037 -178.187 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 11' ' ' ILE . 58.6 t80 -89.46 110.03 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.785 -179.982 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.5 p -109.86 30.65 6.5 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.553 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.4 -179.05 24.98 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.93 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.5 150.12 63.22 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.487 1.458 . . . . 0.0 109.761 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.5 p -106.92 11.62 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.926 -178.001 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.53 116.28 28.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ALA . 16.4 m -83.1 139.23 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.094 179.847 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -40.73 147.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.604 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.19 153.65 1.91 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.36 -20.66 32.8 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.429 179.197 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.18 174.21 6.35 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.946 -0.701 . . . . 0.0 111.004 -179.609 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -179.59 5.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.443 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -99.85 139.43 35.54 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.206 -179.356 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.18 113.38 8.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.217 179.531 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.07 138.37 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 -60.87 1.63 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.511 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -145.5 175.42 2.76 Favored Pre-proline 0 N--CA 1.505 2.275 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.63 . . . . . . . . 3 3 . 1 . 041 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.478 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -70.08 22.35 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.616 0.877 . . . . 0.0 111.851 -178.413 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.9 m-85 -155.81 19.11 0.38 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.549 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -172.8 127.54 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.816 -178.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.3 m -130.46 113.0 13.76 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.574 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.11 156.88 16.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.06 0.85 . . . . 0.0 112.224 -176.84 . . . . . . . . 1 1 . 1 . 041 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.4 m -106.19 130.92 53.97 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 041 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.76 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.259 0.552 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -143.5 149.0 36.88 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.034 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.89 173.98 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.304 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.644 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.0 t-160 -47.84 158.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.695 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.5 m-85 46.91 23.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.341 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.06 135.12 11.96 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.308 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -65.16 100.98 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.36 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -89.86 -16.6 29.76 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.612 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.6 -179.79 31.85 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 118.514 -1.803 . . . . 0.0 111.537 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.66 131.69 3.33 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 87.3 mt -48.25 148.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.604 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.14 -14.46 14.89 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.611 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -79.39 138.64 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.022 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.8 p -137.71 63.12 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.6 178.99 21.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.91 166.11 7.35 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.8 p -135.15 0.43 2.84 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.83 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -80.68 112.42 18.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.495 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.8 m -71.21 147.02 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.353 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 142.19 49.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.163 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -44.95 146.22 0.84 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.55 -25.76 27.0 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.33 163.0 17.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.476 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.4 OUTLIER -126.64 169.71 12.84 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.812 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.7 t -95.34 120.56 35.79 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.038 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.488 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 22.5 mp0 -110.72 113.78 26.65 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.746 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.27 106.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.312 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.97 -54.06 14.98 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.034 -1.067 . . . . 0.0 109.184 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 m-80 -150.2 174.59 3.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.534 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -68.59 24.36 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 120.837 1.024 . . . . 0.0 112.208 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.29 17.56 0.48 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.452 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 42.8 t80 -170.21 131.97 1.02 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.975 -178.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 m -142.66 110.82 6.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.16 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.455 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 0.6 OUTLIER -99.2 145.28 27.4 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.099 -177.805 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.0 m -84.43 118.72 24.44 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.559 -179.189 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.425 ' HG1' ' H2 ' ' A' ' 1' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -82.87 153.54 25.07 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.709 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -172.29 2.22 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.193 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.7 t-160 -67.24 149.68 50.09 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 44.9 m-85 54.28 25.79 6.21 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.913 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.9 150.21 18.66 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.737 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.5 109.64 10.39 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.612 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -96.4 -25.46 15.7 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.694 179.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.44 -153.27 6.31 Favored Glycine 0 N--CA 1.48 1.597 0 C-N-CA 118.279 -1.915 . . . . 0.0 112.131 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.31 132.47 7.5 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -48.0 149.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.756 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.31 -0.4 87.76 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.056 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.62 139.19 33.07 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -131.07 31.2 4.47 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.585 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.18 175.82 16.9 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.51 160.58 23.5 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.515 1.477 . . . . 0.0 110.333 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.4 p -124.59 22.15 8.37 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.586 -178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.93 108.61 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.718 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -75.71 147.2 39.56 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.43 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.26 152.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.726 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 m -56.51 139.54 49.09 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.927 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.18 32.49 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.527 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -105.13 161.57 14.14 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.881 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -129.18 162.86 26.82 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.29 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.4 t -90.76 116.91 28.98 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.04 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 22.0 mp0 -107.39 107.74 18.77 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.463 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.63 120.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 118.719 -1.193 . . . . 0.0 108.666 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -81.14 -62.11 1.76 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -178.639 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.55 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.9 m-80 -141.04 175.32 3.15 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.44 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 4.3 Cg_exo -69.03 23.51 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.1 0.714 . . . . 0.0 111.712 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.55 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.1 m-85 -155.26 21.64 0.42 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.987 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 16.5 t80 -173.68 130.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.099 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.9 m -134.07 116.26 15.26 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.471 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.494 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tt0 -98.75 154.38 18.03 Favored 'General case' 0 N--CA 1.513 2.69 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.636 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 67.7 m -92.37 120.44 32.89 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.602 178.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.482 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 90.5 mt . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.197 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.68 HE22 ' N ' ' A' ' 7' ' ' GLN . 3.2 tt0 -109.53 -174.04 2.4 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.348 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -179.15 4.23 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.817 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.8 t-160 -54.83 150.97 9.1 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 19.6 m-85 52.89 17.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.351 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -81.35 134.18 12.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.696 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.68 ' N ' HE22 ' A' ' 2' ' ' GLN . 30.6 tt0 -69.99 101.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.31 -18.37 28.65 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.026 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.37 -172.04 22.57 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.445 -1.836 . . . . 0.0 112.314 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.96 126.48 4.55 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 96.9 mt -44.51 153.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.978 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.95 -12.84 52.03 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.701 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -90.14 146.94 23.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.049 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 p -140.27 22.78 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.808 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.39 177.36 24.86 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.84 159.8 16.74 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.485 1.457 . . . . 0.0 110.447 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.3 p -124.56 26.09 7.36 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.16 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.92 114.8 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.081 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -79.27 133.98 36.65 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.326 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.42 159.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.323 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.52 155.67 9.23 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.923 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.28 -15.68 32.96 Favored Glycine 0 N--CA 1.482 1.728 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.522 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 167.03 14.37 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.27 164.97 25.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.727 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.98 113.29 24.93 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.27 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -104.13 126.1 50.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.73 140.9 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.902 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.456 ' CD2' HD22 ' A' ' 29' ' ' ASN . 10.5 tp -108.14 -60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.858 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -149.15 175.89 2.53 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.8 24.4 0.15 Allowed 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 120.902 1.068 . . . . 0.0 111.67 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.549 ' H ' ' C ' ' A' ' 29' ' ' ASN . 96.2 m-85 -147.39 9.99 0.96 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.074 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 75.3 t80 -169.96 138.96 1.81 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.413 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -150.03 113.24 4.89 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.1 tt0 -95.98 150.53 20.36 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.156 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.7 m -89.36 115.96 27.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.479 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.501 -179.398 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 7.0 tp60 -104.62 148.69 26.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.432 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -178.66 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.599 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.646 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.8 t-160 -59.73 150.4 27.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 82.2 m-85 56.96 9.75 0.67 Allowed 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.856 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.33 155.29 24.14 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.176 -1.488 . . . . 0.0 112.116 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.489 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 39.9 tt0 -76.63 122.28 24.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.78 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -108.71 -23.48 11.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.57 -157.56 8.06 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 117.866 -2.111 . . . . 0.0 112.735 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 146.63 13.12 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.9 mt -59.51 154.65 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.131 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.77 -5.92 21.45 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.762 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -94.0 112.97 24.87 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.735 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -110.6 55.36 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.283 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.35 -179.64 16.42 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.64 154.09 67.59 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.365 1.377 . . . . 0.0 110.409 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 16.4 p -127.5 28.1 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.207 -178.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.03 109.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.803 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.9 m -78.76 137.59 37.82 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.324 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.42 150.04 1.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.74 154.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.314 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.1 -15.71 58.93 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.585 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.64 176.24 7.94 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.528 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 163.16 33.65 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.49 116.55 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.131 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.56 140.41 41.95 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.846 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.47 117.67 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.551 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.61 -62.54 1.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -144.63 176.07 2.44 Favored Pre-proline 0 N--CA 1.501 2.076 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.0 Cg_exo -69.21 23.63 0.16 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 120.674 0.916 . . . . 0.0 111.841 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASN . 80.0 m-85 -155.39 19.89 0.41 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.873 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -173.0 117.83 0.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.452 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.6 m -119.91 111.83 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.525 178.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.96 157.93 17.01 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.349 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.5 m -100.77 121.77 42.25 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.887 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.12 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.71 HE22 ' HH ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -81.24 -163.91 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.425 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.47 177.9 7.97 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.874 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 10.7 t-160 -60.04 133.08 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 4' ' ' HIS . 27.5 m-85 66.77 22.84 10.23 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.32 155.37 19.87 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.222 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 54.0 tt0 -79.81 120.75 24.49 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -108.97 -27.33 9.73 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.613 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.46 -151.57 5.53 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.347 -1.882 . . . . 0.0 112.328 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 141.85 12.61 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.69 151.62 5.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.716 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.75 -15.06 44.38 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.25 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.71 ' HH ' HE22 ' A' ' 2' ' ' GLN . 45.2 t80 -82.87 138.64 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.471 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -131.22 27.17 4.83 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.25 -176.79 21.42 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.91 155.61 68.55 Favored 'Trans proline' 0 C--O 1.211 -0.842 0 C-N-CA 121.699 1.599 . . . . 0.0 110.865 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 57.1 p -117.29 7.55 12.92 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.34 -178.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -90.19 113.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.335 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 m -82.59 148.41 28.03 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.945 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.25 139.83 8.14 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.014 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -47.21 141.83 4.25 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.88 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.77 -27.25 21.29 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.607 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -112.87 158.96 19.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 157.99 36.89 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.454 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.7 t -87.77 111.42 21.34 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.132 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -107.33 117.79 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.116 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -53.08 132.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.333 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.51 -51.32 4.81 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.341 -1.344 . . . . 0.0 107.797 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.0 p30 -161.52 172.98 5.05 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.3 Cg_exo -66.94 24.93 0.11 Allowed 'Trans proline' 0 C--O 1.214 -0.706 0 CA-C-N 119.366 0.809 . . . . 0.0 112.533 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.72 14.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.176 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 30.6 t80 -172.47 130.16 0.56 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.906 -177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.8 m -130.17 116.23 18.15 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.468 177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.458 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tp-100 -100.09 150.16 22.76 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.452 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.9 m -97.19 116.59 29.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.784 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 116.306 -1.807 . . . . 0.0 109.982 -179.456 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -127.34 -170.16 2.17 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.087 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.28 177.77 7.58 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.001 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.9 t-160 -59.94 132.32 53.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 26.5 m-85 67.98 26.38 7.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.69 153.65 17.88 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.13 108.22 13.55 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -97.53 -21.7 16.95 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.864 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.44 -155.09 6.61 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 118.544 -1.788 . . . . 0.0 111.831 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 144.77 12.58 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.2 mt -60.57 148.51 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.995 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.9 -12.23 30.82 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.627 -1.273 . . . . 0.0 111.042 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -78.16 120.87 23.58 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.4 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.41 ' O ' ' OG ' ' A' ' 14' ' ' SER . 48.0 p -114.51 58.18 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.367 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.13 170.55 25.91 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.777 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.25 153.62 38.95 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.339 1.359 . . . . 0.0 110.052 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -119.56 33.3 5.68 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.609 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.9 107.15 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.116 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.7 m -74.94 143.61 43.62 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.769 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.446 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.69 148.22 0.78 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.683 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -53.08 160.5 1.01 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.121 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.29 -18.45 23.24 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -124.18 163.63 21.16 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.092 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.01 160.73 31.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.339 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -88.13 117.85 27.3 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.422 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -115.27 116.11 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.422 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.23 129.01 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.372 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -87.3 -51.36 6.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.578 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.37 176.08 2.84 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.2 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.429 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.0 Cg_exo -68.27 24.62 0.14 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.601 0.867 . . . . 0.0 111.459 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.578 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.0 m-85 -150.52 10.34 0.65 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.739 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -173.65 127.73 0.41 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.594 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 21.7 m -125.32 115.67 20.71 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.884 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -100.32 158.4 15.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.95 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 61.1 m -98.28 123.24 42.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 116.361 -1.781 . . . . 0.0 110.289 -178.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.978 0.418 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' A' ' 3' ' ' SER . 5.6 tp60 -104.34 -175.95 2.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.418 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.73 -172.58 2.41 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.647 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.61 149.94 46.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 67.5 m-85 53.59 18.05 1.34 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.681 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 152.78 21.53 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.806 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -81.65 119.43 23.81 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.55 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -107.73 -21.96 12.66 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -169.43 15.83 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.211 -1.947 . . . . 0.0 112.427 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 143.28 9.03 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.9 mt -54.64 154.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.998 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.31 -11.7 48.89 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -95.56 129.56 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.304 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.5 p -137.92 57.94 1.7 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.662 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.32 -177.28 15.4 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.43 157.6 14.46 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.797 0.998 . . . . 0.0 109.664 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.4 p -131.83 26.47 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.487 -178.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.97 115.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.484 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.71 161.26 30.44 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.788 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.9 171.18 0.98 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.294 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -63.77 141.57 58.72 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.11 -5.72 84.64 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.584 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -124.05 165.09 18.09 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.15 -179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -140.37 162.1 36.12 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.014 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.6 t -90.27 113.32 25.14 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.513 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 29.1 mp0 -105.46 125.61 51.18 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.952 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.31 126.21 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.553 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -89.13 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.706 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.0 p30 -155.61 178.59 1.6 Allowed Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.804 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 5.4 Cg_exo -67.6 23.4 0.12 Allowed 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 120.989 1.126 . . . . 0.0 113.116 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.485 ' H ' ' C ' ' A' ' 29' ' ' ASN . 81.6 m-85 -154.62 16.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.072 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -174.69 133.72 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.541 -1.264 . . . . 0.0 111.767 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m -136.06 113.17 10.47 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.385 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 5' ' ' TYR . 5.0 tp60 -89.56 153.71 20.56 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 20.4 m -106.69 114.14 28.07 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.168 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.449 -1.739 . . . . 0.0 109.821 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -89.19 144.25 26.25 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.795 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.02 -170.58 2.14 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.171 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.62 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.4 t-160 -61.16 135.03 57.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.466 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 68.8 m-85 70.17 24.01 5.04 Favored 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.22 153.85 23.86 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.741 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 60.8 tt0 -90.19 111.13 22.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.691 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -97.95 -21.14 17.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.603 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 -156.32 7.38 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 117.938 -2.077 . . . . 0.0 112.526 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.1 131.1 6.86 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.517 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.6 mt -46.58 145.95 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.51 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.79 9.66 84.23 Favored Glycine 0 C--N 1.292 -1.889 0 C-N-CA 119.582 -1.295 . . . . 0.0 111.202 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 80.6 t80 -110.8 126.28 54.45 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.6 p -120.5 11.02 11.28 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.43 -176.41 50.47 Favored Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -69.54 161.16 46.99 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.575 1.517 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 p -120.54 38.02 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.06 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.1 110.98 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -75.17 157.69 34.2 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.097 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -72.59 149.96 43.51 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.842 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -44.49 142.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.712 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -24.45 32.15 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.348 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -116.16 176.68 4.99 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.139 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.19 152.61 39.5 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.626 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.1 t -80.37 127.99 33.03 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.606 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -136.97 126.84 25.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.63 134.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.217 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.23 -47.67 5.37 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.9 p30 -162.64 171.81 6.06 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.308 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -67.75 24.56 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 CA-C-N 119.624 0.902 . . . . 0.0 112.26 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' H ' ' C ' ' A' ' 29' ' ' ASN . 57.5 m-85 -153.39 16.13 0.53 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.28 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -174.8 125.47 0.28 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.837 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -127.06 113.23 16.16 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.123 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 -93.09 149.77 20.99 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.192 -177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 32.1 m -102.95 110.04 21.81 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.646 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.505 2.322 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.165 -179.985 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.457 ' H2 ' ' HG1' ' A' ' 1' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 2.4 tp-100 -131.07 165.98 22.06 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.594 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -168.11 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.186 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.645 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.2 t-160 -73.99 132.28 42.24 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.145 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 60.5 m-85 70.43 20.12 6.11 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.447 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.88 154.9 19.26 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.491 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -75.99 119.34 19.82 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.885 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -103.2 -29.7 11.13 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.554 178.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.71 -163.5 10.91 Favored Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.002 -1.57 . . . . 0.0 111.611 -179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 142.71 10.54 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 ' C ' ' H ' ' A' ' 13' ' ' TYR . 87.8 mt -50.17 156.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.618 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.55 -15.69 9.16 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.542 -179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 46.2 t80 -89.41 131.36 35.51 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.334 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 p -126.26 18.25 7.66 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.03 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.93 -178.35 33.39 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.768 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.04 153.09 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.591 1.527 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.9 p -117.5 27.37 9.11 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.467 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.36 122.23 54.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.931 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.98 163.72 18.73 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.843 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -68.28 154.59 41.45 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.67 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 m -45.1 141.35 2.36 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.035 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.82 -8.72 76.34 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.527 -1.32 . . . . 0.0 112.254 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -133.58 169.75 16.54 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.907 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.497 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.5 OUTLIER -145.16 171.81 14.0 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.491 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -92.23 144.94 24.9 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.263 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.497 HE22 ' C ' ' A' ' 24' ' ' THR . 28.9 mp0 -139.86 116.55 10.83 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.3 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.73 103.08 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.764 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.22 -52.03 65.39 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.827 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.533 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.92 174.52 3.72 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.179 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.421 ' O ' ' CD1' ' A' ' 11' ' ' ILE . 4.9 Cg_exo -66.97 24.65 0.11 Allowed 'Trans proline' 0 C--O 1.211 -0.839 0 C-N-CA 120.628 0.885 . . . . 0.0 112.84 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.6 m-85 -149.51 12.53 0.81 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.28 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.8 t80 -170.59 134.67 1.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.496 -179.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.8 m -135.98 110.53 8.58 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.584 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -87.48 154.42 20.65 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.598 -178.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.85 109.98 21.43 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.012 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.027 -179.016 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 11.7 pm0 -101.66 -164.52 1.11 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.538 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.93 -174.78 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.845 -178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.593 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.1 t-160 -57.38 140.66 49.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 52.4 m-85 65.64 18.18 11.13 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.01 157.03 34.9 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.82 116.34 27.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.418 ' HB3' HE21 ' A' ' 2' ' ' GLN . 1.1 p -105.06 -21.69 13.23 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.747 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.83 -166.06 13.02 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 118.329 -1.891 . . . . 0.0 113.163 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.28 144.81 13.62 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.424 HG21 ' H ' ' A' ' 12' ' ' GLY . 35.1 mt -61.63 156.49 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.333 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.424 ' H ' HG21 ' A' ' 11' ' ' ILE . . . 75.62 -2.12 55.08 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.485 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.614 ' HH ' ' N ' ' A' ' 16' ' ' PRO . 29.5 t80 -86.26 132.46 33.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.976 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 p -129.91 36.38 4.05 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.524 ' C ' ' HH ' ' A' ' 13' ' ' TYR . . . -121.34 -174.22 14.79 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.212 -0.994 . . . . 0.0 110.771 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.614 ' N ' ' HH ' ' A' ' 13' ' ' TYR . 1.6 Cg_endo -66.93 153.96 76.18 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.754 1.636 . . . . 0.0 111.211 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.512 ' H ' ' HG1' ' A' ' 17' ' ' THR . 7.7 p -104.34 -6.08 21.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.745 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.35 122.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.609 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 20' ' ' ALA . 92.2 m -84.13 148.46 26.78 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.618 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -39.96 140.14 0.59 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.583 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -49.9 140.0 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.93 13.71 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.5 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -102.69 -170.73 1.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.888 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.43 173.15 12.54 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.4 t -100.12 116.58 32.48 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.868 HE22 ' H ' ' A' ' 36' ' ' LEU . 3.6 mp0 -107.41 110.07 21.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.6 t -53.77 125.65 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.179 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -56.93 2.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.27 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.2 p30 -162.71 172.81 4.98 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 2.9 Cg_exo -66.07 25.37 0.1 OUTLIER 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.84 1.027 . . . . 0.0 113.124 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 29' ' ' ASN . 91.4 m-85 -153.72 13.53 0.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.16 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -175.31 137.57 0.39 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.793 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.7 m -136.41 114.4 11.37 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 40.6 tt0 -86.42 165.64 16.17 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.794 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 64.2 m -113.24 128.38 56.46 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.679 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.868 ' H ' HE22 ' A' ' 26' ' ' GLN . 93.8 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.48 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -83.95 167.32 17.06 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.258 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -162.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.444 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 19.6 t-160 -72.94 134.74 44.87 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.051 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 36.3 m-85 69.04 16.84 8.65 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.29 155.73 30.04 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.417 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -86.93 110.04 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -93.0 -17.98 23.24 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.939 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.62 -165.69 12.35 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 118.529 -1.796 . . . . 0.0 111.504 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.27 130.53 5.25 Favored Glycine 0 C--N 1.301 -1.415 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 47.9 mt -51.9 144.14 3.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.799 -1.161 . . . . 0.0 110.757 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.43 65.14 Favored Glycine 0 CA--C 1.548 2.095 0 C-N-CA 119.869 -1.158 . . . . 0.0 111.876 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 71.2 t80 -83.93 113.19 20.8 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.606 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -106.75 55.41 0.66 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.711 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.13 172.98 22.13 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.62 145.31 82.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.136 1.224 . . . . 0.0 110.832 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.3 p -107.18 30.49 6.16 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.03 -178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -116.06 119.7 62.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.661 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.1 m -79.63 164.64 23.64 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.64 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -65.68 168.08 8.2 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.979 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.02 147.94 52.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.777 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.05 26.61 Favored Glycine 0 C--N 1.297 -1.634 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -107.99 178.73 4.43 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.504 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.83 162.45 41.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.89 127.35 39.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.093 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.27 112.63 15.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.146 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.67 130.63 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.623 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -92.91 -54.98 3.52 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.58 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -154.53 175.34 3.14 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.416 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 4.7 Cg_exo -70.24 24.09 0.19 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.439 0.759 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.58 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.7 m-85 -149.55 10.82 0.76 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.131 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 22.4 t80 -174.74 128.81 0.32 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.806 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 70.4 m -131.68 113.56 13.73 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.505 ' NE2' ' OH ' ' A' ' 32' ' ' TYR . 1.2 tt0 -89.61 151.01 22.13 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 124.67 1.231 . . . . 0.0 112.693 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.8 m -105.72 111.34 23.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.555 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 116.386 -1.769 . . . . 0.0 109.95 179.74 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.411 ' HG3' ' H ' ' A' ' 3' ' ' SER . 10.4 tp60 -78.97 -168.43 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.411 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -132.3 163.92 27.59 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.754 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -53.33 141.71 23.45 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 58.34 22.88 9.87 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.729 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 153.48 19.69 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -81.7 115.58 21.01 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.8 OUTLIER -94.67 -31.05 13.99 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.882 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.36 -174.32 22.8 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.47 -1.824 . . . . 0.0 112.377 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 117.81 129.08 4.08 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 10' ' ' GLY . 90.7 mt -40.55 154.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.457 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.7 31.29 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.661 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -87.45 141.78 28.37 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.318 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 14' ' ' SER . 54.2 p -138.62 56.29 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.0 177.32 23.53 Favored Glycine 0 N--CA 1.479 1.502 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.706 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.72 157.38 42.79 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.125 1.216 . . . . 0.0 109.747 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.1 p -118.99 2.79 11.52 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.015 -178.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.09 108.59 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.596 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.9 156.93 37.62 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.871 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.456 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.83 170.19 2.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.188 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.35 155.43 37.37 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.821 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.03 37.11 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.296 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.456 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.11 169.33 12.9 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.42 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.47 154.71 42.53 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.459 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -80.18 141.76 35.37 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.544 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -137.17 107.5 6.44 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 t -60.59 115.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.432 -179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -52.3 8.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -153.43 176.12 2.62 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.424 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.5 Cg_exo -69.0 24.25 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.771 0.981 . . . . 0.0 112.007 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.7 m-85 -149.65 14.75 0.85 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.08 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -173.13 130.76 0.48 Allowed 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.399 -1.32 . . . . 0.0 111.748 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -136.89 111.62 8.76 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -96.53 147.79 23.49 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.847 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 70.8 m -101.63 111.53 23.81 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.413 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 116.381 -1.771 . . . . 0.0 109.772 -179.469 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -107.17 169.22 8.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.559 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 172.53 6.76 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.431 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 15.7 t-160 -55.75 128.04 32.94 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.548 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.7 m-85 75.93 23.89 1.28 Allowed 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.975 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.02 140.32 14.81 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.042 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.3 114.89 5.7 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.667 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.6 p -101.57 -24.69 14.09 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.22 16.58 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.592 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.58 130.66 5.43 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.7 mt -44.87 154.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.333 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.77 -16.16 21.85 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.634 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -91.19 131.17 36.9 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.397 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 p -127.02 51.49 1.87 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.089 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.56 174.15 20.85 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.95 156.62 23.15 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.217 1.278 . . . . 0.0 110.415 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 62.4 p -121.66 15.26 11.05 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.845 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -80.44 119.27 29.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.4 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 24' ' ' THR . 8.0 m -83.17 141.57 31.84 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.423 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.9 149.02 1.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.965 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -51.69 143.18 13.2 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.522 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.57 -20.09 46.65 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.004 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -121.15 167.14 12.99 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.982 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -135.77 166.76 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.594 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -85.43 124.91 32.56 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.729 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -115.4 109.96 18.65 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.8 110.43 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.817 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD21 HD22 ' A' ' 29' ' ' ASN . 6.1 tp -72.12 -59.37 2.77 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.009 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.586 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -141.79 175.6 2.9 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -68.87 24.38 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.59 0.86 . . . . 0.0 111.415 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.586 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.5 m-85 -148.4 11.82 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.493 ' C ' ' HG ' ' A' ' 33' ' ' SER . 50.3 t80 -169.83 136.26 1.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.078 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.493 ' HG ' ' C ' ' A' ' 32' ' ' TYR . 16.3 m -143.26 113.34 7.2 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.154 177.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -98.4 149.0 23.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.879 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.1 m -84.58 115.56 22.69 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.919 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 116.321 -1.8 . . . . 0.0 110.269 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' ALA . 8.9 tp60 -126.35 160.64 29.86 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.73 170.28 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.576 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.65 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.8 t-160 -52.25 150.15 4.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.362 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.65 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 56.6 m-85 56.99 11.94 1.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.71 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.55 156.37 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.469 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.49 109.78 10.49 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -97.04 -22.89 16.54 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.248 177.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.0 -179.91 25.28 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 118.932 -1.604 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 127.74 2.86 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.355 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.4 mt -48.9 148.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.486 -179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.54 54.75 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.998 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -79.64 147.45 32.03 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.308 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -137.24 44.13 2.3 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.77 175.24 20.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.18 160.7 25.5 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.176 1.251 . . . . 0.0 110.573 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 61.7 p -121.12 21.91 11.1 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.699 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.43 113.51 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.885 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.66 150.05 46.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.339 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -54.05 141.38 28.61 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.105 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ALA . 4.5 m -42.33 139.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 -25.13 29.01 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.09 167.24 11.65 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.374 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.472 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.7 OUTLIER -131.04 -177.59 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.542 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -102.14 125.85 48.95 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.022 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.472 HE22 ' CB ' ' A' ' 24' ' ' THR . 24.4 mp0 -124.68 121.89 35.96 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.492 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.22 146.67 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.16 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -56.38 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -153.68 177.47 1.96 Allowed Pre-proline 0 N--CA 1.508 2.455 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.167 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 Cg_exo -68.43 23.5 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.88 1.053 . . . . 0.0 112.066 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.5 m-85 -153.73 14.08 0.48 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.101 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -172.53 127.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.812 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.1 m -127.17 114.16 17.32 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.04 159.85 20.13 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.699 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -100.58 125.85 47.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.86 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.157 -178.978 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.201 0.524 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -97.91 152.48 19.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.109 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.545 ' H ' ' HG ' ' A' ' 3' ' ' SER . 0.1 OUTLIER -94.27 -166.69 1.53 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.612 -178.98 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.651 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.2 t-160 -73.5 139.47 45.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.217 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.4 m-85 66.51 20.81 10.85 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.65 155.46 20.5 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.42 102.66 6.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.615 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -94.09 -10.12 34.39 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.599 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.26 179.23 38.55 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 117.867 -2.111 . . . . 0.0 111.947 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.06 153.72 8.04 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 52.7 mt -67.39 151.95 10.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.282 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.04 -5.18 20.02 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.775 -1.202 . . . . 0.0 111.516 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.6 126.27 37.61 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.605 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.4 p -120.27 36.22 4.62 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.34 -178.18 21.93 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.739 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.36 162.15 15.26 Favored 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.375 1.384 . . . . 0.0 109.69 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.7 p -132.38 5.67 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.044 -177.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 124.48 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.764 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 24' ' ' THR . 61.8 m -77.53 156.28 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -62.8 165.37 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.562 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.486 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -56.17 150.22 14.57 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.925 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.58 -22.57 2.67 Favored Glycine 0 N--CA 1.48 1.624 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.986 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.486 ' H ' ' C ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -105.64 158.48 16.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.956 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.431 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -131.58 174.22 10.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.535 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -100.41 127.07 46.83 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.392 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.875 HE22 ' H ' ' A' ' 36' ' ' LEU . 4.1 mp0 -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.41 108.49 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.06 -46.74 67.07 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.284 -1.366 . . . . 0.0 107.508 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -163.56 173.75 3.95 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.457 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -66.88 24.64 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.817 0 C-N-CA 121.238 1.292 . . . . 0.0 113.199 -176.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.512 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.3 m-85 -152.39 18.35 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.459 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 43.9 t80 -175.51 135.2 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.574 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -138.42 112.4 8.49 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.049 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.466 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 0.7 OUTLIER -92.14 146.29 23.84 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.608 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.418 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.7 m -85.48 116.53 23.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.145 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.875 ' H ' HE22 ' A' ' 26' ' ' GLN . 70.8 mt . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.036 0.446 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.633 HE22 ' N ' ' A' ' 8' ' ' CYS . 1.2 tt0 -133.95 163.83 28.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.784 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.17 176.46 5.24 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.699 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -61.46 140.37 58.08 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.8 m-85 69.88 11.62 7.78 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.98 155.5 34.98 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.528 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.588 ' C ' HE22 ' A' ' 2' ' ' GLN . 42.1 tt0 -78.06 104.97 8.97 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.66 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.633 ' N ' HE22 ' A' ' 2' ' ' GLN . 1.6 p -89.79 -16.23 30.67 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.53 -156.74 9.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 117.862 -2.114 . . . . 0.0 112.425 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.27 144.46 16.94 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.196 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 85.9 mt -49.16 153.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.292 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.38 79.79 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.087 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.12 109.64 13.72 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.886 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.5 p -109.05 21.23 17.45 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.275 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.27 178.99 42.03 Favored Glycine 0 N--CA 1.483 1.789 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.691 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.31 157.17 51.54 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.347 1.365 . . . . 0.0 109.79 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.4 p -119.79 8.46 11.15 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.804 -177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.62 109.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.224 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.9 m -69.11 168.62 13.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.69 174.86 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -68.4 140.92 55.83 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -11.36 52.22 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.575 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.429 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -107.23 169.12 8.76 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.179 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.5 177.37 7.98 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -100.32 147.84 25.35 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.539 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' OE1' ' N ' ' A' ' 36' ' ' LEU . 24.9 mp0 -145.2 125.38 13.74 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.035 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.23 110.28 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.572 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.98 -58.31 3.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.105 -1.438 . . . . 0.0 108.248 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.7 p30 -151.22 174.37 3.62 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.919 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 6.8 Cg_exo -64.73 24.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 120.952 1.101 . . . . 0.0 113.509 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.8 m-85 -153.95 20.48 0.51 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.02 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -175.24 131.24 0.29 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.318 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.9 m -131.57 106.75 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.957 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -86.25 153.25 22.14 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.775 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.46 128.19 43.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.629 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 75.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.079 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.446 ' H3 ' ' HG1' ' A' ' 1' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 166.7 10.97 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.684 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.49 174.02 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.811 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.64 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.8 t-160 -53.77 135.11 41.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 61.7 m-85 69.53 18.73 7.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.98 142.07 18.9 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.85 120.27 19.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -108.6 -15.53 14.4 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.922 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 -155.91 7.4 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 118.095 -2.003 . . . . 0.0 112.151 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.46 128.21 3.74 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.9 mt -46.67 152.25 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.699 -1.2 . . . . 0.0 110.506 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.25 -7.36 78.75 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.61 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -97.11 130.65 44.36 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.755 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.415 ' OG ' ' O ' ' A' ' 14' ' ' SER . 54.4 p -124.86 61.09 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.371 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.88 177.97 23.0 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.02 155.22 45.93 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.105 1.203 . . . . 0.0 110.414 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 66.7 p -118.34 32.66 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.73 -178.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -105.07 123.52 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.943 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 24' ' ' THR . 58.8 m -88.24 143.25 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.847 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 168.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.765 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 p -59.13 144.7 44.91 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.064 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.22 -15.42 53.92 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.907 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.0 166.27 11.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.681 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.408 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -136.55 175.25 9.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.97 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -96.73 121.1 38.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.606 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -121.39 132.6 54.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.37 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -85.95 143.02 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.578 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.462 HD21 HD22 ' A' ' 29' ' ' ASN . 6.1 tp -107.86 -59.91 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -139.44 175.14 3.44 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.97 24.65 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.538 0.825 . . . . 0.0 111.073 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' ASN . 82.9 m-85 -150.6 10.16 0.64 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -163.67 122.06 1.93 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.537 -1.265 . . . . 0.0 112.229 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -131.29 112.64 12.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.099 -1.04 . . . . 0.0 109.466 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -91.09 153.41 20.11 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.662 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -92.9 112.56 24.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.157 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.355 -179.165 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.36 -158.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.253 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 163.87 31.71 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.01 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.6 t-160 -47.08 137.37 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.472 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 49.3 m-85 62.47 34.23 15.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.9 150.03 18.19 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.364 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.69 102.55 10.79 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.285 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -89.9 -25.14 21.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.298 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.78 -176.27 25.16 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.363 -1.875 . . . . 0.0 112.305 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.95 133.74 4.05 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.5 mt -44.92 148.11 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.336 -179.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.02 -17.4 22.64 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.775 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -80.37 139.43 36.54 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.422 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -131.5 10.13 4.76 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.998 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 177.9 46.76 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.779 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.52 155.29 69.67 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.488 1.459 . . . . 0.0 110.807 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.4 p -111.62 30.15 7.22 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.887 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.93 111.47 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.434 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -77.47 145.87 36.79 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.449 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -44.52 144.17 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.891 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -48.86 141.02 7.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.131 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -27.11 22.12 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.967 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -110.21 169.86 8.45 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.424 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 154.78 47.77 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.603 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.8 t -75.24 143.2 43.2 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.091 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -143.06 106.72 4.63 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.117 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.39 131.29 5.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.954 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -101.2 -48.95 4.23 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.8 p30 -162.18 170.4 7.96 Favored Pre-proline 0 CA--C 1.565 1.556 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.666 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.9 Cg_exo -67.72 25.06 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.708 0.939 . . . . 0.0 112.798 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 71.0 m-85 -155.27 16.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.506 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 54.9 t80 -175.18 132.39 0.31 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.689 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -135.8 113.94 11.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.894 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.6 tp-100 -94.69 149.04 21.65 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.396 1.06 . . . . 0.0 112.072 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.3 m -104.89 122.62 46.18 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.88 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 116.351 -1.785 . . . . 0.0 109.988 -179.242 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 28.0 tp60 -91.72 159.06 16.03 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.84 179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.461 ' H ' ' HG ' ' A' ' 3' ' ' SER . 0.3 OUTLIER -99.33 171.84 7.72 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.774 -179.857 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -56.65 158.18 4.76 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 78.1 m-85 48.89 18.21 0.19 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.466 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -89.64 153.73 23.47 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.863 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -80.22 110.7 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.011 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -94.65 -15.57 23.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.57 179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 -176.46 26.53 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 118.429 -1.843 . . . . 0.0 112.14 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.25 143.21 5.33 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.88 142.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.117 -1.433 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.51 -5.84 63.01 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.497 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.39 108.3 17.78 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 p -101.88 46.68 0.92 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.009 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.84 166.01 15.37 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.568 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.39 162.81 0.78 Allowed 'Trans proline' 0 C--O 1.207 -1.067 0 C-N-CA 121.265 1.31 . . . . 0.0 110.206 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 22.9 p -125.61 -3.72 7.22 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.683 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 t -78.57 122.89 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.208 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -77.2 154.91 32.63 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.077 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.425 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.9 163.48 3.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.916 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -60.27 155.74 17.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.605 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -6.86 24.73 Favored Glycine 0 N--CA 1.481 1.679 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.452 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.425 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -129.43 163.79 25.07 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.666 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.63 176.74 8.19 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.788 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.43 141.65 29.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.931 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.85 112.21 9.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.671 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.4 t -74.91 113.05 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.057 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.2 tp -78.21 -56.74 4.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.302 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.558 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.4 m-80 -150.09 174.19 3.69 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.2 23.63 0.22 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.493 0.795 . . . . 0.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.558 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -144.62 8.03 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.528 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -169.51 132.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.104 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.5 m -141.16 108.96 5.66 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.028 177.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -85.27 157.94 20.45 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.731 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 6' ' ' GLY . 1.5 m -101.53 115.43 30.49 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.375 -1.774 . . . . 0.0 109.344 179.556 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -121.9 -179.97 4.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.694 179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.9 -176.55 3.21 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.647 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.9 t-160 -60.75 136.11 57.97 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.222 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 35.4 m-85 68.67 13.0 8.86 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 123.39 0.431 . . . . 0.0 110.127 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 154.95 34.9 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.435 -1.364 . . . . 0.0 111.797 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -82.28 118.95 23.51 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.878 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -111.05 -16.14 13.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.484 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.69 -162.15 10.87 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.156 -1.973 . . . . 0.0 112.315 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.23 138.54 10.16 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.452 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 53.8 mt -49.61 146.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.884 -1.127 . . . . 0.0 110.027 -179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.86 14.45 64.94 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.009 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -121.19 119.76 33.27 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.021 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.2 p -117.42 57.9 0.8 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.594 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.36 174.76 22.73 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.514 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.0 154.67 49.28 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.244 1.296 . . . . 0.0 110.137 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.1 p -112.64 5.23 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.709 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.69 116.29 20.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.989 -1.085 . . . . 0.0 109.323 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -83.31 164.57 19.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.327 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.57 156.6 10.39 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.8 m -58.62 144.45 43.04 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.781 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.03 -15.21 63.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.928 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -117.84 -177.86 3.35 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.682 -179.368 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.57 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -146.17 171.29 15.15 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.855 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -100.61 114.15 27.58 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.094 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.57 HE22 ' C ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -105.58 118.36 36.39 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.862 178.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.66 130.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.566 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.37 -56.43 2.94 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.146 -1.422 . . . . 0.0 109.144 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.2 p30 -154.39 176.53 2.44 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.131 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -65.98 25.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.958 1.106 . . . . 0.0 112.812 -177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -152.68 15.85 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.642 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -175.27 135.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.599 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.6 m -136.51 113.68 10.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -82.6 164.05 21.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.368 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 21.3 m -111.26 112.94 25.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.714 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 20.5 mt . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 116.472 -1.728 . . . . 0.0 110.189 -179.927 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.47 -162.51 0.85 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.557 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.61 174.68 8.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.9 179.535 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.636 ' ND1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -50.91 144.18 9.0 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.178 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CE2' ' ND1' ' A' ' 4' ' ' HIS . 25.7 m-85 62.65 15.41 7.99 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.177 -177.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.4 150.6 31.85 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.737 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -85.3 103.8 14.57 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.05 -16.79 29.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.255 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.93 -176.34 29.87 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.305 -1.902 . . . . 0.0 112.359 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.54 130.57 3.31 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 120.056 -1.068 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.4 mt -46.9 148.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.252 179.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.2 -9.16 27.9 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.369 -1.396 . . . . 0.0 111.05 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -88.78 130.32 35.39 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 p -130.19 62.35 1.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.38 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.3 173.41 23.04 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.79 154.55 12.38 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 N-CA-C 109.473 -1.01 . . . . 0.0 109.473 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.0 p -122.06 18.14 10.84 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.817 -178.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -91.82 125.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.424 -0.91 . . . . 0.0 108.904 178.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 67.2 m -80.87 157.14 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.392 -179.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.98 151.97 11.0 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 m -56.93 139.68 51.0 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.031 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.29 -20.1 39.29 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.28 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -112.21 161.59 16.4 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.35 30.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 t -80.74 107.39 13.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.164 -179.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -106.84 108.88 20.6 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.274 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -49.65 141.37 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.458 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -106.05 -57.82 1.99 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.49 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.4 p30 -155.76 172.32 6.16 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.121 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -68.94 23.76 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 120.972 1.115 . . . . 0.0 113.127 -176.806 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.49 ' H ' ' C ' ' A' ' 29' ' ' ASN . 66.4 m-85 -154.16 18.07 0.49 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.183 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 40.8 t80 -174.45 128.24 0.34 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.399 -177.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m -125.59 115.74 20.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.421 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.4 tp60 -93.32 150.62 20.34 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.198 0.937 . . . . 0.0 112.691 -177.028 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 m -102.24 116.26 32.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.133 -178.651 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.024 0.44 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -100.34 -165.79 1.25 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -136.26 171.59 14.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.044 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -57.15 149.37 19.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 50.0 m-85 53.72 26.74 6.19 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.221 -178.156 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.67 149.8 17.39 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.824 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.7 117.61 18.5 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.3 p -105.81 -24.98 12.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.763 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.77 -154.09 6.56 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.592 -1.766 . . . . 0.0 112.23 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 151.6 23.2 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -178.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.418 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -61.83 153.37 5.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.945 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.54 35.27 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.801 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -88.58 135.64 33.39 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -133.96 41.24 3.02 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.47 173.69 16.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.37 158.33 23.19 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.379 1.386 . . . . 0.0 110.095 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.9 p -127.36 29.4 5.55 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.976 -178.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.46 109.45 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.194 178.336 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' C ' ' A' ' 24' ' ' THR . 52.4 m -70.87 157.01 38.87 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.085 -178.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.56 169.49 0.2 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.5 m -63.64 143.24 57.99 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.923 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.51 -15.47 40.75 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.429 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.34 169.27 8.99 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.709 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.446 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.591 179.709 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 t -92.75 142.87 26.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.292 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -139.31 123.98 18.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.906 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.79 131.59 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.988 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.96 -57.26 2.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.56 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.7 m-80 -143.1 173.54 4.44 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.454 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 5.0 Cg_exo -70.1 25.11 0.18 Allowed 'Trans proline' 0 C--O 1.212 -0.787 0 CA-C-N 119.319 0.792 . . . . 0.0 111.107 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.56 ' H ' ' C ' ' A' ' 29' ' ' ASN . 72.0 m-85 -152.06 20.87 0.67 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.206 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 62.3 t80 -175.46 125.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.71 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 m -130.92 113.96 14.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.175 177.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 9.2 tt0 -101.36 159.53 15.19 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.914 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -97.03 128.63 44.18 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.051 179.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.109 -178.501 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -120.0 -167.08 1.38 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.781 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 162.77 25.93 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.484 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 11.5 t-160 -51.3 128.69 22.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.371 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.485 ' C ' HE21 ' A' ' 34' ' ' GLN . 54.8 m-85 72.22 20.31 4.21 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 123.912 0.758 . . . . 0.0 109.78 -178.202 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.55 154.98 22.45 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.92 117.13 21.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.125 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -107.91 -15.91 14.43 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.96 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.27 -178.6 24.42 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 118.0 -2.047 . . . . 0.0 111.729 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.78 154.01 7.81 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.84 137.67 22.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.045 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.86 -20.6 11.77 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.572 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.437 ' OH ' ' O ' ' A' ' 16' ' ' PRO . 53.2 t80 -69.26 100.37 1.31 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.595 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.6 p -92.01 16.04 12.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.592 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.41 177.46 50.28 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.729 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' O ' ' OH ' ' A' ' 13' ' ' TYR . 1.7 Cg_endo -61.41 153.98 62.14 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.578 1.519 . . . . 0.0 110.243 179.65 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -119.89 20.03 12.28 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.31 -177.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.51 112.22 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.352 178.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.92 175.31 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -75.27 173.72 10.48 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.115 178.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.4 m -66.52 143.74 56.89 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.917 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.09 -15.81 19.88 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.972 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.432 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -106.32 162.43 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.494 -179.846 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 166.81 22.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.867 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.1 127.01 43.8 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.264 -179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -126.74 117.32 22.45 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.753 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.27 136.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.164 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -53.46 3.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.566 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -153.42 177.07 2.1 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.44 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.53 24.17 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.534 0.822 . . . . 0.0 111.156 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.566 ' H ' ' C ' ' A' ' 29' ' ' ASN . 37.1 m-85 -151.0 0.15 0.39 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.756 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -159.83 138.21 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.426 -178.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 m -135.7 118.71 16.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.227 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.485 HE21 ' C ' ' A' ' 5' ' ' TYR . 1.2 tt0 -96.16 146.12 24.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.497 1.123 . . . . 0.0 113.16 -177.078 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 8.8 m -95.52 116.49 28.9 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.7 mm? . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 116.413 -1.756 . . . . 0.0 110.055 -179.922 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.042 0.449 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -92.12 -178.22 4.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.696 179.578 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.58 -179.61 3.73 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.426 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.637 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.3 t-160 -66.99 142.37 57.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 72.9 m-85 59.65 27.84 17.15 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.345 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.62 156.37 20.64 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.999 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -86.87 117.09 25.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.157 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -102.32 -21.87 14.23 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.776 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.37 -169.13 15.51 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.473 -179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.76 132.47 5.52 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.415 ' C ' ' H ' ' A' ' 13' ' ' TYR . 97.7 mt -50.23 155.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.45 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.17 -18.45 13.51 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.191 -178.899 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.415 ' H ' ' C ' ' A' ' 11' ' ' ILE . 44.9 t80 -82.7 148.11 28.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.978 179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 p -141.1 11.07 2.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.514 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.66 -175.81 49.46 Favored Glycine 0 N--CA 1.478 1.473 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.16 154.2 70.46 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.525 1.483 . . . . 0.0 109.866 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.4 p -115.9 15.44 16.27 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.53 -178.462 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.41 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.679 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -73.62 149.58 41.94 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.547 -179.058 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.5 165.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.306 179.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.5 m -62.08 141.23 58.23 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.75 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.86 72.91 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.724 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.37 178.51 6.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.368 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.63 173.98 11.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.754 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 t -100.08 129.91 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.194 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.41 117.4 22.09 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.816 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.19 142.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.079 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.5 -56.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.209 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.3 m-80 -144.01 175.41 2.84 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.36 24.64 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 CA-C-N 119.126 0.723 . . . . 0.0 111.356 -178.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.7 m-85 -148.24 6.15 0.76 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -162.85 139.64 7.58 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.218 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -143.97 114.39 7.53 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.474 176.817 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -88.07 164.07 15.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.101 -178.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -108.48 118.23 36.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.416 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 116.325 -1.798 . . . . 0.0 109.641 -179.889 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 4.1 tp60 -119.83 -164.34 1.07 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.165 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.491 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -141.66 174.1 10.88 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.713 -179.735 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 20.4 t-160 -53.83 135.32 42.02 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.109 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.457 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 52.1 m-85 60.22 23.83 13.2 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.441 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.17 143.47 16.17 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 22.7 tt0 -67.43 111.62 4.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.347 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.92 -21.84 18.38 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.488 179.096 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.06 -175.14 24.17 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 118.321 -1.895 . . . . 0.0 112.342 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.21 137.69 4.81 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 70.3 mt -47.9 151.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.167 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.08 7.36 66.68 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.957 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.54 128.0 44.7 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -119.87 56.56 0.95 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.015 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.81 179.96 18.35 Favored Glycine 0 N--CA 1.487 2.081 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.969 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.34 158.4 55.3 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.69 1.593 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 21.7 p -121.96 11.75 10.35 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.555 -178.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.27 117.2 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.107 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 24' ' ' THR . 97.6 m -77.24 145.06 37.78 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.492 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.84 163.2 5.93 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.841 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 m -54.44 147.28 14.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.25 -18.8 38.92 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.069 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -122.3 172.44 8.31 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.493 0.663 . . . . 0.0 111.218 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.46 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -149.22 162.4 40.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.378 179.718 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.67 136.2 33.12 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.448 -178.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -130.22 116.54 18.55 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.172 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.23 118.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.561 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -84.6 -57.66 3.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.151 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.582 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.16 178.37 1.64 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.476 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -69.76 24.01 0.17 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.734 0.956 . . . . 0.0 111.132 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.582 ' H ' ' C ' ' A' ' 29' ' ' ASN . 76.7 m-85 -152.16 11.35 0.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 33' ' ' SER . 4.7 t80 -173.15 138.56 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.682 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.428 ' N ' ' CD1' ' A' ' 32' ' ' TYR . 66.9 m -139.71 115.9 10.46 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.239 178.018 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 1.7 tt0 -90.77 152.5 20.77 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.916 -176.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.21 103.17 14.62 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.31 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.364 -1.779 . . . . 0.0 109.562 179.301 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.036 0.446 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -121.31 -169.23 1.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 -179.48 5.11 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 19.0 t-160 -67.64 136.24 54.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 45.1 m-85 65.81 20.54 11.45 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.878 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.37 148.85 19.1 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.44 115.28 16.03 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 17' ' ' THR . 5.8 p -95.5 -19.06 20.14 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.379 179.127 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.55 -170.26 27.12 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.237 -1.935 . . . . 0.0 112.656 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.66 134.41 4.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 30.8 mt -43.88 142.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.667 -179.524 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.42 -17.54 53.69 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.687 -1.244 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.7 159.82 22.51 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.636 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 p -144.33 3.57 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.949 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.0 173.34 39.5 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.624 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.51 165.1 8.18 Favored 'Trans proline' 0 C--O 1.209 -0.959 0 C-N-CA 121.596 1.531 . . . . 0.0 110.215 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 29.1 p -128.17 14.45 6.73 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.14 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.8 114.73 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.662 178.386 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 24' ' ' THR . 64.2 m -77.28 147.43 36.29 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.329 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.23 170.34 0.22 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -60.53 148.18 38.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.614 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.97 44.49 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.379 179.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.19 165.45 17.57 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.458 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.443 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -143.49 165.91 26.26 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.608 179.825 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.2 t -82.28 128.06 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.75 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -120.72 115.51 23.46 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.094 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.93 121.41 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.599 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tp -90.22 -57.35 2.87 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.753 -1.179 . . . . 0.0 109.427 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.8 p30 -157.49 176.84 2.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.032 -178.26 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 4.1 Cg_exo -66.58 27.6 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 120.958 1.106 . . . . 0.0 112.989 -177.1 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.8 m-85 -154.75 14.84 0.42 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.947 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -174.87 140.7 0.57 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.661 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -143.9 113.25 6.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.11 158.27 17.37 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.794 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -99.77 112.82 25.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.007 178.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.236 179.669 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.154 0.502 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.25 150.43 52.16 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.01 -174.92 3.1 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.743 -178.226 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.657 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 21.5 t-160 -61.65 158.07 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.079 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.0 m-85 48.7 21.53 0.43 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.561 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 155.46 19.12 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.598 -1.287 . . . . 0.0 111.962 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -83.66 121.02 26.7 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.163 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.5 p -107.46 -27.96 10.11 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.656 179.125 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.38 -148.97 4.87 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.222 -1.942 . . . . 0.0 112.872 -178.515 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.04 134.25 7.58 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -178.226 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.1 mt -51.37 152.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.976 -178.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -11.29 47.87 Favored Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.346 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -86.26 130.5 34.5 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.6 p -121.09 62.32 0.89 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.624 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.84 -175.74 19.16 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.642 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.69 159.2 53.75 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.493 1.462 . . . . 0.0 109.909 179.05 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.4 p -122.66 30.94 6.26 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.581 -178.183 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.42 116.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.394 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.2 m -82.01 155.79 24.98 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.09 151.66 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.341 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -49.56 141.77 9.02 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.077 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 -26.44 21.1 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.093 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.51 165.81 12.36 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.102 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.91 160.16 39.45 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.764 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.42 102.31 5.92 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.229 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -95.48 108.99 21.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.606 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.7 135.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.412 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -102.19 -55.5 2.46 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.577 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.8 p30 -154.14 173.42 4.73 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.436 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -66.87 24.99 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.504 0.859 . . . . 0.0 112.035 -177.879 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.577 ' H ' ' C ' ' A' ' 29' ' ' ASN . 47.4 m-85 -150.38 -5.65 0.32 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.611 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -152.54 132.41 13.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.409 -178.282 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -127.79 112.28 14.6 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.925 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -89.83 155.33 19.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.121 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -99.83 113.2 25.56 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.533 178.899 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 116.385 -1.769 . . . . 0.0 109.934 179.206 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.07 159.9 17.32 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.476 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -177.42 3.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.88 -179.432 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 14.0 t-160 -70.27 127.93 34.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.606 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 68.5 m-85 79.87 18.32 0.7 Allowed 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.052 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.1 154.46 20.5 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.869 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.85 114.33 17.7 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.453 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -99.26 -19.25 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.98 -167.02 13.51 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.276 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.95 146.91 10.38 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.198 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.6 mt -59.34 153.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.094 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -12.81 39.87 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.101 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -88.19 152.97 21.6 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.642 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.4 p -148.59 13.32 0.93 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.944 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.81 -172.73 43.97 Favored Glycine 0 N--CA 1.483 1.783 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.76 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.76 160.44 32.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.306 1.337 . . . . 0.0 110.252 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -128.96 27.62 5.41 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.059 -178.475 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -105.7 120.42 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.99 178.684 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.4 m -80.27 145.48 32.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.986 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -50.1 145.24 6.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.74 178.757 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -50.01 141.67 10.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.007 -179.281 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.45 -26.89 22.62 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.339 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.1 p -105.92 -173.46 2.3 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.28 157.37 43.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.724 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.79 136.25 33.06 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.428 -1.309 . . . . 0.0 109.301 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -136.53 120.62 17.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.392 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.24 118.46 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.639 178.635 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.411 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -84.28 -56.82 3.44 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.674 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.3 p30 -149.06 171.59 6.13 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.08 26.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 119.41 0.825 . . . . 0.0 111.95 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 83.3 m-85 -154.39 14.97 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -173.8 126.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.403 -177.487 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.7 m -126.85 111.49 14.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.665 178.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.767 1.292 . . . . 0.0 112.561 -176.939 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.9 m -99.66 105.94 17.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.998 179.331 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mm? . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 116.269 -1.824 . . . . 0.0 109.823 179.705 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -117.14 152.49 34.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.416 ' H ' ' HG ' ' A' ' 3' ' ' SER . 0.3 OUTLIER -109.69 170.45 8.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.694 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.5 t-160 -40.98 130.29 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 42.8 m-85 68.53 40.75 1.85 Allowed 'General case' 0 N--CA 1.511 2.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.26 -178.468 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.12 152.62 17.3 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.78 100.85 11.19 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.161 179.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.8 p -89.85 -17.51 27.96 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.802 179.984 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.43 -159.21 8.75 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.944 -2.074 . . . . 0.0 112.675 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 106.09 124.57 5.33 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -178.571 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 10' ' ' GLY . 96.4 mt -41.67 147.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.966 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.52 31.6 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.879 -1.153 . . . . 0.0 111.411 -179.247 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.32 114.11 21.63 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 p -108.11 17.47 22.27 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.78 176.73 42.96 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.594 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.64 158.65 44.96 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.453 1.435 . . . . 0.0 110.234 179.389 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 74.7 p -119.22 16.4 13.16 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.582 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -95.03 118.78 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.459 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 m -84.99 152.93 23.1 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.076 -1.049 . . . . 0.0 109.949 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.7 137.0 58.17 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ALA . 3.3 m -41.36 145.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.39 -24.02 30.06 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.403 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -120.98 -171.63 2.23 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.558 0.694 . . . . 0.0 110.473 179.69 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.88 162.12 41.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.92 136.53 34.05 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.904 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -132.64 139.07 47.57 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.499 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.98 123.29 35.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.4 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -88.1 -56.39 3.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.552 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.87 174.78 3.57 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.04 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.4 Cg_exo -64.78 24.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.211 -0.825 0 C-N-CA 121.005 1.137 . . . . 0.0 112.769 -179.138 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.552 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.2 m-85 -154.9 14.03 0.4 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.204 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.406 ' HH ' ' CD ' ' A' ' 34' ' ' GLN . 24.7 t80 -172.43 125.79 0.51 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.701 -178.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.4 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 72.2 m -126.84 115.43 19.31 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.342 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' CD ' ' HH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -93.92 149.32 21.34 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.669 -177.641 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 55.0 m -103.42 117.2 33.91 Favored 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.066 179.125 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.415 ' CD2' ' N ' ' A' ' 36' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 116.308 -1.805 . . . . 0.0 110.173 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.048 0.451 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.696 HE22 ' N ' ' A' ' 8' ' ' CYS . 3.1 tt0 -85.7 -168.45 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.305 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 160.28 32.86 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.956 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.654 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 18.7 t-160 -46.62 132.67 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.37 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 25.2 m-85 72.58 24.62 2.8 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.526 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 2' ' ' GLN . . . -92.44 144.54 17.16 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.111 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.512 ' C ' HE22 ' A' ' 2' ' ' GLN . 38.1 tt0 -76.13 96.37 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.614 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.696 ' N ' HE22 ' A' ' 2' ' ' GLN . 1.8 p -88.56 -12.0 44.0 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.663 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.53 -160.96 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.047 -2.025 . . . . 0.0 112.181 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.26 149.64 23.11 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.489 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.416 ' CG2' ' N ' ' A' ' 12' ' ' GLY . 81.9 mt -69.73 157.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.455 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.416 ' N ' ' CG2' ' A' ' 11' ' ' ILE . . . 73.74 -3.29 35.91 Favored Glycine 0 N--CA 1.484 1.89 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.338 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 16.7 t80 -85.1 154.24 22.18 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -146.8 57.26 1.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.463 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.64 177.26 24.15 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.331 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.48 164.64 6.92 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.13 1.22 . . . . 0.0 109.799 179.382 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.48 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 29.8 p -127.15 29.33 5.61 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.326 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.89 120.9 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.913 179.131 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 24' ' ' THR . 10.3 m -77.67 142.33 38.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.437 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.6 168.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.04 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.11 149.99 46.49 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.512 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.1 -15.14 57.07 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.497 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.545 ' H ' ' HG1' ' A' ' 23' ' ' THR . 0.8 OUTLIER -114.9 -175.2 2.64 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.032 -179.715 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.653 ' HG1' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -150.96 162.46 40.77 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.53 179.631 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.2 t -92.37 124.61 36.55 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.494 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.653 ' NE2' ' HG1' ' A' ' 24' ' ' THR . 28.9 mp0 -125.42 128.52 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.787 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.59 142.12 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -108.42 -56.72 2.22 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.886 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 10.3 p30 -161.36 171.87 6.39 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -67.25 24.24 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.601 0.867 . . . . 0.0 112.817 -176.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 62.3 m-85 -150.54 14.21 0.76 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' HH ' ' CG ' ' A' ' 34' ' ' GLN . 6.0 t80 -175.34 134.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 -179.27 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -132.74 114.33 14.02 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.502 ' CG ' ' HH ' ' A' ' 32' ' ' TYR . 49.9 tt0 -90.62 156.08 18.38 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.986 -176.974 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.2 m -104.04 131.03 51.71 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.048 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.403 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 70.6 mt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 116.404 -1.76 . . . . 0.0 109.875 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.46 ' O ' ' CB ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -131.23 166.5 21.04 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.48 179.499 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -175.71 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.123 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.635 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 23.1 t-160 -68.06 147.51 52.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 54.4 m-85 55.52 26.13 8.67 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.444 -177.975 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.93 145.92 18.07 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -77.05 116.94 18.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -17.37 14.49 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.816 179.715 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.48 -168.54 15.51 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 118.641 -1.743 . . . . 0.0 111.873 -179.308 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.81 133.91 5.59 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 63.0 mt -46.55 147.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.01 -179.661 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.41 -11.42 24.71 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.816 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -82.37 110.65 17.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 p -111.43 59.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.432 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.81 179.46 18.2 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.713 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.18 149.06 91.96 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.432 1.421 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.2 p -110.61 -12.6 14.32 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.536 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 t -76.77 108.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.43 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.65 156.86 38.93 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.664 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' CB ' ' O ' ' A' ' 2' ' ' GLN . . . -52.92 152.3 4.06 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.224 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.11 152.24 4.38 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.94 -17.04 55.36 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.745 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -120.77 -179.94 4.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.227 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 163.25 37.4 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.085 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -89.72 138.37 31.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.534 -179.449 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -130.96 106.08 8.17 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.074 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.36 114.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -79.09 -51.82 9.04 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.51 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 p30 -158.68 174.78 3.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.202 -179.051 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -65.57 24.87 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.01 1.14 . . . . 0.0 113.213 -176.87 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' ASN . 93.5 m-85 -152.33 10.2 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.703 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -169.67 134.4 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.053 -178.843 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -138.07 113.73 9.7 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.452 177.295 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.61 163.54 15.78 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.862 -178.415 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.1 m -107.35 115.02 29.43 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.363 179.609 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.198 -179.804 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.4 tp60 -98.58 153.02 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 179.07 5.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.6 t-160 -55.42 145.47 22.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.336 -0.946 . . . . 0.0 108.8 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 48.7 m-85 60.46 29.59 19.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.61 155.11 20.46 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.81 -179.064 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 57.5 tt0 -89.82 104.54 17.1 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.357 179.455 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.11 -22.67 21.66 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.132 179.557 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.65 19.19 Favored Glycine 0 N--CA 1.486 1.984 0 C-N-CA 118.241 -1.933 . . . . 0.0 112.323 -178.783 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.52 136.49 4.64 Favored Glycine 0 C--O 1.211 -1.313 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 29.6 mt -48.06 142.03 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.554 -179.408 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.2 65.5 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.844 179.606 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 87.9 t80 -95.97 100.45 12.12 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.531 179.767 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -97.43 40.75 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.254 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.03 169.88 13.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.27 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -51.05 149.78 14.71 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.199 1.266 . . . . 0.0 109.899 179.482 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -111.84 -12.13 13.84 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -82.28 125.72 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.776 -1.169 . . . . 0.0 109.666 179.161 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.7 m -80.34 160.49 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.076 179.611 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -62.09 175.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.508 -179.926 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.6 m -62.63 144.79 55.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.251 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.27 60.03 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.667 -1.254 . . . . 0.0 112.435 178.684 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.35 166.47 13.49 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.603 -179.655 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.36 158.52 44.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -82.14 132.16 35.24 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.274 -179.012 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -127.57 119.25 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.104 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.67 122.3 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.595 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.46 -53.28 4.13 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.459 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.563 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -154.23 175.02 3.3 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.754 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -72.75 23.27 0.29 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 120.512 0.808 . . . . 0.0 110.716 -179.673 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.563 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.1 m-85 -150.63 13.09 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.867 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -174.16 126.65 0.35 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.836 -178.84 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.4 m -128.68 112.66 14.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.103 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -90.13 149.82 22.3 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.597 -176.973 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.7 m -105.51 110.59 22.98 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.409 179.566 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.1 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.388 -1.768 . . . . 0.0 109.857 -179.359 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -120.45 151.33 39.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.239 179.467 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.53 175.95 5.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.662 -178.848 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.579 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.7 t-160 -52.01 136.12 29.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.464 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.9 m-85 70.53 25.03 4.33 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.885 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.51 149.13 19.06 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.821 -1.181 . . . . 0.0 111.441 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.62 111.27 17.76 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.629 179.698 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.425 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.4 p -103.45 -12.76 16.95 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.08 -163.55 14.31 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 118.451 -1.833 . . . . 0.0 112.083 -179.761 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.0 133.35 8.04 Favored Glycine 0 N--CA 1.48 1.628 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.54 -179.634 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -50.6 154.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.014 -1.074 . . . . 0.0 109.696 -179.765 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.04 81.34 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.148 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CZ ' ' CA ' ' A' ' 15' ' ' GLY . 21.2 t80 -105.63 153.29 22.01 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.148 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 p -136.42 2.06 2.69 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.479 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' CZ ' ' A' ' 13' ' ' TYR . . . -93.97 178.59 37.67 Favored Glycine 0 CA--C 1.551 2.294 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.584 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.41 161.78 29.84 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.189 1.926 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 33.7 p -116.44 25.46 10.6 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.846 -178.653 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.07 116.63 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.875 179.407 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.22 149.44 25.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.56 150.51 12.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.013 179.58 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.404 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.1 OUTLIER -53.46 160.24 1.26 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.481 179.467 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.7 -20.15 9.93 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.069 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.83 163.43 23.61 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.668 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -135.84 173.82 11.29 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.821 179.214 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -87.09 148.81 25.08 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.371 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . 0.448 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 29.5 mp0 -143.64 124.54 14.3 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.558 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.56 113.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.167 179.04 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.406 HD11 HD21 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -81.97 -57.05 3.58 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.797 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -150.69 171.86 5.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.346 179.579 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -66.07 24.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.739 0.959 . . . . 0.0 113.123 -177.028 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.544 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.3 m-85 -155.58 16.63 0.39 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.903 178.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.443 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 52.9 t80 -171.65 121.8 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.571 -176.414 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -118.44 111.81 19.15 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.656 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.443 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 6.0 tp60 -90.51 144.02 26.19 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.448 -177.559 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.6 m -87.85 115.13 25.09 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.822 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 33.0 mt . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 116.391 -1.766 . . . . 0.0 110.197 -178.356 . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -106.87 148.25 28.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.884 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -93.46 -167.43 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.153 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.636 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -66.71 132.12 47.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.649 -179.466 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.5 m-85 71.35 29.35 2.77 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.518 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.01 154.62 20.25 Favored Glycine 0 N--CA 1.481 1.693 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.54 117.3 25.23 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.41 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.2 p -102.7 -33.16 9.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.624 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 33' ' ' SER . . . -152.42 -178.75 27.4 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 117.433 -2.318 . . . . 0.0 113.828 -177.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.81 151.57 8.23 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 12.3 mt -59.32 149.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.07 8.13 Favored Glycine 0 C--N 1.296 -1.663 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.211 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -82.38 138.17 34.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.561 179.578 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -136.53 40.13 2.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.462 -179.759 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.44 176.3 16.27 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.151 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.9 155.95 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 N-CA-C 109.407 -1.036 . . . . 0.0 109.407 179.132 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 38.8 p -117.89 32.64 6.04 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.869 -178.652 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.96 119.13 60.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.843 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.7 m -80.02 171.31 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.641 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -74.16 147.32 42.72 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.236 179.345 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 m -43.05 139.26 1.82 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.677 -179.579 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.43 -26.8 22.92 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.248 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -114.01 171.46 7.59 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.183 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 161.57 37.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.973 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.0 t -85.69 140.39 30.56 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.864 -179.383 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -137.19 117.47 13.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.56 126.33 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.568 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -57.64 2.3 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.568 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.03 177.03 2.05 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.065 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -67.43 24.08 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.774 0.983 . . . . 0.0 111.716 -178.985 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.568 ' H ' ' C ' ' A' ' 29' ' ' ASN . 98.3 m-85 -154.38 12.82 0.42 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.034 179.522 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -171.98 137.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.435 -178.137 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLY . 50.8 m -136.88 115.98 12.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.402 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 4.8 tp60 -89.64 155.69 19.07 Favored 'General case' 0 N--CA 1.51 2.563 0 O-C-N 124.119 0.887 . . . . 0.0 113.062 -176.795 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.406 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 8.6 m -105.85 106.09 16.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.459 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.502 2.155 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.705 179.918 . . . . . . . . 0 0 . 1 . 035 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.771 HE22 ' HH ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -101.97 151.65 21.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.053 179.797 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.67 179.87 4.53 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.756 -179.706 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.7 t-160 -57.85 147.5 28.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 86.8 m-85 58.12 23.75 10.5 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.007 -178.884 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 35' ' ' CYS . . . -99.67 156.11 19.77 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.898 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.51 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 58.3 tt0 -83.85 110.06 18.06 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.416 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' O ' ' CG2' ' A' ' 17' ' ' THR . 3.4 p -96.24 -19.61 19.18 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.207 179.046 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.84 -149.96 5.28 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.47 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.11 126.09 5.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 54.3 mt -48.61 149.6 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.526 -179.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.28 -13.55 20.38 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.771 ' HH ' HE22 ' A' ' 2' ' ' GLN . 49.4 t80 -70.46 153.5 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.231 -179.934 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -143.47 52.89 1.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.687 -179.573 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.01 174.3 23.72 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.442 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.12 163.64 5.92 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.072 1.181 . . . . 0.0 109.795 179.073 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 74.9 p -127.4 15.65 7.14 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.971 -178.332 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.21 115.61 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.926 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ALA . 54.0 m -79.99 130.13 35.03 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.537 -179.217 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 21' ' ' SER . . . -41.12 132.01 2.54 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.978 179.625 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -40.07 144.85 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.57 -179.683 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.88 30.78 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.72 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.82 176.96 5.69 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.2 167.84 20.52 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.675 179.209 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.65 106.32 18.3 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.653 -179.117 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -106.77 136.68 46.18 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.264 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.77 104.2 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.926 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.06 -57.86 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -146.03 173.42 4.27 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.073 178.31 . . . . . . . . 3 3 . 1 . 035 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.405 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.41 23.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.413 0.742 . . . . 0.0 111.99 -177.972 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.517 ' H ' ' C ' ' A' ' 29' ' ' ASN . 34.2 m-85 -147.56 7.62 0.87 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.239 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.569 ' HH ' ' NE2' ' A' ' 34' ' ' GLN . 73.2 t80 -163.62 112.76 1.26 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.163 -178.949 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -115.87 114.29 24.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.982 177.647 . . . . . . . . 1 1 . 1 . 035 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.569 ' NE2' ' HH ' ' A' ' 32' ' ' TYR . 18.0 tt0 -94.65 166.95 11.76 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.488 -177.792 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' N ' ' O ' ' A' ' 6' ' ' GLY . 13.9 m -100.44 108.31 20.27 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.826 179.722 . . . . . . . . 2 2 . 1 . 035 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.229 -1.844 . . . . 0.0 109.951 -179.634 . . . . . . . . 0 0 . 1 . 036 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -94.64 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.096 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.69 -175.42 3.89 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.408 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.631 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.5 t-160 -71.39 154.38 41.61 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.056 179.725 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 63.4 m-85 51.18 18.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.697 -178.338 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.66 155.67 22.21 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.165 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -83.27 110.86 18.44 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.644 179.666 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -93.78 -26.23 17.06 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.868 179.495 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.14 -151.36 5.62 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.343 -1.884 . . . . 0.0 112.601 -178.972 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 150.42 18.78 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 77.3 mt -62.16 149.73 9.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.33 -179.439 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.18 -4.09 42.41 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.676 -1.249 . . . . 0.0 111.313 -179.144 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -80.44 125.56 30.09 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.1 p -117.53 58.91 0.79 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.149 179.678 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.03 21.42 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.322 -179.562 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -68.44 159.77 51.99 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.758 1.638 . . . . 0.0 110.506 179.458 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -120.23 12.63 11.83 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.569 -178.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.62 116.54 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.116 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -79.11 149.41 32.07 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.199 -179.765 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.0 146.69 41.71 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.09 179.757 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -43.09 149.66 0.21 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.599 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.89 68.46 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.298 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -134.04 178.83 6.65 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.095 -179.971 . . . . . . . . 3 3 . 1 . 036 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.63 168.69 19.55 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.677 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -89.87 136.44 33.04 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.914 -179.535 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -128.27 133.1 48.71 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.147 -179.661 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.11 108.32 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.633 179.041 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.69 -51.03 38.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.557 -179.359 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.4 p30 -159.54 173.87 4.52 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.843 -179.122 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.444 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.1 Cg_exo -66.34 24.93 0.1 OUTLIER 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 120.909 1.073 . . . . 0.0 113.106 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.527 ' H ' ' C ' ' A' ' 29' ' ' ASN . 99.3 m-85 -152.75 19.37 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.468 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -175.99 130.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.094 -179.452 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.1 m -132.57 112.04 11.74 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.834 177.166 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -93.73 157.77 15.99 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.071 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.3 m -102.39 121.14 41.73 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.145 179.36 . . . . . . . . 1 1 . 1 . 036 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 116.132 -1.89 . . . . 0.0 109.567 -179.949 . . . . . . . . 0 0 . 1 . 037 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 7' ' ' GLN . 11.7 tp60 -113.51 147.54 37.73 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.563 179.604 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 164.71 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.937 -178.944 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.621 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -44.73 159.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.159 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.621 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 67.3 m-85 47.57 19.37 0.14 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.727 -179.511 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.25 154.39 20.44 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.736 -178.707 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 39.7 tt0 -78.17 108.49 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.367 179.755 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 2.0 p -92.61 -24.72 18.6 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.794 179.386 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.26 -157.03 7.66 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.253 -178.763 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 113.94 126.38 4.35 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.876 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.433 ' C ' ' O ' ' A' ' 10' ' ' GLY . 17.4 mt -40.41 145.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.62 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.9 -1.04 56.29 Favored Glycine 0 CA--C 1.544 1.903 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.795 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -91.43 101.3 13.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.424 179.693 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.6 p -95.1 55.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.07 171.76 22.0 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.228 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.68 161.9 13.97 Favored 'Trans proline' 0 C--O 1.205 -1.162 0 C-N-CA 121.756 1.637 . . . . 0.0 110.415 179.593 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.0 p -131.33 20.14 4.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.712 -178.813 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.21 116.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.379 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.06 144.07 29.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.149 -179.529 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.34 169.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.5 p -67.07 143.45 56.7 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.474 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.79 -17.36 45.83 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.39 169.9 8.7 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.515 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.53 160.03 41.8 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.223 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.3 t -79.97 116.73 20.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.114 -179.269 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -113.99 136.16 53.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.394 179.19 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -83.43 132.09 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.547 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.2 m-80 -149.74 173.33 4.36 Favored Pre-proline 0 N--CA 1.495 1.811 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.876 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' O ' ' CD2' ' A' ' 31' ' ' TYR . 3.7 Cg_exo -70.42 23.88 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.539 0.826 . . . . 0.0 111.39 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.547 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.0 m-85 -152.88 20.17 0.59 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.661 179.305 . . . . . . . . 2 2 . 1 . 037 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -173.96 129.76 0.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.6 m -136.79 119.45 16.07 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.549 177.927 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -99.81 158.28 15.91 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.431 -178.464 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 m -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 116.415 -1.755 . . . . 0.0 110.066 -178.681 . . . . . . . . 0 0 . 1 . 038 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 3.7 tp60 -127.8 -176.89 3.91 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.177 179.771 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.42 174.77 8.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.415 -179.87 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.615 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.3 t-160 -55.17 134.08 49.37 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.801 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.2 m-85 69.23 -3.48 1.54 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -61.45 152.75 41.02 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.765 179.715 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -84.61 111.93 19.98 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.72 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.416 ' O ' ' CG2' ' A' ' 17' ' ' THR . 1.7 p -89.69 -34.42 16.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.937 179.123 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.8 -155.54 6.75 Favored Glycine 0 N--CA 1.48 1.569 0 C-N-CA 118.303 -1.903 . . . . 0.0 112.395 -178.797 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.31 152.52 14.67 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.456 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 11.0 mt -60.87 146.9 10.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.917 -179.309 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.48 -8.76 52.85 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.736 -179.909 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.479 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 52.2 t80 -82.64 119.21 23.99 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.865 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -113.04 57.62 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.329 179.791 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.27 21.6 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -69.19 157.14 62.62 Favored 'Trans proline' 0 C--O 1.21 -0.907 0 C-N-CA 121.818 1.679 . . . . 0.0 110.596 179.55 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.416 ' CG2' ' O ' ' A' ' 8' ' ' CYS . 47.7 p -115.87 13.31 16.01 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.716 -178.281 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.31 110.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.663 179.322 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -77.01 149.56 35.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.877 -179.067 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 155.98 0.34 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.239 179.804 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -52.64 144.8 13.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.428 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.06 -25.15 10.52 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.673 178.718 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.46 173.86 6.14 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.726 -179.462 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.64 170.14 17.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.65 140.99 28.96 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -141.9 113.88 8.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.43 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.86 111.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.87 -48.97 50.96 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.021 -1.471 . . . . 0.0 107.651 179.299 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.6 p30 -163.27 175.09 3.0 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.655 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 6.3 Cg_exo -65.93 28.9 0.1 OUTLIER 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 121.001 1.134 . . . . 0.0 113.6 -177.278 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' ASN . 70.7 m-85 -154.48 13.78 0.43 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.144 178.425 . . . . . . . . 2 2 . 1 . 038 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -175.35 133.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.747 -178.544 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -131.54 109.07 9.99 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.487 177.286 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -86.82 153.18 21.85 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.72 -177.85 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 m -97.4 115.33 27.54 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.847 178.961 . . . . . . . . 1 1 . 1 . 038 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 116.403 -1.76 . . . . 0.0 110.329 -179.879 . . . . . . . . 0 0 . 1 . 039 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 1.3 tp60 -118.15 169.22 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.642 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.37 166.34 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.405 -179.214 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.0 t-160 -48.56 139.67 9.02 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.56 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 79.8 m-85 58.21 30.13 18.98 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.297 -178.491 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.59 148.34 18.59 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.976 -178.98 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -75.81 102.39 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.694 179.643 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -91.21 -14.25 31.34 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.054 179.389 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.08 -154.29 6.92 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.423 -1.846 . . . . 0.0 112.378 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 137.23 8.69 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.813 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.04 145.21 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.79 4.72 89.52 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.594 -179.575 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 87.4 t80 -100.25 113.64 26.49 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.222 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 p -111.05 46.5 1.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.718 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.79 172.89 16.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.31 155.89 54.36 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.837 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 32.8 p -117.01 20.34 13.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.647 -178.536 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.46 120.82 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.305 178.718 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.0 m -83.19 156.47 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.774 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.409 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.47 152.95 20.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.706 179.395 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.72 144.98 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.72 -12.02 69.97 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.373 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.409 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -127.03 163.68 23.21 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.722 -179.699 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.22 158.92 39.27 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.179 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -89.53 131.87 35.35 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.775 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -131.48 119.05 21.03 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.159 179.663 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -54.29 117.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.664 179.668 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -82.3 -58.01 3.12 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -179.923 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.16 176.75 2.2 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.327 . . . . . . . . 3 3 . 1 . 039 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -67.99 24.56 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.056 1.171 . . . . 0.0 112.047 -178.636 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.537 ' H ' ' C ' ' A' ' 29' ' ' ASN . 88.9 m-85 -155.01 15.03 0.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.043 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' OH ' ' CD ' ' A' ' 34' ' ' GLN . 21.2 t80 -174.17 124.42 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.062 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 22.3 m -124.98 115.44 20.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.948 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 5.4 tp60 -94.34 151.69 19.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.733 -176.251 . . . . . . . . 2 2 . 1 . 039 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.3 m -100.98 107.21 18.62 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.515 179.061 . . . . . . . . 1 1 . 1 . 039 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.413 -1.755 . . . . 0.0 109.943 -179.615 . . . . . . . . 0 0 . 1 . 040 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -97.57 154.39 17.56 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.149 179.877 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.457 ' H ' ' HG ' ' A' ' 3' ' ' SER . 2.6 p -99.73 -172.95 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.867 -179.617 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.61 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 22.8 t-160 -61.8 160.71 11.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.312 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.61 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 81.9 m-85 47.09 19.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.631 -1.227 . . . . 0.0 109.125 -178.046 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -87.09 154.06 26.11 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.62 -178.138 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -89.13 114.72 26.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.381 179.577 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.8 p -103.05 -21.51 13.91 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.093 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.32 -153.32 6.49 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 118.175 -1.964 . . . . 0.0 112.765 -179.145 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 139.3 10.41 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.948 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 12' ' ' GLY . 90.9 mt -51.32 151.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.069 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' N ' ' CG2' ' A' ' 11' ' ' ILE . . . 80.68 -15.98 16.97 Favored Glycine 0 C--N 1.296 -1.676 0 C-N-CA 119.508 -1.329 . . . . 0.0 111.032 -179.701 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -82.06 124.5 29.88 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.394 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -120.55 37.29 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.12 -175.5 17.94 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.133 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.28 158.71 56.38 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 121.798 1.665 . . . . 0.0 110.493 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.7 p -122.23 31.09 6.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.544 -0.863 . . . . 0.0 112.012 -178.184 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -111.52 117.07 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.733 178.707 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 4.3 m -85.32 142.17 29.53 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -49.13 146.93 3.22 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.358 179.851 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -47.3 153.84 0.46 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.733 -179.853 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.3 -26.11 12.77 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.422 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -119.59 171.97 7.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.129 179.779 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 155.91 43.31 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.88 179.265 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 14.8 t -70.71 130.33 41.46 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.733 -178.801 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.43 103.07 6.93 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.228 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.02 128.14 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.673 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.78 -56.45 3.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.337 . . . . . . . . 3 3 . 1 . 040 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.28 171.44 6.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.256 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 3.4 Cg_exo -67.81 24.79 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.36 0.807 . . . . 0.0 112.26 -177.341 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' ASN . 84.9 m-85 -151.27 11.91 0.63 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.87 178.861 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -171.88 131.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.649 -178.619 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.0 m -131.7 113.49 13.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.656 178.153 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -98.45 161.07 13.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.482 1.113 . . . . 0.0 111.464 -178.001 . . . . . . . . 1 1 . 1 . 040 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.3 m -111.94 121.54 45.3 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.073 179.311 . . . . . . . . 2 2 . 1 . 040 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 116.236 -1.84 . . . . 0.0 109.872 -179.684 . . . . . . . . 0 0 . 1 . 041 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.41 ' OE1' ' C ' ' A' ' 7' ' ' GLN . 0.3 OUTLIER -136.81 -166.13 1.85 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.207 179.774 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -171.32 1.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.905 -179.45 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.678 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 23.0 t-160 -59.11 164.87 2.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.553 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.678 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 30.7 m-85 47.82 23.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.538 -178.272 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -86.01 157.58 30.95 Favored Glycine 0 N--CA 1.484 1.874 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.069 -179.06 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 2' ' ' GLN . 50.8 tt0 -93.69 106.07 18.06 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.147 -179.049 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -91.9 -19.04 22.9 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.735 -1.186 . . . . 0.0 110.777 179.997 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.45 -161.63 10.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.174 -1.965 . . . . 0.0 112.288 -179.381 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 110.35 127.32 5.24 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.408 ' C ' ' O ' ' A' ' 10' ' ' GLY . 78.5 mt -44.96 154.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.028 -179.379 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 -12.84 25.17 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.037 -178.187 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.403 ' H ' ' C ' ' A' ' 11' ' ' ILE . 58.6 t80 -89.46 110.03 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.785 -179.982 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.5 p -109.86 30.65 6.5 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.553 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.4 -179.05 24.98 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.93 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.5 150.12 63.22 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.487 1.458 . . . . 0.0 109.761 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.5 p -106.92 11.62 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.926 -178.001 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.53 116.28 28.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ALA . 16.4 m -83.1 139.23 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.094 179.847 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.43 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -40.73 147.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.604 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.19 153.65 1.91 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.36 -20.66 32.8 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.429 179.197 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.43 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.18 174.21 6.35 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.946 -0.701 . . . . 0.0 111.004 -179.609 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -179.59 5.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.443 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -99.85 139.43 35.54 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.206 -179.356 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.18 113.38 8.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.217 179.531 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.07 138.37 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.3 -60.87 1.63 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.511 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -145.5 175.42 2.76 Favored Pre-proline 0 N--CA 1.505 2.275 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.63 . . . . . . . . 3 3 . 1 . 041 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.478 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -70.08 22.35 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.616 0.877 . . . . 0.0 111.851 -178.413 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.9 m-85 -155.81 19.11 0.38 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.549 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -172.8 127.54 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.816 -178.505 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.3 m -130.46 113.0 13.76 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.574 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.11 156.88 16.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.06 0.85 . . . . 0.0 112.224 -176.84 . . . . . . . . 1 1 . 1 . 041 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.4 m -106.19 130.92 53.97 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 041 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.76 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.89 173.98 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.304 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.516 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.4 t60 -47.84 158.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.695 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 84.5 m-85 46.91 23.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.341 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.06 135.12 11.96 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.308 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -65.16 100.98 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.36 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.69 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -89.86 -16.6 29.76 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.612 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.6 -179.79 31.85 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 118.514 -1.803 . . . . 0.0 111.537 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.66 131.69 3.33 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.3 mt -48.25 148.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.604 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.14 -14.46 14.89 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.611 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -79.39 138.64 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.022 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.8 p -137.71 63.12 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.6 178.99 21.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.91 166.11 7.35 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.8 p -135.15 0.43 2.84 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.83 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -80.68 112.42 18.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.495 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.8 m -71.21 147.02 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.353 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 142.19 49.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.163 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -44.95 146.22 0.84 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.55 -25.76 27.0 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.33 163.0 17.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -126.64 169.71 12.84 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.812 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.7 t -95.34 120.56 35.79 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.038 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.758 ' NE2' ' H ' ' A' ' 36' ' ' LEU . 2.3 mp0 -110.72 113.78 26.65 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.746 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.27 106.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.312 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.97 -54.06 14.98 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.034 -1.067 . . . . 0.0 109.184 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.3 m120 -150.2 174.59 3.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.534 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -68.59 24.36 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 120.837 1.024 . . . . 0.0 112.208 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.29 17.56 0.48 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.452 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -170.21 131.97 1.02 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.975 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 m -142.66 110.82 6.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.16 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.2 145.28 27.4 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.099 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.0 m -84.43 118.72 24.44 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.758 ' H ' ' NE2' ' A' ' 26' ' ' GLN . 93.5 mt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.559 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -172.29 2.22 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.193 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.82 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.9 t60 -67.24 149.68 50.09 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.82 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 44.9 m-85 54.28 25.79 6.21 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.913 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.9 150.21 18.66 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.737 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.5 109.64 10.39 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.612 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.556 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -96.4 -25.46 15.7 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.694 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.44 -153.27 6.31 Favored Glycine 0 N--CA 1.48 1.597 0 C-N-CA 118.279 -1.915 . . . . 0.0 112.131 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.31 132.47 7.5 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 30' ' ' PRO . 20.1 mt -48.0 149.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.756 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.31 -0.4 87.76 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.056 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.62 139.19 33.07 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -131.07 31.2 4.47 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.585 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.18 175.82 16.9 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.51 160.58 23.5 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.515 1.477 . . . . 0.0 110.333 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 8' ' ' CYS . 63.4 p -124.59 22.15 8.37 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.586 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.93 108.61 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.718 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -75.71 147.2 39.56 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.43 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.26 152.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.726 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 m -56.51 139.54 49.09 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.927 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.18 32.49 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.527 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -105.13 161.57 14.14 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.881 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -129.18 162.86 26.82 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.29 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.4 t -90.76 116.91 28.98 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.04 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 22.0 mp0 -107.39 107.74 18.77 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.463 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.63 120.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 118.719 -1.193 . . . . 0.0 108.666 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -81.14 -62.11 1.76 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -178.639 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.1 m120 -141.04 175.32 3.15 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -69.03 23.51 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.1 0.714 . . . . 0.0 111.712 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.1 m-85 -155.26 21.64 0.42 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.987 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 16.5 t80 -173.68 130.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.099 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.9 m -134.07 116.26 15.26 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.471 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.494 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tt0 -98.75 154.38 18.03 Favored 'General case' 0 N--CA 1.513 2.69 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.636 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 67.7 m -92.37 120.44 32.89 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.602 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.482 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 90.5 mt . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.197 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.705 HE22 ' N ' ' A' ' 7' ' ' GLN . 3.2 tt0 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -179.15 4.23 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.817 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.7 t60 -54.83 150.97 9.1 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 19.6 m-85 52.89 17.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.351 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -81.35 134.18 12.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.696 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.705 ' N ' HE22 ' A' ' 2' ' ' GLN . 30.6 tt0 -69.99 101.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.31 -18.37 28.65 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.026 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.37 -172.04 22.57 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.445 -1.836 . . . . 0.0 112.314 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.96 126.48 4.55 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 12' ' ' GLY . 96.9 mt -44.51 153.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.978 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 83.95 -12.84 52.03 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.701 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -90.14 146.94 23.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.049 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 p -140.27 22.78 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.808 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.39 177.36 24.86 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.84 159.8 16.74 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.485 1.457 . . . . 0.0 110.447 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.3 p -124.56 26.09 7.36 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.16 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.92 114.8 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.081 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -79.27 133.98 36.65 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.326 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.42 159.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.323 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.52 155.67 9.23 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.923 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.28 -15.68 32.96 Favored Glycine 0 N--CA 1.482 1.728 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.522 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 167.03 14.37 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.27 164.97 25.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.727 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.98 113.29 24.93 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.27 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -104.13 126.1 50.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.73 140.9 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.902 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 tp -108.14 -60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.858 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -149.15 175.89 2.53 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.8 24.4 0.15 Allowed 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 120.902 1.068 . . . . 0.0 111.67 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 29' ' ' ASN . 96.2 m-85 -147.39 9.99 0.96 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.074 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 75.3 t80 -169.96 138.96 1.81 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.413 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -150.03 113.24 4.89 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.1 tt0 -95.98 150.53 20.36 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.156 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 19.7 m -89.36 115.96 27.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.479 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.501 -179.398 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 7.0 tp60 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -178.66 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.599 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.52 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.2 t60 -59.73 150.4 27.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 82.2 m-85 56.96 9.75 0.67 Allowed 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.856 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.33 155.29 24.14 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.176 -1.488 . . . . 0.0 112.116 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.489 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 39.9 tt0 -76.63 122.28 24.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.78 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -108.71 -23.48 11.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.57 -157.56 8.06 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 117.866 -2.111 . . . . 0.0 112.735 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 146.63 13.12 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 30' ' ' PRO . 65.9 mt -59.51 154.65 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.131 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.77 -5.92 21.45 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.762 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -94.0 112.97 24.87 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.735 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -110.6 55.36 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.283 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.35 -179.64 16.42 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.64 154.09 67.59 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.365 1.377 . . . . 0.0 110.409 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 8' ' ' CYS . 16.4 p -127.5 28.1 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.207 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.03 109.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.803 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.9 m -78.76 137.59 37.82 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.324 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.42 150.04 1.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.74 154.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.314 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.1 -15.71 58.93 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.585 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.64 176.24 7.94 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.528 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 163.16 33.65 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.49 116.55 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.131 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.56 140.41 41.95 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.846 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.47 117.67 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.551 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -81.61 -62.54 1.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.66 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -144.63 176.07 2.44 Favored Pre-proline 0 N--CA 1.501 2.076 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.523 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -69.21 23.63 0.16 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 120.674 0.916 . . . . 0.0 111.841 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' ASN . 80.0 m-85 -155.39 19.89 0.41 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.873 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -173.0 117.83 0.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.452 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.6 m -119.91 111.83 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.525 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.96 157.93 17.01 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.349 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.5 m -100.77 121.77 42.25 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.887 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.12 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.106 0.479 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.47 177.9 7.97 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.874 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.835 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -60.04 133.08 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.835 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 27.5 m-85 66.77 22.84 10.23 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.32 155.37 19.87 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.222 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -79.81 120.75 24.49 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.684 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -108.97 -27.33 9.73 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.613 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.46 -151.57 5.53 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.347 -1.882 . . . . 0.0 112.328 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 141.85 12.61 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.69 151.62 5.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.716 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.75 -15.06 44.38 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.25 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -82.87 138.64 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.471 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -131.22 27.17 4.83 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.25 -176.79 21.42 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.91 155.61 68.55 Favored 'Trans proline' 0 C--O 1.211 -0.842 0 C-N-CA 121.699 1.599 . . . . 0.0 110.865 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 8' ' ' CYS . 57.1 p -117.29 7.55 12.92 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.34 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -90.19 113.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.335 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 m -82.59 148.41 28.03 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.945 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.25 139.83 8.14 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.014 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -47.21 141.83 4.25 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.88 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.77 -27.25 21.29 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.607 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -112.87 158.96 19.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 157.99 36.89 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.454 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.7 t -87.77 111.42 21.34 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.132 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -107.33 117.79 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.116 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -53.08 132.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.333 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -94.51 -51.32 4.81 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.341 -1.344 . . . . 0.0 107.797 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.0 p30 -161.52 172.98 5.05 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.3 Cg_exo -66.94 24.93 0.11 Allowed 'Trans proline' 0 C--O 1.214 -0.706 0 CA-C-N 119.366 0.809 . . . . 0.0 112.533 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.72 14.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.176 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -172.47 130.16 0.56 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.906 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.8 m -130.17 116.23 18.15 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.468 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.3 tp-100 -100.09 150.16 22.76 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.452 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.9 m -97.19 116.59 29.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.784 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 116.306 -1.807 . . . . 0.0 109.982 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.28 177.77 7.58 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.001 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.619 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -59.94 132.32 53.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 26.5 m-85 67.98 26.38 7.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.69 153.65 17.88 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.13 108.22 13.55 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -97.53 -21.7 16.95 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.864 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.44 -155.09 6.61 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 118.544 -1.788 . . . . 0.0 111.831 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 144.77 12.58 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 30' ' ' PRO . 62.2 mt -60.57 148.51 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.995 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.9 -12.23 30.82 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.627 -1.273 . . . . 0.0 111.042 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -78.16 120.87 23.58 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.4 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 p -114.51 58.18 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.13 170.55 25.91 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.777 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.25 153.62 38.95 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.339 1.359 . . . . 0.0 110.052 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -119.56 33.3 5.68 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.609 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.9 107.15 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.116 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.7 m -74.94 143.61 43.62 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.769 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.69 148.22 0.78 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.683 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -53.08 160.5 1.01 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.121 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.29 -18.45 23.24 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -124.18 163.63 21.16 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.092 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.01 160.73 31.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.339 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -88.13 117.85 27.3 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.422 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -115.27 116.11 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.422 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.23 129.01 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.372 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.477 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -87.3 -51.36 6.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.554 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -157.37 176.08 2.84 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.2 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -68.27 24.62 0.14 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.601 0.867 . . . . 0.0 111.459 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.554 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.0 m-85 -150.52 10.34 0.65 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.739 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -173.65 127.73 0.41 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.594 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.477 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 21.7 m -125.32 115.67 20.71 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.884 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -100.32 158.4 15.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.95 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 61.1 m -98.28 123.24 42.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 116.361 -1.781 . . . . 0.0 110.289 -178.95 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 3' ' ' SER . 5.6 tp60 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.416 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.73 -172.58 2.41 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.647 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -70.61 149.94 46.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 67.5 m-85 53.59 18.05 1.34 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.681 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 152.78 21.53 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.806 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -81.65 119.43 23.81 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.55 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -107.73 -21.96 12.66 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -169.43 15.83 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.211 -1.947 . . . . 0.0 112.427 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 143.28 9.03 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -54.64 154.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.998 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.31 -11.7 48.89 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -95.56 129.56 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.304 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.5 p -137.92 57.94 1.7 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.662 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.32 -177.28 15.4 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.43 157.6 14.46 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.797 0.998 . . . . 0.0 109.664 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 8' ' ' CYS . 43.4 p -131.83 26.47 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.487 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.97 115.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.484 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.71 161.26 30.44 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.788 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.9 171.18 0.98 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.294 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -63.77 141.57 58.72 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.11 -5.72 84.64 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.584 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.05 165.09 18.09 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.15 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -140.37 162.1 36.12 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.014 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.6 t -90.27 113.32 25.14 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.1 mp0 -105.46 125.61 51.18 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.952 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.31 126.21 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.553 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -89.13 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.706 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.0 p30 -155.61 178.59 1.6 Allowed Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.804 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.4 Cg_exo -67.6 23.4 0.12 Allowed 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 120.989 1.126 . . . . 0.0 113.116 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 29' ' ' ASN . 81.6 m-85 -154.62 16.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.072 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -174.69 133.72 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.541 -1.264 . . . . 0.0 111.767 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m -136.06 113.17 10.47 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.385 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 5' ' ' TYR . 5.0 tp60 -89.56 153.71 20.56 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 20.4 m -106.69 114.14 28.07 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.168 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.449 -1.739 . . . . 0.0 109.821 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.02 -170.58 2.14 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.171 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -61.16 135.03 57.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.466 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 68.8 m-85 70.17 24.01 5.04 Favored 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.22 153.85 23.86 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.741 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 60.8 tt0 -90.19 111.13 22.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.691 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -97.95 -21.14 17.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.603 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 -156.32 7.38 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 117.938 -2.077 . . . . 0.0 112.526 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.1 131.1 6.86 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.517 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 11' ' ' ILE . 39.6 mt -46.58 145.95 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.79 9.66 84.23 Favored Glycine 0 C--N 1.292 -1.889 0 C-N-CA 119.582 -1.295 . . . . 0.0 111.202 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 80.6 t80 -110.8 126.28 54.45 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.6 p -120.5 11.02 11.28 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.43 -176.41 50.47 Favored Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -69.54 161.16 46.99 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.575 1.517 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 p -120.54 38.02 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.06 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.1 110.98 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -75.17 157.69 34.2 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.097 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -72.59 149.96 43.51 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.842 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -44.49 142.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.712 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -24.45 32.15 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.348 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -116.16 176.68 4.99 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.139 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.19 152.61 39.5 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.626 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.1 t -80.37 127.99 33.03 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.606 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -136.97 126.84 25.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.63 134.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.217 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.23 -47.67 5.37 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.3 p-10 -162.64 171.81 6.06 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.308 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -67.75 24.56 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 CA-C-N 119.624 0.902 . . . . 0.0 112.26 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 29' ' ' ASN . 57.5 m-85 -153.39 16.13 0.53 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.28 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -174.8 125.47 0.28 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.837 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -127.06 113.23 16.16 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.123 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 5.3 tp60 -93.09 149.77 20.99 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.192 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 32.1 m -102.95 110.04 21.81 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.646 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.505 2.322 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.165 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -168.11 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.186 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -73.99 132.28 42.24 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.145 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 60.5 m-85 70.43 20.12 6.11 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.447 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.88 154.9 19.26 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.491 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -75.99 119.34 19.82 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.885 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -103.2 -29.7 11.13 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.554 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -148.71 -163.5 10.91 Favored Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.002 -1.57 . . . . 0.0 111.611 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 142.71 10.54 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.8 mt -50.17 156.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.618 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 78.55 -15.69 9.16 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -89.41 131.36 35.51 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.334 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 p -126.26 18.25 7.66 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.03 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.93 -178.35 33.39 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.768 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.04 153.09 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.591 1.527 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.9 p -117.5 27.37 9.11 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.467 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.36 122.23 54.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.931 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.98 163.72 18.73 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.843 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -68.28 154.59 41.45 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.67 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 m -45.1 141.35 2.36 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.035 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.82 -8.72 76.34 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.527 -1.32 . . . . 0.0 112.254 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -133.58 169.75 16.54 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.907 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.524 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.5 OUTLIER -145.16 171.81 14.0 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.491 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -92.23 144.94 24.9 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.263 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.524 HE22 ' C ' ' A' ' 24' ' ' THR . 28.9 mp0 -139.86 116.55 10.83 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.3 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.73 103.08 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.764 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.22 -52.03 65.39 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.827 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.92 174.52 3.72 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.179 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -66.97 24.65 0.11 Allowed 'Trans proline' 0 C--O 1.211 -0.839 0 C-N-CA 120.628 0.885 . . . . 0.0 112.84 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.6 m-85 -149.51 12.53 0.81 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.28 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 33.8 t80 -170.59 134.67 1.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.496 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 14.8 m -135.98 110.53 8.58 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.584 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 36' ' ' LEU . 46.3 tt0 -87.48 154.42 20.65 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.598 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.85 109.98 21.43 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.012 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 34' ' ' GLN . 15.3 mt . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.027 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.961 ' N ' HE21 ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.93 -174.78 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.845 -178.32 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.718 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -57.38 140.66 49.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.718 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 52.4 m-85 65.64 18.18 11.13 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.01 157.03 34.9 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.82 116.34 27.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.1 p -105.06 -21.69 13.23 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.747 179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -149.83 -166.06 13.02 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 118.329 -1.891 . . . . 0.0 113.163 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.28 144.81 13.62 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -61.63 156.49 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 -2.12 55.08 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.485 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -86.26 132.46 33.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.976 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 p -129.91 36.38 4.05 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.34 -174.22 14.79 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.212 -0.994 . . . . 0.0 110.771 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.582 ' HB2' HE22 ' A' ' 2' ' ' GLN . 1.6 Cg_endo -66.93 153.96 76.18 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.754 1.636 . . . . 0.0 111.211 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.34 -6.08 21.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.745 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.35 122.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.609 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 20' ' ' ALA . 92.2 m -84.13 148.46 26.78 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.618 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 3' ' ' SER . . . -39.96 140.14 0.59 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.583 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -49.9 140.0 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.93 13.71 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.5 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -102.69 -170.73 1.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.888 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.43 173.15 12.54 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.4 t -100.12 116.58 32.48 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.919 HE22 ' H ' ' A' ' 36' ' ' LEU . 3.6 mp0 -107.41 110.07 21.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.6 t -53.77 125.65 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.179 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -56.93 2.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.27 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.5 p-10 -162.71 172.81 4.98 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 2.9 Cg_exo -66.07 25.37 0.1 OUTLIER 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.84 1.027 . . . . 0.0 113.124 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' ASN . 91.4 m-85 -153.72 13.53 0.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.16 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -175.31 137.57 0.39 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.793 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 9' ' ' GLY . 13.7 m -136.41 114.4 11.37 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 40.6 tt0 -86.42 165.64 16.17 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.794 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 64.2 m -113.24 128.38 56.46 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.679 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.919 ' H ' HE22 ' A' ' 26' ' ' GLN . 93.8 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.48 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.704 0.288 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -162.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.444 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.461 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -72.94 134.74 44.87 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.051 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.461 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 36.3 m-85 69.04 16.84 8.65 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.29 155.73 30.04 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.417 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -86.93 110.04 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.0 -17.98 23.24 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.939 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.62 -165.69 12.35 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 118.529 -1.796 . . . . 0.0 111.504 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.27 130.53 5.25 Favored Glycine 0 C--N 1.301 -1.415 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 30' ' ' PRO . 47.9 mt -51.9 144.14 3.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.799 -1.161 . . . . 0.0 110.757 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.43 65.14 Favored Glycine 0 CA--C 1.548 2.095 0 C-N-CA 119.869 -1.158 . . . . 0.0 111.876 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -83.93 113.19 20.8 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -106.75 55.41 0.66 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.711 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.13 172.98 22.13 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.62 145.31 82.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.136 1.224 . . . . 0.0 110.832 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 8' ' ' CYS . 23.3 p -107.18 30.49 6.16 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.03 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -116.06 119.7 62.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.661 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.1 m -79.63 164.64 23.64 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.64 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -65.68 168.08 8.2 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.979 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.02 147.94 52.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.777 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.05 26.61 Favored Glycine 0 C--N 1.297 -1.634 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -107.99 178.73 4.43 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.504 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.83 162.45 41.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.89 127.35 39.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.093 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.27 112.63 15.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.146 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.67 130.63 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.623 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -92.91 -54.98 3.52 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -154.53 175.34 3.14 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.7 Cg_exo -70.24 24.09 0.19 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.439 0.759 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.7 m-85 -149.55 10.82 0.76 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.131 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -174.74 128.81 0.32 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.806 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 70.4 m -131.68 113.56 13.73 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.413 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.1 tt0 -89.61 151.01 22.13 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 124.67 1.231 . . . . 0.0 112.693 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.8 m -105.72 111.34 23.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.555 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 116.386 -1.769 . . . . 0.0 109.95 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 3' ' ' SER . 10.4 tp60 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -132.3 163.92 27.59 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.754 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 1.6 t60 -53.33 141.71 23.45 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.414 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 47.3 m-85 58.34 22.88 9.87 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.729 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 153.48 19.69 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -81.7 115.58 21.01 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.797 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.67 -31.05 13.99 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.882 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.36 -174.32 22.8 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.47 -1.824 . . . . 0.0 112.377 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 117.81 129.08 4.08 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.7 mt -40.55 154.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.457 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.7 31.29 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.661 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -87.45 141.78 28.37 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.318 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 14' ' ' SER . 54.2 p -138.62 56.29 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.0 177.32 23.53 Favored Glycine 0 N--CA 1.479 1.502 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.706 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.72 157.38 42.79 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.125 1.216 . . . . 0.0 109.747 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' CYS . 79.1 p -118.99 2.79 11.52 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.015 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.09 108.59 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.596 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.9 156.93 37.62 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.871 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.83 170.19 2.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.188 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.35 155.43 37.37 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.821 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.03 37.11 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.296 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.11 169.33 12.9 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.42 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.47 154.71 42.53 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.459 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -80.18 141.76 35.37 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.544 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -137.17 107.5 6.44 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 27' ' ' VAL . 3.3 t -60.59 115.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.432 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -52.3 8.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.2 m120 -153.43 176.12 2.62 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_exo -69.0 24.25 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.771 0.981 . . . . 0.0 112.007 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.7 m-85 -149.65 14.75 0.85 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.08 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -173.13 130.76 0.48 Allowed 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.399 -1.32 . . . . 0.0 111.748 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -136.89 111.62 8.76 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -96.53 147.79 23.49 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.847 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 70.8 m -101.63 111.53 23.81 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.413 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 116.381 -1.771 . . . . 0.0 109.772 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 172.53 6.76 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.431 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.54 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -55.75 128.04 32.94 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.548 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.7 m-85 75.93 23.89 1.28 Allowed 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.975 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.02 140.32 14.81 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.042 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.3 114.89 5.7 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.667 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.879 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -101.57 -24.69 14.09 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.22 16.58 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.592 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.58 130.66 5.43 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 30' ' ' PRO . 60.7 mt -44.87 154.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.333 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.77 -16.16 21.85 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.634 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -91.19 131.17 36.9 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.397 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 p -127.02 51.49 1.87 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.089 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.56 174.15 20.85 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.95 156.62 23.15 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.217 1.278 . . . . 0.0 110.415 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 8' ' ' CYS . 62.4 p -121.66 15.26 11.05 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.845 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -80.44 119.27 29.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.4 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 24' ' ' THR . 8.0 m -83.17 141.57 31.84 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.9 149.02 1.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -51.69 143.18 13.2 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.522 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.57 -20.09 46.65 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.004 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.15 167.14 12.99 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.982 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -135.77 166.76 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.594 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -85.43 124.91 32.56 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.729 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -115.4 109.96 18.65 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.8 110.43 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.817 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.12 -59.37 2.77 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.009 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -141.79 175.6 2.9 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.227 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -68.87 24.38 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.59 0.86 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.5 m-85 -148.4 11.82 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 50.3 t80 -169.83 136.26 1.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.078 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 m -143.26 113.34 7.2 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.154 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -98.4 149.0 23.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.879 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.1 m -84.58 115.56 22.69 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.919 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 116.321 -1.8 . . . . 0.0 110.269 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' ALA . 8.9 tp60 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.777 0.322 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.73 170.28 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.576 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.739 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t60 -52.25 150.15 4.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.362 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.739 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 56.6 m-85 56.99 11.94 1.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.71 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.55 156.37 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.469 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.49 109.78 10.49 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -97.04 -22.89 16.54 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.248 177.779 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.0 -179.91 25.28 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 118.932 -1.604 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 127.74 2.86 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.355 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 11' ' ' ILE . 30.4 mt -48.9 148.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.486 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.54 54.75 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.998 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -79.64 147.45 32.03 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.308 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -137.24 44.13 2.3 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.77 175.24 20.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.18 160.7 25.5 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.176 1.251 . . . . 0.0 110.573 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 61.7 p -121.12 21.91 11.1 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.699 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.43 113.51 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.885 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.66 150.05 46.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.339 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -54.05 141.38 28.61 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.105 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ALA . 4.5 m -42.33 139.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 -25.13 29.01 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.09 167.24 11.65 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.374 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.507 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.7 OUTLIER -131.04 -177.59 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.542 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -102.14 125.85 48.95 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.022 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 24' ' ' THR . 24.4 mp0 -124.68 121.89 35.96 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.492 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.22 146.67 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.16 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -110.66 -56.38 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -153.68 177.47 1.96 Allowed Pre-proline 0 N--CA 1.508 2.455 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.167 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 Cg_exo -68.43 23.5 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.88 1.053 . . . . 0.0 112.066 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.509 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.5 m-85 -153.73 14.08 0.48 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.101 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -172.53 127.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.812 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.1 m -127.17 114.16 17.32 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.04 159.85 20.13 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.699 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -100.58 125.85 47.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.86 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 4' ' ' HIS . 79.1 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.157 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.27 -166.69 1.53 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.612 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.542 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -73.5 139.47 45.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.217 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.542 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 84.4 m-85 66.51 20.81 10.85 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.65 155.46 20.5 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.42 102.66 6.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.615 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -94.09 -10.12 34.39 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.599 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.26 179.23 38.55 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 117.867 -2.111 . . . . 0.0 111.947 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.06 153.72 8.04 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 30' ' ' PRO . 52.7 mt -67.39 151.95 10.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.04 -5.18 20.02 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.775 -1.202 . . . . 0.0 111.516 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.6 126.27 37.61 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.605 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.4 p -120.27 36.22 4.62 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.34 -178.18 21.93 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.739 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.36 162.15 15.26 Favored 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.375 1.384 . . . . 0.0 109.69 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 8' ' ' CYS . 35.7 p -132.38 5.67 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.044 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 124.48 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.764 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 24' ' ' THR . 61.8 m -77.53 156.28 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 165.37 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.562 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -56.17 150.22 14.57 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.925 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.58 -22.57 2.67 Favored Glycine 0 N--CA 1.48 1.624 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.986 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -105.64 158.48 16.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.956 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.431 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -131.58 174.22 10.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.535 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -100.41 127.07 46.83 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.392 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.904 HE22 ' H ' ' A' ' 36' ' ' LEU . 4.1 mp0 -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.41 108.49 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.06 -46.74 67.07 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.284 -1.366 . . . . 0.0 107.508 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -163.56 173.75 3.95 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.457 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.2 Cg_exo -66.88 24.64 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.817 0 C-N-CA 121.238 1.292 . . . . 0.0 113.199 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.3 m-85 -152.39 18.35 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.459 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 43.9 t80 -175.51 135.2 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.574 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -138.42 112.4 8.49 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.049 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 0.7 OUTLIER -92.14 146.29 23.84 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.608 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.7 m -85.48 116.53 23.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.145 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.904 ' H ' HE22 ' A' ' 26' ' ' GLN . 70.8 mt . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.746 HE22 ' HA ' ' A' ' 8' ' ' CYS . 1.3 tt0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.17 176.46 5.24 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.699 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.733 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.1 t60 -61.46 140.37 58.08 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.733 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 24.8 m-85 69.88 11.62 7.78 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.98 155.5 34.98 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.528 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.454 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 42.1 tt0 -78.06 104.97 8.97 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.66 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.746 ' HA ' HE22 ' A' ' 2' ' ' GLN . 1.6 p -89.79 -16.23 30.67 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.53 -156.74 9.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 117.862 -2.114 . . . . 0.0 112.425 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.27 144.46 16.94 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.196 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -49.16 153.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.292 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.38 79.79 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.087 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.12 109.64 13.72 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.886 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.5 p -109.05 21.23 17.45 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.275 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.27 178.99 42.03 Favored Glycine 0 N--CA 1.483 1.789 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.691 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.31 157.17 51.54 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.347 1.365 . . . . 0.0 109.79 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 8' ' ' CYS . 40.4 p -119.79 8.46 11.15 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.804 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.62 109.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.224 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.9 m -69.11 168.62 13.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.69 174.86 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -68.4 140.92 55.83 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -11.36 52.22 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.575 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -107.23 169.12 8.76 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.179 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.5 177.37 7.98 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -100.32 147.84 25.35 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.539 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' OE1' ' N ' ' A' ' 36' ' ' LEU . 24.9 mp0 -145.2 125.38 13.74 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.035 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.23 110.28 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.572 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.98 -58.31 3.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.105 -1.438 . . . . 0.0 108.248 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.7 p30 -151.22 174.37 3.62 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.919 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.606 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.8 Cg_exo -64.73 24.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 120.952 1.101 . . . . 0.0 113.509 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.8 m-85 -153.95 20.48 0.51 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.02 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -175.24 131.24 0.29 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.318 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.9 m -131.57 106.75 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.957 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -86.25 153.25 22.14 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.775 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.46 128.19 43.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.629 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 75.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.079 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.49 174.02 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.811 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.663 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -53.77 135.11 41.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.663 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 61.7 m-85 69.53 18.73 7.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.98 142.07 18.9 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.85 120.27 19.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.714 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -108.6 -15.53 14.4 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.922 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 -155.91 7.4 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 118.095 -2.003 . . . . 0.0 112.151 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.46 128.21 3.74 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.9 mt -46.67 152.25 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.699 -1.2 . . . . 0.0 110.506 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.25 -7.36 78.75 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.61 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -97.11 130.65 44.36 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.755 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.4 p -124.86 61.09 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.88 177.97 23.0 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.02 155.22 45.93 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.105 1.203 . . . . 0.0 110.414 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 8' ' ' CYS . 66.7 p -118.34 32.66 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.73 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -105.07 123.52 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.943 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 24' ' ' THR . 58.8 m -88.24 143.25 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.847 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 168.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.765 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 p -59.13 144.7 44.91 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.064 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.22 -15.42 53.92 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.907 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.0 166.27 11.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.681 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.408 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -136.55 175.25 9.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.97 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -96.73 121.1 38.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.606 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -121.39 132.6 54.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.37 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -85.95 143.02 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.578 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 tp -107.86 -59.91 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -139.44 175.14 3.44 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.97 24.65 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.538 0.825 . . . . 0.0 111.073 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' H ' ' C ' ' A' ' 29' ' ' ASN . 82.9 m-85 -150.6 10.16 0.64 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -163.67 122.06 1.93 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.537 -1.265 . . . . 0.0 112.229 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -131.29 112.64 12.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.099 -1.04 . . . . 0.0 109.466 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -91.09 153.41 20.11 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.662 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -92.9 112.56 24.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.157 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.355 -179.165 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 163.87 31.71 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.01 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -47.08 137.37 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.446 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 49.3 m-85 62.47 34.23 15.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.9 150.03 18.19 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.364 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.69 102.55 10.79 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.285 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -89.9 -25.14 21.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.298 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.78 -176.27 25.16 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.363 -1.875 . . . . 0.0 112.305 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.95 133.74 4.05 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 66.5 mt -44.92 148.11 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.336 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.02 -17.4 22.64 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.775 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -80.37 139.43 36.54 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.422 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -131.5 10.13 4.76 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.998 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 177.9 46.76 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.779 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.52 155.29 69.67 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.488 1.459 . . . . 0.0 110.807 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.4 p -111.62 30.15 7.22 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.887 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.93 111.47 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.434 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -77.47 145.87 36.79 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -44.52 144.17 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.891 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -48.86 141.02 7.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.131 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -27.11 22.12 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.967 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -110.21 169.86 8.45 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.424 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 154.78 47.77 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.603 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.8 t -75.24 143.2 43.2 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.091 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -143.06 106.72 4.63 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.117 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.39 131.29 5.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.954 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -48.95 4.23 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.1 p-10 -162.18 170.4 7.96 Favored Pre-proline 0 CA--C 1.565 1.556 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.666 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.9 Cg_exo -67.72 25.06 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.708 0.939 . . . . 0.0 112.798 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 71.0 m-85 -155.27 16.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.506 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -175.18 132.39 0.31 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.689 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -135.8 113.94 11.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.894 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.6 tp-100 -94.69 149.04 21.65 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.396 1.06 . . . . 0.0 112.072 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.3 m -104.89 122.62 46.18 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.88 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 116.351 -1.785 . . . . 0.0 109.988 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 28.0 tp60 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.33 171.84 7.72 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.774 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.758 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.0 t60 -56.65 158.18 4.76 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.758 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 78.1 m-85 48.89 18.21 0.19 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.466 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -89.64 153.73 23.47 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.863 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -80.22 110.7 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.011 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.672 ' O ' HG22 ' A' ' 17' ' ' THR . 1.0 OUTLIER -94.65 -15.57 23.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.57 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 -176.46 26.53 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 118.429 -1.843 . . . . 0.0 112.14 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.25 143.21 5.33 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.88 142.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.117 -1.433 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.51 -5.84 63.01 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.497 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.39 108.3 17.78 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 p -101.88 46.68 0.92 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.009 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.84 166.01 15.37 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.568 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.39 162.81 0.78 Allowed 'Trans proline' 0 C--O 1.207 -1.067 0 C-N-CA 121.265 1.31 . . . . 0.0 110.206 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' CYS . 22.9 p -125.61 -3.72 7.22 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.683 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 t -78.57 122.89 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.208 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -77.2 154.91 32.63 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.077 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -58.9 163.48 3.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.916 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -60.27 155.74 17.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.605 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -6.86 24.73 Favored Glycine 0 N--CA 1.481 1.679 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.452 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.43 163.79 25.07 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.666 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.63 176.74 8.19 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.788 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.43 141.65 29.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.931 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.85 112.21 9.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.671 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.405 HG13 ' OG ' ' A' ' 33' ' ' SER . 2.4 t -74.91 113.05 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 33' ' ' SER . 6.2 tp -78.21 -56.74 4.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.302 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.5 m120 -150.09 174.19 3.69 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.2 23.63 0.22 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.493 0.795 . . . . 0.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -144.62 8.03 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.528 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -169.51 132.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.104 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 67.5 m -141.16 108.96 5.66 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.028 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -85.27 157.94 20.45 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.731 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 6' ' ' GLY . 1.5 m -101.53 115.43 30.49 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.375 -1.774 . . . . 0.0 109.344 179.556 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.9 mp0 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.9 -176.55 3.21 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.789 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -60.75 136.11 57.97 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.222 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.789 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 35.4 m-85 68.67 13.0 8.86 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 123.39 0.431 . . . . 0.0 110.127 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 154.95 34.9 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.435 -1.364 . . . . 0.0 111.797 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -82.28 118.95 23.51 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.878 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -111.05 -16.14 13.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.484 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.69 -162.15 10.87 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.156 -1.973 . . . . 0.0 112.315 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.23 138.54 10.16 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.452 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.447 HD12 ' O ' ' A' ' 30' ' ' PRO . 53.8 mt -49.61 146.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.884 -1.127 . . . . 0.0 110.027 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.86 14.45 64.94 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.009 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -121.19 119.76 33.27 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.021 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.2 p -117.42 57.9 0.8 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.594 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.36 174.76 22.73 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.514 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.0 154.67 49.28 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.244 1.296 . . . . 0.0 110.137 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.1 p -112.64 5.23 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.709 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.69 116.29 20.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.989 -1.085 . . . . 0.0 109.323 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -83.31 164.57 19.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.327 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.57 156.6 10.39 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.8 m -58.62 144.45 43.04 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.781 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.03 -15.21 63.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.928 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -117.84 -177.86 3.35 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.682 -179.368 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.17 171.29 15.15 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.855 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.478 ' C ' ' NE2' ' A' ' 26' ' ' GLN . 11.3 t -100.61 114.15 27.58 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.094 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.528 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -105.58 118.36 36.39 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.862 178.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.66 130.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.566 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.37 -56.43 2.94 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.146 -1.422 . . . . 0.0 109.144 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.2 p30 -154.39 176.53 2.44 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.131 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -65.98 25.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.958 1.106 . . . . 0.0 112.812 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -152.68 15.85 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.642 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -175.27 135.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.599 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.6 m -136.51 113.68 10.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -82.6 164.05 21.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.368 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 21.3 m -111.26 112.94 25.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.714 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 23' ' ' THR . 20.5 mt . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 116.472 -1.728 . . . . 0.0 110.189 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -127.61 174.68 8.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.9 179.535 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.821 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.7 t60 -50.91 144.18 9.0 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.178 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.821 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 25.7 m-85 62.65 15.41 7.99 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.177 -177.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.4 150.6 31.85 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.737 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -85.3 103.8 14.57 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.755 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -90.05 -16.79 29.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.255 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.93 -176.34 29.87 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.305 -1.902 . . . . 0.0 112.359 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.54 130.57 3.31 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 120.056 -1.068 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 30' ' ' PRO . 41.4 mt -46.9 148.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.252 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.2 -9.16 27.9 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.369 -1.396 . . . . 0.0 111.05 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -88.78 130.32 35.39 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 p -130.19 62.35 1.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.38 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.3 173.41 23.04 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.79 154.55 12.38 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 N-CA-C 109.473 -1.01 . . . . 0.0 109.473 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.0 p -122.06 18.14 10.84 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.817 -178.424 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -91.82 125.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.424 -0.91 . . . . 0.0 108.904 178.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 67.2 m -80.87 157.14 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.392 -179.029 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.98 151.97 11.0 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 m -56.93 139.68 51.0 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.031 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.29 -20.1 39.29 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.28 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -112.21 161.59 16.4 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.35 30.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 t -80.74 107.39 13.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.164 -179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -106.84 108.88 20.6 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.274 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -49.65 141.37 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -106.05 -57.82 1.99 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.59 HD22 HD12 ' A' ' 28' ' ' LEU . 11.4 p30 -155.76 172.32 6.16 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.121 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.8 Cg_exo -68.94 23.76 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 120.972 1.115 . . . . 0.0 113.127 -176.806 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' H ' ' C ' ' A' ' 29' ' ' ASN . 66.4 m-85 -154.16 18.07 0.49 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.183 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 40.8 t80 -174.45 128.24 0.34 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.399 -177.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m -125.59 115.74 20.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.4 tp60 -93.32 150.62 20.34 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.198 0.937 . . . . 0.0 112.691 -177.028 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 m -102.24 116.26 32.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.799 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.133 -178.651 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -136.26 171.59 14.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.044 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.779 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.8 t60 -57.15 149.37 19.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.779 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 50.0 m-85 53.72 26.74 6.19 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.221 -178.156 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.67 149.8 17.39 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.824 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.7 117.61 18.5 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.435 ' O ' HG22 ' A' ' 17' ' ' THR . 1.3 p -105.81 -24.98 12.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.77 -154.09 6.56 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.592 -1.766 . . . . 0.0 112.23 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 151.6 23.2 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -178.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -61.83 153.37 5.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.945 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.54 35.27 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.801 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -88.58 135.64 33.39 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -133.96 41.24 3.02 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.47 173.69 16.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.37 158.33 23.19 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.379 1.386 . . . . 0.0 110.095 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 8' ' ' CYS . 11.9 p -127.36 29.4 5.55 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.976 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.46 109.45 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.194 178.336 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' C ' ' A' ' 24' ' ' THR . 52.4 m -70.87 157.01 38.87 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.085 -178.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.56 169.49 0.2 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.5 m -63.64 143.24 57.99 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.923 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.51 -15.47 40.75 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.429 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.34 169.27 8.99 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.709 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.446 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.591 179.709 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 t -92.75 142.87 26.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.292 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -139.31 123.98 18.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.906 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.79 131.59 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.988 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.96 -57.26 2.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.0 m120 -143.1 173.54 4.44 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -70.1 25.11 0.18 Allowed 'Trans proline' 0 C--O 1.212 -0.787 0 CA-C-N 119.319 0.792 . . . . 0.0 111.107 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 29' ' ' ASN . 72.0 m-85 -152.06 20.87 0.67 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.206 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 62.3 t80 -175.46 125.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.71 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 m -130.92 113.96 14.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.175 177.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 9.2 tt0 -101.36 159.53 15.19 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.914 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -97.03 128.63 44.18 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.051 179.376 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.109 -178.501 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 162.77 25.93 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.684 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -51.3 128.69 22.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.371 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.684 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 54.8 m-85 72.22 20.31 4.21 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 123.912 0.758 . . . . 0.0 109.78 -178.202 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.55 154.98 22.45 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.92 117.13 21.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.125 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -107.91 -15.91 14.43 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.96 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.27 -178.6 24.42 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 118.0 -2.047 . . . . 0.0 111.729 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.78 154.01 7.81 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.84 137.67 22.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.045 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.86 -20.6 11.77 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.572 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -69.26 100.37 1.31 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.595 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.6 p -92.01 16.04 12.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.592 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.41 177.46 50.28 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.729 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.41 153.98 62.14 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.578 1.519 . . . . 0.0 110.243 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -119.89 20.03 12.28 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.31 -177.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.51 112.22 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.352 178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.92 175.31 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.27 173.72 10.48 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.115 178.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.4 m -66.52 143.74 56.89 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.917 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.09 -15.81 19.88 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.972 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.32 162.43 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.494 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 166.81 22.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.867 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.1 127.01 43.8 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.264 -179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -126.74 117.32 22.45 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.753 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.27 136.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.164 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.437 HD12 HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -97.01 -53.46 3.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.704 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -153.42 177.07 2.1 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.44 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.53 24.17 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.534 0.822 . . . . 0.0 111.156 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' ASN . 37.1 m-85 -151.0 0.15 0.39 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.756 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -159.83 138.21 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.426 -178.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 m -135.7 118.71 16.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.227 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 146.12 24.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.497 1.123 . . . . 0.0 113.16 -177.078 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 8.8 m -95.52 116.49 28.9 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 116.413 -1.756 . . . . 0.0 110.055 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.3 tp60 . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.58 -179.61 3.73 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.426 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.478 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.7 t60 -66.99 142.37 57.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.478 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 72.9 m-85 59.65 27.84 17.15 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.345 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.62 156.37 20.64 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.999 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -86.87 117.09 25.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.157 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -102.32 -21.87 14.23 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.776 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.37 -169.13 15.51 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.473 -179.229 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.76 132.47 5.52 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 30' ' ' PRO . 97.7 mt -50.23 155.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.45 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.17 -18.45 13.51 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.191 -178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.7 148.11 28.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.978 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 p -141.1 11.07 2.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.514 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.66 -175.81 49.46 Favored Glycine 0 N--CA 1.478 1.473 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.16 154.2 70.46 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.525 1.483 . . . . 0.0 109.866 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 8' ' ' CYS . 30.4 p -115.9 15.44 16.27 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.53 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.41 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.679 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -73.62 149.58 41.94 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.547 -179.058 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -51.5 165.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.306 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.5 m -62.08 141.23 58.23 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.75 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.86 72.91 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.724 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.37 178.51 6.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.368 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.63 173.98 11.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.754 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 t -100.08 129.91 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.194 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.41 117.4 22.09 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.816 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.19 142.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.079 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.5 -56.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.209 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.9 m120 -144.01 175.41 2.84 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -69.36 24.64 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 CA-C-N 119.126 0.723 . . . . 0.0 111.356 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.7 m-85 -148.24 6.15 0.76 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -162.85 139.64 7.58 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.218 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -143.97 114.39 7.53 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.474 176.817 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -88.07 164.07 15.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.101 -178.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -108.48 118.23 36.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.416 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 116.325 -1.798 . . . . 0.0 109.641 -179.889 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 4.1 tp60 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.504 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -141.66 174.1 10.88 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.713 -179.735 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 20.4 t-160 -53.83 135.32 42.02 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.109 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.457 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 52.1 m-85 60.22 23.83 13.2 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.441 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.17 143.47 16.17 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 22.7 tt0 -67.43 111.62 4.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.347 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -94.92 -21.84 18.38 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.488 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.06 -175.14 24.17 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 118.321 -1.895 . . . . 0.0 112.342 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.21 137.69 4.81 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 30' ' ' PRO . 70.3 mt -47.9 151.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.08 7.36 66.68 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.957 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.54 128.0 44.7 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -119.87 56.56 0.95 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.015 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.81 179.96 18.35 Favored Glycine 0 N--CA 1.487 2.081 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.969 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.34 158.4 55.3 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.69 1.593 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.7 p -121.96 11.75 10.35 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.555 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.27 117.2 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.107 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 24' ' ' THR . 97.6 m -77.24 145.06 37.78 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.492 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.84 163.2 5.93 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.841 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 m -54.44 147.28 14.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.25 -18.8 38.92 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.069 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.593 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -122.3 172.44 8.31 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.493 0.663 . . . . 0.0 111.218 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.46 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -149.22 162.4 40.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.378 179.718 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.67 136.2 33.12 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.448 -178.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -130.22 116.54 18.55 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.172 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.23 118.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.561 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -84.6 -57.66 3.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.151 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.16 178.37 1.64 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.476 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.1 Cg_exo -69.76 24.01 0.17 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.734 0.956 . . . . 0.0 111.132 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' ASN . 76.7 m-85 -152.16 11.35 0.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 33' ' ' SER . 4.7 t80 -173.15 138.56 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.682 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 66.9 m -139.71 115.9 10.46 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.239 178.018 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.7 tt0 -90.77 152.5 20.77 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.916 -176.957 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.21 103.17 14.62 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.31 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.593 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.9 mm? . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.364 -1.779 . . . . 0.0 109.562 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 -179.48 5.11 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.704 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.3 t60 -67.64 136.24 54.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.704 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 45.1 m-85 65.81 20.54 11.45 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.878 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.37 148.85 19.1 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.44 115.28 16.03 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' THR . 5.8 p -95.5 -19.06 20.14 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.379 179.127 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.55 -170.26 27.12 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.237 -1.935 . . . . 0.0 112.656 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.66 134.41 4.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 30' ' ' PRO . 30.8 mt -43.88 142.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.667 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.42 -17.54 53.69 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.687 -1.244 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.7 159.82 22.51 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.636 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 p -144.33 3.57 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.949 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.0 173.34 39.5 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.624 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.51 165.1 8.18 Favored 'Trans proline' 0 C--O 1.209 -0.959 0 C-N-CA 121.596 1.531 . . . . 0.0 110.215 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.1 p -128.17 14.45 6.73 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.14 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.8 114.73 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.662 178.386 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 24' ' ' THR . 64.2 m -77.28 147.43 36.29 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.329 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.23 170.34 0.22 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -60.53 148.18 38.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.614 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.97 44.49 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.379 179.709 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.19 165.45 17.57 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.458 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.443 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -143.49 165.91 26.26 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.608 179.825 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.2 t -82.28 128.06 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.75 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -120.72 115.51 23.46 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.094 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.93 121.41 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.599 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tp -90.22 -57.35 2.87 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.753 -1.179 . . . . 0.0 109.427 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.8 p30 -157.49 176.84 2.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.032 -178.26 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 4.1 Cg_exo -66.58 27.6 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 120.958 1.106 . . . . 0.0 112.989 -177.1 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.8 m-85 -154.75 14.84 0.42 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.947 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -174.87 140.7 0.57 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.661 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -143.9 113.25 6.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.11 158.27 17.37 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.794 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -99.77 112.82 25.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.007 178.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.236 179.669 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.01 -174.92 3.1 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.743 -178.226 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.724 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t60 -61.65 158.07 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.079 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.724 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 28.0 m-85 48.7 21.53 0.43 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.561 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 155.46 19.12 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.598 -1.287 . . . . 0.0 111.962 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -83.66 121.02 26.7 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.163 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' O ' HG22 ' A' ' 17' ' ' THR . 1.5 p -107.46 -27.96 10.11 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.656 179.125 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.38 -148.97 4.87 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.222 -1.942 . . . . 0.0 112.872 -178.515 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.04 134.25 7.58 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -178.226 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.1 mt -51.37 152.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.976 -178.855 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -11.29 47.87 Favored Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.346 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -86.26 130.5 34.5 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.6 p -121.09 62.32 0.89 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.624 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.84 -175.74 19.16 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.642 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.69 159.2 53.75 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.493 1.462 . . . . 0.0 109.909 179.05 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 8' ' ' CYS . 81.4 p -122.66 30.94 6.26 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.581 -178.183 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.42 116.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.394 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.2 m -82.01 155.79 24.98 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.09 151.66 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.341 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -49.56 141.77 9.02 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.077 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 -26.44 21.1 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.093 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.51 165.81 12.36 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.102 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.91 160.16 39.45 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.764 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.42 102.31 5.92 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.229 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -95.48 108.99 21.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.606 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.7 135.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.412 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -102.19 -55.5 2.46 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.8 p30 -154.14 173.42 4.73 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.474 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -66.87 24.99 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.504 0.859 . . . . 0.0 112.035 -177.879 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 47.4 m-85 -150.38 -5.65 0.32 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.611 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CD2' ' HG ' ' A' ' 28' ' ' LEU . 6.3 t80 -152.54 132.41 13.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.409 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -127.79 112.28 14.6 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.925 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -89.83 155.33 19.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.121 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -99.83 113.2 25.56 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.533 178.899 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 116.385 -1.769 . . . . 0.0 109.934 179.206 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -177.42 3.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.88 -179.432 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -70.27 127.93 34.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.606 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 68.5 m-85 79.87 18.32 0.7 Allowed 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.052 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.1 154.46 20.5 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.869 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.85 114.33 17.7 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.453 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -99.26 -19.25 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.98 -167.02 13.51 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.276 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.95 146.91 10.38 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.198 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.6 mt -59.34 153.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.094 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -12.81 39.87 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.101 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -88.19 152.97 21.6 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.642 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.4 p -148.59 13.32 0.93 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.944 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.81 -172.73 43.97 Favored Glycine 0 N--CA 1.483 1.783 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.76 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.76 160.44 32.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.306 1.337 . . . . 0.0 110.252 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -128.96 27.62 5.41 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.059 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -105.7 120.42 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.99 178.684 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.4 m -80.27 145.48 32.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.986 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -50.1 145.24 6.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.74 178.757 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -50.01 141.67 10.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.007 -179.281 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.45 -26.89 22.62 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.339 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.669 HG22 ' OXT' ' A' ' 36' ' ' LEU . 1.1 p -105.92 -173.46 2.3 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.28 157.37 43.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.724 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.79 136.25 33.06 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.428 -1.309 . . . . 0.0 109.301 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -136.53 120.62 17.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.392 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.24 118.46 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.639 178.635 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -84.28 -56.82 3.44 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.674 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.534 HD22 HD12 ' A' ' 28' ' ' LEU . 4.3 p30 -149.06 171.59 6.13 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.08 26.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 119.41 0.825 . . . . 0.0 111.95 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 83.3 m-85 -154.39 14.97 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.416 ' HB3' HD21 ' A' ' 29' ' ' ASN . 74.6 t80 -173.8 126.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 17.7 m -126.85 111.49 14.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.665 178.148 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.6 tp60 -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.767 1.292 . . . . 0.0 112.561 -176.939 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.9 m -99.66 105.94 17.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.998 179.331 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.669 ' OXT' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 116.269 -1.824 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 4' ' ' HIS . 0.3 OUTLIER -109.69 170.45 8.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.694 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.812 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -40.98 130.29 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.47 -179.764 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.812 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.8 m-85 68.53 40.75 1.85 Allowed 'General case' 0 N--CA 1.511 2.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.26 -178.468 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.12 152.62 17.3 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.78 100.85 11.19 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.161 179.521 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -89.85 -17.51 27.96 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.43 -159.21 8.75 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.944 -2.074 . . . . 0.0 112.675 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 106.09 124.57 5.33 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -178.571 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 10' ' ' GLY . 96.4 mt -41.67 147.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.966 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.52 31.6 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.879 -1.153 . . . . 0.0 111.411 -179.247 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.32 114.11 21.63 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 p -108.11 17.47 22.27 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.78 176.73 42.96 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.594 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.64 158.65 44.96 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.453 1.435 . . . . 0.0 110.234 179.389 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.7 p -119.22 16.4 13.16 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.582 -178.322 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -95.03 118.78 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.459 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 m -84.99 152.93 23.1 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.076 -1.049 . . . . 0.0 109.949 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.7 137.0 58.17 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ALA . 3.3 m -41.36 145.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.39 -24.02 30.06 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -120.98 -171.63 2.23 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.558 0.694 . . . . 0.0 110.473 179.69 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.88 162.12 41.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.92 136.53 34.05 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.904 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -132.64 139.07 47.57 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.499 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.98 123.29 35.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -88.1 -56.39 3.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -154.87 174.78 3.57 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.04 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.4 Cg_exo -64.78 24.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.211 -0.825 0 C-N-CA 121.005 1.137 . . . . 0.0 112.769 -179.138 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.2 m-85 -154.9 14.03 0.4 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.204 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -172.43 125.79 0.51 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.701 -178.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 72.2 m -126.84 115.43 19.31 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.342 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG2' HD11 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -93.92 149.32 21.34 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.669 -177.641 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.444 ' C ' HD22 ' A' ' 36' ' ' LEU . 55.0 m -103.42 117.2 33.91 Favored 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.066 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 116.308 -1.805 . . . . 0.0 110.173 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.4 tt0 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 160.28 32.86 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.956 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.514 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.2 t60 -46.62 132.67 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.37 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 25.2 m-85 72.58 24.62 2.8 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.526 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.44 144.54 17.16 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 38.1 tt0 -76.13 96.37 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.614 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.847 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -88.56 -12.0 44.0 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.663 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.53 -160.96 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.047 -2.025 . . . . 0.0 112.181 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.26 149.64 23.11 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.489 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 30' ' ' PRO . 81.9 mt -69.73 157.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.455 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.74 -3.29 35.91 Favored Glycine 0 N--CA 1.484 1.89 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.338 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 16.7 t80 -85.1 154.24 22.18 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -146.8 57.26 1.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.463 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.64 177.26 24.15 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.331 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.48 164.64 6.92 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.13 1.22 . . . . 0.0 109.799 179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.8 p -127.15 29.33 5.61 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.326 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.89 120.9 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.913 179.131 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 24' ' ' THR . 10.3 m -77.67 142.33 38.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -45.6 168.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.04 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.11 149.99 46.49 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.512 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.1 -15.14 57.07 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.497 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -114.9 -175.2 2.64 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.032 -179.715 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.451 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -150.96 162.46 40.77 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.53 179.631 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.2 t -92.37 124.61 36.55 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.494 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 24' ' ' THR . 28.9 mp0 -125.42 128.52 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.787 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.59 142.12 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HG ' ' CD2' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -108.42 -56.72 2.22 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.886 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.0 p-10 -161.36 171.87 6.39 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.9 Cg_exo -67.25 24.24 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.601 0.867 . . . . 0.0 112.817 -176.789 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 29' ' ' ASN . 62.3 m-85 -150.54 14.21 0.76 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' HG ' ' A' ' 28' ' ' LEU . 6.0 t80 -175.34 134.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 -179.27 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -132.74 114.33 14.02 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -90.62 156.08 18.38 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.986 -176.974 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.2 m -104.04 131.03 51.71 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.048 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 70.6 mt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 116.404 -1.76 . . . . 0.0 109.875 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -175.71 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.123 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.9 t60 -68.06 147.51 52.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 54.4 m-85 55.52 26.13 8.67 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.444 -177.975 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.93 145.92 18.07 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -77.05 116.94 18.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -17.37 14.49 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.816 179.715 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.48 -168.54 15.51 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 118.641 -1.743 . . . . 0.0 111.873 -179.308 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.81 133.91 5.59 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 30' ' ' PRO . 63.0 mt -46.55 147.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.01 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.41 -11.42 24.71 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.816 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -82.37 110.65 17.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 p -111.43 59.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.432 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.81 179.46 18.2 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.713 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.18 149.06 91.96 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.432 1.421 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.2 p -110.61 -12.6 14.32 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.536 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 t -76.77 108.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.43 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.65 156.86 38.93 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.664 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -52.92 152.3 4.06 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.224 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.11 152.24 4.38 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.94 -17.04 55.36 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.745 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -120.77 -179.94 4.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.227 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 163.25 37.4 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.085 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -89.72 138.37 31.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.534 -179.449 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -130.96 106.08 8.17 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.074 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.36 114.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -79.09 -51.82 9.04 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.51 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 p30 -158.68 174.78 3.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.202 -179.051 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -65.57 24.87 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.01 1.14 . . . . 0.0 113.213 -176.87 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 93.5 m-85 -152.33 10.2 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.703 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.8 t80 -169.67 134.4 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.053 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -138.07 113.73 9.7 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.452 177.295 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.61 163.54 15.78 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.862 -178.415 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.1 m -107.35 115.02 29.43 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.363 179.609 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.198 -179.804 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.4 tp60 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 179.07 5.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.667 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.8 t60 -55.42 145.47 22.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.336 -0.946 . . . . 0.0 108.8 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 48.7 m-85 60.46 29.59 19.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.61 155.11 20.46 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.81 -179.064 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 57.5 tt0 -89.82 104.54 17.1 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.357 179.455 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.11 -22.67 21.66 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.132 179.557 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.65 19.19 Favored Glycine 0 N--CA 1.486 1.984 0 C-N-CA 118.241 -1.933 . . . . 0.0 112.323 -178.783 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.52 136.49 4.64 Favored Glycine 0 C--O 1.211 -1.313 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -48.06 142.03 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.554 -179.408 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.2 65.5 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.844 179.606 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 87.9 t80 -95.97 100.45 12.12 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.531 179.767 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -97.43 40.75 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.254 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.03 169.88 13.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.27 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -51.05 149.78 14.71 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.199 1.266 . . . . 0.0 109.899 179.482 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -111.84 -12.13 13.84 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -82.28 125.72 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.776 -1.169 . . . . 0.0 109.666 179.161 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.7 m -80.34 160.49 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.076 179.611 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -62.09 175.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.508 -179.926 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.6 m -62.63 144.79 55.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.251 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.27 60.03 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.667 -1.254 . . . . 0.0 112.435 178.684 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.35 166.47 13.49 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.603 -179.655 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.36 158.52 44.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -82.14 132.16 35.24 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.274 -179.012 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -127.57 119.25 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.104 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.67 122.3 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.595 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.433 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -93.46 -53.28 4.13 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.459 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -154.23 175.02 3.3 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.754 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.0 Cg_exo -72.75 23.27 0.29 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 120.512 0.808 . . . . 0.0 110.716 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.1 m-85 -150.63 13.09 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.867 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -174.16 126.65 0.35 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.836 -178.84 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 38.4 m -128.68 112.66 14.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.103 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HG2' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -90.13 149.82 22.3 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.597 -176.973 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.7 m -105.51 110.59 22.98 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.409 179.566 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.388 -1.768 . . . . 0.0 109.857 -179.359 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 033 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.53 175.95 5.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.662 -178.848 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.721 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.1 t60 -52.01 136.12 29.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.464 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.721 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 42.9 m-85 70.53 25.03 4.33 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.885 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.51 149.13 19.06 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.821 -1.181 . . . . 0.0 111.441 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.62 111.27 17.76 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.629 179.698 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.843 ' O ' HG22 ' A' ' 17' ' ' THR . 1.4 p -103.45 -12.76 16.95 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.08 -163.55 14.31 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 118.451 -1.833 . . . . 0.0 112.083 -179.761 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.0 133.35 8.04 Favored Glycine 0 N--CA 1.48 1.628 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.54 -179.634 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -50.6 154.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.014 -1.074 . . . . 0.0 109.696 -179.765 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.04 81.34 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.148 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CZ ' ' CA ' ' A' ' 15' ' ' GLY . 21.2 t80 -105.63 153.29 22.01 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.148 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 p -136.42 2.06 2.69 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.479 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' CZ ' ' A' ' 13' ' ' TYR . . . -93.97 178.59 37.67 Favored Glycine 0 CA--C 1.551 2.294 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.584 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.41 161.78 29.84 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.189 1.926 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 8' ' ' CYS . 33.7 p -116.44 25.46 10.6 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.846 -178.653 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.07 116.63 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.875 179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.22 149.44 25.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.56 150.51 12.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.013 179.58 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.46 160.24 1.26 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.481 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.7 -20.15 9.93 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.069 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.83 163.43 23.61 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.668 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -135.84 173.82 11.29 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.821 179.214 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -87.09 148.81 25.08 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.371 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.448 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.5 mp0 -143.64 124.54 14.3 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.558 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.56 113.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.167 179.04 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -81.97 -57.05 3.58 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.797 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -150.69 171.86 5.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.346 179.579 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -66.07 24.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.739 0.959 . . . . 0.0 113.123 -177.028 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.3 m-85 -155.58 16.63 0.39 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.903 178.934 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 52.9 t80 -171.65 121.8 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.571 -176.414 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 13.8 m -118.44 111.81 19.15 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.656 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 36' ' ' LEU . 6.0 tp60 -90.51 144.02 26.19 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.448 -177.559 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.6 m -87.85 115.13 25.09 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.822 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 34' ' ' GLN . 33.0 mt . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 116.391 -1.766 . . . . 0.0 110.197 -178.356 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -93.46 -167.43 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.153 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 1.1 t60 -66.71 132.12 47.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.649 -179.466 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.5 m-85 71.35 29.35 2.77 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.518 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.01 154.62 20.25 Favored Glycine 0 N--CA 1.481 1.693 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.54 117.3 25.23 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.886 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -102.7 -33.16 9.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.624 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 33' ' ' SER . . . -152.42 -178.75 27.4 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 117.433 -2.318 . . . . 0.0 113.828 -177.767 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.81 151.57 8.23 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 12.3 mt -59.32 149.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.915 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.07 8.13 Favored Glycine 0 C--N 1.296 -1.663 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.211 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -82.38 138.17 34.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.561 179.578 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -136.53 40.13 2.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.462 -179.759 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.44 176.3 16.27 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.151 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.9 155.95 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 N-CA-C 109.407 -1.036 . . . . 0.0 109.407 179.132 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.8 p -117.89 32.64 6.04 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.869 -178.652 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.96 119.13 60.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.843 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.7 m -80.02 171.31 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.641 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -74.16 147.32 42.72 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.236 179.345 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 m -43.05 139.26 1.82 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.677 -179.579 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.43 -26.8 22.92 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.248 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.613 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -114.01 171.46 7.59 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.183 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 161.57 37.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.973 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.0 t -85.69 140.39 30.56 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.864 -179.383 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -137.19 117.47 13.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.56 126.33 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.568 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -95.94 -57.64 2.3 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.802 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -152.03 177.03 2.05 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.065 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -67.43 24.08 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.774 0.983 . . . . 0.0 111.716 -178.985 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' ASN . 98.3 m-85 -154.38 12.82 0.42 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.034 179.522 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -171.98 137.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.435 -178.137 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLY . 50.8 m -136.88 115.98 12.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.402 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 4.8 tp60 -89.64 155.69 19.07 Favored 'General case' 0 N--CA 1.51 2.563 0 O-C-N 124.119 0.887 . . . . 0.0 113.062 -176.795 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 8.6 m -105.85 106.09 16.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.459 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.7 mm? . . . . . 0 N--CA 1.502 2.155 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.705 179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.8 tp60 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.67 179.87 4.53 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.756 -179.706 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.508 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.9 t60 -57.85 147.5 28.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 86.8 m-85 58.12 23.75 10.5 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.007 -178.884 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.67 156.11 19.77 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.898 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -83.85 110.06 18.06 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.416 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.846 ' O ' HG22 ' A' ' 17' ' ' THR . 3.4 p -96.24 -19.61 19.18 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.207 179.046 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.84 -149.96 5.28 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.47 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.11 126.09 5.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.3 mt -48.61 149.6 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.526 -179.291 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.28 -13.55 20.38 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -70.46 153.5 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.231 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -143.47 52.89 1.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.687 -179.573 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.01 174.3 23.72 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.442 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.12 163.64 5.92 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.072 1.181 . . . . 0.0 109.795 179.073 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.846 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.9 p -127.4 15.65 7.14 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.971 -178.332 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.21 115.61 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.926 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ALA . 54.0 m -79.99 130.13 35.03 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.537 -179.217 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -41.12 132.01 2.54 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.978 179.625 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -40.07 144.85 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.57 -179.683 . . . . . . . . 3 3 . 1 . 035 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.88 30.78 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.72 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.82 176.96 5.69 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.2 167.84 20.52 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.675 179.209 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.65 106.32 18.3 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.653 -179.117 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -106.77 136.68 46.18 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.264 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.77 104.2 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.926 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.06 -57.86 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.5 m120 -146.03 173.42 4.27 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.073 178.31 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.495 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.7 Cg_exo -69.41 23.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.413 0.742 . . . . 0.0 111.99 -177.972 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 34.2 m-85 -147.56 7.62 0.87 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.239 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -163.62 112.76 1.26 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.163 -178.949 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -115.87 114.29 24.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.982 177.647 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -94.65 166.95 11.76 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.488 -177.792 . . . . . . . . 1 1 . 1 . 035 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' H ' ' A' ' 6' ' ' GLY . 13.9 m -100.44 108.31 20.27 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.826 179.722 . . . . . . . . 2 2 . 1 . 035 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.229 -1.844 . . . . 0.0 109.951 -179.634 . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 036 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.69 -175.42 3.89 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.408 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.717 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 3.1 t60 -71.39 154.38 41.61 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.056 179.725 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.717 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 63.4 m-85 51.18 18.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.697 -178.338 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.66 155.67 22.21 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.165 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -83.27 110.86 18.44 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.644 179.666 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.848 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.78 -26.23 17.06 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.868 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.14 -151.36 5.62 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.343 -1.884 . . . . 0.0 112.601 -178.972 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 150.42 18.78 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 77.3 mt -62.16 149.73 9.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.33 -179.439 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.18 -4.09 42.41 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.676 -1.249 . . . . 0.0 111.313 -179.144 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -80.44 125.56 30.09 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.1 p -117.53 58.91 0.79 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.149 179.678 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.03 21.42 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.322 -179.562 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -68.44 159.77 51.99 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.758 1.638 . . . . 0.0 110.506 179.458 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 8' ' ' CYS . 15.0 p -120.23 12.63 11.83 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.569 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.62 116.54 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.116 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -79.11 149.41 32.07 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.199 -179.765 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.0 146.69 41.71 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.09 179.757 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -43.09 149.66 0.21 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.599 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.89 68.46 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.298 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -134.04 178.83 6.65 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.095 -179.971 . . . . . . . . 3 3 . 1 . 036 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.63 168.69 19.55 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.677 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -89.87 136.44 33.04 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.914 -179.535 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -128.27 133.1 48.71 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.147 -179.661 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.11 108.32 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.633 179.041 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.69 -51.03 38.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.557 -179.359 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.4 p30 -159.54 173.87 4.52 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.843 -179.122 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.1 Cg_exo -66.34 24.93 0.1 OUTLIER 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 120.909 1.073 . . . . 0.0 113.106 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 99.3 m-85 -152.75 19.37 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.468 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.3 t80 -175.99 130.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.094 -179.452 . . . . . . . . 2 2 . 1 . 036 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.1 m -132.57 112.04 11.74 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.834 177.166 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -93.73 157.77 15.99 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.071 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.3 m -102.39 121.14 41.73 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.145 179.36 . . . . . . . . 1 1 . 1 . 036 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 116.132 -1.89 . . . . 0.0 109.567 -179.949 . . . . . . . . 0 0 . 1 . 037 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 7' ' ' GLN . 11.7 tp60 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 164.71 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.937 -178.944 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.425 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 3.0 t60 -44.73 159.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.159 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.425 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 67.3 m-85 47.57 19.37 0.14 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.727 -179.511 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.25 154.39 20.44 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.736 -178.707 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 39.7 tt0 -78.17 108.49 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.367 179.755 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 17' ' ' THR . 2.0 p -92.61 -24.72 18.6 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.794 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.26 -157.03 7.66 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.253 -178.763 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 113.94 126.38 4.35 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.876 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 30' ' ' PRO . 17.4 mt -40.41 145.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.62 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.9 -1.04 56.29 Favored Glycine 0 CA--C 1.544 1.903 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.795 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -91.43 101.3 13.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.424 179.693 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.6 p -95.1 55.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.07 171.76 22.0 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.228 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.68 161.9 13.97 Favored 'Trans proline' 0 C--O 1.205 -1.162 0 C-N-CA 121.756 1.637 . . . . 0.0 110.415 179.593 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -131.33 20.14 4.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.712 -178.813 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.21 116.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.379 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.06 144.07 29.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.149 -179.529 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.34 169.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.5 p -67.07 143.45 56.7 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.474 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.79 -17.36 45.83 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.39 169.9 8.7 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.515 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.53 160.03 41.8 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.223 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.3 t -79.97 116.73 20.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.114 -179.269 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -113.99 136.16 53.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.394 179.19 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -83.43 132.09 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' TYR . 3.1 m120 -149.74 173.33 4.36 Favored Pre-proline 0 N--CA 1.495 1.811 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.876 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.694 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.7 Cg_exo -70.42 23.88 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.539 0.826 . . . . 0.0 111.39 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.0 m-85 -152.88 20.17 0.59 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.661 179.305 . . . . . . . . 2 2 . 1 . 037 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -173.96 129.76 0.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.6 m -136.79 119.45 16.07 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.549 177.927 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -99.81 158.28 15.91 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.431 -178.464 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 m -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 116.415 -1.755 . . . . 0.0 110.066 -178.681 . . . . . . . . 0 0 . 1 . 038 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.42 174.77 8.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.415 -179.87 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.593 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.1 t60 -55.17 134.08 49.37 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.801 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 42.2 m-85 69.23 -3.48 1.54 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -61.45 152.75 41.02 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.765 179.715 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -84.61 111.93 19.98 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.72 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.904 ' O ' HG22 ' A' ' 17' ' ' THR . 1.7 p -89.69 -34.42 16.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.937 179.123 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.8 -155.54 6.75 Favored Glycine 0 N--CA 1.48 1.569 0 C-N-CA 118.303 -1.903 . . . . 0.0 112.395 -178.797 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.31 152.52 14.67 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.456 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 11.0 mt -60.87 146.9 10.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.917 -179.309 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.48 -8.76 52.85 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.736 -179.909 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -82.64 119.21 23.99 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -113.04 57.62 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.329 179.791 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.27 21.6 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -69.19 157.14 62.62 Favored 'Trans proline' 0 C--O 1.21 -0.907 0 C-N-CA 121.818 1.679 . . . . 0.0 110.596 179.55 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 8' ' ' CYS . 47.7 p -115.87 13.31 16.01 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.716 -178.281 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.31 110.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.663 179.322 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -77.01 149.56 35.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.877 -179.067 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 155.98 0.34 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.239 179.804 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -52.64 144.8 13.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.428 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.06 -25.15 10.52 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.673 178.718 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.46 173.86 6.14 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.726 -179.462 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.64 170.14 17.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.65 140.99 28.96 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -141.9 113.88 8.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.43 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.86 111.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.87 -48.97 50.96 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.021 -1.471 . . . . 0.0 107.651 179.299 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.6 p30 -163.27 175.09 3.0 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.655 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 6.3 Cg_exo -65.93 28.9 0.1 OUTLIER 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 121.001 1.134 . . . . 0.0 113.6 -177.278 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 70.7 m-85 -154.48 13.78 0.43 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.144 178.425 . . . . . . . . 2 2 . 1 . 038 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -175.35 133.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.747 -178.544 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -131.54 109.07 9.99 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.487 177.286 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.82 153.18 21.85 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.72 -177.85 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 m -97.4 115.33 27.54 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.847 178.961 . . . . . . . . 1 1 . 1 . 038 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 116.403 -1.76 . . . . 0.0 110.329 -179.879 . . . . . . . . 0 0 . 1 . 039 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.37 166.34 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.405 -179.214 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.423 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -48.56 139.67 9.02 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.56 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.423 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 79.8 m-85 58.21 30.13 18.98 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.297 -178.491 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.59 148.34 18.59 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.976 -178.98 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -75.81 102.39 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.694 179.643 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -91.21 -14.25 31.34 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.054 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.08 -154.29 6.92 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.423 -1.846 . . . . 0.0 112.378 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 137.23 8.69 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.813 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.04 145.21 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.79 4.72 89.52 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.594 -179.575 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -100.25 113.64 26.49 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.222 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 p -111.05 46.5 1.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.718 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.79 172.89 16.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.31 155.89 54.36 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.837 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 8' ' ' CYS . 32.8 p -117.01 20.34 13.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.647 -178.536 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.46 120.82 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.305 178.718 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.0 m -83.19 156.47 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.774 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -59.47 152.95 20.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.706 179.395 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.72 144.98 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.72 -12.02 69.97 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.373 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.03 163.68 23.21 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.722 -179.699 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.22 158.92 39.27 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.179 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -89.53 131.87 35.35 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.775 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -131.48 119.05 21.03 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.159 179.663 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -54.29 117.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.664 179.668 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -82.3 -58.01 3.12 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -179.923 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -152.16 176.75 2.2 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.327 . . . . . . . . 3 3 . 1 . 039 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -67.99 24.56 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.056 1.171 . . . . 0.0 112.047 -178.636 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 29' ' ' ASN . 88.9 m-85 -155.01 15.03 0.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.043 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' OH ' ' CD ' ' A' ' 34' ' ' GLN . 21.2 t80 -174.17 124.42 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.062 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 22.3 m -124.98 115.44 20.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.948 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 5.4 tp60 -94.34 151.69 19.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.733 -176.251 . . . . . . . . 2 2 . 1 . 039 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.3 m -100.98 107.21 18.62 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.515 179.061 . . . . . . . . 1 1 . 1 . 039 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.413 -1.755 . . . . 0.0 109.943 -179.615 . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 040 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 p -99.73 -172.95 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.867 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.541 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.4 t60 -61.8 160.71 11.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.312 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.541 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 81.9 m-85 47.09 19.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.631 -1.227 . . . . 0.0 109.125 -178.046 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.486 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -87.09 154.06 26.11 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.62 -178.138 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -89.13 114.72 26.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.381 179.577 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.861 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -103.05 -21.51 13.91 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.093 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -155.32 -153.32 6.49 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 118.175 -1.964 . . . . 0.0 112.765 -179.145 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 139.3 10.41 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.948 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.9 mt -51.32 151.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.069 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 80.68 -15.98 16.97 Favored Glycine 0 C--N 1.296 -1.676 0 C-N-CA 119.508 -1.329 . . . . 0.0 111.032 -179.701 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -82.06 124.5 29.88 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.394 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -120.55 37.29 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.12 -175.5 17.94 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.133 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.28 158.71 56.38 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 121.798 1.665 . . . . 0.0 110.493 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 8' ' ' CYS . 41.7 p -122.23 31.09 6.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.544 -0.863 . . . . 0.0 112.012 -178.184 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -111.52 117.07 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.733 178.707 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 4.3 m -85.32 142.17 29.53 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -49.13 146.93 3.22 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.358 179.851 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -47.3 153.84 0.46 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.733 -179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.3 -26.11 12.77 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -119.59 171.97 7.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.129 179.779 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 155.91 43.31 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.88 179.265 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 14.8 t -70.71 130.33 41.46 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.733 -178.801 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.43 103.07 6.93 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.228 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.02 128.14 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.673 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.78 -56.45 3.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.337 . . . . . . . . 3 3 . 1 . 040 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.28 171.44 6.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.256 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_exo -67.81 24.79 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.36 0.807 . . . . 0.0 112.26 -177.341 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 84.9 m-85 -151.27 11.91 0.63 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.87 178.861 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -171.88 131.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.649 -178.619 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.48 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.0 m -131.7 113.49 13.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.656 178.153 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -98.45 161.07 13.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.482 1.113 . . . . 0.0 111.464 -178.001 . . . . . . . . 1 1 . 1 . 040 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.3 m -111.94 121.54 45.3 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.073 179.311 . . . . . . . . 2 2 . 1 . 040 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 116.236 -1.84 . . . . 0.0 109.872 -179.684 . . . . . . . . 0 0 . 1 . 041 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -171.32 1.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.905 -179.45 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 4' ' ' HIS . . . . . 0.693 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t60 -59.11 164.87 2.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.553 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.693 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 30.7 m-85 47.82 23.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.538 -178.272 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -86.01 157.58 30.95 Favored Glycine 0 N--CA 1.484 1.874 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.069 -179.06 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 2' ' ' GLN . 50.8 tt0 -93.69 106.07 18.06 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.147 -179.049 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -91.9 -19.04 22.9 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.735 -1.186 . . . . 0.0 110.777 179.997 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.45 -161.63 10.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.174 -1.965 . . . . 0.0 112.288 -179.381 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 110.35 127.32 5.24 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 30' ' ' PRO . 78.5 mt -44.96 154.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.028 -179.379 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 -12.84 25.17 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.037 -178.187 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -89.46 110.03 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.785 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.5 p -109.86 30.65 6.5 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.553 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.4 -179.05 24.98 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.93 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.5 150.12 63.22 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.487 1.458 . . . . 0.0 109.761 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 45.5 p -106.92 11.62 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.926 -178.001 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.53 116.28 28.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ALA . 16.4 m -83.1 139.23 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.094 179.847 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -40.73 147.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.604 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.19 153.65 1.91 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.36 -20.66 32.8 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.429 179.197 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.18 174.21 6.35 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.946 -0.701 . . . . 0.0 111.004 -179.609 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -179.59 5.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.443 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -99.85 139.43 35.54 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.206 -179.356 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.18 113.38 8.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.217 179.531 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.07 138.37 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -107.3 -60.87 1.63 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.511 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -145.5 175.42 2.76 Favored Pre-proline 0 N--CA 1.505 2.275 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.63 . . . . . . . . 3 3 . 1 . 041 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.538 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.9 Cg_exo -70.08 22.35 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.616 0.877 . . . . 0.0 111.851 -178.413 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.9 m-85 -155.81 19.11 0.38 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.549 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -172.8 127.54 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.816 -178.505 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.3 m -130.46 113.0 13.76 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.574 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.11 156.88 16.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.06 0.85 . . . . 0.0 112.224 -176.84 . . . . . . . . 1 1 . 1 . 041 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.4 m -106.19 130.92 53.97 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 041 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.76 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.259 0.552 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -143.5 149.0 36.88 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.034 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.89 173.98 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.304 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.516 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.4 t60 -47.84 158.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.695 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.516 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 84.5 m-85 46.91 23.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.341 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.06 135.12 11.96 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.308 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -65.16 100.98 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.36 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.69 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -89.86 -16.6 29.76 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.612 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.6 -179.79 31.85 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 118.514 -1.803 . . . . 0.0 111.537 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.66 131.69 3.33 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.3 mt -48.25 148.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.604 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.14 -14.46 14.89 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.611 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -79.39 138.64 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.022 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.8 p -137.71 63.12 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.6 178.99 21.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.91 166.11 7.35 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.8 p -135.15 0.43 2.84 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.83 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -80.68 112.42 18.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.495 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.8 m -71.21 147.02 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.353 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 142.19 49.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.163 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -44.95 146.22 0.84 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.55 -25.76 27.0 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.33 163.0 17.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.463 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.4 OUTLIER -126.64 169.71 12.84 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.812 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.7 t -95.34 120.56 35.79 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.038 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.758 ' NE2' ' H ' ' A' ' 36' ' ' LEU . 2.3 mp0 -110.72 113.78 26.65 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.746 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.27 106.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.312 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.97 -54.06 14.98 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.034 -1.067 . . . . 0.0 109.184 -178.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.3 m120 -150.2 174.59 3.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.534 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -68.59 24.36 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 120.837 1.024 . . . . 0.0 112.208 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.29 17.56 0.48 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.452 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -170.21 131.97 1.02 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.975 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 m -142.66 110.82 6.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.16 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.2 145.28 27.4 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.099 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.0 m -84.43 118.72 24.44 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.758 ' H ' ' NE2' ' A' ' 26' ' ' GLN . 93.5 mt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.559 -179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -82.87 153.54 25.07 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.709 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -172.29 2.22 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.193 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.82 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.9 t60 -67.24 149.68 50.09 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.82 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 44.9 m-85 54.28 25.79 6.21 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.913 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.9 150.21 18.66 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.737 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.5 109.64 10.39 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.612 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.556 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -96.4 -25.46 15.7 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.694 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.44 -153.27 6.31 Favored Glycine 0 N--CA 1.48 1.597 0 C-N-CA 118.279 -1.915 . . . . 0.0 112.131 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.31 132.47 7.5 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 30' ' ' PRO . 20.1 mt -48.0 149.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.756 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.31 -0.4 87.76 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.056 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.62 139.19 33.07 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -131.07 31.2 4.47 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.585 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.18 175.82 16.9 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.51 160.58 23.5 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.515 1.477 . . . . 0.0 110.333 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 8' ' ' CYS . 63.4 p -124.59 22.15 8.37 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.586 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.93 108.61 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.718 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -75.71 147.2 39.56 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.43 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.26 152.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.726 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 m -56.51 139.54 49.09 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.927 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.18 32.49 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.527 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -105.13 161.57 14.14 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.881 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -129.18 162.86 26.82 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.29 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.4 t -90.76 116.91 28.98 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.04 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 22.0 mp0 -107.39 107.74 18.77 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.463 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.63 120.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 118.719 -1.193 . . . . 0.0 108.666 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -81.14 -62.11 1.76 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -178.639 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.1 m120 -141.04 175.32 3.15 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -69.03 23.51 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.1 0.714 . . . . 0.0 111.712 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.1 m-85 -155.26 21.64 0.42 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.987 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 16.5 t80 -173.68 130.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.099 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.9 m -134.07 116.26 15.26 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.471 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.494 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tt0 -98.75 154.38 18.03 Favored 'General case' 0 N--CA 1.513 2.69 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.636 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 67.7 m -92.37 120.44 32.89 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.602 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.482 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 90.5 mt . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.197 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.705 HE22 ' N ' ' A' ' 7' ' ' GLN . 3.2 tt0 -109.53 -174.04 2.4 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.348 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -179.15 4.23 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.817 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.616 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.7 t60 -54.83 150.97 9.1 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.616 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 19.6 m-85 52.89 17.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.351 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -81.35 134.18 12.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.696 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.705 ' N ' HE22 ' A' ' 2' ' ' GLN . 30.6 tt0 -69.99 101.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.31 -18.37 28.65 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.026 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.37 -172.04 22.57 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.445 -1.836 . . . . 0.0 112.314 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.96 126.48 4.55 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 12' ' ' GLY . 96.9 mt -44.51 153.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.978 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 83.95 -12.84 52.03 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.701 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -90.14 146.94 23.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.049 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 p -140.27 22.78 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.808 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.39 177.36 24.86 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.84 159.8 16.74 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.485 1.457 . . . . 0.0 110.447 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.3 p -124.56 26.09 7.36 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.16 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.92 114.8 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.081 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -79.27 133.98 36.65 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.326 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.42 159.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.323 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.52 155.67 9.23 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.923 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.28 -15.68 32.96 Favored Glycine 0 N--CA 1.482 1.728 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.522 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 167.03 14.37 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.27 164.97 25.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.727 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.98 113.29 24.93 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.27 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -104.13 126.1 50.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.73 140.9 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.902 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 tp -108.14 -60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.858 179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.5 OUTLIER -149.15 175.89 2.53 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.8 24.4 0.15 Allowed 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 120.902 1.068 . . . . 0.0 111.67 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 29' ' ' ASN . 96.2 m-85 -147.39 9.99 0.96 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.074 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 75.3 t80 -169.96 138.96 1.81 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.413 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -150.03 113.24 4.89 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.1 tt0 -95.98 150.53 20.36 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.156 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 19.7 m -89.36 115.96 27.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.479 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.501 -179.398 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 7.0 tp60 -104.62 148.69 26.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.432 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -178.66 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.599 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.52 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.2 t60 -59.73 150.4 27.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.52 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 82.2 m-85 56.96 9.75 0.67 Allowed 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.856 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.33 155.29 24.14 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.176 -1.488 . . . . 0.0 112.116 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.489 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 39.9 tt0 -76.63 122.28 24.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.78 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -108.71 -23.48 11.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.57 -157.56 8.06 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 117.866 -2.111 . . . . 0.0 112.735 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 146.63 13.12 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 30' ' ' PRO . 65.9 mt -59.51 154.65 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.131 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.77 -5.92 21.45 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.762 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -94.0 112.97 24.87 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.735 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -110.6 55.36 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.283 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.35 -179.64 16.42 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.64 154.09 67.59 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.365 1.377 . . . . 0.0 110.409 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 8' ' ' CYS . 16.4 p -127.5 28.1 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.207 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.03 109.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.803 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.9 m -78.76 137.59 37.82 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.324 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.42 150.04 1.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.74 154.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.314 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.1 -15.71 58.93 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.585 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.64 176.24 7.94 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.528 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 163.16 33.65 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.49 116.55 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.131 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.56 140.41 41.95 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.846 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.47 117.67 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.551 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -81.61 -62.54 1.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -144.63 176.07 2.44 Favored Pre-proline 0 N--CA 1.501 2.076 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.523 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -69.21 23.63 0.16 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 120.674 0.916 . . . . 0.0 111.841 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' ASN . 80.0 m-85 -155.39 19.89 0.41 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.873 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -173.0 117.83 0.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.452 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.6 m -119.91 111.83 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.525 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.96 157.93 17.01 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.349 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.5 m -100.77 121.77 42.25 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.887 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.12 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -81.24 -163.91 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.425 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.47 177.9 7.97 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.874 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.835 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -60.04 133.08 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.835 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 27.5 m-85 66.77 22.84 10.23 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.32 155.37 19.87 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.222 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -79.81 120.75 24.49 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.684 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -108.97 -27.33 9.73 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.613 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.46 -151.57 5.53 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.347 -1.882 . . . . 0.0 112.328 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 141.85 12.61 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.69 151.62 5.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.716 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.75 -15.06 44.38 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.25 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.2 t80 -82.87 138.64 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.471 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -131.22 27.17 4.83 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.25 -176.79 21.42 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.91 155.61 68.55 Favored 'Trans proline' 0 C--O 1.211 -0.842 0 C-N-CA 121.699 1.599 . . . . 0.0 110.865 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 8' ' ' CYS . 57.1 p -117.29 7.55 12.92 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.34 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -90.19 113.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.335 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 m -82.59 148.41 28.03 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.945 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.25 139.83 8.14 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.014 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -47.21 141.83 4.25 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.88 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.77 -27.25 21.29 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.607 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -112.87 158.96 19.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 157.99 36.89 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.454 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.7 t -87.77 111.42 21.34 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.132 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -107.33 117.79 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.116 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -53.08 132.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.333 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -94.51 -51.32 4.81 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.341 -1.344 . . . . 0.0 107.797 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.0 p30 -161.52 172.98 5.05 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.3 Cg_exo -66.94 24.93 0.11 Allowed 'Trans proline' 0 C--O 1.214 -0.706 0 CA-C-N 119.366 0.809 . . . . 0.0 112.533 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.72 14.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.176 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -172.47 130.16 0.56 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.906 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.8 m -130.17 116.23 18.15 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.468 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.3 tp-100 -100.09 150.16 22.76 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.452 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.9 m -97.19 116.59 29.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.784 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 116.306 -1.807 . . . . 0.0 109.982 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -127.34 -170.16 2.17 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.087 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.28 177.77 7.58 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.001 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.619 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.0 OUTLIER -59.94 132.32 53.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.619 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 26.5 m-85 67.98 26.38 7.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.69 153.65 17.88 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.13 108.22 13.55 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -97.53 -21.7 16.95 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.864 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.44 -155.09 6.61 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 118.544 -1.788 . . . . 0.0 111.831 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 144.77 12.58 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 30' ' ' PRO . 62.2 mt -60.57 148.51 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.995 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.9 -12.23 30.82 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.627 -1.273 . . . . 0.0 111.042 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -78.16 120.87 23.58 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.4 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 p -114.51 58.18 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.13 170.55 25.91 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.777 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.25 153.62 38.95 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.339 1.359 . . . . 0.0 110.052 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -119.56 33.3 5.68 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.609 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.9 107.15 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.116 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.7 m -74.94 143.61 43.62 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.769 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.69 148.22 0.78 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.683 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -53.08 160.5 1.01 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.121 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.29 -18.45 23.24 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -124.18 163.63 21.16 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.092 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.01 160.73 31.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.339 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -88.13 117.85 27.3 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.422 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -115.27 116.11 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.422 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.23 129.01 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.372 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -87.3 -51.36 6.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.554 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -157.37 176.08 2.84 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.2 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -68.27 24.62 0.14 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.601 0.867 . . . . 0.0 111.459 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.554 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.0 m-85 -150.52 10.34 0.65 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.739 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -173.65 127.73 0.41 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.594 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.477 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 21.7 m -125.32 115.67 20.71 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.884 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -100.32 158.4 15.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.95 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 61.1 m -98.28 123.24 42.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 116.361 -1.781 . . . . 0.0 110.289 -178.95 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.978 0.418 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 3' ' ' SER . 5.6 tp60 -104.34 -175.95 2.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.416 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.73 -172.58 2.41 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.647 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -70.61 149.94 46.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 67.5 m-85 53.59 18.05 1.34 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.681 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 152.78 21.53 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.806 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -81.65 119.43 23.81 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.55 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -107.73 -21.96 12.66 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -169.43 15.83 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.211 -1.947 . . . . 0.0 112.427 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 143.28 9.03 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -54.64 154.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.998 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.31 -11.7 48.89 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -95.56 129.56 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.304 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.5 p -137.92 57.94 1.7 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.662 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.32 -177.28 15.4 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.43 157.6 14.46 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.797 0.998 . . . . 0.0 109.664 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 8' ' ' CYS . 43.4 p -131.83 26.47 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.487 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.97 115.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.484 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.71 161.26 30.44 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.788 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.9 171.18 0.98 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.294 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -63.77 141.57 58.72 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.11 -5.72 84.64 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.584 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.05 165.09 18.09 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.15 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -140.37 162.1 36.12 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.014 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.6 t -90.27 113.32 25.14 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.1 mp0 -105.46 125.61 51.18 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.952 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.31 126.21 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.553 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -89.13 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.706 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.0 p30 -155.61 178.59 1.6 Allowed Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.804 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.4 Cg_exo -67.6 23.4 0.12 Allowed 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 120.989 1.126 . . . . 0.0 113.116 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 29' ' ' ASN . 81.6 m-85 -154.62 16.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.072 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -174.69 133.72 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.541 -1.264 . . . . 0.0 111.767 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m -136.06 113.17 10.47 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.385 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 5' ' ' TYR . 5.0 tp60 -89.56 153.71 20.56 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 20.4 m -106.69 114.14 28.07 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.168 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.449 -1.739 . . . . 0.0 109.821 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -89.19 144.25 26.25 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.795 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.02 -170.58 2.14 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.171 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -61.16 135.03 57.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.466 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 68.8 m-85 70.17 24.01 5.04 Favored 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.22 153.85 23.86 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.741 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 60.8 tt0 -90.19 111.13 22.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.691 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -97.95 -21.14 17.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.603 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 -156.32 7.38 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 117.938 -2.077 . . . . 0.0 112.526 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.1 131.1 6.86 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.517 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 11' ' ' ILE . 39.6 mt -46.58 145.95 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.79 9.66 84.23 Favored Glycine 0 C--N 1.292 -1.889 0 C-N-CA 119.582 -1.295 . . . . 0.0 111.202 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 80.6 t80 -110.8 126.28 54.45 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.6 p -120.5 11.02 11.28 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.43 -176.41 50.47 Favored Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -69.54 161.16 46.99 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.575 1.517 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 p -120.54 38.02 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.06 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.1 110.98 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -75.17 157.69 34.2 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.097 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -72.59 149.96 43.51 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.842 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -44.49 142.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.712 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -24.45 32.15 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.348 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -116.16 176.68 4.99 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.139 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.19 152.61 39.5 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.626 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.1 t -80.37 127.99 33.03 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.606 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -136.97 126.84 25.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.63 134.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.217 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.23 -47.67 5.37 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.3 p-10 -162.64 171.81 6.06 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.308 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -67.75 24.56 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 CA-C-N 119.624 0.902 . . . . 0.0 112.26 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 29' ' ' ASN . 57.5 m-85 -153.39 16.13 0.53 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.28 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -174.8 125.47 0.28 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.837 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -127.06 113.23 16.16 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.123 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 5.3 tp60 -93.09 149.77 20.99 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.192 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 32.1 m -102.95 110.04 21.81 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.646 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.505 2.322 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.165 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.5 tp60 -131.07 165.98 22.06 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.594 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -168.11 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.186 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -73.99 132.28 42.24 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.145 -179.681 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 60.5 m-85 70.43 20.12 6.11 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.447 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.88 154.9 19.26 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.491 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -75.99 119.34 19.82 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.885 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -103.2 -29.7 11.13 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.554 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -148.71 -163.5 10.91 Favored Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.002 -1.57 . . . . 0.0 111.611 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 142.71 10.54 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.8 mt -50.17 156.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.618 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 78.55 -15.69 9.16 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 46.2 t80 -89.41 131.36 35.51 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.334 -179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 p -126.26 18.25 7.66 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.03 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.93 -178.35 33.39 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.768 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.04 153.09 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.591 1.527 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.9 p -117.5 27.37 9.11 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.467 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.36 122.23 54.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.931 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.98 163.72 18.73 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.843 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -68.28 154.59 41.45 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.67 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 m -45.1 141.35 2.36 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.035 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.82 -8.72 76.34 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.527 -1.32 . . . . 0.0 112.254 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -133.58 169.75 16.54 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.907 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.524 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.5 OUTLIER -145.16 171.81 14.0 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.491 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -92.23 144.94 24.9 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.263 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.524 HE22 ' C ' ' A' ' 24' ' ' THR . 28.9 mp0 -139.86 116.55 10.83 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.3 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.73 103.08 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.764 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.22 -52.03 65.39 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.827 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.92 174.52 3.72 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.179 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -66.97 24.65 0.11 Allowed 'Trans proline' 0 C--O 1.211 -0.839 0 C-N-CA 120.628 0.885 . . . . 0.0 112.84 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.6 m-85 -149.51 12.53 0.81 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.28 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 33.8 t80 -170.59 134.67 1.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.496 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 14.8 m -135.98 110.53 8.58 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.584 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 36' ' ' LEU . 46.3 tt0 -87.48 154.42 20.65 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.598 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.85 109.98 21.43 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.012 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 34' ' ' GLN . 15.3 mt . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.027 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 11.7 pm0 -101.66 -164.52 1.11 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.538 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.93 -174.78 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.845 -178.32 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.718 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -57.38 140.66 49.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.718 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 52.4 m-85 65.64 18.18 11.13 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.01 157.03 34.9 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.82 116.34 27.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' HE21 ' A' ' 2' ' ' GLN . 1.1 p -105.06 -21.69 13.23 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.747 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -149.83 -166.06 13.02 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 118.329 -1.891 . . . . 0.0 113.163 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.28 144.81 13.62 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -61.63 156.49 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 -2.12 55.08 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.485 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -86.26 132.46 33.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.976 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 p -129.91 36.38 4.05 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.34 -174.22 14.79 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.212 -0.994 . . . . 0.0 110.771 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.93 153.96 76.18 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.754 1.636 . . . . 0.0 111.211 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.34 -6.08 21.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.745 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.35 122.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.609 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 20' ' ' ALA . 92.2 m -84.13 148.46 26.78 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.618 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 3' ' ' SER . . . -39.96 140.14 0.59 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.583 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -49.9 140.0 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.93 13.71 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.5 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -102.69 -170.73 1.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.888 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.43 173.15 12.54 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.4 t -100.12 116.58 32.48 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.919 HE22 ' H ' ' A' ' 36' ' ' LEU . 3.6 mp0 -107.41 110.07 21.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.6 t -53.77 125.65 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.179 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.09 -56.93 2.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.27 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.5 p-10 -162.71 172.81 4.98 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 2.9 Cg_exo -66.07 25.37 0.1 OUTLIER 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.84 1.027 . . . . 0.0 113.124 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' ASN . 91.4 m-85 -153.72 13.53 0.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.16 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -175.31 137.57 0.39 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.793 -179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 9' ' ' GLY . 13.7 m -136.41 114.4 11.37 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 40.6 tt0 -86.42 165.64 16.17 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.794 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 64.2 m -113.24 128.38 56.46 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.679 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.919 ' H ' HE22 ' A' ' 26' ' ' GLN . 93.8 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.48 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -83.95 167.32 17.06 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.258 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -162.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.444 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.461 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -72.94 134.74 44.87 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.051 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.461 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 36.3 m-85 69.04 16.84 8.65 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.29 155.73 30.04 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.417 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -86.93 110.04 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.0 -17.98 23.24 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.939 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.62 -165.69 12.35 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 118.529 -1.796 . . . . 0.0 111.504 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.27 130.53 5.25 Favored Glycine 0 C--N 1.301 -1.415 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 30' ' ' PRO . 47.9 mt -51.9 144.14 3.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.799 -1.161 . . . . 0.0 110.757 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.43 65.14 Favored Glycine 0 CA--C 1.548 2.095 0 C-N-CA 119.869 -1.158 . . . . 0.0 111.876 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -83.93 113.19 20.8 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.606 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -106.75 55.41 0.66 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.711 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.13 172.98 22.13 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.62 145.31 82.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.136 1.224 . . . . 0.0 110.832 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 8' ' ' CYS . 23.3 p -107.18 30.49 6.16 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.03 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -116.06 119.7 62.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.661 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.1 m -79.63 164.64 23.64 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.64 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -65.68 168.08 8.2 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.979 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.02 147.94 52.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.777 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.05 26.61 Favored Glycine 0 C--N 1.297 -1.634 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -107.99 178.73 4.43 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.504 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.83 162.45 41.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.89 127.35 39.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.093 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.27 112.63 15.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.146 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.67 130.63 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.623 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -92.91 -54.98 3.52 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -154.53 175.34 3.14 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.7 Cg_exo -70.24 24.09 0.19 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.439 0.759 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.7 m-85 -149.55 10.82 0.76 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.131 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -174.74 128.81 0.32 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.806 -178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 70.4 m -131.68 113.56 13.73 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.413 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.1 tt0 -89.61 151.01 22.13 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 124.67 1.231 . . . . 0.0 112.693 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.8 m -105.72 111.34 23.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.555 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 116.386 -1.769 . . . . 0.0 109.95 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 3' ' ' SER . 10.4 tp60 -78.97 -168.43 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -132.3 163.92 27.59 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.754 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.414 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 1.6 t60 -53.33 141.71 23.45 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.414 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 47.3 m-85 58.34 22.88 9.87 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.729 -178.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 153.48 19.69 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -81.7 115.58 21.01 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.797 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.67 -31.05 13.99 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.882 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.36 -174.32 22.8 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.47 -1.824 . . . . 0.0 112.377 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 117.81 129.08 4.08 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.7 mt -40.55 154.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.457 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.7 31.29 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.661 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -87.45 141.78 28.37 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.318 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 14' ' ' SER . 54.2 p -138.62 56.29 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.0 177.32 23.53 Favored Glycine 0 N--CA 1.479 1.502 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.706 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.72 157.38 42.79 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.125 1.216 . . . . 0.0 109.747 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' CYS . 79.1 p -118.99 2.79 11.52 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.015 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.09 108.59 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.596 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.9 156.93 37.62 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.871 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.83 170.19 2.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.188 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.35 155.43 37.37 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.821 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.03 37.11 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.296 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.11 169.33 12.9 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.42 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.47 154.71 42.53 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.459 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -80.18 141.76 35.37 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.544 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -137.17 107.5 6.44 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 27' ' ' VAL . 3.3 t -60.59 115.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.432 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.3 tp -79.78 -52.3 8.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.513 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.2 m120 -153.43 176.12 2.62 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.66 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_exo -69.0 24.25 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.771 0.981 . . . . 0.0 112.007 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.7 m-85 -149.65 14.75 0.85 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.08 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -173.13 130.76 0.48 Allowed 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.399 -1.32 . . . . 0.0 111.748 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -136.89 111.62 8.76 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -96.53 147.79 23.49 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.847 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 70.8 m -101.63 111.53 23.81 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.413 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 116.381 -1.771 . . . . 0.0 109.772 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -107.17 169.22 8.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.559 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 172.53 6.76 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.431 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.54 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -55.75 128.04 32.94 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.548 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.54 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.7 m-85 75.93 23.89 1.28 Allowed 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.975 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.02 140.32 14.81 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.042 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.3 114.89 5.7 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.667 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.879 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -101.57 -24.69 14.09 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.22 16.58 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.592 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.58 130.66 5.43 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 30' ' ' PRO . 60.7 mt -44.87 154.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.333 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.77 -16.16 21.85 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.634 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -91.19 131.17 36.9 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.397 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 p -127.02 51.49 1.87 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.089 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.56 174.15 20.85 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.95 156.62 23.15 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.217 1.278 . . . . 0.0 110.415 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 8' ' ' CYS . 62.4 p -121.66 15.26 11.05 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.845 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -80.44 119.27 29.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.4 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 24' ' ' THR . 8.0 m -83.17 141.57 31.84 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.9 149.02 1.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -51.69 143.18 13.2 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.522 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.57 -20.09 46.65 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.004 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.15 167.14 12.99 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.982 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -135.77 166.76 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.594 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -85.43 124.91 32.56 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.729 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -115.4 109.96 18.65 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.8 110.43 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.817 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 tp -72.12 -59.37 2.77 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.009 -179.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.559 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -141.79 175.6 2.9 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.227 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -68.87 24.38 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.59 0.86 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.5 m-85 -148.4 11.82 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 50.3 t80 -169.83 136.26 1.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.078 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 m -143.26 113.34 7.2 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.154 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -98.4 149.0 23.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.879 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.1 m -84.58 115.56 22.69 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.919 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 116.321 -1.8 . . . . 0.0 110.269 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' ALA . 8.9 tp60 -126.35 160.64 29.86 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.73 170.28 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.576 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.739 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t60 -52.25 150.15 4.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.362 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.739 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 56.6 m-85 56.99 11.94 1.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.71 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.55 156.37 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.469 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.49 109.78 10.49 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -97.04 -22.89 16.54 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.248 177.779 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.0 -179.91 25.28 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 118.932 -1.604 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 127.74 2.86 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.355 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 11' ' ' ILE . 30.4 mt -48.9 148.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.486 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.54 54.75 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.998 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -79.64 147.45 32.03 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.308 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -137.24 44.13 2.3 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.77 175.24 20.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.18 160.7 25.5 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.176 1.251 . . . . 0.0 110.573 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 61.7 p -121.12 21.91 11.1 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.699 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.43 113.51 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.885 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.66 150.05 46.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.339 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -54.05 141.38 28.61 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.105 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ALA . 4.5 m -42.33 139.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 -25.13 29.01 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.09 167.24 11.65 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.374 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.507 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.7 OUTLIER -131.04 -177.59 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.542 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -102.14 125.85 48.95 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.022 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 24' ' ' THR . 24.4 mp0 -124.68 121.89 35.96 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.492 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.22 146.67 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.16 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -110.66 -56.38 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -153.68 177.47 1.96 Allowed Pre-proline 0 N--CA 1.508 2.455 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.167 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 Cg_exo -68.43 23.5 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.88 1.053 . . . . 0.0 112.066 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.5 m-85 -153.73 14.08 0.48 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.101 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -172.53 127.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.812 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.1 m -127.17 114.16 17.32 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.04 159.85 20.13 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.699 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -100.58 125.85 47.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.86 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.414 HD23 ' CE1' ' A' ' 4' ' ' HIS . 79.1 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.157 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.201 0.524 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.8 tp60 -97.91 152.48 19.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.109 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.27 -166.69 1.53 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.612 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.542 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -73.5 139.47 45.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.217 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.542 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 84.4 m-85 66.51 20.81 10.85 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.65 155.46 20.5 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.42 102.66 6.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.615 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -94.09 -10.12 34.39 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.599 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.26 179.23 38.55 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 117.867 -2.111 . . . . 0.0 111.947 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.06 153.72 8.04 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 30' ' ' PRO . 52.7 mt -67.39 151.95 10.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.04 -5.18 20.02 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.775 -1.202 . . . . 0.0 111.516 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.6 126.27 37.61 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.605 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.4 p -120.27 36.22 4.62 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.34 -178.18 21.93 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.739 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.36 162.15 15.26 Favored 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.375 1.384 . . . . 0.0 109.69 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 8' ' ' CYS . 35.7 p -132.38 5.67 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.044 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 124.48 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.764 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 24' ' ' THR . 61.8 m -77.53 156.28 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 165.37 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.562 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -56.17 150.22 14.57 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.925 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.58 -22.57 2.67 Favored Glycine 0 N--CA 1.48 1.624 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.986 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -105.64 158.48 16.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.956 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.431 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -131.58 174.22 10.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.535 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -100.41 127.07 46.83 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.392 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.904 HE22 ' H ' ' A' ' 36' ' ' LEU . 4.1 mp0 -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.41 108.49 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.06 -46.74 67.07 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.284 -1.366 . . . . 0.0 107.508 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -163.56 173.75 3.95 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.457 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.2 Cg_exo -66.88 24.64 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.817 0 C-N-CA 121.238 1.292 . . . . 0.0 113.199 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.3 m-85 -152.39 18.35 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.459 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 43.9 t80 -175.51 135.2 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.574 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -138.42 112.4 8.49 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.049 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 0.7 OUTLIER -92.14 146.29 23.84 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.608 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.7 m -85.48 116.53 23.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.145 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.904 ' H ' HE22 ' A' ' 26' ' ' GLN . 70.8 mt . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.036 0.446 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.746 HE22 ' HA ' ' A' ' 8' ' ' CYS . 1.3 tt0 -133.95 163.83 28.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.784 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.17 176.46 5.24 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.699 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.733 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.1 t60 -61.46 140.37 58.08 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.733 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 24.8 m-85 69.88 11.62 7.78 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.98 155.5 34.98 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.528 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.454 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 42.1 tt0 -78.06 104.97 8.97 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.66 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.746 ' HA ' HE22 ' A' ' 2' ' ' GLN . 1.6 p -89.79 -16.23 30.67 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.53 -156.74 9.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 117.862 -2.114 . . . . 0.0 112.425 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.27 144.46 16.94 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.196 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -49.16 153.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.292 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.38 79.79 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.087 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.12 109.64 13.72 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.886 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.5 p -109.05 21.23 17.45 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.275 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.27 178.99 42.03 Favored Glycine 0 N--CA 1.483 1.789 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.691 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.31 157.17 51.54 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.347 1.365 . . . . 0.0 109.79 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 8' ' ' CYS . 40.4 p -119.79 8.46 11.15 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.804 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.62 109.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.224 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.9 m -69.11 168.62 13.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.69 174.86 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -68.4 140.92 55.83 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -11.36 52.22 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.575 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -107.23 169.12 8.76 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.179 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.5 177.37 7.98 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -100.32 147.84 25.35 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.539 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' OE1' ' N ' ' A' ' 36' ' ' LEU . 24.9 mp0 -145.2 125.38 13.74 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.035 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.23 110.28 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.572 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.98 -58.31 3.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.105 -1.438 . . . . 0.0 108.248 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.7 p30 -151.22 174.37 3.62 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.919 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.606 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.8 Cg_exo -64.73 24.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 120.952 1.101 . . . . 0.0 113.509 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.8 m-85 -153.95 20.48 0.51 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.02 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -175.24 131.24 0.29 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.318 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.9 m -131.57 106.75 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.957 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -86.25 153.25 22.14 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.775 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.46 128.19 43.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.629 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 75.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.079 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 166.7 10.97 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.684 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.49 174.02 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.811 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.663 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -53.77 135.11 41.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.663 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 61.7 m-85 69.53 18.73 7.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.98 142.07 18.9 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.85 120.27 19.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.714 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -108.6 -15.53 14.4 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.922 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 -155.91 7.4 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 118.095 -2.003 . . . . 0.0 112.151 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.46 128.21 3.74 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.9 mt -46.67 152.25 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.699 -1.2 . . . . 0.0 110.506 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.25 -7.36 78.75 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.61 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -97.11 130.65 44.36 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.755 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.4 p -124.86 61.09 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.88 177.97 23.0 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.02 155.22 45.93 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.105 1.203 . . . . 0.0 110.414 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 8' ' ' CYS . 66.7 p -118.34 32.66 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.73 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -105.07 123.52 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.943 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 24' ' ' THR . 58.8 m -88.24 143.25 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.847 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 168.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.765 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 p -59.13 144.7 44.91 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.064 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.22 -15.42 53.92 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.907 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.0 166.27 11.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.681 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.408 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -136.55 175.25 9.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.97 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -96.73 121.1 38.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.606 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -121.39 132.6 54.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.37 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -85.95 143.02 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.578 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.1 tp -107.86 -59.91 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.543 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -139.44 175.14 3.44 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.97 24.65 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.538 0.825 . . . . 0.0 111.073 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' H ' ' C ' ' A' ' 29' ' ' ASN . 82.9 m-85 -150.6 10.16 0.64 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -163.67 122.06 1.93 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.537 -1.265 . . . . 0.0 112.229 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -131.29 112.64 12.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.099 -1.04 . . . . 0.0 109.466 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -91.09 153.41 20.11 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.662 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -92.9 112.56 24.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.157 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.355 -179.165 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.36 -158.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.253 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 163.87 31.71 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.01 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.446 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -47.08 137.37 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.446 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 49.3 m-85 62.47 34.23 15.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.9 150.03 18.19 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.364 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.69 102.55 10.79 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.285 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -89.9 -25.14 21.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.298 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.78 -176.27 25.16 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.363 -1.875 . . . . 0.0 112.305 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.95 133.74 4.05 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 66.5 mt -44.92 148.11 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.336 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.02 -17.4 22.64 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.775 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -80.37 139.43 36.54 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.422 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -131.5 10.13 4.76 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.998 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 177.9 46.76 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.779 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.52 155.29 69.67 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.488 1.459 . . . . 0.0 110.807 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.4 p -111.62 30.15 7.22 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.887 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.93 111.47 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.434 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -77.47 145.87 36.79 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -44.52 144.17 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.891 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -48.86 141.02 7.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.131 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -27.11 22.12 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.967 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -110.21 169.86 8.45 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.424 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 154.78 47.77 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.603 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.8 t -75.24 143.2 43.2 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.091 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -143.06 106.72 4.63 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.117 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.39 131.29 5.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.954 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -101.2 -48.95 4.23 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.1 p-10 -162.18 170.4 7.96 Favored Pre-proline 0 CA--C 1.565 1.556 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.666 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.9 Cg_exo -67.72 25.06 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.708 0.939 . . . . 0.0 112.798 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 71.0 m-85 -155.27 16.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.506 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -175.18 132.39 0.31 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.689 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -135.8 113.94 11.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.894 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.6 tp-100 -94.69 149.04 21.65 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.396 1.06 . . . . 0.0 112.072 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.3 m -104.89 122.62 46.18 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.88 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 116.351 -1.785 . . . . 0.0 109.988 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 28.0 tp60 -91.72 159.06 16.03 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.84 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.33 171.84 7.72 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.774 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.758 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.0 t60 -56.65 158.18 4.76 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.758 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 78.1 m-85 48.89 18.21 0.19 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.466 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -89.64 153.73 23.47 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.863 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -80.22 110.7 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.011 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.672 ' O ' HG22 ' A' ' 17' ' ' THR . 1.0 OUTLIER -94.65 -15.57 23.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.57 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 -176.46 26.53 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 118.429 -1.843 . . . . 0.0 112.14 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.25 143.21 5.33 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.88 142.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.117 -1.433 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.51 -5.84 63.01 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.497 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.39 108.3 17.78 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 p -101.88 46.68 0.92 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.009 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.84 166.01 15.37 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.568 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.39 162.81 0.78 Allowed 'Trans proline' 0 C--O 1.207 -1.067 0 C-N-CA 121.265 1.31 . . . . 0.0 110.206 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' CYS . 22.9 p -125.61 -3.72 7.22 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.683 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 t -78.57 122.89 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.208 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -77.2 154.91 32.63 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.077 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -58.9 163.48 3.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.916 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -60.27 155.74 17.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.605 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -6.86 24.73 Favored Glycine 0 N--CA 1.481 1.679 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.452 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -129.43 163.79 25.07 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.666 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.63 176.74 8.19 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.788 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.43 141.65 29.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.931 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.85 112.21 9.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.671 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.405 HG13 ' OG ' ' A' ' 33' ' ' SER . 2.4 t -74.91 113.05 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' H ' ' HA ' ' A' ' 33' ' ' SER . 6.2 tp -78.21 -56.74 4.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.302 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.5 m120 -150.09 174.19 3.69 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.2 23.63 0.22 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.493 0.795 . . . . 0.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -144.62 8.03 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.528 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -169.51 132.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.104 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 67.5 m -141.16 108.96 5.66 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.028 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -85.27 157.94 20.45 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.731 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 6' ' ' GLY . 1.5 m -101.53 115.43 30.49 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.375 -1.774 . . . . 0.0 109.344 179.556 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.9 mp0 -121.9 -179.97 4.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.694 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.9 -176.55 3.21 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.789 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.5 t60 -60.75 136.11 57.97 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.222 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.789 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 35.4 m-85 68.67 13.0 8.86 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 123.39 0.431 . . . . 0.0 110.127 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 154.95 34.9 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.435 -1.364 . . . . 0.0 111.797 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -82.28 118.95 23.51 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.878 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -111.05 -16.14 13.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.484 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.69 -162.15 10.87 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.156 -1.973 . . . . 0.0 112.315 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.23 138.54 10.16 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.452 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.447 HD12 ' O ' ' A' ' 30' ' ' PRO . 53.8 mt -49.61 146.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.884 -1.127 . . . . 0.0 110.027 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.86 14.45 64.94 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.009 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -121.19 119.76 33.27 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.021 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.2 p -117.42 57.9 0.8 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.594 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.36 174.76 22.73 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.514 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.0 154.67 49.28 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.244 1.296 . . . . 0.0 110.137 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.1 p -112.64 5.23 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.709 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.69 116.29 20.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.989 -1.085 . . . . 0.0 109.323 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -83.31 164.57 19.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.327 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.57 156.6 10.39 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.8 m -58.62 144.45 43.04 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.781 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.03 -15.21 63.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.928 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -117.84 -177.86 3.35 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.682 -179.368 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -146.17 171.29 15.15 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.855 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.478 ' C ' ' NE2' ' A' ' 26' ' ' GLN . 11.3 t -100.61 114.15 27.58 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.094 -179.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.528 ' CD ' ' N ' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -105.58 118.36 36.39 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.862 178.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.66 130.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.566 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.37 -56.43 2.94 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.146 -1.422 . . . . 0.0 109.144 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.2 p30 -154.39 176.53 2.44 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.131 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -65.98 25.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.958 1.106 . . . . 0.0 112.812 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -152.68 15.85 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.642 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -175.27 135.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.599 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.6 m -136.51 113.68 10.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -82.6 164.05 21.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.368 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 21.3 m -111.26 112.94 25.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.714 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 23' ' ' THR . 20.5 mt . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 116.472 -1.728 . . . . 0.0 110.189 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.47 -162.51 0.85 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.557 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -127.61 174.68 8.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.9 179.535 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.821 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.7 t60 -50.91 144.18 9.0 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.178 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.821 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 25.7 m-85 62.65 15.41 7.99 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.177 -177.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.4 150.6 31.85 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.737 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -85.3 103.8 14.57 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.755 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -90.05 -16.79 29.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.255 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.93 -176.34 29.87 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.305 -1.902 . . . . 0.0 112.359 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.54 130.57 3.31 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 120.056 -1.068 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 30' ' ' PRO . 41.4 mt -46.9 148.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.252 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.2 -9.16 27.9 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.369 -1.396 . . . . 0.0 111.05 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -88.78 130.32 35.39 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 p -130.19 62.35 1.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.38 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.3 173.41 23.04 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.79 154.55 12.38 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 N-CA-C 109.473 -1.01 . . . . 0.0 109.473 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.0 p -122.06 18.14 10.84 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.817 -178.424 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -91.82 125.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.424 -0.91 . . . . 0.0 108.904 178.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 67.2 m -80.87 157.14 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.392 -179.029 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.98 151.97 11.0 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 m -56.93 139.68 51.0 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.031 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.29 -20.1 39.29 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.28 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -112.21 161.59 16.4 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.35 30.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 t -80.74 107.39 13.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.164 -179.251 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -106.84 108.88 20.6 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.274 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -49.65 141.37 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -106.05 -57.82 1.99 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.59 HD22 HD12 ' A' ' 28' ' ' LEU . 11.4 p30 -155.76 172.32 6.16 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.121 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.8 Cg_exo -68.94 23.76 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 120.972 1.115 . . . . 0.0 113.127 -176.806 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' H ' ' C ' ' A' ' 29' ' ' ASN . 66.4 m-85 -154.16 18.07 0.49 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.183 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 40.8 t80 -174.45 128.24 0.34 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.399 -177.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m -125.59 115.74 20.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.4 tp60 -93.32 150.62 20.34 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.198 0.937 . . . . 0.0 112.691 -177.028 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 m -102.24 116.26 32.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.799 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.133 -178.651 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.024 0.44 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -100.34 -165.79 1.25 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -136.26 171.59 14.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.044 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.779 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.8 t60 -57.15 149.37 19.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.779 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 50.0 m-85 53.72 26.74 6.19 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.221 -178.156 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.67 149.8 17.39 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.824 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.7 117.61 18.5 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.435 ' O ' HG22 ' A' ' 17' ' ' THR . 1.3 p -105.81 -24.98 12.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.77 -154.09 6.56 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.592 -1.766 . . . . 0.0 112.23 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 151.6 23.2 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -178.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -61.83 153.37 5.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.945 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.54 35.27 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.801 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -88.58 135.64 33.39 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -133.96 41.24 3.02 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.47 173.69 16.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.37 158.33 23.19 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.379 1.386 . . . . 0.0 110.095 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 8' ' ' CYS . 11.9 p -127.36 29.4 5.55 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.976 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.46 109.45 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.194 178.336 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' C ' ' A' ' 24' ' ' THR . 52.4 m -70.87 157.01 38.87 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.085 -178.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.56 169.49 0.2 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.5 m -63.64 143.24 57.99 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.923 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.51 -15.47 40.75 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.429 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.34 169.27 8.99 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.709 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.446 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.591 179.709 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 t -92.75 142.87 26.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.292 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -139.31 123.98 18.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.906 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.79 131.59 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.988 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.96 -57.26 2.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.305 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.0 m120 -143.1 173.54 4.44 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -70.1 25.11 0.18 Allowed 'Trans proline' 0 C--O 1.212 -0.787 0 CA-C-N 119.319 0.792 . . . . 0.0 111.107 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 29' ' ' ASN . 72.0 m-85 -152.06 20.87 0.67 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.206 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 62.3 t80 -175.46 125.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.71 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 m -130.92 113.96 14.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.175 177.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 9.2 tt0 -101.36 159.53 15.19 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.914 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -97.03 128.63 44.18 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.051 179.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.109 -178.501 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -120.0 -167.08 1.38 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.781 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 162.77 25.93 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.684 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.7 OUTLIER -51.3 128.69 22.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.371 -179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.684 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 54.8 m-85 72.22 20.31 4.21 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 123.912 0.758 . . . . 0.0 109.78 -178.202 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.55 154.98 22.45 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.92 117.13 21.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.125 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -107.91 -15.91 14.43 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.96 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.27 -178.6 24.42 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 118.0 -2.047 . . . . 0.0 111.729 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.78 154.01 7.81 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.84 137.67 22.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.045 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.86 -20.6 11.77 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.572 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -69.26 100.37 1.31 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.595 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.6 p -92.01 16.04 12.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.592 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.41 177.46 50.28 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.729 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.41 153.98 62.14 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.578 1.519 . . . . 0.0 110.243 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -119.89 20.03 12.28 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.31 -177.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.51 112.22 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.352 178.696 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.92 175.31 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.27 173.72 10.48 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.115 178.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.4 m -66.52 143.74 56.89 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.917 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.09 -15.81 19.88 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.972 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.32 162.43 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.494 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 166.81 22.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.867 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.1 127.01 43.8 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.264 -179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -126.74 117.32 22.45 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.753 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.27 136.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.164 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.437 HD12 HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -97.01 -53.46 3.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.704 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -153.42 177.07 2.1 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.44 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.53 24.17 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.534 0.822 . . . . 0.0 111.156 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' ASN . 37.1 m-85 -151.0 0.15 0.39 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.756 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -159.83 138.21 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.426 -178.429 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 m -135.7 118.71 16.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.227 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -96.16 146.12 24.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.497 1.123 . . . . 0.0 113.16 -177.078 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 8.8 m -95.52 116.49 28.9 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 116.413 -1.756 . . . . 0.0 110.055 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.042 0.449 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.3 tp60 -92.12 -178.22 4.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.696 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.58 -179.61 3.73 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.426 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.478 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.7 t60 -66.99 142.37 57.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.478 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 72.9 m-85 59.65 27.84 17.15 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.345 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.62 156.37 20.64 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.999 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -86.87 117.09 25.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.157 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -102.32 -21.87 14.23 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.776 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.37 -169.13 15.51 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.473 -179.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.76 132.47 5.52 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 30' ' ' PRO . 97.7 mt -50.23 155.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.45 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.17 -18.45 13.51 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.191 -178.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.7 148.11 28.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.978 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 p -141.1 11.07 2.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.514 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.66 -175.81 49.46 Favored Glycine 0 N--CA 1.478 1.473 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.16 154.2 70.46 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.525 1.483 . . . . 0.0 109.866 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 8' ' ' CYS . 30.4 p -115.9 15.44 16.27 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.53 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.41 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.679 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -73.62 149.58 41.94 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.547 -179.058 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -51.5 165.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.306 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.5 m -62.08 141.23 58.23 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.75 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.86 72.91 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.724 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.37 178.51 6.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.368 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.63 173.98 11.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.754 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 t -100.08 129.91 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.194 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.41 117.4 22.09 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.816 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.19 142.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.079 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -105.5 -56.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.209 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.541 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.9 m120 -144.01 175.41 2.84 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -69.36 24.64 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 CA-C-N 119.126 0.723 . . . . 0.0 111.356 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.7 m-85 -148.24 6.15 0.76 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -162.85 139.64 7.58 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.218 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -143.97 114.39 7.53 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.474 176.817 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -88.07 164.07 15.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.101 -178.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -108.48 118.23 36.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.416 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 116.325 -1.798 . . . . 0.0 109.641 -179.889 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 4.1 tp60 -119.83 -164.34 1.07 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.165 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.504 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -141.66 174.1 10.88 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.713 -179.735 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 20.4 t-160 -53.83 135.32 42.02 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.109 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.457 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 52.1 m-85 60.22 23.83 13.2 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.441 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.17 143.47 16.17 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 22.7 tt0 -67.43 111.62 4.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.347 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -94.92 -21.84 18.38 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.488 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.06 -175.14 24.17 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 118.321 -1.895 . . . . 0.0 112.342 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.21 137.69 4.81 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 30' ' ' PRO . 70.3 mt -47.9 151.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.08 7.36 66.68 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.957 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.54 128.0 44.7 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -119.87 56.56 0.95 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.015 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.81 179.96 18.35 Favored Glycine 0 N--CA 1.487 2.081 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.969 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.34 158.4 55.3 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.69 1.593 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.7 p -121.96 11.75 10.35 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.555 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.27 117.2 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.107 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 24' ' ' THR . 97.6 m -77.24 145.06 37.78 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.492 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.84 163.2 5.93 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.841 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 m -54.44 147.28 14.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.25 -18.8 38.92 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.069 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.593 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -122.3 172.44 8.31 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.493 0.663 . . . . 0.0 111.218 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.46 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -149.22 162.4 40.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.378 179.718 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.67 136.2 33.12 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.448 -178.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -130.22 116.54 18.55 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.172 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.23 118.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.561 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -84.6 -57.66 3.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.151 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.16 178.37 1.64 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.476 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.1 Cg_exo -69.76 24.01 0.17 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.734 0.956 . . . . 0.0 111.132 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' ASN . 76.7 m-85 -152.16 11.35 0.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 33' ' ' SER . 4.7 t80 -173.15 138.56 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.682 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 66.9 m -139.71 115.9 10.46 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.239 178.018 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.7 tt0 -90.77 152.5 20.77 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.916 -176.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.21 103.17 14.62 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.31 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.593 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.9 mm? . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.364 -1.779 . . . . 0.0 109.562 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.036 0.446 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -121.31 -169.23 1.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 -179.48 5.11 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.704 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.3 t60 -67.64 136.24 54.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.704 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 45.1 m-85 65.81 20.54 11.45 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.878 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.37 148.85 19.1 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.44 115.28 16.03 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' THR . 5.8 p -95.5 -19.06 20.14 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.379 179.127 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.55 -170.26 27.12 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.237 -1.935 . . . . 0.0 112.656 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.66 134.41 4.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 30' ' ' PRO . 30.8 mt -43.88 142.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.667 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.42 -17.54 53.69 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.687 -1.244 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.7 159.82 22.51 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.636 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 p -144.33 3.57 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.949 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.0 173.34 39.5 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.624 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.51 165.1 8.18 Favored 'Trans proline' 0 C--O 1.209 -0.959 0 C-N-CA 121.596 1.531 . . . . 0.0 110.215 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.1 p -128.17 14.45 6.73 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.14 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.8 114.73 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.662 178.386 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 24' ' ' THR . 64.2 m -77.28 147.43 36.29 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.329 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.23 170.34 0.22 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -60.53 148.18 38.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.614 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.97 44.49 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.379 179.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.19 165.45 17.57 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.458 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.443 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -143.49 165.91 26.26 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.608 179.825 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.2 t -82.28 128.06 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.75 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -120.72 115.51 23.46 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.094 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.93 121.41 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.599 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tp -90.22 -57.35 2.87 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.753 -1.179 . . . . 0.0 109.427 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.8 p30 -157.49 176.84 2.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.032 -178.26 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 4.1 Cg_exo -66.58 27.6 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 120.958 1.106 . . . . 0.0 112.989 -177.1 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.8 m-85 -154.75 14.84 0.42 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.947 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -174.87 140.7 0.57 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.661 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -143.9 113.25 6.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.11 158.27 17.37 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.794 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -99.77 112.82 25.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.007 178.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.236 179.669 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.154 0.502 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.25 150.43 52.16 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.01 -174.92 3.1 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.743 -178.226 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.724 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t60 -61.65 158.07 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.079 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.724 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 28.0 m-85 48.7 21.53 0.43 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.561 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 155.46 19.12 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.598 -1.287 . . . . 0.0 111.962 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -83.66 121.02 26.7 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.163 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' O ' HG22 ' A' ' 17' ' ' THR . 1.5 p -107.46 -27.96 10.11 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.656 179.125 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.38 -148.97 4.87 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.222 -1.942 . . . . 0.0 112.872 -178.515 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.04 134.25 7.58 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -178.226 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.1 mt -51.37 152.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.976 -178.855 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -11.29 47.87 Favored Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.346 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -86.26 130.5 34.5 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.6 p -121.09 62.32 0.89 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.624 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.84 -175.74 19.16 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.642 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.69 159.2 53.75 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.493 1.462 . . . . 0.0 109.909 179.05 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 8' ' ' CYS . 81.4 p -122.66 30.94 6.26 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.581 -178.183 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.42 116.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.394 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.2 m -82.01 155.79 24.98 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.09 151.66 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.341 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -49.56 141.77 9.02 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.077 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 -26.44 21.1 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.093 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.51 165.81 12.36 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.102 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.91 160.16 39.45 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.764 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.42 102.31 5.92 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.229 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -95.48 108.99 21.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.606 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.7 135.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.412 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -102.19 -55.5 2.46 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.8 p30 -154.14 173.42 4.73 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -66.87 24.99 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.504 0.859 . . . . 0.0 112.035 -177.879 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 47.4 m-85 -150.38 -5.65 0.32 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.611 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CD2' ' HG ' ' A' ' 28' ' ' LEU . 6.3 t80 -152.54 132.41 13.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.409 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -127.79 112.28 14.6 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.925 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -89.83 155.33 19.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.121 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -99.83 113.2 25.56 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.533 178.899 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 116.385 -1.769 . . . . 0.0 109.934 179.206 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.07 159.9 17.32 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.476 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -177.42 3.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.88 -179.432 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -70.27 127.93 34.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.606 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 68.5 m-85 79.87 18.32 0.7 Allowed 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.052 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.1 154.46 20.5 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.869 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.85 114.33 17.7 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.453 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -99.26 -19.25 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.98 -167.02 13.51 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.276 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.95 146.91 10.38 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.198 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.6 mt -59.34 153.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.094 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -12.81 39.87 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.101 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -88.19 152.97 21.6 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.642 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.4 p -148.59 13.32 0.93 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.944 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.81 -172.73 43.97 Favored Glycine 0 N--CA 1.483 1.783 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.76 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.76 160.44 32.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.306 1.337 . . . . 0.0 110.252 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -128.96 27.62 5.41 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.059 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -105.7 120.42 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.99 178.684 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.4 m -80.27 145.48 32.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.986 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -50.1 145.24 6.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.74 178.757 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -50.01 141.67 10.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.007 -179.281 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.45 -26.89 22.62 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.339 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.669 HG22 ' OXT' ' A' ' 36' ' ' LEU . 1.1 p -105.92 -173.46 2.3 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.28 157.37 43.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.724 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.79 136.25 33.06 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.428 -1.309 . . . . 0.0 109.301 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -136.53 120.62 17.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.392 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.24 118.46 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.639 178.635 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -84.28 -56.82 3.44 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.674 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.534 HD22 HD12 ' A' ' 28' ' ' LEU . 4.3 p30 -149.06 171.59 6.13 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.08 26.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 119.41 0.825 . . . . 0.0 111.95 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 83.3 m-85 -154.39 14.97 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.416 ' HB3' HD21 ' A' ' 29' ' ' ASN . 74.6 t80 -173.8 126.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 17.7 m -126.85 111.49 14.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.665 178.148 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.6 tp60 -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.767 1.292 . . . . 0.0 112.561 -176.939 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.9 m -99.66 105.94 17.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.998 179.331 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.669 ' OXT' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 116.269 -1.824 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -117.14 152.49 34.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 4' ' ' HIS . 0.3 OUTLIER -109.69 170.45 8.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.694 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.812 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 0.8 OUTLIER -40.98 130.29 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.47 -179.764 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.812 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.8 m-85 68.53 40.75 1.85 Allowed 'General case' 0 N--CA 1.511 2.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.26 -178.468 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.12 152.62 17.3 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.78 100.85 11.19 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.161 179.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -89.85 -17.51 27.96 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.43 -159.21 8.75 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.944 -2.074 . . . . 0.0 112.675 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 106.09 124.57 5.33 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -178.571 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 10' ' ' GLY . 96.4 mt -41.67 147.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.966 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.52 31.6 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.879 -1.153 . . . . 0.0 111.411 -179.247 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.32 114.11 21.63 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 p -108.11 17.47 22.27 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.78 176.73 42.96 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.594 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.64 158.65 44.96 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.453 1.435 . . . . 0.0 110.234 179.389 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.7 p -119.22 16.4 13.16 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.582 -178.322 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -95.03 118.78 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.459 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 m -84.99 152.93 23.1 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.076 -1.049 . . . . 0.0 109.949 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.7 137.0 58.17 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ALA . 3.3 m -41.36 145.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.39 -24.02 30.06 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -120.98 -171.63 2.23 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.558 0.694 . . . . 0.0 110.473 179.69 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.88 162.12 41.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.92 136.53 34.05 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.904 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -132.64 139.07 47.57 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.499 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.98 123.29 35.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -88.1 -56.39 3.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -154.87 174.78 3.57 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.04 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.4 Cg_exo -64.78 24.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.211 -0.825 0 C-N-CA 121.005 1.137 . . . . 0.0 112.769 -179.138 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.2 m-85 -154.9 14.03 0.4 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.204 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -172.43 125.79 0.51 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.701 -178.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 72.2 m -126.84 115.43 19.31 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.342 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG2' HD11 ' A' ' 36' ' ' LEU . 0.5 OUTLIER -93.92 149.32 21.34 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.669 -177.641 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' C ' HD22 ' A' ' 36' ' ' LEU . 55.0 m -103.42 117.2 33.91 Favored 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.066 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 116.308 -1.805 . . . . 0.0 110.173 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.048 0.451 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.574 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.4 tt0 -85.7 -168.45 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.305 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 160.28 32.86 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.956 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.514 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.2 t60 -46.62 132.67 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.37 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.514 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 25.2 m-85 72.58 24.62 2.8 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.526 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.44 144.54 17.16 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.111 -179.854 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.539 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 38.1 tt0 -76.13 96.37 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.614 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.847 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -88.56 -12.0 44.0 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.663 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.53 -160.96 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.047 -2.025 . . . . 0.0 112.181 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.26 149.64 23.11 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.489 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 30' ' ' PRO . 81.9 mt -69.73 157.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.455 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.74 -3.29 35.91 Favored Glycine 0 N--CA 1.484 1.89 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.338 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 16.7 t80 -85.1 154.24 22.18 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -146.8 57.26 1.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.463 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.64 177.26 24.15 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.331 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.48 164.64 6.92 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.13 1.22 . . . . 0.0 109.799 179.382 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.8 p -127.15 29.33 5.61 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.326 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.89 120.9 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.913 179.131 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 24' ' ' THR . 10.3 m -77.67 142.33 38.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -45.6 168.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.04 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.11 149.99 46.49 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.512 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.1 -15.14 57.07 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.497 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -114.9 -175.2 2.64 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.032 -179.715 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.451 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -150.96 162.46 40.77 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.53 179.631 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.2 t -92.37 124.61 36.55 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.494 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 24' ' ' THR . 28.9 mp0 -125.42 128.52 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.787 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.59 142.12 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.408 ' HG ' ' CD2' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -108.42 -56.72 2.22 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.886 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.0 p-10 -161.36 171.87 6.39 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.9 Cg_exo -67.25 24.24 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.601 0.867 . . . . 0.0 112.817 -176.789 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 29' ' ' ASN . 62.3 m-85 -150.54 14.21 0.76 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' CD2' ' HG ' ' A' ' 28' ' ' LEU . 6.0 t80 -175.34 134.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 -179.27 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -132.74 114.33 14.02 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -90.62 156.08 18.38 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.986 -176.974 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.2 m -104.04 131.03 51.71 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.048 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.403 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 70.6 mt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 116.404 -1.76 . . . . 0.0 109.875 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -131.23 166.5 21.04 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.48 179.499 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -175.71 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.123 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.9 t60 -68.06 147.51 52.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 54.4 m-85 55.52 26.13 8.67 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.444 -177.975 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.93 145.92 18.07 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -77.05 116.94 18.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -17.37 14.49 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.816 179.715 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.48 -168.54 15.51 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 118.641 -1.743 . . . . 0.0 111.873 -179.308 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.81 133.91 5.59 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 30' ' ' PRO . 63.0 mt -46.55 147.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.01 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.41 -11.42 24.71 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.816 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -82.37 110.65 17.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 p -111.43 59.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.432 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.81 179.46 18.2 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.713 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.18 149.06 91.96 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.432 1.421 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.2 p -110.61 -12.6 14.32 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.536 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 t -76.77 108.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.43 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.65 156.86 38.93 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.664 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -52.92 152.3 4.06 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.224 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.11 152.24 4.38 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.94 -17.04 55.36 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.745 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -120.77 -179.94 4.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.227 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 163.25 37.4 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.085 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -89.72 138.37 31.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.534 -179.449 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -130.96 106.08 8.17 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.074 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.36 114.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -79.09 -51.82 9.04 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.51 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 p30 -158.68 174.78 3.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.202 -179.051 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -65.57 24.87 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.01 1.14 . . . . 0.0 113.213 -176.87 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 93.5 m-85 -152.33 10.2 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.703 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.8 t80 -169.67 134.4 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.053 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -138.07 113.73 9.7 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.452 177.295 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.61 163.54 15.78 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.862 -178.415 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.1 m -107.35 115.02 29.43 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.363 179.609 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.198 -179.804 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.4 tp60 -98.58 153.02 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 179.07 5.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.667 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.8 t60 -55.42 145.47 22.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.336 -0.946 . . . . 0.0 108.8 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.667 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 48.7 m-85 60.46 29.59 19.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.61 155.11 20.46 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.81 -179.064 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 57.5 tt0 -89.82 104.54 17.1 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.357 179.455 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.11 -22.67 21.66 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.132 179.557 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.65 19.19 Favored Glycine 0 N--CA 1.486 1.984 0 C-N-CA 118.241 -1.933 . . . . 0.0 112.323 -178.783 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.52 136.49 4.64 Favored Glycine 0 C--O 1.211 -1.313 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -48.06 142.03 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.554 -179.408 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.2 65.5 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.844 179.606 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 87.9 t80 -95.97 100.45 12.12 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.531 179.767 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -97.43 40.75 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.254 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.03 169.88 13.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.27 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -51.05 149.78 14.71 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.199 1.266 . . . . 0.0 109.899 179.482 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -111.84 -12.13 13.84 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -82.28 125.72 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.776 -1.169 . . . . 0.0 109.666 179.161 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.7 m -80.34 160.49 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.076 179.611 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -62.09 175.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.508 -179.926 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.6 m -62.63 144.79 55.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.251 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.27 60.03 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.667 -1.254 . . . . 0.0 112.435 178.684 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.35 166.47 13.49 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.603 -179.655 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.36 158.52 44.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -82.14 132.16 35.24 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.274 -179.012 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -127.57 119.25 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.104 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.67 122.3 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.595 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.433 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -93.46 -53.28 4.13 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.459 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -154.23 175.02 3.3 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.754 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.0 Cg_exo -72.75 23.27 0.29 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 120.512 0.808 . . . . 0.0 110.716 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.1 m-85 -150.63 13.09 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.867 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -174.16 126.65 0.35 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.836 -178.84 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 38.4 m -128.68 112.66 14.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.103 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HG2' HD21 ' A' ' 36' ' ' LEU . 0.1 OUTLIER -90.13 149.82 22.3 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.597 -176.973 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.7 m -105.51 110.59 22.98 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.409 179.566 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.388 -1.768 . . . . 0.0 109.857 -179.359 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -120.45 151.33 39.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.239 179.467 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.53 175.95 5.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.662 -178.848 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.721 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.1 t60 -52.01 136.12 29.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.464 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.721 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 42.9 m-85 70.53 25.03 4.33 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.885 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.51 149.13 19.06 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.821 -1.181 . . . . 0.0 111.441 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.62 111.27 17.76 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.629 179.698 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.843 ' O ' HG22 ' A' ' 17' ' ' THR . 1.4 p -103.45 -12.76 16.95 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.08 -163.55 14.31 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 118.451 -1.833 . . . . 0.0 112.083 -179.761 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.0 133.35 8.04 Favored Glycine 0 N--CA 1.48 1.628 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.54 -179.634 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -50.6 154.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.014 -1.074 . . . . 0.0 109.696 -179.765 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.04 81.34 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.148 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CZ ' ' CA ' ' A' ' 15' ' ' GLY . 21.2 t80 -105.63 153.29 22.01 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.148 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 p -136.42 2.06 2.69 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.479 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' CZ ' ' A' ' 13' ' ' TYR . . . -93.97 178.59 37.67 Favored Glycine 0 CA--C 1.551 2.294 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.584 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.41 161.78 29.84 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.189 1.926 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 8' ' ' CYS . 33.7 p -116.44 25.46 10.6 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.846 -178.653 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.07 116.63 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.875 179.407 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.22 149.44 25.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.56 150.51 12.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.013 179.58 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.46 160.24 1.26 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.481 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.7 -20.15 9.93 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.069 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.83 163.43 23.61 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.668 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -135.84 173.82 11.29 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.821 179.214 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -87.09 148.81 25.08 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.371 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.448 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.5 mp0 -143.64 124.54 14.3 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.558 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.56 113.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.167 179.04 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -81.97 -57.05 3.58 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.797 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -150.69 171.86 5.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.346 179.579 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -66.07 24.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.739 0.959 . . . . 0.0 113.123 -177.028 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.3 m-85 -155.58 16.63 0.39 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.903 178.934 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 52.9 t80 -171.65 121.8 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.571 -176.414 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 13.8 m -118.44 111.81 19.15 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.656 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 36' ' ' LEU . 6.0 tp60 -90.51 144.02 26.19 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.448 -177.559 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.6 m -87.85 115.13 25.09 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.822 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 34' ' ' GLN . 33.0 mt . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 116.391 -1.766 . . . . 0.0 110.197 -178.356 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -106.87 148.25 28.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.884 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -93.46 -167.43 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.153 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.495 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 1.1 t60 -66.71 132.12 47.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.649 -179.466 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.495 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.5 m-85 71.35 29.35 2.77 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.518 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.01 154.62 20.25 Favored Glycine 0 N--CA 1.481 1.693 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.54 117.3 25.23 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.886 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -102.7 -33.16 9.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.624 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 33' ' ' SER . . . -152.42 -178.75 27.4 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 117.433 -2.318 . . . . 0.0 113.828 -177.767 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.81 151.57 8.23 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 12.3 mt -59.32 149.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.915 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.07 8.13 Favored Glycine 0 C--N 1.296 -1.663 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.211 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -82.38 138.17 34.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.561 179.578 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -136.53 40.13 2.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.462 -179.759 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.44 176.3 16.27 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.151 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.9 155.95 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 N-CA-C 109.407 -1.036 . . . . 0.0 109.407 179.132 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.8 p -117.89 32.64 6.04 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.869 -178.652 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.96 119.13 60.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.843 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.7 m -80.02 171.31 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.641 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -74.16 147.32 42.72 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.236 179.345 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 m -43.05 139.26 1.82 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.677 -179.579 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.43 -26.8 22.92 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.248 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.613 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -114.01 171.46 7.59 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.183 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 161.57 37.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.973 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.0 t -85.69 140.39 30.56 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.864 -179.383 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -137.19 117.47 13.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.56 126.33 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.568 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.478 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -95.94 -57.64 2.3 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.802 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -152.03 177.03 2.05 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.065 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -67.43 24.08 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.774 0.983 . . . . 0.0 111.716 -178.985 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' ASN . 98.3 m-85 -154.38 12.82 0.42 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.034 179.522 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -171.98 137.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.435 -178.137 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLY . 50.8 m -136.88 115.98 12.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.402 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 4.8 tp60 -89.64 155.69 19.07 Favored 'General case' 0 N--CA 1.51 2.563 0 O-C-N 124.119 0.887 . . . . 0.0 113.062 -176.795 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 8.6 m -105.85 106.09 16.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.459 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.7 mm? . . . . . 0 N--CA 1.502 2.155 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.705 179.918 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.453 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.8 tp60 -101.97 151.65 21.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.053 179.797 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.67 179.87 4.53 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.756 -179.706 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.508 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.9 t60 -57.85 147.5 28.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.508 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 86.8 m-85 58.12 23.75 10.5 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.007 -178.884 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.67 156.11 19.77 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.898 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -83.85 110.06 18.06 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.416 -179.837 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.846 ' O ' HG22 ' A' ' 17' ' ' THR . 3.4 p -96.24 -19.61 19.18 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.207 179.046 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.84 -149.96 5.28 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.47 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.11 126.09 5.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.3 mt -48.61 149.6 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.526 -179.291 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.28 -13.55 20.38 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -70.46 153.5 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.231 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -143.47 52.89 1.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.687 -179.573 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.01 174.3 23.72 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.442 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.12 163.64 5.92 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.072 1.181 . . . . 0.0 109.795 179.073 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.846 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.9 p -127.4 15.65 7.14 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.971 -178.332 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.21 115.61 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.926 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ALA . 54.0 m -79.99 130.13 35.03 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.537 -179.217 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -41.12 132.01 2.54 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.978 179.625 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -40.07 144.85 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.57 -179.683 . . . . . . . . 3 3 . 1 . 035 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.88 30.78 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.72 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.82 176.96 5.69 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.2 167.84 20.52 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.675 179.209 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.65 106.32 18.3 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.653 -179.117 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -106.77 136.68 46.18 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.264 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.77 104.2 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.926 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.5 tp -62.06 -57.86 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.321 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.5 m120 -146.03 173.42 4.27 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.073 178.31 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.495 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.7 Cg_exo -69.41 23.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.413 0.742 . . . . 0.0 111.99 -177.972 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 34.2 m-85 -147.56 7.62 0.87 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.239 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -163.62 112.76 1.26 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.163 -178.949 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -115.87 114.29 24.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.982 177.647 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -94.65 166.95 11.76 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.488 -177.792 . . . . . . . . 1 1 . 1 . 035 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' H ' ' A' ' 6' ' ' GLY . 13.9 m -100.44 108.31 20.27 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.826 179.722 . . . . . . . . 2 2 . 1 . 035 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.229 -1.844 . . . . 0.0 109.951 -179.634 . . . . . . . . 0 0 . 1 . 036 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -94.64 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.096 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.69 -175.42 3.89 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.408 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.717 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 3.1 t60 -71.39 154.38 41.61 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.056 179.725 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.717 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 63.4 m-85 51.18 18.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.697 -178.338 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.66 155.67 22.21 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.165 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -83.27 110.86 18.44 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.644 179.666 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.848 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.78 -26.23 17.06 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.868 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.14 -151.36 5.62 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.343 -1.884 . . . . 0.0 112.601 -178.972 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 150.42 18.78 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 77.3 mt -62.16 149.73 9.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.33 -179.439 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.18 -4.09 42.41 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.676 -1.249 . . . . 0.0 111.313 -179.144 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -80.44 125.56 30.09 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.1 p -117.53 58.91 0.79 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.149 179.678 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.03 21.42 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.322 -179.562 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -68.44 159.77 51.99 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.758 1.638 . . . . 0.0 110.506 179.458 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 8' ' ' CYS . 15.0 p -120.23 12.63 11.83 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.569 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.62 116.54 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.116 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -79.11 149.41 32.07 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.199 -179.765 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.0 146.69 41.71 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.09 179.757 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -43.09 149.66 0.21 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.599 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.89 68.46 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.298 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -134.04 178.83 6.65 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.095 -179.971 . . . . . . . . 3 3 . 1 . 036 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.63 168.69 19.55 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.677 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -89.87 136.44 33.04 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.914 -179.535 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -128.27 133.1 48.71 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.147 -179.661 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.11 108.32 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.633 179.041 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.69 -51.03 38.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.557 -179.359 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.4 p30 -159.54 173.87 4.52 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.843 -179.122 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.1 Cg_exo -66.34 24.93 0.1 OUTLIER 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 120.909 1.073 . . . . 0.0 113.106 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 99.3 m-85 -152.75 19.37 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.468 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.3 t80 -175.99 130.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.094 -179.452 . . . . . . . . 2 2 . 1 . 036 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.1 m -132.57 112.04 11.74 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.834 177.166 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -93.73 157.77 15.99 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.071 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.3 m -102.39 121.14 41.73 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.145 179.36 . . . . . . . . 1 1 . 1 . 036 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 116.132 -1.89 . . . . 0.0 109.567 -179.949 . . . . . . . . 0 0 . 1 . 037 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 7' ' ' GLN . 11.7 tp60 -113.51 147.54 37.73 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.563 179.604 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 164.71 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.937 -178.944 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.425 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 3.0 t60 -44.73 159.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.159 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.425 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 67.3 m-85 47.57 19.37 0.14 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.727 -179.511 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.25 154.39 20.44 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.736 -178.707 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 39.7 tt0 -78.17 108.49 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.367 179.755 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 17' ' ' THR . 2.0 p -92.61 -24.72 18.6 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.794 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.26 -157.03 7.66 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.253 -178.763 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 113.94 126.38 4.35 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.876 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 30' ' ' PRO . 17.4 mt -40.41 145.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.62 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.9 -1.04 56.29 Favored Glycine 0 CA--C 1.544 1.903 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.795 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -91.43 101.3 13.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.424 179.693 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.6 p -95.1 55.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.07 171.76 22.0 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.228 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.68 161.9 13.97 Favored 'Trans proline' 0 C--O 1.205 -1.162 0 C-N-CA 121.756 1.637 . . . . 0.0 110.415 179.593 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -131.33 20.14 4.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.712 -178.813 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.21 116.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.379 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.06 144.07 29.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.149 -179.529 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.34 169.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.5 p -67.07 143.45 56.7 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.474 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.79 -17.36 45.83 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.39 169.9 8.7 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.515 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.53 160.03 41.8 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.223 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.3 t -79.97 116.73 20.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.114 -179.269 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -113.99 136.16 53.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.394 179.19 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -83.43 132.09 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.0 tp -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.399 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' TYR . 3.1 m120 -149.74 173.33 4.36 Favored Pre-proline 0 N--CA 1.495 1.811 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.876 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.694 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.7 Cg_exo -70.42 23.88 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.539 0.826 . . . . 0.0 111.39 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.0 m-85 -152.88 20.17 0.59 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.661 179.305 . . . . . . . . 2 2 . 1 . 037 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -173.96 129.76 0.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.6 m -136.79 119.45 16.07 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.549 177.927 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -99.81 158.28 15.91 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.431 -178.464 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 m -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 116.415 -1.755 . . . . 0.0 110.066 -178.681 . . . . . . . . 0 0 . 1 . 038 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -127.8 -176.89 3.91 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.177 179.771 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.42 174.77 8.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.415 -179.87 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.593 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 1.1 t60 -55.17 134.08 49.37 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.801 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 42.2 m-85 69.23 -3.48 1.54 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -61.45 152.75 41.02 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.765 179.715 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -84.61 111.93 19.98 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.72 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.904 ' O ' HG22 ' A' ' 17' ' ' THR . 1.7 p -89.69 -34.42 16.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.937 179.123 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.8 -155.54 6.75 Favored Glycine 0 N--CA 1.48 1.569 0 C-N-CA 118.303 -1.903 . . . . 0.0 112.395 -178.797 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.31 152.52 14.67 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.456 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 11.0 mt -60.87 146.9 10.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.917 -179.309 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.48 -8.76 52.85 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.736 -179.909 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -82.64 119.21 23.99 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.865 -179.652 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -113.04 57.62 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.329 179.791 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.27 21.6 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -69.19 157.14 62.62 Favored 'Trans proline' 0 C--O 1.21 -0.907 0 C-N-CA 121.818 1.679 . . . . 0.0 110.596 179.55 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 8' ' ' CYS . 47.7 p -115.87 13.31 16.01 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.716 -178.281 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.31 110.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.663 179.322 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -77.01 149.56 35.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.877 -179.067 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 155.98 0.34 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.239 179.804 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -52.64 144.8 13.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.428 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.06 -25.15 10.52 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.673 178.718 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.46 173.86 6.14 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.726 -179.462 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.64 170.14 17.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.65 140.99 28.96 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -141.9 113.88 8.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.43 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.86 111.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.87 -48.97 50.96 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.021 -1.471 . . . . 0.0 107.651 179.299 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.6 p30 -163.27 175.09 3.0 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.655 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 6.3 Cg_exo -65.93 28.9 0.1 OUTLIER 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 121.001 1.134 . . . . 0.0 113.6 -177.278 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 70.7 m-85 -154.48 13.78 0.43 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.144 178.425 . . . . . . . . 2 2 . 1 . 038 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -175.35 133.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.747 -178.544 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -131.54 109.07 9.99 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.487 177.286 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -86.82 153.18 21.85 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.72 -177.85 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 m -97.4 115.33 27.54 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.847 178.961 . . . . . . . . 1 1 . 1 . 038 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 116.403 -1.76 . . . . 0.0 110.329 -179.879 . . . . . . . . 0 0 . 1 . 039 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.432 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -118.15 169.22 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.642 179.647 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.37 166.34 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.405 -179.214 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.423 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 1.4 t60 -48.56 139.67 9.02 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.56 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.423 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 79.8 m-85 58.21 30.13 18.98 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.297 -178.491 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.59 148.34 18.59 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.976 -178.98 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -75.81 102.39 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.694 179.643 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -91.21 -14.25 31.34 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.054 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.08 -154.29 6.92 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.423 -1.846 . . . . 0.0 112.378 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 137.23 8.69 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.813 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.04 145.21 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.79 4.72 89.52 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.594 -179.575 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -100.25 113.64 26.49 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.222 179.979 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 p -111.05 46.5 1.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.718 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.79 172.89 16.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.31 155.89 54.36 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.837 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 8' ' ' CYS . 32.8 p -117.01 20.34 13.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.647 -178.536 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.46 120.82 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.305 178.718 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.0 m -83.19 156.47 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.774 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -59.47 152.95 20.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.706 179.395 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.72 144.98 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.72 -12.02 69.97 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.373 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.03 163.68 23.21 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.722 -179.699 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.22 158.92 39.27 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.179 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -89.53 131.87 35.35 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.775 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -131.48 119.05 21.03 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.159 179.663 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -54.29 117.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.664 179.668 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -82.3 -58.01 3.12 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -179.923 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.1 OUTLIER -152.16 176.75 2.2 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.327 . . . . . . . . 3 3 . 1 . 039 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -67.99 24.56 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.056 1.171 . . . . 0.0 112.047 -178.636 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 29' ' ' ASN . 88.9 m-85 -155.01 15.03 0.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.043 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' OH ' ' CD ' ' A' ' 34' ' ' GLN . 21.2 t80 -174.17 124.42 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.062 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 22.3 m -124.98 115.44 20.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.948 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 5.4 tp60 -94.34 151.69 19.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.733 -176.251 . . . . . . . . 2 2 . 1 . 039 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.3 m -100.98 107.21 18.62 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.515 179.061 . . . . . . . . 1 1 . 1 . 039 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.413 -1.755 . . . . 0.0 109.943 -179.615 . . . . . . . . 0 0 . 1 . 040 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -97.57 154.39 17.56 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.149 179.877 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 p -99.73 -172.95 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.867 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.541 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.4 t60 -61.8 160.71 11.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.312 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.541 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 81.9 m-85 47.09 19.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.631 -1.227 . . . . 0.0 109.125 -178.046 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -87.09 154.06 26.11 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.62 -178.138 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -89.13 114.72 26.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.381 179.577 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.861 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -103.05 -21.51 13.91 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.093 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -155.32 -153.32 6.49 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 118.175 -1.964 . . . . 0.0 112.765 -179.145 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 139.3 10.41 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.948 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.9 mt -51.32 151.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.069 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 80.68 -15.98 16.97 Favored Glycine 0 C--N 1.296 -1.676 0 C-N-CA 119.508 -1.329 . . . . 0.0 111.032 -179.701 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -82.06 124.5 29.88 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.394 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -120.55 37.29 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.12 -175.5 17.94 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.133 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.28 158.71 56.38 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 121.798 1.665 . . . . 0.0 110.493 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 8' ' ' CYS . 41.7 p -122.23 31.09 6.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.544 -0.863 . . . . 0.0 112.012 -178.184 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -111.52 117.07 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.733 178.707 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 4.3 m -85.32 142.17 29.53 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -49.13 146.93 3.22 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.358 179.851 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -47.3 153.84 0.46 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.733 -179.853 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.3 -26.11 12.77 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -119.59 171.97 7.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.129 179.779 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 155.91 43.31 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.88 179.265 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 14.8 t -70.71 130.33 41.46 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.733 -178.801 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.43 103.07 6.93 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.228 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.02 128.14 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.673 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.78 -56.45 3.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.337 . . . . . . . . 3 3 . 1 . 040 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.28 171.44 6.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.256 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_exo -67.81 24.79 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.36 0.807 . . . . 0.0 112.26 -177.341 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 84.9 m-85 -151.27 11.91 0.63 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.87 178.861 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -171.88 131.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.649 -178.619 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.48 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.0 m -131.7 113.49 13.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.656 178.153 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -98.45 161.07 13.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.482 1.113 . . . . 0.0 111.464 -178.001 . . . . . . . . 1 1 . 1 . 040 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.3 m -111.94 121.54 45.3 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.073 179.311 . . . . . . . . 2 2 . 1 . 040 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 116.236 -1.84 . . . . 0.0 109.872 -179.684 . . . . . . . . 0 0 . 1 . 041 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -136.81 -166.13 1.85 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.207 179.774 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -171.32 1.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.905 -179.45 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.693 ' CD2' ' CE2' ' A' ' 5' ' ' TYR . 2.3 t60 -59.11 164.87 2.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.553 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.693 ' CE2' ' CD2' ' A' ' 4' ' ' HIS . 30.7 m-85 47.82 23.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.538 -178.272 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -86.01 157.58 30.95 Favored Glycine 0 N--CA 1.484 1.874 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.069 -179.06 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 2' ' ' GLN . 50.8 tt0 -93.69 106.07 18.06 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.147 -179.049 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -91.9 -19.04 22.9 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.735 -1.186 . . . . 0.0 110.777 179.997 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.45 -161.63 10.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.174 -1.965 . . . . 0.0 112.288 -179.381 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 110.35 127.32 5.24 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 30' ' ' PRO . 78.5 mt -44.96 154.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.028 -179.379 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 -12.84 25.17 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.037 -178.187 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -89.46 110.03 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.785 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.5 p -109.86 30.65 6.5 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.553 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.4 -179.05 24.98 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.93 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.5 150.12 63.22 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.487 1.458 . . . . 0.0 109.761 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 45.5 p -106.92 11.62 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.926 -178.001 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.53 116.28 28.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ALA . 16.4 m -83.1 139.23 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.094 179.847 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -40.73 147.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.604 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.19 153.65 1.91 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.36 -20.66 32.8 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.429 179.197 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.18 174.21 6.35 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.946 -0.701 . . . . 0.0 111.004 -179.609 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -179.59 5.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.443 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -99.85 139.43 35.54 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.206 -179.356 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.18 113.38 8.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.217 179.531 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.07 138.37 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.419 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -107.3 -60.87 1.63 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.511 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -145.5 175.42 2.76 Favored Pre-proline 0 N--CA 1.505 2.275 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.63 . . . . . . . . 3 3 . 1 . 041 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.538 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.9 Cg_exo -70.08 22.35 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.616 0.877 . . . . 0.0 111.851 -178.413 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.9 m-85 -155.81 19.11 0.38 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.549 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -172.8 127.54 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.816 -178.505 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.3 m -130.46 113.0 13.76 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.574 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.11 156.88 16.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.06 0.85 . . . . 0.0 112.224 -176.84 . . . . . . . . 1 1 . 1 . 041 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.4 m -106.19 130.92 53.97 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 041 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.76 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.89 173.98 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.304 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.644 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.0 t-160 -47.84 158.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.695 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.5 m-85 46.91 23.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.341 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.06 135.12 11.96 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.308 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -65.16 100.98 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.36 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.69 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -89.86 -16.6 29.76 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.612 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.6 -179.79 31.85 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 118.514 -1.803 . . . . 0.0 111.537 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.66 131.69 3.33 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.3 mt -48.25 148.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.604 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.14 -14.46 14.89 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.611 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -79.39 138.64 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.022 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.8 p -137.71 63.12 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.6 178.99 21.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.91 166.11 7.35 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.8 p -135.15 0.43 2.84 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.83 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -80.68 112.42 18.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.495 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.8 m -71.21 147.02 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.353 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 142.19 49.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.163 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -44.95 146.22 0.84 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.55 -25.76 27.0 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.33 163.0 17.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.505 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.4 OUTLIER -126.64 169.71 12.84 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.812 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.7 t -95.34 120.56 35.79 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.038 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.505 HE22 ' CB ' ' A' ' 24' ' ' THR . 22.5 mp0 -110.72 113.78 26.65 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.746 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.27 106.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.312 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.496 HD23 ' ND2' ' A' ' 29' ' ' ASN . 4.1 tp -69.97 -54.06 14.98 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.034 -1.067 . . . . 0.0 109.184 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 m-80 -150.2 174.59 3.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.534 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -68.59 24.36 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 120.837 1.024 . . . . 0.0 112.208 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.29 17.56 0.48 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.452 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -170.21 131.97 1.02 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.975 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 m -142.66 110.82 6.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.16 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.2 145.28 27.4 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.099 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.0 m -84.43 118.72 24.44 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.559 -179.189 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -172.29 2.22 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.193 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.7 t-160 -67.24 149.68 50.09 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 44.9 m-85 54.28 25.79 6.21 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.913 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.9 150.21 18.66 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.737 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.5 109.64 10.39 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.612 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.556 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -96.4 -25.46 15.7 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.694 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.44 -153.27 6.31 Favored Glycine 0 N--CA 1.48 1.597 0 C-N-CA 118.279 -1.915 . . . . 0.0 112.131 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.31 132.47 7.5 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 30' ' ' PRO . 20.1 mt -48.0 149.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.756 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.31 -0.4 87.76 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.056 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.62 139.19 33.07 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -131.07 31.2 4.47 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.585 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.18 175.82 16.9 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.51 160.58 23.5 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.515 1.477 . . . . 0.0 110.333 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 8' ' ' CYS . 63.4 p -124.59 22.15 8.37 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.586 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.93 108.61 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.718 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -75.71 147.2 39.56 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.43 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.26 152.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.726 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 m -56.51 139.54 49.09 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.927 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.18 32.49 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.527 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -105.13 161.57 14.14 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.881 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -129.18 162.86 26.82 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.29 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.4 t -90.76 116.91 28.98 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.04 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 22.0 mp0 -107.39 107.74 18.77 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.463 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.63 120.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 118.719 -1.193 . . . . 0.0 108.666 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -81.14 -62.11 1.76 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -178.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.9 m-80 -141.04 175.32 3.15 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -69.03 23.51 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.1 0.714 . . . . 0.0 111.712 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.1 m-85 -155.26 21.64 0.42 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.987 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 16.5 t80 -173.68 130.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.099 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.9 m -134.07 116.26 15.26 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.471 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.494 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tt0 -98.75 154.38 18.03 Favored 'General case' 0 N--CA 1.513 2.69 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.636 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 67.7 m -92.37 120.44 32.89 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.602 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.482 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 90.5 mt . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.197 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.705 HE22 ' N ' ' A' ' 7' ' ' GLN . 3.2 tt0 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -179.15 4.23 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.817 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.8 t-160 -54.83 150.97 9.1 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 19.6 m-85 52.89 17.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.351 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -81.35 134.18 12.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.696 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.705 ' N ' HE22 ' A' ' 2' ' ' GLN . 30.6 tt0 -69.99 101.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.31 -18.37 28.65 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.026 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.37 -172.04 22.57 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.445 -1.836 . . . . 0.0 112.314 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.96 126.48 4.55 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 12' ' ' GLY . 96.9 mt -44.51 153.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.978 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 83.95 -12.84 52.03 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.701 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -90.14 146.94 23.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.049 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 p -140.27 22.78 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.808 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.39 177.36 24.86 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.84 159.8 16.74 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.485 1.457 . . . . 0.0 110.447 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.3 p -124.56 26.09 7.36 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.16 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.92 114.8 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.081 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -79.27 133.98 36.65 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.326 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.42 159.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.323 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.52 155.67 9.23 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.923 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.28 -15.68 32.96 Favored Glycine 0 N--CA 1.482 1.728 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.522 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 167.03 14.37 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.27 164.97 25.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.727 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.98 113.29 24.93 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.27 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -104.13 126.1 50.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.73 140.9 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.902 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.51 HD23 HD21 ' A' ' 29' ' ' ASN . 10.5 tp -108.14 -60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.858 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -149.15 175.89 2.53 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.8 24.4 0.15 Allowed 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 120.902 1.068 . . . . 0.0 111.67 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 29' ' ' ASN . 96.2 m-85 -147.39 9.99 0.96 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.074 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 75.3 t80 -169.96 138.96 1.81 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.413 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -150.03 113.24 4.89 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.1 tt0 -95.98 150.53 20.36 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.156 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 19.7 m -89.36 115.96 27.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.479 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.501 -179.398 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 7.0 tp60 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -178.66 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.599 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.646 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.8 t-160 -59.73 150.4 27.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 82.2 m-85 56.96 9.75 0.67 Allowed 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.856 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.33 155.29 24.14 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.176 -1.488 . . . . 0.0 112.116 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.489 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 39.9 tt0 -76.63 122.28 24.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.78 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -108.71 -23.48 11.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.57 -157.56 8.06 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 117.866 -2.111 . . . . 0.0 112.735 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 146.63 13.12 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 30' ' ' PRO . 65.9 mt -59.51 154.65 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.131 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.77 -5.92 21.45 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.762 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -94.0 112.97 24.87 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.735 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -110.6 55.36 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.283 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.35 -179.64 16.42 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.64 154.09 67.59 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.365 1.377 . . . . 0.0 110.409 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 8' ' ' CYS . 16.4 p -127.5 28.1 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.207 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.03 109.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.803 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.9 m -78.76 137.59 37.82 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.324 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.42 150.04 1.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.74 154.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.314 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.1 -15.71 58.93 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.585 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.64 176.24 7.94 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.528 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 163.16 33.65 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.49 116.55 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.131 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.56 140.41 41.95 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.846 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.47 117.67 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.551 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -81.61 -62.54 1.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -144.63 176.07 2.44 Favored Pre-proline 0 N--CA 1.501 2.076 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.523 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -69.21 23.63 0.16 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 120.674 0.916 . . . . 0.0 111.841 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' ASN . 80.0 m-85 -155.39 19.89 0.41 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.873 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -173.0 117.83 0.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.452 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.6 m -119.91 111.83 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.525 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.96 157.93 17.01 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.349 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.5 m -100.77 121.77 42.25 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.887 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.12 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.521 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.106 0.479 . . . . 0.0 110.425 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.47 177.9 7.97 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.874 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 10.7 t-160 -60.04 133.08 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 4' ' ' HIS . 27.5 m-85 66.77 22.84 10.23 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.32 155.37 19.87 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.222 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 54.0 tt0 -79.81 120.75 24.49 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -108.97 -27.33 9.73 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.613 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.46 -151.57 5.53 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.347 -1.882 . . . . 0.0 112.328 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 141.85 12.61 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.69 151.62 5.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.716 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.75 -15.06 44.38 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.25 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 45.2 t80 -82.87 138.64 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.471 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -131.22 27.17 4.83 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.25 -176.79 21.42 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.91 155.61 68.55 Favored 'Trans proline' 0 C--O 1.211 -0.842 0 C-N-CA 121.699 1.599 . . . . 0.0 110.865 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 8' ' ' CYS . 57.1 p -117.29 7.55 12.92 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.34 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -90.19 113.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.335 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 m -82.59 148.41 28.03 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.945 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.25 139.83 8.14 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.014 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -47.21 141.83 4.25 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.88 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.77 -27.25 21.29 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.607 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -112.87 158.96 19.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 157.99 36.89 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.454 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.7 t -87.77 111.42 21.34 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.132 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -107.33 117.79 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.116 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -53.08 132.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.333 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.492 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -94.51 -51.32 4.81 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.341 -1.344 . . . . 0.0 107.797 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.0 p30 -161.52 172.98 5.05 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.3 Cg_exo -66.94 24.93 0.11 Allowed 'Trans proline' 0 C--O 1.214 -0.706 0 CA-C-N 119.366 0.809 . . . . 0.0 112.533 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.72 14.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.176 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -172.47 130.16 0.56 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.906 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.8 m -130.17 116.23 18.15 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.468 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.3 tp-100 -100.09 150.16 22.76 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.452 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.9 m -97.19 116.59 29.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.784 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 116.306 -1.807 . . . . 0.0 109.982 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.28 177.77 7.58 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.001 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.9 t-160 -59.94 132.32 53.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 26.5 m-85 67.98 26.38 7.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.69 153.65 17.88 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.13 108.22 13.55 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -97.53 -21.7 16.95 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.864 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.44 -155.09 6.61 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 118.544 -1.788 . . . . 0.0 111.831 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 144.77 12.58 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 30' ' ' PRO . 62.2 mt -60.57 148.51 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.995 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.9 -12.23 30.82 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.627 -1.273 . . . . 0.0 111.042 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -78.16 120.87 23.58 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.4 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 p -114.51 58.18 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.13 170.55 25.91 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.777 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.25 153.62 38.95 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.339 1.359 . . . . 0.0 110.052 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -119.56 33.3 5.68 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.609 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.9 107.15 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.116 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.7 m -74.94 143.61 43.62 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.769 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.69 148.22 0.78 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.683 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -53.08 160.5 1.01 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.121 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.29 -18.45 23.24 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -124.18 163.63 21.16 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.092 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.01 160.73 31.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.339 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -88.13 117.85 27.3 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.422 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -115.27 116.11 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.422 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.23 129.01 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.372 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.477 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -87.3 -51.36 6.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.554 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.37 176.08 2.84 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -68.27 24.62 0.14 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.601 0.867 . . . . 0.0 111.459 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.554 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.0 m-85 -150.52 10.34 0.65 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.739 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -173.65 127.73 0.41 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.594 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.477 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 21.7 m -125.32 115.67 20.71 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.884 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -100.32 158.4 15.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.95 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 61.1 m -98.28 123.24 42.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 116.361 -1.781 . . . . 0.0 110.289 -178.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 3' ' ' SER . 5.6 tp60 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.416 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.73 -172.58 2.41 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.647 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.61 149.94 46.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.419 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 67.5 m-85 53.59 18.05 1.34 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.681 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 152.78 21.53 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.806 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -81.65 119.43 23.81 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.55 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -107.73 -21.96 12.66 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -169.43 15.83 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.211 -1.947 . . . . 0.0 112.427 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 143.28 9.03 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -54.64 154.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.998 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.31 -11.7 48.89 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -95.56 129.56 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.304 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.5 p -137.92 57.94 1.7 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.662 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.32 -177.28 15.4 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.43 157.6 14.46 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.797 0.998 . . . . 0.0 109.664 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 8' ' ' CYS . 43.4 p -131.83 26.47 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.487 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.97 115.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.484 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.71 161.26 30.44 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.788 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.9 171.18 0.98 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.294 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -63.77 141.57 58.72 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.11 -5.72 84.64 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.584 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.05 165.09 18.09 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.15 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -140.37 162.1 36.12 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.014 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.6 t -90.27 113.32 25.14 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.1 mp0 -105.46 125.61 51.18 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.952 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.31 126.21 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.553 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -89.13 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.706 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.0 p30 -155.61 178.59 1.6 Allowed Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.804 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.4 Cg_exo -67.6 23.4 0.12 Allowed 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 120.989 1.126 . . . . 0.0 113.116 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 29' ' ' ASN . 81.6 m-85 -154.62 16.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.072 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -174.69 133.72 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.541 -1.264 . . . . 0.0 111.767 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m -136.06 113.17 10.47 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.385 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 5' ' ' TYR . 5.0 tp60 -89.56 153.71 20.56 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 20.4 m -106.69 114.14 28.07 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.168 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.449 -1.739 . . . . 0.0 109.821 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.02 -170.58 2.14 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.171 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.62 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.4 t-160 -61.16 135.03 57.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.466 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 68.8 m-85 70.17 24.01 5.04 Favored 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.22 153.85 23.86 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.741 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 60.8 tt0 -90.19 111.13 22.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.691 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -97.95 -21.14 17.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.603 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 -156.32 7.38 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 117.938 -2.077 . . . . 0.0 112.526 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.1 131.1 6.86 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.517 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 11' ' ' ILE . 39.6 mt -46.58 145.95 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.79 9.66 84.23 Favored Glycine 0 C--N 1.292 -1.889 0 C-N-CA 119.582 -1.295 . . . . 0.0 111.202 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 80.6 t80 -110.8 126.28 54.45 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.6 p -120.5 11.02 11.28 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.43 -176.41 50.47 Favored Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -69.54 161.16 46.99 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.575 1.517 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 p -120.54 38.02 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.06 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.1 110.98 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -75.17 157.69 34.2 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.097 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -72.59 149.96 43.51 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.842 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -44.49 142.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.712 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -24.45 32.15 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.348 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -116.16 176.68 4.99 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.139 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.19 152.61 39.5 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.626 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.1 t -80.37 127.99 33.03 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.606 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -136.97 126.84 25.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.63 134.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.217 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -98.23 -47.67 5.37 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.9 p30 -162.64 171.81 6.06 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.308 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -67.75 24.56 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 CA-C-N 119.624 0.902 . . . . 0.0 112.26 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 29' ' ' ASN . 57.5 m-85 -153.39 16.13 0.53 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.28 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -174.8 125.47 0.28 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.837 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -127.06 113.23 16.16 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.123 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 5.3 tp60 -93.09 149.77 20.99 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.192 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 32.1 m -102.95 110.04 21.81 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.646 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.505 2.322 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.165 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.487 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 2.4 tp-100 . . . . . 0 N--CA 1.494 1.773 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -168.11 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.186 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.645 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.2 t-160 -73.99 132.28 42.24 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.145 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 60.5 m-85 70.43 20.12 6.11 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.447 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.88 154.9 19.26 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.491 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -75.99 119.34 19.82 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.885 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -103.2 -29.7 11.13 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.554 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -148.71 -163.5 10.91 Favored Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.002 -1.57 . . . . 0.0 111.611 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 142.71 10.54 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.8 mt -50.17 156.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.618 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 78.55 -15.69 9.16 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.487 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 46.2 t80 -89.41 131.36 35.51 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.334 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 p -126.26 18.25 7.66 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.03 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.93 -178.35 33.39 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.768 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.04 153.09 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.591 1.527 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.9 p -117.5 27.37 9.11 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.467 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.36 122.23 54.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.931 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.98 163.72 18.73 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.843 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -68.28 154.59 41.45 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.67 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 m -45.1 141.35 2.36 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.035 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.82 -8.72 76.34 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.527 -1.32 . . . . 0.0 112.254 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -133.58 169.75 16.54 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.907 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.524 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.5 OUTLIER -145.16 171.81 14.0 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.491 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -92.23 144.94 24.9 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.263 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.524 HE22 ' C ' ' A' ' 24' ' ' THR . 28.9 mp0 -139.86 116.55 10.83 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.3 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.73 103.08 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.764 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.22 -52.03 65.39 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.827 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.92 174.52 3.72 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.179 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -66.97 24.65 0.11 Allowed 'Trans proline' 0 C--O 1.211 -0.839 0 C-N-CA 120.628 0.885 . . . . 0.0 112.84 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.6 m-85 -149.51 12.53 0.81 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.28 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 33.8 t80 -170.59 134.67 1.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.496 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 14.8 m -135.98 110.53 8.58 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.584 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 36' ' ' LEU . 46.3 tt0 -87.48 154.42 20.65 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.598 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.85 109.98 21.43 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.012 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 34' ' ' GLN . 15.3 mt . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.027 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 11.7 pm0 . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.93 -174.78 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.845 -178.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.593 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.1 t-160 -57.38 140.66 49.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 52.4 m-85 65.64 18.18 11.13 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.01 157.03 34.9 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.82 116.34 27.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' HE21 ' A' ' 2' ' ' GLN . 1.1 p -105.06 -21.69 13.23 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.747 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -149.83 -166.06 13.02 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 118.329 -1.891 . . . . 0.0 113.163 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.28 144.81 13.62 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -61.63 156.49 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 -2.12 55.08 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.485 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -86.26 132.46 33.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.976 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 p -129.91 36.38 4.05 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.34 -174.22 14.79 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.212 -0.994 . . . . 0.0 110.771 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.93 153.96 76.18 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.754 1.636 . . . . 0.0 111.211 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.34 -6.08 21.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.745 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.35 122.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.609 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 20' ' ' ALA . 92.2 m -84.13 148.46 26.78 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.618 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 3' ' ' SER . . . -39.96 140.14 0.59 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.583 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -49.9 140.0 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.93 13.71 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.5 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -102.69 -170.73 1.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.888 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.43 173.15 12.54 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.4 t -100.12 116.58 32.48 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.919 HE22 ' H ' ' A' ' 36' ' ' LEU . 3.6 mp0 -107.41 110.07 21.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.6 t -53.77 125.65 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.179 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.493 HD12 HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -95.09 -56.93 2.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.27 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.2 p30 -162.71 172.81 4.98 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 2.9 Cg_exo -66.07 25.37 0.1 OUTLIER 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.84 1.027 . . . . 0.0 113.124 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' ASN . 91.4 m-85 -153.72 13.53 0.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.16 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 29' ' ' ASN . 11.1 t80 -175.31 137.57 0.39 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.793 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 9' ' ' GLY . 13.7 m -136.41 114.4 11.37 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 40.6 tt0 -86.42 165.64 16.17 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.794 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 64.2 m -113.24 128.38 56.46 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.679 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.919 ' H ' HE22 ' A' ' 26' ' ' GLN . 93.8 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.48 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.458 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 120.704 0.288 . . . . 0.0 110.258 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -162.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.444 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 19.6 t-160 -72.94 134.74 44.87 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.051 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 36.3 m-85 69.04 16.84 8.65 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.29 155.73 30.04 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.417 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -86.93 110.04 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.596 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.0 -17.98 23.24 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.939 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.62 -165.69 12.35 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 118.529 -1.796 . . . . 0.0 111.504 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.27 130.53 5.25 Favored Glycine 0 C--N 1.301 -1.415 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 30' ' ' PRO . 47.9 mt -51.9 144.14 3.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.799 -1.161 . . . . 0.0 110.757 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.43 65.14 Favored Glycine 0 CA--C 1.548 2.095 0 C-N-CA 119.869 -1.158 . . . . 0.0 111.876 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 71.2 t80 -83.93 113.19 20.8 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.606 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -106.75 55.41 0.66 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.711 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.13 172.98 22.13 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.62 145.31 82.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.136 1.224 . . . . 0.0 110.832 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 8' ' ' CYS . 23.3 p -107.18 30.49 6.16 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.03 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -116.06 119.7 62.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.661 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.1 m -79.63 164.64 23.64 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.64 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -65.68 168.08 8.2 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.979 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.02 147.94 52.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.777 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.05 26.61 Favored Glycine 0 C--N 1.297 -1.634 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -107.99 178.73 4.43 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.504 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.83 162.45 41.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.89 127.35 39.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.093 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.27 112.63 15.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.146 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.67 130.63 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.623 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -92.91 -54.98 3.52 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -154.53 175.34 3.14 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.7 Cg_exo -70.24 24.09 0.19 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.439 0.759 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.7 m-85 -149.55 10.82 0.76 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.131 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 22.4 t80 -174.74 128.81 0.32 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.806 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 70.4 m -131.68 113.56 13.73 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.505 ' NE2' ' OH ' ' A' ' 32' ' ' TYR . 1.2 tt0 -89.61 151.01 22.13 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 124.67 1.231 . . . . 0.0 112.693 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.8 m -105.72 111.34 23.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.555 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 116.386 -1.769 . . . . 0.0 109.95 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 3' ' ' SER . 10.4 tp60 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -132.3 163.92 27.59 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.754 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -53.33 141.71 23.45 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 58.34 22.88 9.87 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.729 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 153.48 19.69 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -81.7 115.58 21.01 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.797 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.67 -31.05 13.99 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.882 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.36 -174.32 22.8 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.47 -1.824 . . . . 0.0 112.377 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 117.81 129.08 4.08 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.7 mt -40.55 154.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.457 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.7 31.29 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.661 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -87.45 141.78 28.37 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.318 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 14' ' ' SER . 54.2 p -138.62 56.29 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.0 177.32 23.53 Favored Glycine 0 N--CA 1.479 1.502 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.706 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.72 157.38 42.79 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.125 1.216 . . . . 0.0 109.747 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' CYS . 79.1 p -118.99 2.79 11.52 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.015 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.09 108.59 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.596 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.9 156.93 37.62 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.871 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.83 170.19 2.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.188 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.35 155.43 37.37 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.821 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.03 37.11 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.296 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.11 169.33 12.9 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.42 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.47 154.71 42.53 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.459 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -80.18 141.76 35.37 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.544 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -137.17 107.5 6.44 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 27' ' ' VAL . 3.3 t -60.59 115.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.432 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 29' ' ' ASN . 4.3 tp -79.78 -52.3 8.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.602 HD21 HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -153.43 176.12 2.62 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_exo -69.0 24.25 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.771 0.981 . . . . 0.0 112.007 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.7 m-85 -149.65 14.75 0.85 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.08 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -173.13 130.76 0.48 Allowed 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.399 -1.32 . . . . 0.0 111.748 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -136.89 111.62 8.76 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -96.53 147.79 23.49 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.847 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 70.8 m -101.63 111.53 23.81 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.413 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 116.381 -1.771 . . . . 0.0 109.772 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 172.53 6.76 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.431 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 15.7 t-160 -55.75 128.04 32.94 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.548 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.7 m-85 75.93 23.89 1.28 Allowed 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.975 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.02 140.32 14.81 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.042 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.3 114.89 5.7 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.667 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.879 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -101.57 -24.69 14.09 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.22 16.58 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.592 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.58 130.66 5.43 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 30' ' ' PRO . 60.7 mt -44.87 154.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.333 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.77 -16.16 21.85 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.634 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -91.19 131.17 36.9 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.397 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 p -127.02 51.49 1.87 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.089 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.56 174.15 20.85 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.95 156.62 23.15 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.217 1.278 . . . . 0.0 110.415 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 8' ' ' CYS . 62.4 p -121.66 15.26 11.05 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.845 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -80.44 119.27 29.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.4 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 24' ' ' THR . 8.0 m -83.17 141.57 31.84 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.9 149.02 1.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -51.69 143.18 13.2 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.522 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.57 -20.09 46.65 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.004 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.15 167.14 12.99 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.982 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -135.77 166.76 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.594 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -85.43 124.91 32.56 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.729 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -115.4 109.96 18.65 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.8 110.43 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.817 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 29' ' ' ASN . 6.1 tp -72.12 -59.37 2.77 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.009 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.615 HD21 HD23 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -141.79 175.6 2.9 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -68.87 24.38 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.59 0.86 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.5 m-85 -148.4 11.82 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 50.3 t80 -169.83 136.26 1.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.078 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 m -143.26 113.34 7.2 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.154 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -98.4 149.0 23.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.879 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.1 m -84.58 115.56 22.69 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.919 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 116.321 -1.8 . . . . 0.0 110.269 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' ALA . 8.9 tp60 . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 120.777 0.322 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.73 170.28 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.576 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.65 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.8 t-160 -52.25 150.15 4.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.362 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.65 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 56.6 m-85 56.99 11.94 1.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.71 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.55 156.37 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.469 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.49 109.78 10.49 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -97.04 -22.89 16.54 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.248 177.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.0 -179.91 25.28 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 118.932 -1.604 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 127.74 2.86 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.355 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 11' ' ' ILE . 30.4 mt -48.9 148.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.486 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.54 54.75 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.998 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -79.64 147.45 32.03 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.308 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -137.24 44.13 2.3 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.77 175.24 20.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.18 160.7 25.5 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.176 1.251 . . . . 0.0 110.573 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 61.7 p -121.12 21.91 11.1 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.699 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.43 113.51 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.885 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.66 150.05 46.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.339 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -54.05 141.38 28.61 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.105 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ALA . 4.5 m -42.33 139.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 -25.13 29.01 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.09 167.24 11.65 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.374 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.507 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.7 OUTLIER -131.04 -177.59 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.542 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -102.14 125.85 48.95 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.022 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 24' ' ' THR . 24.4 mp0 -124.68 121.89 35.96 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.492 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.22 146.67 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.16 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -56.38 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -153.68 177.47 1.96 Allowed Pre-proline 0 N--CA 1.508 2.455 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 Cg_exo -68.43 23.5 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.88 1.053 . . . . 0.0 112.066 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.509 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.5 m-85 -153.73 14.08 0.48 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.101 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -172.53 127.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.812 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.1 m -127.17 114.16 17.32 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.04 159.85 20.13 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.699 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -100.58 125.85 47.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.86 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.157 -178.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.27 -166.69 1.53 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.612 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.651 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.2 t-160 -73.5 139.47 45.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.217 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.4 m-85 66.51 20.81 10.85 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.65 155.46 20.5 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.42 102.66 6.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.615 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.569 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -94.09 -10.12 34.39 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.599 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.26 179.23 38.55 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 117.867 -2.111 . . . . 0.0 111.947 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.06 153.72 8.04 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 30' ' ' PRO . 52.7 mt -67.39 151.95 10.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.04 -5.18 20.02 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.775 -1.202 . . . . 0.0 111.516 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.6 126.27 37.61 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.605 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.4 p -120.27 36.22 4.62 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.34 -178.18 21.93 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.739 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.36 162.15 15.26 Favored 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.375 1.384 . . . . 0.0 109.69 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 8' ' ' CYS . 35.7 p -132.38 5.67 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.044 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 124.48 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.764 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 24' ' ' THR . 61.8 m -77.53 156.28 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 165.37 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.562 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -56.17 150.22 14.57 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.925 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.58 -22.57 2.67 Favored Glycine 0 N--CA 1.48 1.624 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.986 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -105.64 158.48 16.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.956 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.431 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -131.58 174.22 10.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.535 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -100.41 127.07 46.83 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.392 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.904 HE22 ' H ' ' A' ' 36' ' ' LEU . 4.1 mp0 -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.41 108.49 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.06 -46.74 67.07 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.284 -1.366 . . . . 0.0 107.508 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -163.56 173.75 3.95 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.457 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.2 Cg_exo -66.88 24.64 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.817 0 C-N-CA 121.238 1.292 . . . . 0.0 113.199 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.3 m-85 -152.39 18.35 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.459 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.431 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 43.9 t80 -175.51 135.2 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.574 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -138.42 112.4 8.49 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.049 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 0.7 OUTLIER -92.14 146.29 23.84 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.608 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.7 m -85.48 116.53 23.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.145 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.904 ' H ' HE22 ' A' ' 26' ' ' GLN . 70.8 mt . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.677 HE22 ' N ' ' A' ' 8' ' ' CYS . 1.2 tt0 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.17 176.46 5.24 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.699 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -61.46 140.37 58.08 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.8 m-85 69.88 11.62 7.78 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.98 155.5 34.98 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.528 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.622 ' C ' HE22 ' A' ' 2' ' ' GLN . 42.1 tt0 -78.06 104.97 8.97 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.66 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.677 ' N ' HE22 ' A' ' 2' ' ' GLN . 1.6 p -89.79 -16.23 30.67 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.53 -156.74 9.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 117.862 -2.114 . . . . 0.0 112.425 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.27 144.46 16.94 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.196 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -49.16 153.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.292 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.38 79.79 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.087 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.12 109.64 13.72 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.886 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.5 p -109.05 21.23 17.45 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.275 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.27 178.99 42.03 Favored Glycine 0 N--CA 1.483 1.789 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.691 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.31 157.17 51.54 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.347 1.365 . . . . 0.0 109.79 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 8' ' ' CYS . 40.4 p -119.79 8.46 11.15 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.804 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.62 109.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.224 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.9 m -69.11 168.62 13.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.69 174.86 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -68.4 140.92 55.83 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -11.36 52.22 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.575 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -107.23 169.12 8.76 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.179 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.5 177.37 7.98 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -100.32 147.84 25.35 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.539 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.401 ' OE1' ' N ' ' A' ' 36' ' ' LEU . 24.9 mp0 -145.2 125.38 13.74 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.035 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.23 110.28 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.572 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.98 -58.31 3.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.105 -1.438 . . . . 0.0 108.248 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.7 p30 -151.22 174.37 3.62 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.919 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.606 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.8 Cg_exo -64.73 24.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 120.952 1.101 . . . . 0.0 113.509 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.8 m-85 -153.95 20.48 0.51 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.02 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -175.24 131.24 0.29 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.318 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.9 m -131.57 106.75 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.957 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -86.25 153.25 22.14 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.775 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.46 128.19 43.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.629 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 75.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.079 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.49 174.02 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.811 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.64 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.8 t-160 -53.77 135.11 41.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 61.7 m-85 69.53 18.73 7.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.98 142.07 18.9 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.85 120.27 19.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.714 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -108.6 -15.53 14.4 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.922 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 -155.91 7.4 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 118.095 -2.003 . . . . 0.0 112.151 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.46 128.21 3.74 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.9 mt -46.67 152.25 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.699 -1.2 . . . . 0.0 110.506 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.25 -7.36 78.75 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.61 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -97.11 130.65 44.36 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.755 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.4 p -124.86 61.09 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.88 177.97 23.0 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.02 155.22 45.93 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.105 1.203 . . . . 0.0 110.414 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 8' ' ' CYS . 66.7 p -118.34 32.66 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.73 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -105.07 123.52 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.943 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 24' ' ' THR . 58.8 m -88.24 143.25 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.847 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 168.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.765 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 p -59.13 144.7 44.91 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.064 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.22 -15.42 53.92 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.907 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.0 166.27 11.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.681 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.408 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -136.55 175.25 9.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.97 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -96.73 121.1 38.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.606 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -121.39 132.6 54.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.37 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -85.95 143.02 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.578 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 29' ' ' ASN . 6.1 tp -107.86 -59.91 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.654 HD21 HD23 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -139.44 175.14 3.44 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.97 24.65 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.538 0.825 . . . . 0.0 111.073 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.543 ' H ' ' C ' ' A' ' 29' ' ' ASN . 82.9 m-85 -150.6 10.16 0.64 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -163.67 122.06 1.93 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.537 -1.265 . . . . 0.0 112.229 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -131.29 112.64 12.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.099 -1.04 . . . . 0.0 109.466 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -91.09 153.41 20.11 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.662 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -92.9 112.56 24.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.157 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.355 -179.165 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.45 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 163.87 31.71 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.01 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.6 t-160 -47.08 137.37 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.472 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 49.3 m-85 62.47 34.23 15.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.9 150.03 18.19 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.364 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.69 102.55 10.79 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.285 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -89.9 -25.14 21.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.298 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.78 -176.27 25.16 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.363 -1.875 . . . . 0.0 112.305 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.95 133.74 4.05 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 66.5 mt -44.92 148.11 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.336 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.02 -17.4 22.64 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.775 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -80.37 139.43 36.54 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.422 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -131.5 10.13 4.76 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.998 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 177.9 46.76 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.779 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.52 155.29 69.67 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.488 1.459 . . . . 0.0 110.807 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.4 p -111.62 30.15 7.22 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.887 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.93 111.47 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.434 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -77.47 145.87 36.79 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -44.52 144.17 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.891 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -48.86 141.02 7.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.131 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -27.11 22.12 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.967 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -110.21 169.86 8.45 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.424 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 154.78 47.77 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.603 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.8 t -75.24 143.2 43.2 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.091 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -143.06 106.72 4.63 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.117 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.39 131.29 5.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.954 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.556 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -101.2 -48.95 4.23 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.556 HD22 HD12 ' A' ' 28' ' ' LEU . 7.8 p30 -162.18 170.4 7.96 Favored Pre-proline 0 CA--C 1.565 1.556 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.666 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.9 Cg_exo -67.72 25.06 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.708 0.939 . . . . 0.0 112.798 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 71.0 m-85 -155.27 16.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.506 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 54.9 t80 -175.18 132.39 0.31 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.689 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -135.8 113.94 11.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.894 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.447 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.6 tp-100 -94.69 149.04 21.65 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.396 1.06 . . . . 0.0 112.072 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.3 m -104.89 122.62 46.18 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.88 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 116.351 -1.785 . . . . 0.0 109.988 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 28.0 tp60 . . . . . 0 N--CA 1.482 1.17 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.33 171.84 7.72 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.774 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -56.65 158.18 4.76 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 78.1 m-85 48.89 18.21 0.19 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.466 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.456 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -89.64 153.73 23.47 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.863 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -80.22 110.7 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.011 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.672 ' O ' HG22 ' A' ' 17' ' ' THR . 1.0 OUTLIER -94.65 -15.57 23.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.57 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 -176.46 26.53 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 118.429 -1.843 . . . . 0.0 112.14 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.25 143.21 5.33 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.88 142.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.117 -1.433 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.51 -5.84 63.01 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.497 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.39 108.3 17.78 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 p -101.88 46.68 0.92 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.009 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.84 166.01 15.37 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.568 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.39 162.81 0.78 Allowed 'Trans proline' 0 C--O 1.207 -1.067 0 C-N-CA 121.265 1.31 . . . . 0.0 110.206 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' CYS . 22.9 p -125.61 -3.72 7.22 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.683 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 t -78.57 122.89 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.208 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -77.2 154.91 32.63 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.077 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -58.9 163.48 3.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.916 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -60.27 155.74 17.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.605 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -6.86 24.73 Favored Glycine 0 N--CA 1.481 1.679 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.452 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.467 HG21 ' CD2' ' A' ' 4' ' ' HIS . 0.8 OUTLIER -129.43 163.79 25.07 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.666 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.63 176.74 8.19 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.788 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.43 141.65 29.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.931 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.85 112.21 9.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.671 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.405 HG13 ' OG ' ' A' ' 33' ' ' SER . 2.4 t -74.91 113.05 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.51 HD23 ' ND2' ' A' ' 29' ' ' ASN . 6.2 tp -78.21 -56.74 4.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.302 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.4 m-80 -150.09 174.19 3.69 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.2 23.63 0.22 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.493 0.795 . . . . 0.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -144.62 8.03 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.528 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -169.51 132.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.104 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 67.5 m -141.16 108.96 5.66 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.028 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -85.27 157.94 20.45 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.731 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 6' ' ' GLY . 1.5 m -101.53 115.43 30.49 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.375 -1.774 . . . . 0.0 109.344 179.556 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.9 mp0 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.9 -176.55 3.21 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.647 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.9 t-160 -60.75 136.11 57.97 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.222 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 35.4 m-85 68.67 13.0 8.86 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 123.39 0.431 . . . . 0.0 110.127 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 154.95 34.9 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.435 -1.364 . . . . 0.0 111.797 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -82.28 118.95 23.51 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.878 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -111.05 -16.14 13.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.484 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.69 -162.15 10.87 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.156 -1.973 . . . . 0.0 112.315 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.23 138.54 10.16 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.452 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.447 HD12 ' O ' ' A' ' 30' ' ' PRO . 53.8 mt -49.61 146.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.884 -1.127 . . . . 0.0 110.027 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.86 14.45 64.94 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.009 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -121.19 119.76 33.27 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.021 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.2 p -117.42 57.9 0.8 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.594 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.36 174.76 22.73 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.514 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.0 154.67 49.28 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.244 1.296 . . . . 0.0 110.137 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.1 p -112.64 5.23 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.709 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.69 116.29 20.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.989 -1.085 . . . . 0.0 109.323 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -83.31 164.57 19.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.327 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.57 156.6 10.39 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.8 m -58.62 144.45 43.04 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.781 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.03 -15.21 63.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.928 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -117.84 -177.86 3.35 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.682 -179.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.609 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -146.17 171.29 15.15 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.855 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -100.61 114.15 27.58 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.094 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.609 HE22 ' C ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -105.58 118.36 36.39 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.862 178.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.66 130.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.566 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.37 -56.43 2.94 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.146 -1.422 . . . . 0.0 109.144 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.2 p30 -154.39 176.53 2.44 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.131 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -65.98 25.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.958 1.106 . . . . 0.0 112.812 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -152.68 15.85 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.642 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -175.27 135.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.599 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.6 m -136.51 113.68 10.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -82.6 164.05 21.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.368 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 21.3 m -111.26 112.94 25.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.714 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 23' ' ' THR . 20.5 mt . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 116.472 -1.728 . . . . 0.0 110.189 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -127.61 174.68 8.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.9 179.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.636 ' ND1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -50.91 144.18 9.0 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.178 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CE2' ' ND1' ' A' ' 4' ' ' HIS . 25.7 m-85 62.65 15.41 7.99 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.177 -177.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.4 150.6 31.85 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.737 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -85.3 103.8 14.57 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.755 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -90.05 -16.79 29.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.255 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.93 -176.34 29.87 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.305 -1.902 . . . . 0.0 112.359 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.54 130.57 3.31 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 120.056 -1.068 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 30' ' ' PRO . 41.4 mt -46.9 148.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.252 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.2 -9.16 27.9 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.369 -1.396 . . . . 0.0 111.05 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -88.78 130.32 35.39 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 p -130.19 62.35 1.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.38 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.3 173.41 23.04 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.79 154.55 12.38 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 N-CA-C 109.473 -1.01 . . . . 0.0 109.473 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.0 p -122.06 18.14 10.84 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.817 -178.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -91.82 125.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.424 -0.91 . . . . 0.0 108.904 178.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 67.2 m -80.87 157.14 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.392 -179.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.98 151.97 11.0 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 m -56.93 139.68 51.0 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.031 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.29 -20.1 39.29 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.28 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -112.21 161.59 16.4 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.35 30.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 t -80.74 107.39 13.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.164 -179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -106.84 108.88 20.6 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.274 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -49.65 141.37 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -106.05 -57.82 1.99 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.59 HD22 HD12 ' A' ' 28' ' ' LEU . 11.4 p30 -155.76 172.32 6.16 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.121 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.485 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.8 Cg_exo -68.94 23.76 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 120.972 1.115 . . . . 0.0 113.127 -176.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' H ' ' C ' ' A' ' 29' ' ' ASN . 66.4 m-85 -154.16 18.07 0.49 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.183 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 40.8 t80 -174.45 128.24 0.34 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.399 -177.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m -125.59 115.74 20.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.4 tp60 -93.32 150.62 20.34 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.198 0.937 . . . . 0.0 112.691 -177.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 m -102.24 116.26 32.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.133 -178.651 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -136.26 171.59 14.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.044 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -57.15 149.37 19.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 50.0 m-85 53.72 26.74 6.19 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.221 -178.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.67 149.8 17.39 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.824 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.7 117.61 18.5 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.435 ' O ' HG22 ' A' ' 17' ' ' THR . 1.3 p -105.81 -24.98 12.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.77 -154.09 6.56 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.592 -1.766 . . . . 0.0 112.23 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 151.6 23.2 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -178.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -61.83 153.37 5.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.945 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.54 35.27 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.801 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -88.58 135.64 33.39 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -133.96 41.24 3.02 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.47 173.69 16.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.37 158.33 23.19 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.379 1.386 . . . . 0.0 110.095 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 8' ' ' CYS . 11.9 p -127.36 29.4 5.55 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.976 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.46 109.45 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.194 178.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' C ' ' A' ' 24' ' ' THR . 52.4 m -70.87 157.01 38.87 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.085 -178.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.56 169.49 0.2 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.5 m -63.64 143.24 57.99 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.923 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.51 -15.47 40.75 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.429 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.34 169.27 8.99 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.709 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.446 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.591 179.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 t -92.75 142.87 26.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.292 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -139.31 123.98 18.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.906 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.79 131.59 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.988 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 29' ' ' ASN . 5.0 tp -95.96 -57.26 2.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.305 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.7 m-80 -143.1 173.54 4.44 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -70.1 25.11 0.18 Allowed 'Trans proline' 0 C--O 1.212 -0.787 0 CA-C-N 119.319 0.792 . . . . 0.0 111.107 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 29' ' ' ASN . 72.0 m-85 -152.06 20.87 0.67 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.206 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.448 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 62.3 t80 -175.46 125.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.71 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 m -130.92 113.96 14.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.175 177.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 9.2 tt0 -101.36 159.53 15.19 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.914 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -97.03 128.63 44.18 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.051 179.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.109 -178.501 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 162.77 25.93 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.484 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 11.5 t-160 -51.3 128.69 22.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.371 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.524 ' C ' HE21 ' A' ' 34' ' ' GLN . 54.8 m-85 72.22 20.31 4.21 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 123.912 0.758 . . . . 0.0 109.78 -178.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.55 154.98 22.45 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.92 117.13 21.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.125 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -107.91 -15.91 14.43 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.96 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.27 -178.6 24.42 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 118.0 -2.047 . . . . 0.0 111.729 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.78 154.01 7.81 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.84 137.67 22.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.045 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.86 -20.6 11.77 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.572 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -69.26 100.37 1.31 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.595 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.6 p -92.01 16.04 12.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.592 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.41 177.46 50.28 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.729 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.41 153.98 62.14 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.578 1.519 . . . . 0.0 110.243 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -119.89 20.03 12.28 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.31 -177.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.51 112.22 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.352 178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.92 175.31 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.27 173.72 10.48 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.115 178.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.4 m -66.52 143.74 56.89 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.917 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.09 -15.81 19.88 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.972 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.32 162.43 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.494 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 166.81 22.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.867 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.1 127.01 43.8 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.264 -179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -126.74 117.32 22.45 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.753 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.27 136.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.164 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -53.46 3.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -153.42 177.07 2.1 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.44 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.53 24.17 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.534 0.822 . . . . 0.0 111.156 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' ASN . 37.1 m-85 -151.0 0.15 0.39 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.756 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -159.83 138.21 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.426 -178.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 m -135.7 118.71 16.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.227 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.524 HE21 ' C ' ' A' ' 5' ' ' TYR . 1.2 tt0 -96.16 146.12 24.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.497 1.123 . . . . 0.0 113.16 -177.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 8.8 m -95.52 116.49 28.9 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 116.413 -1.756 . . . . 0.0 110.055 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.3 tp60 . . . . . 0 N--CA 1.487 1.409 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.58 -179.61 3.73 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.426 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.637 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.3 t-160 -66.99 142.37 57.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 72.9 m-85 59.65 27.84 17.15 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.345 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.62 156.37 20.64 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.999 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -86.87 117.09 25.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.157 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.421 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -102.32 -21.87 14.23 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.776 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.37 -169.13 15.51 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.473 -179.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.76 132.47 5.52 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 30' ' ' PRO . 97.7 mt -50.23 155.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.45 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.17 -18.45 13.51 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.191 -178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.7 148.11 28.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.978 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 p -141.1 11.07 2.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.514 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.66 -175.81 49.46 Favored Glycine 0 N--CA 1.478 1.473 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.16 154.2 70.46 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.525 1.483 . . . . 0.0 109.866 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 8' ' ' CYS . 30.4 p -115.9 15.44 16.27 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.53 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.41 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.679 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -73.62 149.58 41.94 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.547 -179.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -51.5 165.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.306 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.5 m -62.08 141.23 58.23 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.75 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.86 72.91 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.724 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.37 178.51 6.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.368 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.63 173.98 11.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.754 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 t -100.08 129.91 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.194 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.41 117.4 22.09 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.816 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.19 142.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.079 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 29' ' ' ASN . 3.8 tp -105.5 -56.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.209 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.615 HD21 HD23 ' A' ' 28' ' ' LEU . 2.3 m-80 -144.01 175.41 2.84 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.512 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -69.36 24.64 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 CA-C-N 119.126 0.723 . . . . 0.0 111.356 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.7 m-85 -148.24 6.15 0.76 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -162.85 139.64 7.58 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.218 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -143.97 114.39 7.53 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.474 176.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -88.07 164.07 15.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.101 -178.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -108.48 118.23 36.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.416 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 116.325 -1.798 . . . . 0.0 109.641 -179.889 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 4.1 tp60 . . . . . 0 N--CA 1.495 1.815 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.504 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -141.66 174.1 10.88 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.713 -179.735 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.457 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 20.4 t-160 -53.83 135.32 42.02 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.109 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.457 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 52.1 m-85 60.22 23.83 13.2 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.441 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.17 143.47 16.17 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.536 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 22.7 tt0 -67.43 111.62 4.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.347 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -94.92 -21.84 18.38 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.488 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.06 -175.14 24.17 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 118.321 -1.895 . . . . 0.0 112.342 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.21 137.69 4.81 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 30' ' ' PRO . 70.3 mt -47.9 151.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.08 7.36 66.68 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.957 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.54 128.0 44.7 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -119.87 56.56 0.95 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.015 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.81 179.96 18.35 Favored Glycine 0 N--CA 1.487 2.081 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.969 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.34 158.4 55.3 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.69 1.593 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.7 p -121.96 11.75 10.35 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.555 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.27 117.2 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.107 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 24' ' ' THR . 97.6 m -77.24 145.06 37.78 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.492 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.84 163.2 5.93 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.841 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 m -54.44 147.28 14.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.25 -18.8 38.92 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.069 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.593 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -122.3 172.44 8.31 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.493 0.663 . . . . 0.0 111.218 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.46 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -149.22 162.4 40.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.378 179.718 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.67 136.2 33.12 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.448 -178.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -130.22 116.54 18.55 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.172 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.23 118.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.561 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.466 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -84.6 -57.66 3.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.151 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.16 178.37 1.64 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.476 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.1 Cg_exo -69.76 24.01 0.17 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.734 0.956 . . . . 0.0 111.132 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' ASN . 76.7 m-85 -152.16 11.35 0.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 33' ' ' SER . 4.7 t80 -173.15 138.56 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.682 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 66.9 m -139.71 115.9 10.46 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.239 178.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.7 tt0 -90.77 152.5 20.77 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.916 -176.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.21 103.17 14.62 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.31 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.593 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.9 mm? . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.364 -1.779 . . . . 0.0 109.562 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 -179.48 5.11 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 19.0 t-160 -67.64 136.24 54.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 45.1 m-85 65.81 20.54 11.45 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.37 148.85 19.1 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.44 115.28 16.03 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' THR . 5.8 p -95.5 -19.06 20.14 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.379 179.127 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.55 -170.26 27.12 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.237 -1.935 . . . . 0.0 112.656 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.66 134.41 4.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 30' ' ' PRO . 30.8 mt -43.88 142.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.667 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.42 -17.54 53.69 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.687 -1.244 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.7 159.82 22.51 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.636 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 p -144.33 3.57 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.949 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.0 173.34 39.5 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.624 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.51 165.1 8.18 Favored 'Trans proline' 0 C--O 1.209 -0.959 0 C-N-CA 121.596 1.531 . . . . 0.0 110.215 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.1 p -128.17 14.45 6.73 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.14 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.8 114.73 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.662 178.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 24' ' ' THR . 64.2 m -77.28 147.43 36.29 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.329 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.23 170.34 0.22 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -60.53 148.18 38.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.614 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.97 44.49 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.379 179.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.19 165.45 17.57 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.458 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.443 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -143.49 165.91 26.26 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.608 179.825 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.2 t -82.28 128.06 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.75 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -120.72 115.51 23.46 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.094 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.93 121.41 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.599 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tp -90.22 -57.35 2.87 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.753 -1.179 . . . . 0.0 109.427 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.8 p30 -157.49 176.84 2.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.032 -178.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 4.1 Cg_exo -66.58 27.6 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 120.958 1.106 . . . . 0.0 112.989 -177.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.8 m-85 -154.75 14.84 0.42 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.947 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -174.87 140.7 0.57 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.661 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -143.9 113.25 6.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.11 158.27 17.37 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.794 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -99.77 112.82 25.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.007 178.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.236 179.669 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 . . . . . 0 N--CA 1.488 1.463 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.01 -174.92 3.1 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.743 -178.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.657 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 21.5 t-160 -61.65 158.07 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.079 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.0 m-85 48.7 21.53 0.43 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.561 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 155.46 19.12 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.598 -1.287 . . . . 0.0 111.962 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -83.66 121.02 26.7 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.163 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.541 ' O ' HG22 ' A' ' 17' ' ' THR . 1.5 p -107.46 -27.96 10.11 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.656 179.125 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.38 -148.97 4.87 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.222 -1.942 . . . . 0.0 112.872 -178.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.04 134.25 7.58 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -178.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.1 mt -51.37 152.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.976 -178.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -11.29 47.87 Favored Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.346 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -86.26 130.5 34.5 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.6 p -121.09 62.32 0.89 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.624 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.84 -175.74 19.16 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.642 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.69 159.2 53.75 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.493 1.462 . . . . 0.0 109.909 179.05 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 8' ' ' CYS . 81.4 p -122.66 30.94 6.26 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.581 -178.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.42 116.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.394 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.2 m -82.01 155.79 24.98 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.09 151.66 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.341 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -49.56 141.77 9.02 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.077 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 -26.44 21.1 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.093 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.51 165.81 12.36 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.102 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.91 160.16 39.45 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.764 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.42 102.31 5.92 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.229 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -95.48 108.99 21.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.606 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.7 135.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.412 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -102.19 -55.5 2.46 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.8 p30 -154.14 173.42 4.73 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.474 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -66.87 24.99 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.504 0.859 . . . . 0.0 112.035 -177.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 47.4 m-85 -150.38 -5.65 0.32 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.611 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CD2' ' HG ' ' A' ' 28' ' ' LEU . 6.3 t80 -152.54 132.41 13.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.409 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -127.79 112.28 14.6 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.925 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -89.83 155.33 19.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.121 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -99.83 113.2 25.56 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.533 178.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 116.385 -1.769 . . . . 0.0 109.934 179.206 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -177.42 3.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.88 -179.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 14.0 t-160 -70.27 127.93 34.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.606 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 68.5 m-85 79.87 18.32 0.7 Allowed 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.052 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.1 154.46 20.5 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.869 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.85 114.33 17.7 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.453 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -99.26 -19.25 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.98 -167.02 13.51 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.276 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.95 146.91 10.38 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.6 mt -59.34 153.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.094 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -12.81 39.87 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.101 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -88.19 152.97 21.6 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.642 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.4 p -148.59 13.32 0.93 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.944 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.81 -172.73 43.97 Favored Glycine 0 N--CA 1.483 1.783 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.76 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.76 160.44 32.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.306 1.337 . . . . 0.0 110.252 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -128.96 27.62 5.41 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.059 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -105.7 120.42 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.99 178.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.4 m -80.27 145.48 32.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.986 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -50.1 145.24 6.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.74 178.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -50.01 141.67 10.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.007 -179.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.45 -26.89 22.62 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.339 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.669 HG22 ' OXT' ' A' ' 36' ' ' LEU . 1.1 p -105.92 -173.46 2.3 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.28 157.37 43.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.724 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.79 136.25 33.06 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.428 -1.309 . . . . 0.0 109.301 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -136.53 120.62 17.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.392 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.24 118.46 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.639 178.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.534 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -84.28 -56.82 3.44 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.674 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.534 HD22 HD12 ' A' ' 28' ' ' LEU . 4.3 p30 -149.06 171.59 6.13 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.08 26.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 119.41 0.825 . . . . 0.0 111.95 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 83.3 m-85 -154.39 14.97 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.416 ' HB3' HD21 ' A' ' 29' ' ' ASN . 74.6 t80 -173.8 126.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 17.7 m -126.85 111.49 14.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.665 178.148 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.6 tp60 -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.767 1.292 . . . . 0.0 112.561 -176.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.9 m -99.66 105.94 17.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.998 179.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.669 ' OXT' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 116.269 -1.824 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 4' ' ' HIS . 0.3 OUTLIER -109.69 170.45 8.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.694 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.5 t-160 -40.98 130.29 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 42.8 m-85 68.53 40.75 1.85 Allowed 'General case' 0 N--CA 1.511 2.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.26 -178.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.12 152.62 17.3 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.78 100.85 11.19 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.161 179.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -89.85 -17.51 27.96 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.43 -159.21 8.75 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.944 -2.074 . . . . 0.0 112.675 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 106.09 124.57 5.33 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -178.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 10' ' ' GLY . 96.4 mt -41.67 147.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.966 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.52 31.6 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.879 -1.153 . . . . 0.0 111.411 -179.247 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.32 114.11 21.63 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 p -108.11 17.47 22.27 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.78 176.73 42.96 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.594 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.64 158.65 44.96 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.453 1.435 . . . . 0.0 110.234 179.389 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.7 p -119.22 16.4 13.16 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.582 -178.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -95.03 118.78 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.459 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 m -84.99 152.93 23.1 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.076 -1.049 . . . . 0.0 109.949 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.7 137.0 58.17 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ALA . 3.3 m -41.36 145.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.39 -24.02 30.06 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -120.98 -171.63 2.23 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.558 0.694 . . . . 0.0 110.473 179.69 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.88 162.12 41.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.92 136.53 34.05 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.904 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -132.64 139.07 47.57 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.499 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.98 123.29 35.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -88.1 -56.39 3.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.87 174.78 3.57 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.04 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.4 Cg_exo -64.78 24.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.211 -0.825 0 C-N-CA 121.005 1.137 . . . . 0.0 112.769 -179.138 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.2 m-85 -154.9 14.03 0.4 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.204 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -172.43 125.79 0.51 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.701 -178.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 72.2 m -126.84 115.43 19.31 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.342 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG2' HD11 ' A' ' 36' ' ' LEU . 1.5 tt0 -93.92 149.32 21.34 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.669 -177.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.444 ' C ' HD22 ' A' ' 36' ' ' LEU . 55.0 m -103.42 117.2 33.91 Favored 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.066 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 116.308 -1.805 . . . . 0.0 110.173 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.737 HE22 ' N ' ' A' ' 8' ' ' CYS . 3.1 tt0 . . . . . 0 N--CA 1.487 1.392 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 160.28 32.86 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.956 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.654 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 18.7 t-160 -46.62 132.67 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.37 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 25.2 m-85 72.58 24.62 2.8 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 2' ' ' GLN . . . -92.44 144.54 17.16 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.111 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.541 ' C ' HE22 ' A' ' 2' ' ' GLN . 38.1 tt0 -76.13 96.37 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.614 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.847 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -88.56 -12.0 44.0 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.663 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.53 -160.96 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.047 -2.025 . . . . 0.0 112.181 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.26 149.64 23.11 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.489 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 30' ' ' PRO . 81.9 mt -69.73 157.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.455 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.74 -3.29 35.91 Favored Glycine 0 N--CA 1.484 1.89 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.338 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 16.7 t80 -85.1 154.24 22.18 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -146.8 57.26 1.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.463 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.64 177.26 24.15 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.331 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.48 164.64 6.92 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.13 1.22 . . . . 0.0 109.799 179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.8 p -127.15 29.33 5.61 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.326 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.89 120.9 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.913 179.131 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 24' ' ' THR . 10.3 m -77.67 142.33 38.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -45.6 168.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.04 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.11 149.99 46.49 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.512 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.1 -15.14 57.07 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.497 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -114.9 -175.2 2.64 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.032 -179.715 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.451 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -150.96 162.46 40.77 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.53 179.631 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.2 t -92.37 124.61 36.55 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.494 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 24' ' ' THR . 28.9 mp0 -125.42 128.52 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.787 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.59 142.12 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -108.42 -56.72 2.22 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.886 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 31' ' ' TYR . 10.3 p30 -161.36 171.87 6.39 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.9 Cg_exo -67.25 24.24 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.601 0.867 . . . . 0.0 112.817 -176.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 29' ' ' ASN . 62.3 m-85 -150.54 14.21 0.76 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' HB3' HD21 ' A' ' 29' ' ' ASN . 6.0 t80 -175.34 134.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 -179.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -132.74 114.33 14.02 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -90.62 156.08 18.38 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.986 -176.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.2 m -104.04 131.03 51.71 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.048 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.403 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 70.6 mt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 116.404 -1.76 . . . . 0.0 109.875 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -175.71 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.123 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.635 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 23.1 t-160 -68.06 147.51 52.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 54.4 m-85 55.52 26.13 8.67 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.444 -177.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.93 145.92 18.07 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -77.05 116.94 18.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -17.37 14.49 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.816 179.715 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.48 -168.54 15.51 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 118.641 -1.743 . . . . 0.0 111.873 -179.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.81 133.91 5.59 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 30' ' ' PRO . 63.0 mt -46.55 147.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.01 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.41 -11.42 24.71 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.816 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -82.37 110.65 17.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 p -111.43 59.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.432 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.81 179.46 18.2 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.713 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.18 149.06 91.96 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.432 1.421 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.2 p -110.61 -12.6 14.32 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.536 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 t -76.77 108.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.43 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.65 156.86 38.93 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.664 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -52.92 152.3 4.06 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.224 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.11 152.24 4.38 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.94 -17.04 55.36 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.745 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -120.77 -179.94 4.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.227 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 163.25 37.4 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.085 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -89.72 138.37 31.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.534 -179.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -130.96 106.08 8.17 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.074 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.36 114.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -79.09 -51.82 9.04 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.51 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 p30 -158.68 174.78 3.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.202 -179.051 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -65.57 24.87 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.01 1.14 . . . . 0.0 113.213 -176.87 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 93.5 m-85 -152.33 10.2 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.703 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.8 t80 -169.67 134.4 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.053 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -138.07 113.73 9.7 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.452 177.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.61 163.54 15.78 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.862 -178.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.1 m -107.35 115.02 29.43 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.363 179.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.198 -179.804 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.4 tp60 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 179.07 5.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.6 t-160 -55.42 145.47 22.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.336 -0.946 . . . . 0.0 108.8 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 48.7 m-85 60.46 29.59 19.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.61 155.11 20.46 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.81 -179.064 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 57.5 tt0 -89.82 104.54 17.1 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.357 179.455 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.11 -22.67 21.66 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.132 179.557 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.65 19.19 Favored Glycine 0 N--CA 1.486 1.984 0 C-N-CA 118.241 -1.933 . . . . 0.0 112.323 -178.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.52 136.49 4.64 Favored Glycine 0 C--O 1.211 -1.313 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -48.06 142.03 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.554 -179.408 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.2 65.5 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.844 179.606 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 87.9 t80 -95.97 100.45 12.12 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.531 179.767 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -97.43 40.75 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.254 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.03 169.88 13.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.27 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -51.05 149.78 14.71 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.199 1.266 . . . . 0.0 109.899 179.482 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -111.84 -12.13 13.84 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -82.28 125.72 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.776 -1.169 . . . . 0.0 109.666 179.161 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.7 m -80.34 160.49 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.076 179.611 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -62.09 175.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.508 -179.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.6 m -62.63 144.79 55.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.251 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.27 60.03 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.667 -1.254 . . . . 0.0 112.435 178.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.35 166.47 13.49 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.603 -179.655 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.36 158.52 44.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -82.14 132.16 35.24 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.274 -179.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -127.57 119.25 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.104 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.67 122.3 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.595 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 HD21 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -93.46 -53.28 4.13 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.459 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -154.23 175.02 3.3 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.754 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.0 Cg_exo -72.75 23.27 0.29 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 120.512 0.808 . . . . 0.0 110.716 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.1 m-85 -150.63 13.09 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.867 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.437 ' HB3' HD22 ' A' ' 29' ' ' ASN . 42.1 t80 -174.16 126.65 0.35 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.836 -178.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 38.4 m -128.68 112.66 14.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.103 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.6 tt0 -90.13 149.82 22.3 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.597 -176.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.7 m -105.51 110.59 22.98 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.409 179.566 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.388 -1.768 . . . . 0.0 109.857 -179.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 . . . . . 0 N--CA 1.493 1.719 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 033 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.53 175.95 5.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.662 -178.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.579 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.7 t-160 -52.01 136.12 29.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.464 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.9 m-85 70.53 25.03 4.33 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.885 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.51 149.13 19.06 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.821 -1.181 . . . . 0.0 111.441 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.62 111.27 17.76 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.629 179.698 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.843 ' O ' HG22 ' A' ' 17' ' ' THR . 1.4 p -103.45 -12.76 16.95 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.08 -163.55 14.31 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 118.451 -1.833 . . . . 0.0 112.083 -179.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.0 133.35 8.04 Favored Glycine 0 N--CA 1.48 1.628 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.54 -179.634 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -50.6 154.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.014 -1.074 . . . . 0.0 109.696 -179.765 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.04 81.34 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.148 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CZ ' ' CA ' ' A' ' 15' ' ' GLY . 21.2 t80 -105.63 153.29 22.01 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.148 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 p -136.42 2.06 2.69 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.479 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' CZ ' ' A' ' 13' ' ' TYR . . . -93.97 178.59 37.67 Favored Glycine 0 CA--C 1.551 2.294 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.584 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.41 161.78 29.84 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.189 1.926 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 8' ' ' CYS . 33.7 p -116.44 25.46 10.6 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.846 -178.653 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.07 116.63 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.875 179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.22 149.44 25.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.56 150.51 12.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.013 179.58 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.46 160.24 1.26 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.481 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.7 -20.15 9.93 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.069 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.83 163.43 23.61 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.668 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -135.84 173.82 11.29 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.821 179.214 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -87.09 148.81 25.08 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.371 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.448 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.5 mp0 -143.64 124.54 14.3 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.558 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.56 113.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.167 179.04 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -81.97 -57.05 3.58 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.797 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -150.69 171.86 5.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.346 179.579 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -66.07 24.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.739 0.959 . . . . 0.0 113.123 -177.028 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.3 m-85 -155.58 16.63 0.39 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.903 178.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 52.9 t80 -171.65 121.8 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.571 -176.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 13.8 m -118.44 111.81 19.15 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.656 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 36' ' ' LEU . 6.0 tp60 -90.51 144.02 26.19 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.448 -177.559 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.6 m -87.85 115.13 25.09 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 34' ' ' GLN . 33.0 mt . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 116.391 -1.766 . . . . 0.0 110.197 -178.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.486 1.337 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 . . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -93.46 -167.43 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.153 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.636 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -66.71 132.12 47.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.649 -179.466 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.5 m-85 71.35 29.35 2.77 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.518 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.01 154.62 20.25 Favored Glycine 0 N--CA 1.481 1.693 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.54 117.3 25.23 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.886 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -102.7 -33.16 9.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.624 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 33' ' ' SER . . . -152.42 -178.75 27.4 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 117.433 -2.318 . . . . 0.0 113.828 -177.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.81 151.57 8.23 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 12.3 mt -59.32 149.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.915 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.07 8.13 Favored Glycine 0 C--N 1.296 -1.663 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.211 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -82.38 138.17 34.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.561 179.578 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -136.53 40.13 2.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.462 -179.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.44 176.3 16.27 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.9 155.95 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 N-CA-C 109.407 -1.036 . . . . 0.0 109.407 179.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.8 p -117.89 32.64 6.04 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.869 -178.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.96 119.13 60.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.843 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.7 m -80.02 171.31 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.641 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -74.16 147.32 42.72 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.236 179.345 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 m -43.05 139.26 1.82 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.677 -179.579 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.43 -26.8 22.92 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.248 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.613 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -114.01 171.46 7.59 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.183 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 161.57 37.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.973 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.0 t -85.69 140.39 30.56 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.864 -179.383 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -137.19 117.47 13.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.56 126.33 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.568 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -57.64 2.3 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.03 177.03 2.05 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.065 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -67.43 24.08 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.774 0.983 . . . . 0.0 111.716 -178.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' ASN . 98.3 m-85 -154.38 12.82 0.42 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.034 179.522 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.412 ' HB3' HD22 ' A' ' 29' ' ' ASN . 11.6 t80 -171.98 137.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.435 -178.137 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLY . 50.8 m -136.88 115.98 12.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.402 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 4.8 tp60 -89.64 155.69 19.07 Favored 'General case' 0 N--CA 1.51 2.563 0 O-C-N 124.119 0.887 . . . . 0.0 113.062 -176.795 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 8.6 m -105.85 106.09 16.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.459 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.613 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.7 mm? . . . . . 0 N--CA 1.502 2.155 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.705 179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 . . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.67 179.87 4.53 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.756 -179.706 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.7 t-160 -57.85 147.5 28.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 86.8 m-85 58.12 23.75 10.5 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.007 -178.884 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.67 156.11 19.77 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.898 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.51 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 58.3 tt0 -83.85 110.06 18.06 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.416 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.846 ' O ' HG22 ' A' ' 17' ' ' THR . 3.4 p -96.24 -19.61 19.18 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.207 179.046 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.84 -149.96 5.28 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.47 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.11 126.09 5.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.3 mt -48.61 149.6 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.526 -179.291 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.28 -13.55 20.38 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -70.46 153.5 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.231 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -143.47 52.89 1.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.687 -179.573 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.01 174.3 23.72 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.442 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.12 163.64 5.92 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.072 1.181 . . . . 0.0 109.795 179.073 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.846 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.9 p -127.4 15.65 7.14 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.971 -178.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.21 115.61 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.926 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ALA . 54.0 m -79.99 130.13 35.03 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.537 -179.217 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -41.12 132.01 2.54 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.978 179.625 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -40.07 144.85 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.57 -179.683 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.88 30.78 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.72 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.82 176.96 5.69 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.2 167.84 20.52 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.675 179.209 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.65 106.32 18.3 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.653 -179.117 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -106.77 136.68 46.18 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.264 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.77 104.2 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.926 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.529 HD23 HD21 ' A' ' 29' ' ' ASN . 7.5 tp -62.06 -57.86 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.321 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.529 HD21 HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -146.03 173.42 4.27 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.073 178.31 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.495 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.7 Cg_exo -69.41 23.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.413 0.742 . . . . 0.0 111.99 -177.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 34.2 m-85 -147.56 7.62 0.87 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.239 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -163.62 112.76 1.26 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.163 -178.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -115.87 114.29 24.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.982 177.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -94.65 166.95 11.76 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.488 -177.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' H ' ' A' ' 6' ' ' GLY . 13.9 m -100.44 108.31 20.27 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.826 179.722 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.229 -1.844 . . . . 0.0 109.951 -179.634 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 036 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.69 -175.42 3.89 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.408 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.631 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.5 t-160 -71.39 154.38 41.61 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.056 179.725 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 63.4 m-85 51.18 18.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.697 -178.338 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.66 155.67 22.21 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.165 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -83.27 110.86 18.44 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.644 179.666 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.848 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.78 -26.23 17.06 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.868 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.14 -151.36 5.62 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.343 -1.884 . . . . 0.0 112.601 -178.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 150.42 18.78 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 77.3 mt -62.16 149.73 9.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.33 -179.439 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.18 -4.09 42.41 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.676 -1.249 . . . . 0.0 111.313 -179.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -80.44 125.56 30.09 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.1 p -117.53 58.91 0.79 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.149 179.678 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.03 21.42 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.322 -179.562 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -68.44 159.77 51.99 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.758 1.638 . . . . 0.0 110.506 179.458 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 8' ' ' CYS . 15.0 p -120.23 12.63 11.83 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.569 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.62 116.54 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.116 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -79.11 149.41 32.07 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.199 -179.765 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.0 146.69 41.71 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.09 179.757 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -43.09 149.66 0.21 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.599 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.89 68.46 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.298 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -134.04 178.83 6.65 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.095 -179.971 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.63 168.69 19.55 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.677 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -89.87 136.44 33.04 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.914 -179.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -128.27 133.1 48.71 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.147 -179.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.11 108.32 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.633 179.041 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.69 -51.03 38.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.557 -179.359 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.4 p30 -159.54 173.87 4.52 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.843 -179.122 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.1 Cg_exo -66.34 24.93 0.1 OUTLIER 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 120.909 1.073 . . . . 0.0 113.106 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 99.3 m-85 -152.75 19.37 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.468 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.3 t80 -175.99 130.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.094 -179.452 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.1 m -132.57 112.04 11.74 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.834 177.166 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -93.73 157.77 15.99 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.071 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.3 m -102.39 121.14 41.73 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.145 179.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 116.132 -1.89 . . . . 0.0 109.567 -179.949 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 7' ' ' GLN . 11.7 tp60 . . . . . 0 N--CA 1.496 1.826 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 164.71 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.937 -178.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.621 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -44.73 159.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.159 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.621 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 67.3 m-85 47.57 19.37 0.14 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.727 -179.511 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.25 154.39 20.44 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.736 -178.707 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 39.7 tt0 -78.17 108.49 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.367 179.755 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 17' ' ' THR . 2.0 p -92.61 -24.72 18.6 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.794 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.26 -157.03 7.66 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.253 -178.763 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 113.94 126.38 4.35 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.876 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 30' ' ' PRO . 17.4 mt -40.41 145.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.62 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.9 -1.04 56.29 Favored Glycine 0 CA--C 1.544 1.903 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.795 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -91.43 101.3 13.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.424 179.693 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.6 p -95.1 55.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.07 171.76 22.0 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.228 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.68 161.9 13.97 Favored 'Trans proline' 0 C--O 1.205 -1.162 0 C-N-CA 121.756 1.637 . . . . 0.0 110.415 179.593 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -131.33 20.14 4.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.712 -178.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.21 116.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.379 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.06 144.07 29.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.149 -179.529 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.34 169.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.5 p -67.07 143.45 56.7 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.474 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.79 -17.36 45.83 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.39 169.9 8.7 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.515 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.53 160.03 41.8 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.223 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.3 t -79.97 116.73 20.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.114 -179.269 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -113.99 136.16 53.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.394 179.19 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -83.43 132.09 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.468 HD23 HD21 ' A' ' 29' ' ' ASN . 5.0 tp -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.399 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.2 m-80 -149.74 173.33 4.36 Favored Pre-proline 0 N--CA 1.495 1.811 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.876 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.694 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.7 Cg_exo -70.42 23.88 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.539 0.826 . . . . 0.0 111.39 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.0 m-85 -152.88 20.17 0.59 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.661 179.305 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -173.96 129.76 0.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.6 m -136.79 119.45 16.07 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.549 177.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -99.81 158.28 15.91 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.431 -178.464 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 m -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 116.415 -1.755 . . . . 0.0 110.066 -178.681 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 3.7 tp60 . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 110.177 -0.305 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.42 174.77 8.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.415 -179.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.615 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.3 t-160 -55.17 134.08 49.37 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.801 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.2 m-85 69.23 -3.48 1.54 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -61.45 152.75 41.02 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.765 179.715 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -84.61 111.93 19.98 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.72 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.904 ' O ' HG22 ' A' ' 17' ' ' THR . 1.7 p -89.69 -34.42 16.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.937 179.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.8 -155.54 6.75 Favored Glycine 0 N--CA 1.48 1.569 0 C-N-CA 118.303 -1.903 . . . . 0.0 112.395 -178.797 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.31 152.52 14.67 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.456 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 11.0 mt -60.87 146.9 10.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.917 -179.309 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.48 -8.76 52.85 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.736 -179.909 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.479 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 52.2 t80 -82.64 119.21 23.99 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.865 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -113.04 57.62 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.329 179.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.27 21.6 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -69.19 157.14 62.62 Favored 'Trans proline' 0 C--O 1.21 -0.907 0 C-N-CA 121.818 1.679 . . . . 0.0 110.596 179.55 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 8' ' ' CYS . 47.7 p -115.87 13.31 16.01 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.716 -178.281 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.31 110.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.663 179.322 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -77.01 149.56 35.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.877 -179.067 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 155.98 0.34 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.239 179.804 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -52.64 144.8 13.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.428 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.06 -25.15 10.52 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.673 178.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.46 173.86 6.14 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.726 -179.462 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.64 170.14 17.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.65 140.99 28.96 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -141.9 113.88 8.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.43 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.86 111.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.87 -48.97 50.96 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.021 -1.471 . . . . 0.0 107.651 179.299 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.6 p30 -163.27 175.09 3.0 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.655 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.491 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 6.3 Cg_exo -65.93 28.9 0.1 OUTLIER 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 121.001 1.134 . . . . 0.0 113.6 -177.278 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 70.7 m-85 -154.48 13.78 0.43 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.144 178.425 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -175.35 133.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.747 -178.544 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -131.54 109.07 9.99 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.487 177.286 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -86.82 153.18 21.85 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.72 -177.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 m -97.4 115.33 27.54 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.847 178.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 116.403 -1.76 . . . . 0.0 110.329 -179.879 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 1.3 tp60 . . . . . 0 N--CA 1.493 1.716 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.37 166.34 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.405 -179.214 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.0 t-160 -48.56 139.67 9.02 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.56 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 79.8 m-85 58.21 30.13 18.98 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.297 -178.491 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.59 148.34 18.59 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.976 -178.98 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -75.81 102.39 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.694 179.643 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -91.21 -14.25 31.34 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.054 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.08 -154.29 6.92 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.423 -1.846 . . . . 0.0 112.378 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 137.23 8.69 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.813 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.04 145.21 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.79 4.72 89.52 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.594 -179.575 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 87.4 t80 -100.25 113.64 26.49 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.222 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 p -111.05 46.5 1.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.718 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.79 172.89 16.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.31 155.89 54.36 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.837 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 8' ' ' CYS . 32.8 p -117.01 20.34 13.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.647 -178.536 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.46 120.82 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.305 178.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.0 m -83.19 156.47 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.774 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -59.47 152.95 20.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.706 179.395 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.72 144.98 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.72 -12.02 69.97 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.373 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.03 163.68 23.21 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.722 -179.699 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.22 158.92 39.27 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.179 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -89.53 131.87 35.35 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.775 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -131.48 119.05 21.03 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.159 179.663 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -54.29 117.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.664 179.668 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.489 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -82.3 -58.01 3.12 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -179.923 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.16 176.75 2.2 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.327 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -67.99 24.56 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.056 1.171 . . . . 0.0 112.047 -178.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 29' ' ' ASN . 88.9 m-85 -155.01 15.03 0.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.043 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' OH ' ' CD ' ' A' ' 34' ' ' GLN . 21.2 t80 -174.17 124.42 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.062 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 22.3 m -124.98 115.44 20.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.948 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 5.4 tp60 -94.34 151.69 19.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.733 -176.251 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.3 m -100.98 107.21 18.62 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.515 179.061 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.413 -1.755 . . . . 0.0 109.943 -179.615 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 0 0 . 1 . 040 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 p -99.73 -172.95 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.867 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.59 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 22.8 t-160 -61.8 160.71 11.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.312 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.59 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 81.9 m-85 47.09 19.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.631 -1.227 . . . . 0.0 109.125 -178.046 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.486 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -87.09 154.06 26.11 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.62 -178.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -89.13 114.72 26.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.381 179.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.861 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -103.05 -21.51 13.91 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.093 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -155.32 -153.32 6.49 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 118.175 -1.964 . . . . 0.0 112.765 -179.145 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 139.3 10.41 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.9 mt -51.32 151.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.069 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 80.68 -15.98 16.97 Favored Glycine 0 C--N 1.296 -1.676 0 C-N-CA 119.508 -1.329 . . . . 0.0 111.032 -179.701 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -82.06 124.5 29.88 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.394 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -120.55 37.29 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.12 -175.5 17.94 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.133 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.28 158.71 56.38 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 121.798 1.665 . . . . 0.0 110.493 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 8' ' ' CYS . 41.7 p -122.23 31.09 6.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.544 -0.863 . . . . 0.0 112.012 -178.184 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -111.52 117.07 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.733 178.707 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 4.3 m -85.32 142.17 29.53 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -49.13 146.93 3.22 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.358 179.851 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -47.3 153.84 0.46 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.733 -179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.3 -26.11 12.77 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -119.59 171.97 7.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.129 179.779 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 155.91 43.31 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.88 179.265 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 14.8 t -70.71 130.33 41.46 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.733 -178.801 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.43 103.07 6.93 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.228 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.02 128.14 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.673 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.78 -56.45 3.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.337 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.28 171.44 6.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.256 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_exo -67.81 24.79 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.36 0.807 . . . . 0.0 112.26 -177.341 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 84.9 m-85 -151.27 11.91 0.63 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.87 178.861 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -171.88 131.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.649 -178.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.48 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.0 m -131.7 113.49 13.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.656 178.153 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -98.45 161.07 13.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.482 1.113 . . . . 0.0 111.464 -178.001 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.3 m -111.94 121.54 45.3 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.073 179.311 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 116.236 -1.84 . . . . 0.0 109.872 -179.684 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -171.32 1.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.905 -179.45 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 4' ' ' HIS . . . . . 0.666 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 23.0 t-160 -59.11 164.87 2.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.553 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.666 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 30.7 m-85 47.82 23.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.538 -178.272 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -86.01 157.58 30.95 Favored Glycine 0 N--CA 1.484 1.874 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.069 -179.06 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 2' ' ' GLN . 50.8 tt0 -93.69 106.07 18.06 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.147 -179.049 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -91.9 -19.04 22.9 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.735 -1.186 . . . . 0.0 110.777 179.997 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.45 -161.63 10.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.174 -1.965 . . . . 0.0 112.288 -179.381 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 110.35 127.32 5.24 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 30' ' ' PRO . 78.5 mt -44.96 154.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.028 -179.379 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 -12.84 25.17 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.037 -178.187 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -89.46 110.03 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.785 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.5 p -109.86 30.65 6.5 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.553 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.4 -179.05 24.98 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.93 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.5 150.12 63.22 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.487 1.458 . . . . 0.0 109.761 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 45.5 p -106.92 11.62 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.926 -178.001 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.53 116.28 28.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ALA . 16.4 m -83.1 139.23 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.094 179.847 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -40.73 147.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.604 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.19 153.65 1.91 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.36 -20.66 32.8 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.429 179.197 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.18 174.21 6.35 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.946 -0.701 . . . . 0.0 111.004 -179.609 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -179.59 5.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.443 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -99.85 139.43 35.54 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.206 -179.356 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.18 113.38 8.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.217 179.531 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.07 138.37 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.449 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -107.3 -60.87 1.63 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.511 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -145.5 175.42 2.76 Favored Pre-proline 0 N--CA 1.505 2.275 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.63 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.538 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.9 Cg_exo -70.08 22.35 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.616 0.877 . . . . 0.0 111.851 -178.413 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.9 m-85 -155.81 19.11 0.38 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.549 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HB3' HD22 ' A' ' 29' ' ' ASN . 47.1 t80 -172.8 127.54 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.816 -178.505 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.3 m -130.46 113.0 13.76 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.574 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.11 156.88 16.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.06 0.85 . . . . 0.0 112.224 -176.84 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.4 m -106.19 130.92 53.97 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.76 -179.886 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.259 0.552 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 22.7 tp60 -143.5 149.0 36.88 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.034 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.89 173.98 7.4 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 119.053 -1.059 . . . . 0.0 111.304 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.644 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.0 t-160 -47.84 158.84 0.19 Allowed 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.695 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.644 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.5 m-85 46.91 23.66 0.29 Allowed 'General case' 0 N--CA 1.501 2.083 0 C-N-CA 119.47 -0.892 . . . . 0.0 110.341 -179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.06 135.12 11.96 Favored Glycine 0 N--CA 1.487 2.076 0 C-N-CA 119.58 -1.295 . . . . 0.0 112.308 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -65.16 100.98 0.49 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.588 -0.845 . . . . 0.0 110.36 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.69 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -89.86 -16.6 29.76 Favored 'General case' 0 C--O 1.209 -1.057 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.612 179.62 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.6 -179.79 31.85 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 118.514 -1.803 . . . . 0.0 111.537 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.66 131.69 3.33 Favored Glycine 0 N--CA 1.478 1.487 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.3 mt -48.25 148.65 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 118.519 -1.273 . . . . 0.0 109.604 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.14 -14.46 14.89 Favored Glycine 0 C--N 1.29 -1.997 0 C-N-CA 119.3 -1.429 . . . . 0.0 110.611 -179.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -79.39 138.64 37.73 Favored 'General case' 0 N--CA 1.496 1.843 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.022 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 82.8 p -137.71 63.12 1.56 Allowed 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 119.701 -0.8 . . . . 0.0 109.872 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.6 178.99 21.37 Favored Glycine 0 N--CA 1.481 1.681 0 N-CA-C 110.155 -1.178 . . . . 0.0 110.155 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.91 166.11 7.35 Favored 'Trans proline' 0 C--N 1.314 -1.255 0 N-CA-C 109.078 -1.162 . . . . 0.0 109.078 179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.69 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.8 p -135.15 0.43 2.84 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 118.86 -1.136 . . . . 0.0 111.83 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.9 t -80.68 112.42 18.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 C-N-CA 118.301 -1.359 . . . . 0.0 109.495 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.8 m -71.21 147.02 48.69 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.544 -0.862 . . . . 0.0 110.353 -179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.56 142.19 49.89 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 118.918 -1.113 . . . . 0.0 109.163 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -44.95 146.22 0.84 Allowed 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 119.333 -0.947 . . . . 0.0 110.969 -179.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.55 -25.76 27.0 Favored Glycine 0 N--CA 1.479 1.557 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.8 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -119.33 163.0 17.83 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.158 -0.617 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.505 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.4 OUTLIER -126.64 169.71 12.84 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 115.165 -0.925 . . . . 0.0 108.812 178.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.7 t -95.34 120.56 35.79 Favored 'General case' 0 N--CA 1.5 2.041 0 C-N-CA 118.852 -1.139 . . . . 0.0 111.038 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.505 HE22 ' CB ' ' A' ' 24' ' ' THR . 22.5 mp0 -110.72 113.78 26.65 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.746 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 43.0 t -72.27 106.29 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 C-N-CA 119.121 -1.031 . . . . 0.0 109.312 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.496 HD23 ' ND2' ' A' ' 29' ' ' ASN . 4.1 tp -69.97 -54.06 14.98 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 119.034 -1.067 . . . . 0.0 109.184 -178.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 m-80 -150.2 174.59 3.37 Favored Pre-proline 0 N--CA 1.496 1.87 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.534 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.611 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -68.59 24.36 0.14 Allowed 'Trans proline' 0 C--O 1.213 -0.752 0 C-N-CA 120.837 1.024 . . . . 0.0 112.208 -177.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.514 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.29 17.56 0.48 Allowed 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.452 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -170.21 131.97 1.02 Allowed 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.975 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.3 m -142.66 110.82 6.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.649 -0.821 . . . . 0.0 109.16 177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.2 145.28 27.4 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.31 -0.859 . . . . 0.0 112.099 -177.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.501 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 64.0 m -84.43 118.72 24.44 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.496 1.872 0 CA-C-O 116.301 -1.809 . . . . 0.0 110.559 -179.189 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -82.87 153.54 25.07 Favored 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.709 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.7 -172.29 2.22 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.193 -179.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.7 t-160 -67.24 149.68 50.09 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 -179.69 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 44.9 m-85 54.28 25.79 6.21 Favored 'General case' 0 N--CA 1.504 2.244 0 C-N-CA 119.554 -0.858 . . . . 0.0 109.913 -178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.9 150.21 18.66 Favored Glycine 0 N--CA 1.491 2.302 0 C-N-CA 119.709 -1.234 . . . . 0.0 111.737 -179.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.6 tt0 -76.5 109.64 10.39 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.647 -0.821 . . . . 0.0 110.612 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.556 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -96.4 -25.46 15.7 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.694 179.382 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.44 -153.27 6.31 Favored Glycine 0 N--CA 1.48 1.597 0 C-N-CA 118.279 -1.915 . . . . 0.0 112.131 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.31 132.47 7.5 Favored Glycine 0 C--N 1.304 -1.232 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -178.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.505 HD12 ' O ' ' A' ' 30' ' ' PRO . 20.1 mt -48.0 149.9 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 C-N-CA 118.85 -1.14 . . . . 0.0 109.756 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.31 -0.4 87.76 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.553 -1.308 . . . . 0.0 111.056 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -96.62 139.19 33.07 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.748 -0.781 . . . . 0.0 110.527 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 60.0 p -131.07 31.2 4.47 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 119.86 -0.736 . . . . 0.0 110.585 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -113.18 175.82 16.9 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 120.189 -1.005 . . . . 0.0 110.854 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.51 160.58 23.5 Favored 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 121.515 1.477 . . . . 0.0 110.333 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 8' ' ' CYS . 63.4 p -124.59 22.15 8.37 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.586 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.1 t -94.93 108.61 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.187 -1.005 . . . . 0.0 109.718 179.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.6 m -75.71 147.2 39.56 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.298 -0.961 . . . . 0.0 110.43 -179.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.26 152.64 0.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.276 -0.97 . . . . 0.0 109.726 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 m -56.51 139.54 49.09 Favored 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 119.089 -1.044 . . . . 0.0 110.927 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.05 -23.18 32.49 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.738 -1.22 . . . . 0.0 111.527 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.2 OUTLIER -105.13 161.57 14.14 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.881 -179.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.442 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 0.2 OUTLIER -129.18 162.86 26.82 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.29 179.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.4 t -90.76 116.91 28.98 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.328 -0.949 . . . . 0.0 111.04 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 22.0 mp0 -107.39 107.74 18.77 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 119.933 -0.707 . . . . 0.0 110.463 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 60.6 t -54.63 120.15 2.12 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 C-N-CA 118.719 -1.193 . . . . 0.0 108.666 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.457 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -81.14 -62.11 1.76 Allowed 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 -178.639 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.53 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.9 m-80 -141.04 175.32 3.15 Favored Pre-proline 0 N--CA 1.492 1.674 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.505 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.3 Cg_exo -69.03 23.51 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 CA-C-N 119.1 0.714 . . . . 0.0 111.712 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.53 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.1 m-85 -155.26 21.64 0.42 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.704 -0.799 . . . . 0.0 109.987 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.494 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 16.5 t80 -173.68 130.62 0.43 Allowed 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.101 -1.039 . . . . 0.0 111.099 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.457 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.9 m -134.07 116.26 15.26 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.503 -0.879 . . . . 0.0 110.471 178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.494 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.3 tt0 -98.75 154.38 18.03 Favored 'General case' 0 N--CA 1.513 2.69 0 C-N-CA 118.943 -1.103 . . . . 0.0 112.636 -179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.423 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 67.7 m -92.37 120.44 32.89 Favored 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.602 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.482 ' O ' ' NE2' ' A' ' 26' ' ' GLN . 90.5 mt . . . . . 0 N--CA 1.495 1.795 0 CA-C-O 116.348 -1.787 . . . . 0.0 110.197 -179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.705 HE22 ' N ' ' A' ' 7' ' ' GLN . 3.2 tt0 -109.53 -174.04 2.4 Favored 'General case' 0 N--CA 1.494 1.766 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.348 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -123.52 -179.15 4.23 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.817 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.8 t-160 -54.83 150.97 9.1 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 19.6 m-85 52.89 17.03 0.79 Allowed 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.351 -177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -81.35 134.18 12.91 Favored Glycine 0 N--CA 1.488 2.158 0 C-N-CA 119.522 -1.323 . . . . 0.0 112.696 -178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.705 ' N ' HE22 ' A' ' 2' ' ' GLN . 30.6 tt0 -69.99 101.55 1.81 Allowed 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 119.782 -0.767 . . . . 0.0 109.64 178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 1.6 p -88.31 -18.37 28.65 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 118.533 -1.267 . . . . 0.0 111.026 -178.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -155.37 -172.04 22.57 Favored Glycine 0 N--CA 1.487 2.035 0 C-N-CA 118.445 -1.836 . . . . 0.0 112.314 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.96 126.48 4.55 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 -179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.414 HG22 ' N ' ' A' ' 12' ' ' GLY . 96.9 mt -44.51 153.2 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 C-N-CA 118.921 -1.112 . . . . 0.0 109.978 -179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.414 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 83.95 -12.84 52.03 Favored Glycine 0 CA--C 1.544 1.847 0 C-N-CA 119.199 -1.477 . . . . 0.0 110.701 -178.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -90.14 146.94 23.91 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.049 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.2 p -140.27 22.78 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.808 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.39 177.36 24.86 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.943 -1.122 . . . . 0.0 111.004 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -57.84 159.8 16.74 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.485 1.457 . . . . 0.0 110.447 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.3 p -124.56 26.09 7.36 Favored 'General case' 0 N--CA 1.497 1.923 0 C-N-CA 119.587 -0.845 . . . . 0.0 111.16 -178.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.92 114.8 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.081 178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -79.27 133.98 36.65 Favored 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 119.346 -0.942 . . . . 0.0 111.326 -178.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -44.42 159.32 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 C-N-CA 119.611 -0.835 . . . . 0.0 110.323 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.52 155.67 9.23 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 119.289 -0.965 . . . . 0.0 110.923 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 83.28 -15.68 32.96 Favored Glycine 0 N--CA 1.482 1.728 0 C-N-CA 119.659 -1.258 . . . . 0.0 111.522 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -123.42 167.03 14.37 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 119.63 -0.828 . . . . 0.0 111.755 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -132.27 164.97 25.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 114.872 -1.058 . . . . 0.0 109.727 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.4 t -89.98 113.29 24.93 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.92 -1.112 . . . . 0.0 110.27 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -104.13 126.1 50.97 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 119.796 -0.762 . . . . 0.0 110.108 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.1 t -82.73 140.9 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.902 -179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.51 HD23 HD21 ' A' ' 29' ' ' ASN . 10.5 tp -108.14 -60.98 1.65 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.715 -0.794 . . . . 0.0 108.858 179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.532 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -149.15 175.89 2.53 Favored Pre-proline 0 N--CA 1.485 1.324 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -68.8 24.4 0.15 Allowed 'Trans proline' 0 C--O 1.213 -0.751 0 C-N-CA 120.902 1.068 . . . . 0.0 111.67 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.532 ' H ' ' C ' ' A' ' 29' ' ' ASN . 96.2 m-85 -147.39 9.99 0.96 Allowed 'General case' 0 C--N 1.301 -1.534 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.074 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 75.3 t80 -169.96 138.96 1.81 Allowed 'General case' 0 C--N 1.307 -1.262 0 C-N-CA 118.342 -1.343 . . . . 0.0 112.413 -177.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.8 m -150.03 113.24 4.89 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.468 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.1 tt0 -95.98 150.53 20.36 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 119.562 -0.855 . . . . 0.0 113.156 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 19.7 m -89.36 115.96 27.21 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.479 178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 73.9 mt . . . . . 0 N--CA 1.498 1.975 0 CA-C-O 116.262 -1.828 . . . . 0.0 110.501 -179.398 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.489 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 7.0 tp60 -104.62 148.69 26.25 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.432 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.86 -178.66 4.58 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 119.225 -0.99 . . . . 0.0 111.599 -179.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.646 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.8 t-160 -59.73 150.4 27.99 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 82.2 m-85 56.96 9.75 0.67 Allowed 'General case' 0 N--CA 1.504 2.237 0 C-N-CA 120.308 -0.557 . . . . 0.0 110.856 -179.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.33 155.29 24.14 Favored Glycine 0 N--CA 1.488 2.112 0 C-N-CA 119.176 -1.488 . . . . 0.0 112.116 -179.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.489 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 39.9 tt0 -76.63 122.28 24.42 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.78 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.488 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -108.71 -23.48 11.77 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 119.72 -0.792 . . . . 0.0 110.4 178.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.57 -157.56 8.06 Favored Glycine 0 N--CA 1.489 2.17 0 C-N-CA 117.866 -2.111 . . . . 0.0 112.735 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.22 146.63 13.12 Favored Glycine 0 N--CA 1.48 1.586 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 30' ' ' PRO . 65.9 mt -59.51 154.65 3.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 118.248 -1.381 . . . . 0.0 110.131 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.77 -5.92 21.45 Favored Glycine 0 N--CA 1.485 1.958 0 C-N-CA 119.677 -1.249 . . . . 0.0 111.762 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.7 t80 -94.0 112.97 24.87 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 119.39 -0.924 . . . . 0.0 110.735 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.0 p -110.6 55.36 0.65 Allowed 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.283 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.35 -179.64 16.42 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -62.64 154.09 67.59 Favored 'Trans proline' 0 C--N 1.317 -1.13 0 C-N-CA 121.365 1.377 . . . . 0.0 110.409 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 8' ' ' CYS . 16.4 p -127.5 28.1 5.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.802 -0.759 . . . . 0.0 111.207 -178.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.5 t -105.03 109.95 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 C-N-CA 119.626 -0.83 . . . . 0.0 109.803 179.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 35.9 m -78.76 137.59 37.82 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.324 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.42 150.04 1.43 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.174 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.74 154.87 0.63 Allowed 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.314 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.1 -15.71 58.93 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 119.335 -1.412 . . . . 0.0 111.585 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.64 176.24 7.94 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.667 -0.813 . . . . 0.0 111.528 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 163.16 33.65 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.053 -0.976 . . . . 0.0 109.782 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -85.49 116.55 23.87 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.017 -1.073 . . . . 0.0 111.131 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -108.56 140.41 41.95 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.846 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.7 t -83.47 117.67 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.551 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.422 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -81.61 -62.54 1.61 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 106.535 -1.654 . . . . 0.0 106.535 179.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.522 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -144.63 176.07 2.44 Favored Pre-proline 0 N--CA 1.501 2.076 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.301 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.523 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -69.21 23.63 0.16 Allowed 'Trans proline' 0 C--O 1.213 -0.745 0 C-N-CA 120.674 0.916 . . . . 0.0 111.841 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 29' ' ' ASN . 80.0 m-85 -155.39 19.89 0.41 Allowed 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.873 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -173.0 117.83 0.31 Allowed 'General case' 0 C--N 1.306 -1.311 0 C-N-CA 119.312 -0.955 . . . . 0.0 110.452 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.422 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.6 m -119.91 111.83 18.43 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.474 -0.891 . . . . 0.0 109.525 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -90.96 157.93 17.01 Favored 'General case' 0 N--CA 1.506 2.362 0 C-N-CA 119.298 -0.961 . . . . 0.0 112.349 -178.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.427 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 65.5 m -100.77 121.77 42.25 Favored 'General case' 0 N--CA 1.504 2.236 0 C-N-CA 120.04 -0.664 . . . . 0.0 109.887 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 72.8 mt . . . . . 0 N--CA 1.499 2.018 0 CA-C-O 116.385 -1.769 . . . . 0.0 110.12 -179.822 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.521 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 0.5 OUTLIER -81.24 -163.91 0.68 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.483 -0.887 . . . . 0.0 110.425 -179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.47 177.9 7.97 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.55 -0.86 . . . . 0.0 110.874 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.634 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 10.7 t-160 -60.04 133.08 55.76 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' NE2' ' A' ' 4' ' ' HIS . 27.5 m-85 66.77 22.84 10.23 Favored 'General case' 0 N--CA 1.5 2.027 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -178.523 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.32 155.37 19.87 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 120.007 -1.092 . . . . 0.0 111.222 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.429 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 54.0 tt0 -79.81 120.75 24.49 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 119.696 -0.801 . . . . 0.0 110.684 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.587 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -108.97 -27.33 9.73 Favored 'General case' 0 C--O 1.211 -0.934 0 C-N-CA 119.603 -0.839 . . . . 0.0 110.613 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.46 -151.57 5.53 Favored Glycine 0 N--CA 1.487 2.044 0 C-N-CA 118.347 -1.882 . . . . 0.0 112.328 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 96.77 141.85 12.61 Favored Glycine 0 C--N 1.302 -1.315 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.3 mt -59.69 151.62 5.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 118.646 -1.221 . . . . 0.0 109.716 -179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.75 -15.06 44.38 Favored Glycine 0 N--CA 1.48 1.596 0 C-N-CA 119.466 -1.349 . . . . 0.0 110.25 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.521 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 45.2 t80 -82.87 138.64 33.83 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.624 -0.83 . . . . 0.0 110.471 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -131.22 27.17 4.83 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 119.977 -0.689 . . . . 0.0 110.425 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -109.25 -176.79 21.42 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 120.225 -0.988 . . . . 0.0 111.214 -179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -65.91 155.61 68.55 Favored 'Trans proline' 0 C--O 1.211 -0.842 0 C-N-CA 121.699 1.599 . . . . 0.0 110.865 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.587 HG22 ' O ' ' A' ' 8' ' ' CYS . 57.1 p -117.29 7.55 12.92 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.34 -178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 98.8 t -90.19 113.33 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.091 -1.044 . . . . 0.0 109.335 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 25.6 m -82.59 148.41 28.03 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.153 -1.019 . . . . 0.0 110.945 -179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -48.25 139.83 8.14 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 119.421 -0.912 . . . . 0.0 110.014 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -47.21 141.83 4.25 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 118.854 -1.139 . . . . 0.0 109.88 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.77 -27.25 21.29 Favored Glycine 0 N--CA 1.485 1.913 0 C-N-CA 119.663 -1.256 . . . . 0.0 110.607 -179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.41 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -112.87 158.96 19.53 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 120.107 -0.637 . . . . 0.0 110.663 179.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.27 157.99 36.89 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.454 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.7 t -87.77 111.42 21.34 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.132 -179.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -107.33 117.79 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 119.854 -0.739 . . . . 0.0 110.116 179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 12.1 t -53.08 132.38 15.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.237 0 C-N-CA 119.349 -0.941 . . . . 0.0 109.333 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.492 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -94.51 -51.32 4.81 Favored 'General case' 0 C--N 1.306 -1.295 0 C-N-CA 118.341 -1.344 . . . . 0.0 107.797 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.511 ' C ' ' H ' ' A' ' 31' ' ' TYR . 11.0 p30 -161.52 172.98 5.05 Favored Pre-proline 0 CA--C 1.566 1.566 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.402 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 3.3 Cg_exo -66.94 24.93 0.11 Allowed 'Trans proline' 0 C--O 1.214 -0.706 0 CA-C-N 119.366 0.809 . . . . 0.0 112.533 -177.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.511 ' H ' ' C ' ' A' ' 29' ' ' ASN . 90.5 m-85 -154.72 14.1 0.42 Allowed 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 119.473 -0.891 . . . . 0.0 110.176 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -172.47 130.16 0.56 Allowed 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 118.655 -1.218 . . . . 0.0 110.906 -177.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.413 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 19.8 m -130.17 116.23 18.15 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.468 177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.451 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.3 tp-100 -100.09 150.16 22.76 Favored 'General case' 0 N--CA 1.507 2.377 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.452 -177.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.557 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 66.9 m -97.19 116.59 29.66 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.784 177.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.575 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.8 mm? . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 116.306 -1.807 . . . . 0.0 109.982 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -127.34 -170.16 2.17 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.087 -179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.28 177.77 7.58 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.662 -0.815 . . . . 0.0 111.001 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.649 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.9 t-160 -59.94 132.32 53.6 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.649 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 26.5 m-85 67.98 26.38 7.41 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 -178.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.69 153.65 17.88 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 120.128 -1.034 . . . . 0.0 111.079 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -80.13 108.22 13.55 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.985 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -97.53 -21.7 16.95 Favored 'General case' 0 C--N 1.31 -1.14 0 C-N-CA 119.21 -0.996 . . . . 0.0 109.864 178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.44 -155.09 6.61 Favored Glycine 0 N--CA 1.484 1.869 0 C-N-CA 118.544 -1.788 . . . . 0.0 111.831 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.82 144.77 12.58 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 -179.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.49 HD12 ' O ' ' A' ' 30' ' ' PRO . 62.2 mt -60.57 148.51 8.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 C-N-CA 118.6 -1.24 . . . . 0.0 109.995 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.9 -12.23 30.82 Favored Glycine 0 N--CA 1.484 1.86 0 C-N-CA 119.627 -1.273 . . . . 0.0 111.042 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -78.16 120.87 23.58 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.672 -0.811 . . . . 0.0 110.4 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.0 p -114.51 58.18 0.7 Allowed 'General case' 0 N--CA 1.497 1.903 0 C-N-CA 119.939 -0.704 . . . . 0.0 110.367 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.13 170.55 25.91 Favored Glycine 0 N--CA 1.484 1.883 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.777 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -57.25 153.62 38.95 Favored 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 121.339 1.359 . . . . 0.0 110.052 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.1 p -119.56 33.3 5.68 Favored 'General case' 0 C--N 1.294 -1.843 0 C-N-CA 119.674 -0.81 . . . . 0.0 111.609 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.8 t -105.9 107.15 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.116 178.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.517 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.7 m -74.94 143.61 43.62 Favored 'General case' 0 C--N 1.297 -1.703 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.769 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -45.69 148.22 0.78 Allowed 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.297 -0.961 . . . . 0.0 109.683 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.4 m -53.08 160.5 1.01 Allowed 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.716 -1.194 . . . . 0.0 110.121 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.29 -18.45 23.24 Favored Glycine 0 N--CA 1.478 1.489 0 C-N-CA 119.448 -1.358 . . . . 0.0 110.818 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -124.18 163.63 21.16 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.959 -0.696 . . . . 0.0 111.092 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.01 160.73 31.02 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.339 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.4 t -88.13 117.85 27.3 Favored 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.422 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -115.27 116.11 27.78 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.422 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.23 129.01 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 118.925 -1.11 . . . . 0.0 109.372 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.477 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -87.3 -51.36 6.0 Favored 'General case' 0 C--N 1.299 -1.615 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 -179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.554 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -157.37 176.08 2.84 Favored Pre-proline 0 N--CA 1.495 1.785 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 177.2 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.49 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -68.27 24.62 0.14 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 C-N-CA 120.601 0.867 . . . . 0.0 111.459 -179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.554 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.0 m-85 -150.52 10.34 0.65 Allowed 'General case' 0 C--N 1.31 -1.126 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.739 -179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.1 t80 -173.65 127.73 0.41 Allowed 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.594 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.477 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 21.7 m -125.32 115.67 20.71 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.884 178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -100.32 158.4 15.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.95 -178.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.545 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 61.1 m -98.28 123.24 42.27 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.604 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 94.3 mt . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 116.361 -1.781 . . . . 0.0 110.289 -178.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 120.978 0.418 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.416 ' HG3' ' H ' ' A' ' 3' ' ' SER . 5.6 tp60 -104.34 -175.95 2.94 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.416 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -120.73 -172.58 2.41 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 119.654 -0.819 . . . . 0.0 110.647 -179.819 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -70.61 149.94 46.54 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.419 ' O ' ' OE1' ' A' ' 34' ' ' GLN . 67.5 m-85 53.59 18.05 1.34 Allowed 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.681 -178.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -91.99 152.78 21.53 Favored Glycine 0 N--CA 1.485 1.953 0 C-N-CA 119.444 -1.36 . . . . 0.0 111.806 -179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -81.65 119.43 23.81 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.55 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.74 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -107.73 -21.96 12.66 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 120.128 -0.629 . . . . 0.0 110.842 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -169.43 15.83 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.211 -1.947 . . . . 0.0 112.427 -178.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.99 143.28 9.03 Favored Glycine 0 N--CA 1.481 1.648 0 N-CA-C 109.771 -1.331 . . . . 0.0 109.771 -179.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.426 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -54.64 154.41 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 118.587 -1.245 . . . . 0.0 109.998 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.31 -11.7 48.89 Favored Glycine 0 N--CA 1.478 1.467 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -95.56 129.56 42.7 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 115.006 -0.597 . . . . 0.0 110.304 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 89.5 p -137.92 57.94 1.7 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 119.747 -0.781 . . . . 0.0 109.662 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.32 -177.28 15.4 Favored Glycine 0 N--CA 1.481 1.695 0 N-CA-C 110.24 -1.144 . . . . 0.0 110.24 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.43 157.6 14.46 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 C-N-CA 120.797 0.998 . . . . 0.0 109.664 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.74 HG22 ' O ' ' A' ' 8' ' ' CYS . 43.4 p -131.83 26.47 4.65 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.403 -0.919 . . . . 0.0 111.487 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.3 t -104.97 115.18 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 C-N-CA 119.749 -0.781 . . . . 0.0 109.484 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.2 m -73.71 161.26 30.44 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.292 -0.963 . . . . 0.0 110.788 -179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.9 171.18 0.98 Allowed 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 119.679 -0.809 . . . . 0.0 110.294 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 63.9 m -63.77 141.57 58.72 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.429 -0.908 . . . . 0.0 110.994 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.11 -5.72 84.64 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 119.67 -1.252 . . . . 0.0 111.584 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -124.05 165.09 18.09 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.994 -0.682 . . . . 0.0 111.15 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.416 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.3 OUTLIER -140.37 162.1 36.12 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.014 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.6 t -90.27 113.32 25.14 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.502 -178.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.513 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.1 mp0 -105.46 125.61 51.18 Favored 'General case' 0 N--CA 1.499 2.024 0 C-N-CA 119.941 -0.703 . . . . 0.0 109.952 178.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.8 t -74.31 126.21 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.553 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.7 tp -89.13 -58.17 2.63 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 118.748 -1.181 . . . . 0.0 109.706 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.0 p30 -155.61 178.59 1.6 Allowed Pre-proline 0 C--N 1.302 -1.472 0 CA-C-N 114.697 -1.138 . . . . 0.0 108.804 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.426 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.4 Cg_exo -67.6 23.4 0.12 Allowed 'Trans proline' 0 C--O 1.213 -0.744 0 C-N-CA 120.989 1.126 . . . . 0.0 113.116 -177.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.468 ' H ' ' C ' ' A' ' 29' ' ' ASN . 81.6 m-85 -154.62 16.3 0.45 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.022 -1.071 . . . . 0.0 111.072 178.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -174.69 133.72 0.36 Allowed 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 118.541 -1.264 . . . . 0.0 111.767 -178.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.8 m -136.06 113.17 10.47 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.385 177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.419 ' OE1' ' O ' ' A' ' 5' ' ' TYR . 5.0 tp60 -89.56 153.71 20.56 Favored 'General case' 0 N--CA 1.508 2.461 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.271 -177.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.585 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 20.4 m -106.69 114.14 28.07 Favored 'General case' 0 N--CA 1.503 2.214 0 C-N-CA 120.142 -0.623 . . . . 0.0 110.168 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mm? . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 116.449 -1.739 . . . . 0.0 109.821 -179.818 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -89.19 144.25 26.25 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.795 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -96.02 -170.58 2.14 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.407 -0.917 . . . . 0.0 110.171 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.62 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.4 t-160 -61.16 135.03 57.63 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 118.877 -1.129 . . . . 0.0 108.466 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.62 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 68.8 m-85 70.17 24.01 5.04 Favored 'General case' 0 N--CA 1.508 2.44 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.22 153.85 23.86 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 119.572 -1.299 . . . . 0.0 110.741 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.421 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 60.8 tt0 -90.19 111.13 22.18 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.691 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.9 p -97.95 -21.14 17.01 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.603 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.65 -156.32 7.38 Favored Glycine 0 N--CA 1.493 2.494 0 C-N-CA 117.938 -2.077 . . . . 0.0 112.526 -179.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.1 131.1 6.86 Favored Glycine 0 N--CA 1.481 1.653 0 C-N-CA 119.795 -1.193 . . . . 0.0 110.517 -179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.431 HG21 HD13 ' A' ' 11' ' ' ILE . 39.6 mt -46.58 145.95 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.074 -1.051 . . . . 0.0 109.51 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 82.79 9.66 84.23 Favored Glycine 0 C--N 1.292 -1.889 0 C-N-CA 119.582 -1.295 . . . . 0.0 111.202 -178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.421 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 80.6 t80 -110.8 126.28 54.45 Favored 'General case' 0 N--CA 1.501 2.109 0 C-N-CA 119.963 -0.695 . . . . 0.0 110.378 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.6 p -120.5 11.02 11.28 Favored 'General case' 0 N--CA 1.497 1.912 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.588 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.43 -176.41 50.47 Favored Glycine 0 N--CA 1.484 1.884 0 C-N-CA 119.322 -1.418 . . . . 0.0 110.539 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -69.54 161.16 46.99 Favored 'Trans proline' 0 C--N 1.318 -1.034 0 C-N-CA 121.575 1.517 . . . . 0.0 110.673 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 20.8 p -120.54 38.02 4.12 Favored 'General case' 0 N--CA 1.495 1.781 0 C-N-CA 119.707 -0.797 . . . . 0.0 111.06 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.6 t -120.1 110.98 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 178.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 m -75.17 157.69 34.2 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.936 -1.106 . . . . 0.0 110.097 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.428 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -72.59 149.96 43.51 Favored 'General case' 0 C--N 1.304 -1.402 0 C-N-CA 119.345 -0.942 . . . . 0.0 109.842 179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.6 m -44.49 142.8 1.49 Allowed 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.712 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.51 -24.45 32.15 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.52 -1.324 . . . . 0.0 111.348 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -116.16 176.68 4.99 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.139 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.19 152.61 39.5 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 114.977 -1.01 . . . . 0.0 109.626 179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 30.1 t -80.37 127.99 33.03 Favored 'General case' 0 C--N 1.294 -1.84 0 C-N-CA 119.03 -1.068 . . . . 0.0 110.606 -178.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -136.97 126.84 25.73 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.643 -0.823 . . . . 0.0 110.795 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 27.9 t -60.63 134.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.727 -0.789 . . . . 0.0 110.217 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.49 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -98.23 -47.67 5.37 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.725 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.536 ' C ' ' H ' ' A' ' 31' ' ' TYR . 4.9 p30 -162.64 171.81 6.06 Favored Pre-proline 0 N--CA 1.492 1.639 0 CA-C-N 113.949 -1.478 . . . . 0.0 107.308 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.507 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 2.8 Cg_exo -67.75 24.56 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 CA-C-N 119.624 0.902 . . . . 0.0 112.26 -177.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.536 ' H ' ' C ' ' A' ' 29' ' ' ASN . 57.5 m-85 -153.39 16.13 0.53 Allowed 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.646 -0.822 . . . . 0.0 110.28 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 34.7 t80 -174.8 125.47 0.28 Allowed 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.123 -1.031 . . . . 0.0 110.837 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.7 m -127.06 113.23 16.16 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.62 -0.832 . . . . 0.0 109.123 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.404 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 5.3 tp60 -93.09 149.77 20.99 Favored 'General case' 0 N--CA 1.506 2.351 0 CA-C-N 114.664 -1.153 . . . . 0.0 112.192 -177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.553 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 32.1 m -102.95 110.04 21.81 Favored 'General case' 0 N--CA 1.495 1.788 0 C-N-CA 119.919 -0.712 . . . . 0.0 109.646 178.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.505 2.322 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.165 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.487 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 2.4 tp-100 -131.07 165.98 22.06 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.594 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.02 -168.11 1.47 Allowed 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 119.822 -0.751 . . . . 0.0 111.186 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.645 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.2 t-160 -73.99 132.28 42.24 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.145 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.645 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 60.5 m-85 70.43 20.12 6.11 Favored 'General case' 0 N--CA 1.511 2.591 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.447 -178.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -100.88 154.9 19.26 Favored Glycine 0 N--CA 1.488 2.154 0 C-N-CA 119.978 -1.106 . . . . 0.0 110.491 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -75.99 119.34 19.82 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 118.87 -1.132 . . . . 0.0 110.885 -179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.657 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -103.2 -29.7 11.13 Favored 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.554 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.407 ' H ' ' HB2' ' A' ' 33' ' ' SER . . . -148.71 -163.5 10.91 Favored Glycine 0 N--CA 1.483 1.805 0 C-N-CA 119.002 -1.57 . . . . 0.0 111.611 -179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.49 142.71 10.54 Favored Glycine 0 N--CA 1.481 1.666 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.662 HD12 ' O ' ' A' ' 30' ' ' PRO . 87.8 mt -50.17 156.2 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 C-N-CA 118.957 -1.097 . . . . 0.0 110.618 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 78.55 -15.69 9.16 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 119.674 -1.251 . . . . 0.0 110.542 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.487 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 46.2 t80 -89.41 131.36 35.51 Favored 'General case' 0 N--CA 1.492 1.636 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.334 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 61.3 p -126.26 18.25 7.66 Favored 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.03 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.93 -178.35 33.39 Favored Glycine 0 N--CA 1.483 1.779 0 C-N-CA 120.014 -1.088 . . . . 0.0 110.768 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -69.04 153.09 72.83 Favored 'Trans proline' 0 C--N 1.318 -1.077 0 C-N-CA 121.591 1.527 . . . . 0.0 110.244 179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.9 p -117.5 27.37 9.11 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.599 -0.84 . . . . 0.0 111.467 -178.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.4 t -102.36 122.23 54.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.931 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.4 m -84.98 163.72 18.73 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.843 -178.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.427 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -68.28 154.59 41.45 Favored 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 115.219 -0.9 . . . . 0.0 109.67 179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.0 m -45.1 141.35 2.36 Favored 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 119.187 -1.005 . . . . 0.0 111.035 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.82 -8.72 76.34 Favored Glycine 0 N--CA 1.487 2.067 0 C-N-CA 119.527 -1.32 . . . . 0.0 112.254 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -133.58 169.75 16.54 Favored 'General case' 0 N--CA 1.499 1.999 0 C-N-CA 119.335 -0.946 . . . . 0.0 111.907 -179.754 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.524 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.5 OUTLIER -145.16 171.81 14.0 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-N 114.585 -1.189 . . . . 0.0 109.491 179.65 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.5 t -92.23 144.94 24.9 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 118.837 -1.145 . . . . 0.0 112.263 -178.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.524 HE22 ' C ' ' A' ' 24' ' ' THR . 28.9 mp0 -139.86 116.55 10.83 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.3 179.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -68.73 103.08 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 C-N-CA 119.354 -0.938 . . . . 0.0 109.764 179.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.7 tp -62.22 -52.03 65.39 Favored 'General case' 0 C--N 1.306 -1.288 0 C-N-CA 118.556 -1.257 . . . . 0.0 107.827 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.92 174.52 3.72 Favored Pre-proline 0 C--N 1.295 -1.775 0 CA-C-N 113.672 -1.604 . . . . 0.0 107.179 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.662 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.9 Cg_exo -66.97 24.65 0.11 Allowed 'Trans proline' 0 C--O 1.211 -0.839 0 C-N-CA 120.628 0.885 . . . . 0.0 112.84 -176.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.6 m-85 -149.51 12.53 0.81 Allowed 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 118.979 -1.089 . . . . 0.0 110.28 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 33.8 t80 -170.59 134.67 1.1 Allowed 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.882 -1.127 . . . . 0.0 111.496 -179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 9' ' ' GLY . 14.8 m -135.98 110.53 8.58 Favored 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.435 -0.906 . . . . 0.0 109.584 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.619 ' OE1' HD21 ' A' ' 36' ' ' LEU . 46.3 tt0 -87.48 154.42 20.65 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.394 -1.275 . . . . 0.0 112.598 -178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.5 m -92.85 109.98 21.43 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.012 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.619 HD21 ' OE1' ' A' ' 34' ' ' GLN . 15.3 mt . . . . . 0 N--CA 1.499 2.025 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.027 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' OE1' ' N ' ' A' ' 2' ' ' GLN . 11.7 pm0 -101.66 -164.52 1.11 Allowed 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.402 -0.919 . . . . 0.0 109.538 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.504 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -118.93 -174.78 2.77 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 119.832 -0.747 . . . . 0.0 111.845 -178.32 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.593 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.1 t-160 -57.38 140.66 49.65 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.593 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 52.4 m-85 65.64 18.18 11.13 Favored 'General case' 0 N--CA 1.503 2.202 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -177.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.01 157.03 34.9 Favored Glycine 0 N--CA 1.483 1.794 0 C-N-CA 120.288 -0.958 . . . . 0.0 111.731 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -88.82 116.34 27.02 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.019 -0.672 . . . . 0.0 110.762 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB3' HE21 ' A' ' 2' ' ' GLN . 1.1 p -105.06 -21.69 13.23 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 119.637 -0.825 . . . . 0.0 110.747 179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.411 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -149.83 -166.06 13.02 Favored Glycine 0 N--CA 1.498 2.803 0 C-N-CA 118.329 -1.891 . . . . 0.0 113.163 -178.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.28 144.81 13.62 Favored Glycine 0 N--CA 1.485 1.957 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 35.1 mt -61.63 156.49 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.333 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.62 -2.12 55.08 Favored Glycine 0 C--N 1.297 -1.585 0 C-N-CA 119.103 -1.522 . . . . 0.0 110.485 -179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -86.26 132.46 33.99 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 119.091 -1.043 . . . . 0.0 109.976 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.2 p -129.91 36.38 4.05 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.235 -179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -121.34 -174.22 14.79 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 120.212 -0.994 . . . . 0.0 110.771 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -66.93 153.96 76.18 Favored 'Trans proline' 0 C--N 1.318 -1.06 0 C-N-CA 121.754 1.636 . . . . 0.0 111.211 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 7.7 p -104.34 -6.08 21.15 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.745 -178.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 50.7 t -87.35 122.36 39.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.609 179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.416 ' O ' ' C ' ' A' ' 20' ' ' ALA . 92.2 m -84.13 148.46 26.78 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.618 -179.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' HB2' ' HA ' ' A' ' 3' ' ' SER . . . -39.96 140.14 0.59 Allowed 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.621 -0.832 . . . . 0.0 110.583 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.6 m -49.9 140.0 12.69 Favored 'General case' 0 C--N 1.299 -1.594 0 C-N-CA 119.263 -0.975 . . . . 0.0 110.827 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.88 -28.93 13.71 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 119.737 -1.22 . . . . 0.0 111.5 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.443 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -102.69 -170.73 1.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.888 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.43 173.15 12.54 Favored 'General case' 0 N--CA 1.492 1.641 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.333 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.4 t -100.12 116.58 32.48 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.141 -1.024 . . . . 0.0 110.833 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.919 HE22 ' H ' ' A' ' 36' ' ' LEU . 3.6 mp0 -107.41 110.07 21.95 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.611 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 56.6 t -53.77 125.65 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.126 -1.03 . . . . 0.0 109.179 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.493 HD12 HD22 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -95.09 -56.93 2.57 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 118.809 -1.156 . . . . 0.0 108.27 -178.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.2 p30 -162.71 172.81 4.98 Favored Pre-proline 0 CA--C 1.567 1.622 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.461 ' O ' ' CG ' ' A' ' 31' ' ' TYR . 2.9 Cg_exo -66.07 25.37 0.1 OUTLIER 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 120.84 1.027 . . . . 0.0 113.124 -176.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.505 ' H ' ' C ' ' A' ' 29' ' ' ASN . 91.4 m-85 -153.72 13.53 0.47 Allowed 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.104 -1.039 . . . . 0.0 110.16 178.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.422 ' HB3' HD21 ' A' ' 29' ' ' ASN . 11.1 t80 -175.31 137.57 0.39 Allowed 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 119.113 -1.035 . . . . 0.0 110.793 -179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.411 ' HB2' ' N ' ' A' ' 9' ' ' GLY . 13.7 m -136.41 114.4 11.37 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.445 ' CG ' ' N ' ' A' ' 35' ' ' CYS . 40.6 tt0 -86.42 165.64 16.17 Favored 'General case' 0 N--CA 1.503 2.201 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.794 -176.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' N ' ' CG ' ' A' ' 34' ' ' GLN . 64.2 m -113.24 128.38 56.46 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.679 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.919 ' H ' HE22 ' A' ' 26' ' ' GLN . 93.8 mt . . . . . 0 N--CA 1.501 2.096 0 CA-C-O 116.438 -1.744 . . . . 0.0 110.48 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.458 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 0.8 OUTLIER -83.95 167.32 17.06 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.258 179.81 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 -162.34 0.8 Allowed 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.074 -0.651 . . . . 0.0 110.444 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 19.6 t-160 -72.94 134.74 44.87 Favored 'General case' 0 C--N 1.301 -1.506 0 C-N-CA 119.569 -0.852 . . . . 0.0 109.051 -179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 36.3 m-85 69.04 16.84 8.65 Favored 'General case' 0 N--CA 1.507 2.407 0 N-CA-C 109.422 -0.585 . . . . 0.0 109.422 -178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.29 155.73 30.04 Favored Glycine 0 N--CA 1.485 1.965 0 C-N-CA 119.824 -1.179 . . . . 0.0 111.417 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -86.93 110.04 19.75 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 119.516 -0.873 . . . . 0.0 111.204 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.596 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.0 -17.98 23.24 Favored 'General case' 0 C--N 1.308 -1.197 0 C-N-CA 119.25 -0.98 . . . . 0.0 109.939 178.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.62 -165.69 12.35 Favored Glycine 0 N--CA 1.481 1.636 0 C-N-CA 118.529 -1.796 . . . . 0.0 111.504 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.27 130.53 5.25 Favored Glycine 0 C--N 1.301 -1.415 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 30' ' ' PRO . 47.9 mt -51.9 144.14 3.12 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.032 0 C-N-CA 118.799 -1.161 . . . . 0.0 110.757 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.58 -6.43 65.14 Favored Glycine 0 CA--C 1.548 2.095 0 C-N-CA 119.869 -1.158 . . . . 0.0 111.876 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 71.2 t80 -83.93 113.19 20.8 Favored 'General case' 0 N--CA 1.499 1.992 0 C-N-CA 119.229 -0.988 . . . . 0.0 110.606 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 77.5 p -106.75 55.41 0.66 Allowed 'General case' 0 N--CA 1.498 1.941 0 C-N-CA 119.815 -0.754 . . . . 0.0 110.711 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -136.13 172.98 22.13 Favored Glycine 0 N--CA 1.483 1.791 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -56.62 145.31 82.09 Favored 'Trans proline' 0 C--N 1.313 -1.295 0 C-N-CA 121.136 1.224 . . . . 0.0 110.832 179.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.596 HG22 ' O ' ' A' ' 8' ' ' CYS . 23.3 p -107.18 30.49 6.16 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 114.828 -1.078 . . . . 0.0 110.03 -178.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.0 t -116.06 119.7 62.69 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.661 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 29.1 m -79.63 164.64 23.64 Favored 'General case' 0 N--CA 1.493 1.702 0 C-N-CA 119.148 -1.021 . . . . 0.0 110.64 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -65.68 168.08 8.2 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 119.581 -0.847 . . . . 0.0 109.979 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.02 147.94 52.56 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 118.72 -1.192 . . . . 0.0 109.777 179.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.24 -21.05 26.61 Favored Glycine 0 C--N 1.297 -1.634 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.875 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -107.99 178.73 4.43 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.833 -0.747 . . . . 0.0 110.504 179.99 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -151.83 162.45 41.03 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.12 -0.945 . . . . 0.0 109.254 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 21.4 t -93.89 127.35 39.61 Favored 'General case' 0 C--N 1.302 -1.483 0 C-N-CA 118.916 -1.114 . . . . 0.0 112.093 -178.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 26.9 mp0 -127.27 112.63 15.3 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.146 178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.0 t -57.67 130.63 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 C-N-CA 119.486 -0.885 . . . . 0.0 109.623 -179.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.47 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -92.91 -54.98 3.52 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 -178.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -154.53 175.34 3.14 Favored Pre-proline 0 N--CA 1.493 1.713 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 178.212 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.503 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.7 Cg_exo -70.24 24.09 0.19 Allowed 'Trans proline' 0 C--O 1.214 -0.695 0 C-N-CA 120.439 0.759 . . . . 0.0 111.085 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.7 m-85 -149.55 10.82 0.76 Allowed 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.629 -0.828 . . . . 0.0 110.131 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.505 ' OH ' ' NE2' ' A' ' 34' ' ' GLN . 22.4 t80 -174.74 128.81 0.32 Allowed 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 119.171 -1.012 . . . . 0.0 110.806 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.47 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 70.4 m -131.68 113.56 13.73 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 177.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.505 ' NE2' ' OH ' ' A' ' 32' ' ' TYR . 1.2 tt0 -89.61 151.01 22.13 Favored 'General case' 0 N--CA 1.503 2.18 0 O-C-N 124.67 1.231 . . . . 0.0 112.693 -176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.52 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 23.8 m -105.72 111.34 23.97 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.555 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.584 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.0 mm? . . . . . 0 N--CA 1.503 2.216 0 CA-C-O 116.386 -1.769 . . . . 0.0 109.95 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 3' ' ' SER . 10.4 tp60 -78.97 -168.43 1.45 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.955 179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.409 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -132.3 163.92 27.59 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.754 -179.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 23.2 t-160 -53.33 141.71 23.45 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 47.3 m-85 58.34 22.88 9.87 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.488 -0.885 . . . . 0.0 109.729 -178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.31 153.48 19.69 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -81.7 115.58 21.01 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.043 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.797 ' O ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -94.67 -31.05 13.99 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 119.469 -0.893 . . . . 0.0 110.882 179.3 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.36 -174.32 22.8 Favored Glycine 0 N--CA 1.485 1.921 0 C-N-CA 118.47 -1.824 . . . . 0.0 112.377 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 117.81 129.08 4.08 Favored Glycine 0 N--CA 1.48 1.631 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.186 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.469 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.7 mt -40.55 154.19 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 C-N-CA 119.361 -0.936 . . . . 0.0 110.457 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.58 -11.7 31.29 Favored Glycine 0 CA--C 1.541 1.664 0 C-N-CA 119.375 -1.393 . . . . 0.0 110.661 -178.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -87.45 141.78 28.37 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.318 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 14' ' ' SER . 54.2 p -138.62 56.29 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.65 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.0 177.32 23.53 Favored Glycine 0 N--CA 1.479 1.502 0 C-N-CA 119.826 -1.178 . . . . 0.0 110.706 -179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -61.72 157.38 42.79 Favored 'Trans proline' 0 C--N 1.316 -1.177 0 C-N-CA 121.125 1.216 . . . . 0.0 109.747 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.797 HG22 ' O ' ' A' ' 8' ' ' CYS . 79.1 p -118.99 2.79 11.52 Favored 'General case' 0 N--CA 1.495 1.825 0 C-N-CA 119.722 -0.791 . . . . 0.0 111.015 -178.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.09 108.59 10.43 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.022 -1.071 . . . . 0.0 109.596 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 66.5 m -68.9 156.93 37.62 Favored 'General case' 0 N--CA 1.496 1.825 0 C-N-CA 119.581 -0.847 . . . . 0.0 110.871 -179.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -61.83 170.19 2.17 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.489 -0.884 . . . . 0.0 110.188 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -66.35 155.43 37.37 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.821 179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.44 -4.03 37.11 Favored Glycine 0 N--CA 1.48 1.571 0 C-N-CA 119.257 -1.449 . . . . 0.0 111.296 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.11 169.33 12.9 Favored 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 119.628 -0.829 . . . . 0.0 111.42 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.47 154.71 42.53 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 114.953 -1.021 . . . . 0.0 109.459 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -80.18 141.76 35.37 Favored 'General case' 0 N--CA 1.5 2.053 0 C-N-CA 119.341 -0.944 . . . . 0.0 110.544 -178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -137.17 107.5 6.44 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 119.974 -0.69 . . . . 0.0 109.875 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.425 ' H ' HG23 ' A' ' 27' ' ' VAL . 3.3 t -60.59 115.24 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.432 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 29' ' ' ASN . 4.3 tp -79.78 -52.3 8.09 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 107.402 -1.333 . . . . 0.0 107.402 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.602 HD21 HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -153.43 176.12 2.62 Favored Pre-proline 0 N--CA 1.496 1.847 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 178.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.469 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.5 Cg_exo -69.0 24.25 0.15 Allowed 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 120.771 0.981 . . . . 0.0 112.007 -178.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.513 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.7 m-85 -149.65 14.75 0.85 Allowed 'General case' 0 C--N 1.298 -1.637 0 C-N-CA 119.339 -0.944 . . . . 0.0 110.08 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 53.5 t80 -173.13 130.76 0.48 Allowed 'General case' 0 C--N 1.301 -1.513 0 C-N-CA 118.399 -1.32 . . . . 0.0 111.748 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.4 m -136.89 111.62 8.76 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 177.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -96.53 147.79 23.49 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.718 -1.128 . . . . 0.0 111.847 -177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 70.8 m -101.63 111.53 23.81 Favored 'General case' 0 N--CA 1.498 1.967 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.413 178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.451 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.2 mm? . . . . . 0 N--CA 1.501 2.094 0 CA-C-O 116.381 -1.771 . . . . 0.0 109.772 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -107.17 169.22 8.69 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.559 179.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.46 172.53 6.76 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.671 -0.812 . . . . 0.0 110.431 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 15.7 t-160 -55.75 128.04 32.94 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.268 -0.973 . . . . 0.0 108.548 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.7 m-85 75.93 23.89 1.28 Allowed 'General case' 0 N--CA 1.509 2.491 0 CA-C-N 115.945 -0.571 . . . . 0.0 109.975 -178.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.02 140.32 14.81 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.903 -1.142 . . . . 0.0 111.042 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -66.3 114.89 5.7 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 119.231 -0.988 . . . . 0.0 110.667 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.879 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -101.57 -24.69 14.09 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.863 -0.735 . . . . 0.0 110.614 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.19 -170.22 16.58 Favored Glycine 0 N--CA 1.482 1.744 0 C-N-CA 118.907 -1.616 . . . . 0.0 111.592 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 112.58 130.66 5.43 Favored Glycine 0 N--CA 1.48 1.602 0 N-CA-C 110.277 -1.129 . . . . 0.0 110.277 -179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.521 HD12 ' O ' ' A' ' 30' ' ' PRO . 60.7 mt -44.87 154.11 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.333 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.77 -16.16 21.85 Favored Glycine 0 N--CA 1.481 1.666 0 C-N-CA 119.479 -1.343 . . . . 0.0 110.634 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -91.19 131.17 36.9 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.688 -0.805 . . . . 0.0 110.397 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 23.9 p -127.02 51.49 1.87 Allowed 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 119.922 -0.711 . . . . 0.0 110.089 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -133.56 174.15 20.85 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.95 156.62 23.15 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 C-N-CA 121.217 1.278 . . . . 0.0 110.415 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.879 HG22 ' O ' ' A' ' 8' ' ' CYS . 62.4 p -121.66 15.26 11.05 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.858 -0.737 . . . . 0.0 110.845 -178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.5 t -80.44 119.27 29.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 119.102 -1.039 . . . . 0.0 109.4 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' C ' ' A' ' 24' ' ' THR . 8.0 m -83.17 141.57 31.84 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.894 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -48.9 149.02 1.97 Allowed 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.965 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.5 m -51.69 143.18 13.2 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.474 -0.891 . . . . 0.0 110.522 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.57 -20.09 46.65 Favored Glycine 0 N--CA 1.482 1.748 0 C-N-CA 119.438 -1.363 . . . . 0.0 111.004 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.15 167.14 12.99 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.982 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.453 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -135.77 166.76 22.52 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.594 179.46 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -85.43 124.91 32.56 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 118.775 -1.17 . . . . 0.0 110.729 -179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -115.4 109.96 18.65 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.213 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.9 t -68.8 110.43 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 C-N-CA 119.253 -0.979 . . . . 0.0 109.817 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 29' ' ' ASN . 6.1 tp -72.12 -59.37 2.77 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 118.59 -1.244 . . . . 0.0 108.009 -179.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.615 HD21 HD23 ' A' ' 28' ' ' LEU . 0.5 OUTLIER -141.79 175.6 2.9 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -68.87 24.38 0.15 Allowed 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 120.59 0.86 . . . . 0.0 111.415 -179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.559 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.5 m-85 -148.4 11.82 0.91 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.604 -0.838 . . . . 0.0 110.132 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 50.3 t80 -169.83 136.26 1.54 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 118.589 -1.244 . . . . 0.0 112.078 -178.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.3 m -143.26 113.34 7.2 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.154 177.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 1.5 tt0 -98.4 149.0 23.12 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 119.742 -0.783 . . . . 0.0 111.879 -178.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.1 m -84.58 115.56 22.69 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 115.558 -0.747 . . . . 0.0 109.919 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 95.6 mt . . . . . 0 N--CA 1.499 2.005 0 CA-C-O 116.321 -1.8 . . . . 0.0 110.269 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 20' ' ' ALA . 8.9 tp60 -126.35 160.64 29.86 Favored 'General case' 0 N--CA 1.496 1.832 0 C-N-CA 119.988 -0.685 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.73 170.28 8.27 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.576 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.65 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.8 t-160 -52.25 150.15 4.86 Favored 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 119.581 -0.848 . . . . 0.0 109.362 -179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.65 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 56.6 m-85 56.99 11.94 1.09 Allowed 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.71 -178.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.55 156.37 25.7 Favored Glycine 0 N--CA 1.494 2.502 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.469 -178.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -76.49 109.78 10.49 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 120.429 -0.508 . . . . 0.0 111.65 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -97.04 -22.89 16.54 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 119.085 -1.046 . . . . 0.0 109.248 177.779 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.0 -179.91 25.28 Favored Glycine 0 N--CA 1.48 1.631 0 C-N-CA 118.932 -1.604 . . . . 0.0 111.411 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 132.08 127.74 2.86 Favored Glycine 0 N--CA 1.48 1.575 0 C-N-CA 119.974 -1.107 . . . . 0.0 110.355 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 11' ' ' ILE . 30.4 mt -48.9 148.39 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 C-N-CA 119.328 -0.949 . . . . 0.0 110.486 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.99 -1.54 54.75 Favored Glycine 0 N--CA 1.487 2.054 0 C-N-CA 120.103 -1.046 . . . . 0.0 111.998 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.7 t80 -79.64 147.45 32.03 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.46 -0.896 . . . . 0.0 110.308 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.7 p -137.24 44.13 2.3 Favored 'General case' 0 N--CA 1.501 2.125 0 C-N-CA 119.535 -0.866 . . . . 0.0 111.047 -179.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -132.77 175.24 20.11 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.601 -1.399 . . . . 0.0 109.601 178.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.18 160.7 25.5 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 121.176 1.251 . . . . 0.0 110.573 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 61.7 p -121.12 21.91 11.1 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.896 -0.722 . . . . 0.0 111.699 -178.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 t -104.43 113.51 41.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.885 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.7 m -70.66 150.05 46.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.316 -0.954 . . . . 0.0 110.339 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -54.05 141.38 28.61 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 119.396 -0.922 . . . . 0.0 110.105 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.403 ' C ' ' O ' ' A' ' 20' ' ' ALA . 4.5 m -42.33 139.81 1.35 Allowed 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.288 -0.965 . . . . 0.0 110.377 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.89 -25.13 29.01 Favored Glycine 0 N--CA 1.482 1.723 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.887 -179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.09 167.24 11.65 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.374 -179.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.507 ' CB ' HE22 ' A' ' 26' ' ' GLN . 0.7 OUTLIER -131.04 -177.59 4.45 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.118 -0.946 . . . . 0.0 109.542 179.181 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.6 t -102.14 125.85 48.95 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.973 -1.091 . . . . 0.0 112.022 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 24' ' ' THR . 24.4 mp0 -124.68 121.89 35.96 Favored 'General case' 0 N--CA 1.502 2.134 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.492 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -60.22 146.67 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 119.719 -0.792 . . . . 0.0 111.16 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.66 -56.38 2.36 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.509 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -153.68 177.47 1.96 Allowed Pre-proline 0 N--CA 1.508 2.455 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 177.167 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.467 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.8 Cg_exo -68.43 23.5 0.14 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.88 1.053 . . . . 0.0 112.066 -178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.509 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.5 m-85 -153.73 14.08 0.48 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.406 -0.917 . . . . 0.0 110.101 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 13.6 t80 -172.53 127.25 0.52 Allowed 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.875 -1.13 . . . . 0.0 110.812 -179.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.1 m -127.17 114.16 17.32 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.8 tt0 -85.04 159.85 20.13 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.88 -1.055 . . . . 0.0 112.699 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.6 m -100.58 125.85 47.0 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.188 -0.915 . . . . 0.0 108.86 178.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 79.1 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 116.59 -1.671 . . . . 0.0 110.157 -178.978 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.201 0.524 . . . . 0.0 110.085 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -97.91 152.48 19.17 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.109 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.27 -166.69 1.53 Allowed 'General case' 0 N--CA 1.496 1.86 0 C-N-CA 119.092 -1.043 . . . . 0.0 111.612 -178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.651 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.2 t-160 -73.5 139.47 45.73 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.217 -178.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.651 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 84.4 m-85 66.51 20.81 10.85 Favored 'General case' 0 N--CA 1.513 2.703 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.562 -179.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.65 155.46 20.5 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.589 -1.291 . . . . 0.0 112.126 -179.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -77.42 102.66 6.94 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.615 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.569 ' O ' HG22 ' A' ' 17' ' ' THR . 1.6 p -94.09 -10.12 34.39 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 119.122 -1.031 . . . . 0.0 110.599 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -163.26 179.23 38.55 Favored Glycine 0 C--N 1.294 -1.773 0 C-N-CA 117.867 -2.111 . . . . 0.0 111.947 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 129.06 153.72 8.04 Favored Glycine 0 N--CA 1.478 1.437 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.685 HD12 ' O ' ' A' ' 30' ' ' PRO . 52.7 mt -67.39 151.95 10.0 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.936 0 C-N-CA 118.803 -1.159 . . . . 0.0 110.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.04 -5.18 20.02 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.775 -1.202 . . . . 0.0 111.516 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -92.6 126.27 37.61 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.464 -0.894 . . . . 0.0 110.605 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.4 p -120.27 36.22 4.62 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 120.016 -0.674 . . . . 0.0 111.193 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -108.34 -178.18 21.93 Favored Glycine 0 N--CA 1.496 2.648 0 C-N-CA 120.186 -1.007 . . . . 0.0 110.739 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -59.36 162.15 15.26 Favored 'Trans proline' 0 C--O 1.207 -1.049 0 C-N-CA 121.375 1.384 . . . . 0.0 109.69 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 8' ' ' CYS . 35.7 p -132.38 5.67 4.09 Favored 'General case' 0 N--CA 1.5 2.037 0 C-N-CA 118.81 -1.156 . . . . 0.0 113.044 -177.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 16.2 t -94.24 124.48 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 C-N-CA 118.676 -1.21 . . . . 0.0 109.764 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.431 ' SG ' ' C ' ' A' ' 24' ' ' THR . 61.8 m -77.53 156.28 31.05 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.382 -0.927 . . . . 0.0 111.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.8 165.37 6.7 Favored 'General case' 0 C--N 1.304 -1.391 0 C-N-CA 119.309 -0.956 . . . . 0.0 109.562 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -56.17 150.22 14.57 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.925 -179.669 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.58 -22.57 2.67 Favored Glycine 0 N--CA 1.48 1.624 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.986 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.439 ' H ' ' C ' ' A' ' 21' ' ' SER . 0.2 OUTLIER -105.64 158.48 16.67 Favored 'General case' 0 N--CA 1.494 1.772 0 C-N-CA 119.496 -0.881 . . . . 0.0 110.956 -179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.431 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.7 OUTLIER -131.58 174.22 10.32 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.535 179.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.2 t -100.41 127.07 46.83 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.392 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.904 HE22 ' H ' ' A' ' 36' ' ' LEU . 4.1 mp0 -122.81 123.75 41.74 Favored 'General case' 0 N--CA 1.496 1.837 0 C-N-CA 119.964 -0.694 . . . . 0.0 110.252 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -70.41 108.49 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 C-N-CA 119.627 -0.829 . . . . 0.0 110.629 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 4.9 tp -69.06 -46.74 67.07 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 118.284 -1.366 . . . . 0.0 107.508 179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -163.56 173.75 3.95 Favored Pre-proline 0 CA--C 1.568 1.667 0 CA-C-N 114.051 -1.431 . . . . 0.0 108.457 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.685 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.2 Cg_exo -66.88 24.64 0.11 Allowed 'Trans proline' 0 N--CA 1.482 0.817 0 C-N-CA 121.238 1.292 . . . . 0.0 113.199 -176.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.487 ' H ' ' C ' ' A' ' 29' ' ' ASN . 97.3 m-85 -152.39 18.35 0.64 Allowed 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.353 -0.939 . . . . 0.0 109.459 179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.431 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 43.9 t80 -175.51 135.2 0.31 Allowed 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.1 -1.04 . . . . 0.0 111.574 -177.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -138.42 112.4 8.49 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.467 -0.893 . . . . 0.0 109.049 176.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.454 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 0.7 OUTLIER -92.14 146.29 23.84 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 115.082 -0.963 . . . . 0.0 112.608 -177.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.454 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 1.7 m -85.48 116.53 23.85 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.145 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.904 ' H ' HE22 ' A' ' 26' ' ' GLN . 70.8 mt . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 116.303 -1.808 . . . . 0.0 110.613 -178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.036 0.446 . . . . 0.0 109.878 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.677 HE22 ' N ' ' A' ' 8' ' ' CYS . 1.2 tt0 -133.95 163.83 28.66 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.784 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.17 176.46 5.24 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.699 179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.639 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -61.46 140.37 58.08 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.639 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 24.8 m-85 69.88 11.62 7.78 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.705 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.98 155.5 34.98 Favored Glycine 0 N--CA 1.486 1.985 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.528 -179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.622 ' C ' HE22 ' A' ' 2' ' ' GLN . 42.1 tt0 -78.06 104.97 8.97 Favored 'General case' 0 N--CA 1.498 1.957 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.66 179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.677 ' N ' HE22 ' A' ' 2' ' ' GLN . 1.6 p -89.79 -16.23 30.67 Favored 'General case' 0 C--N 1.309 -1.179 0 C-N-CA 118.712 -1.195 . . . . 0.0 110.505 179.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -165.53 -156.74 9.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 117.862 -2.114 . . . . 0.0 112.425 179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 98.27 144.46 16.94 Favored Glycine 0 N--CA 1.478 1.436 0 C-N-CA 119.778 -1.201 . . . . 0.0 110.196 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.606 HD12 ' O ' ' A' ' 30' ' ' PRO . 85.9 mt -49.16 153.66 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 C-N-CA 118.983 -1.087 . . . . 0.0 110.292 -179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 73.32 13.38 79.79 Favored Glycine 0 N--CA 1.49 2.261 0 C-N-CA 119.756 -1.211 . . . . 0.0 112.087 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -124.12 109.64 13.72 Favored 'General case' 0 N--CA 1.503 2.209 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.886 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 83.5 p -109.05 21.23 17.45 Favored 'General case' 0 N--CA 1.499 1.998 0 C-N-CA 119.884 -0.727 . . . . 0.0 110.275 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.27 178.99 42.03 Favored Glycine 0 N--CA 1.483 1.789 0 C-N-CA 119.642 -1.266 . . . . 0.0 110.691 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -63.31 157.17 51.54 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 C-N-CA 121.347 1.365 . . . . 0.0 109.79 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 8' ' ' CYS . 40.4 p -119.79 8.46 11.15 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.598 -0.841 . . . . 0.0 111.804 -177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.2 t -84.62 109.65 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 C-N-CA 118.707 -1.197 . . . . 0.0 109.224 178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.9 m -69.11 168.62 13.57 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.174 -1.01 . . . . 0.0 110.068 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.626 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -61.69 174.86 0.71 Allowed 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 119.144 -1.022 . . . . 0.0 110.386 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 87.4 p -68.4 140.92 55.83 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.363 -0.935 . . . . 0.0 110.441 179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.57 -11.36 52.22 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.575 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -107.23 169.12 8.76 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.179 -179.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.5 177.37 7.98 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.409 179.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -100.32 147.84 25.35 Favored 'General case' 0 N--CA 1.497 1.915 0 C-N-CA 119.19 -1.004 . . . . 0.0 111.539 -179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.401 ' OE1' ' N ' ' A' ' 36' ' ' LEU . 24.9 mp0 -145.2 125.38 13.74 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.525 -0.761 . . . . 0.0 110.035 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 15.4 t -75.23 110.28 9.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.572 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.2 tp -70.98 -58.31 3.7 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.105 -1.438 . . . . 0.0 108.248 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' C ' ' H ' ' A' ' 31' ' ' TYR . 9.7 p30 -151.22 174.37 3.62 Favored Pre-proline 0 CA--C 1.566 1.586 0 CA-C-N 114.439 -1.255 . . . . 0.0 107.919 -179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.606 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.8 Cg_exo -64.73 24.4 0.08 OUTLIER 'Trans proline' 0 N--CA 1.481 0.781 0 C-N-CA 120.952 1.101 . . . . 0.0 113.509 -176.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.8 m-85 -153.95 20.48 0.51 Allowed 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.1 -1.04 . . . . 0.0 110.02 178.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 37.1 t80 -175.24 131.24 0.29 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 118.786 -1.165 . . . . 0.0 111.318 -178.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.9 m -131.57 106.75 8.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.383 -0.927 . . . . 0.0 108.957 177.002 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -86.25 153.25 22.14 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.818 -1.537 . . . . 0.0 112.775 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 54.6 m -96.46 128.19 43.16 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 115.248 -0.887 . . . . 0.0 108.629 178.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 75.9 mt . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 116.255 -1.831 . . . . 0.0 110.079 -179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.75 166.7 10.97 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.708 -0.797 . . . . 0.0 109.684 179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -103.49 174.02 6.05 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.811 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.64 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.8 t-160 -53.77 135.11 41.97 Favored 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.364 -0.934 . . . . 0.0 108.635 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.64 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 61.7 m-85 69.53 18.73 7.69 Favored 'General case' 0 N--CA 1.508 2.427 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 -178.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -85.98 142.07 18.9 Favored Glycine 0 N--CA 1.482 1.707 0 C-N-CA 119.551 -1.309 . . . . 0.0 111.133 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.0 tt0 -73.85 120.27 19.21 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.528 -0.869 . . . . 0.0 110.872 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.714 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -108.6 -15.53 14.4 Favored 'General case' 0 C--O 1.212 -0.876 0 C-N-CA 119.902 -0.719 . . . . 0.0 110.922 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.75 -155.91 7.4 Favored Glycine 0 N--CA 1.485 1.934 0 C-N-CA 118.095 -2.003 . . . . 0.0 112.151 -179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.46 128.21 3.74 Favored Glycine 0 C--N 1.302 -1.352 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 60.9 mt -46.67 152.25 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 C-N-CA 118.699 -1.2 . . . . 0.0 110.506 -178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.25 -7.36 78.75 Favored Glycine 0 CA--C 1.548 2.139 0 C-N-CA 119.638 -1.268 . . . . 0.0 112.61 179.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -97.11 130.65 44.36 Favored 'General case' 0 N--CA 1.505 2.292 0 C-N-CA 119.132 -1.027 . . . . 0.0 110.755 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.4 p -124.86 61.09 1.17 Allowed 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.371 179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -144.88 177.97 23.0 Favored Glycine 0 N--CA 1.484 1.844 0 N-CA-C 109.971 -1.252 . . . . 0.0 109.971 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -60.02 155.22 45.93 Favored 'Trans proline' 0 C--N 1.317 -1.119 0 C-N-CA 121.105 1.203 . . . . 0.0 110.414 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.714 HG22 ' O ' ' A' ' 8' ' ' CYS . 66.7 p -118.34 32.66 6.02 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.73 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.9 t -105.07 123.52 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 119.923 -0.711 . . . . 0.0 109.943 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.408 ' SG ' ' C ' ' A' ' 24' ' ' THR . 58.8 m -88.24 143.25 27.15 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.847 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.68 168.58 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 119.129 -1.028 . . . . 0.0 109.765 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.2 p -59.13 144.7 44.91 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.383 -0.927 . . . . 0.0 111.064 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.22 -15.42 53.92 Favored Glycine 0 N--CA 1.484 1.881 0 C-N-CA 119.7 -1.238 . . . . 0.0 111.907 179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -115.0 166.27 11.98 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.681 -179.383 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.408 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -136.55 175.25 9.77 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.97 179.725 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.2 t -96.73 121.1 38.2 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 119.105 -1.038 . . . . 0.0 110.606 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -121.39 132.6 54.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.37 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 10.5 t -85.95 143.02 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.584 -0.847 . . . . 0.0 110.578 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.654 HD23 HD21 ' A' ' 29' ' ' ASN . 6.1 tp -107.86 -59.91 1.78 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.654 HD21 HD23 ' A' ' 28' ' ' LEU . 0.3 OUTLIER -139.44 175.14 3.44 Favored Pre-proline 0 N--CA 1.491 1.578 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 177.801 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -69.97 24.65 0.18 Allowed 'Trans proline' 0 C--O 1.214 -0.702 0 C-N-CA 120.538 0.825 . . . . 0.0 111.073 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.543 ' H ' ' C ' ' A' ' 29' ' ' ASN . 82.9 m-85 -150.6 10.16 0.64 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 119.345 -0.942 . . . . 0.0 110.613 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -163.67 122.06 1.93 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.537 -1.265 . . . . 0.0 112.229 -179.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 m -131.29 112.64 12.94 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.099 -1.04 . . . . 0.0 109.466 176.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -91.09 153.41 20.11 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 114.547 -1.206 . . . . 0.0 111.662 -178.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 m -92.9 112.56 24.57 Favored 'General case' 0 N--CA 1.493 1.686 0 C-N-CA 119.329 -0.949 . . . . 0.0 110.157 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 82.8 mt . . . . . 0 N--CA 1.495 1.816 0 CA-C-O 116.331 -1.795 . . . . 0.0 110.355 -179.165 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -109.36 -158.51 0.65 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.253 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.93 163.87 31.71 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.343 -0.943 . . . . 0.0 111.01 179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.472 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 20.6 t-160 -47.08 137.37 7.76 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.472 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 49.3 m-85 62.47 34.23 15.56 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -177.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.9 150.03 18.19 Favored Glycine 0 N--CA 1.483 1.827 0 C-N-CA 120.095 -1.05 . . . . 0.0 112.364 -178.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -81.69 102.55 10.79 Favored 'General case' 0 C--N 1.303 -1.442 0 C-N-CA 119.935 -0.706 . . . . 0.0 110.285 179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.3 p -89.9 -25.14 21.12 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.759 -1.176 . . . . 0.0 110.298 179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.78 -176.27 25.16 Favored Glycine 0 N--CA 1.485 1.907 0 C-N-CA 118.363 -1.875 . . . . 0.0 112.305 -179.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.95 133.74 4.05 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 66.5 mt -44.92 148.11 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.037 -1.065 . . . . 0.0 110.336 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.02 -17.4 22.64 Favored Glycine 0 N--CA 1.481 1.692 0 C-N-CA 119.636 -1.269 . . . . 0.0 110.775 -179.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -80.37 139.43 36.54 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.736 -0.786 . . . . 0.0 110.422 -179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.2 p -131.5 10.13 4.76 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.998 179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.79 177.9 46.76 Favored Glycine 0 N--CA 1.48 1.619 0 C-N-CA 119.548 -1.311 . . . . 0.0 110.779 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.52 155.29 69.67 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 121.488 1.459 . . . . 0.0 110.807 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.4 p -111.62 30.15 7.22 Favored 'General case' 0 C--N 1.294 -1.832 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.887 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.4 t -109.93 111.47 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.434 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.0 m -77.47 145.87 36.79 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.169 -1.012 . . . . 0.0 110.746 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -44.52 144.17 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 119.433 -0.907 . . . . 0.0 109.891 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.7 m -48.86 141.02 7.98 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 118.862 -1.135 . . . . 0.0 110.131 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.01 -27.11 22.12 Favored Glycine 0 N--CA 1.487 2.063 0 C-N-CA 119.705 -1.236 . . . . 0.0 110.967 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -110.21 169.86 8.45 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 120.055 -0.658 . . . . 0.0 110.424 179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.5 154.78 47.77 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.603 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.8 t -75.24 143.2 43.2 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 119.351 -0.939 . . . . 0.0 111.091 -178.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -143.06 106.72 4.63 Favored 'General case' 0 C--N 1.307 -1.25 0 C-N-CA 119.613 -0.835 . . . . 0.0 110.117 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.4 t -48.39 131.29 5.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.245 0 C-N-CA 119.424 -0.91 . . . . 0.0 109.954 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.556 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -101.2 -48.95 4.23 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.556 HD22 HD12 ' A' ' 28' ' ' LEU . 7.8 p30 -162.18 170.4 7.96 Favored Pre-proline 0 CA--C 1.565 1.556 0 CA-C-N 114.188 -1.369 . . . . 0.0 107.666 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 3.9 Cg_exo -67.72 25.06 0.12 Allowed 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 120.708 0.939 . . . . 0.0 112.798 -176.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.528 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 71.0 m-85 -155.27 16.4 0.4 Allowed 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.506 178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.438 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 54.9 t80 -175.18 132.39 0.31 Allowed 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 119.422 -0.911 . . . . 0.0 110.689 -177.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 69.3 m -135.8 113.94 11.39 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.597 -0.841 . . . . 0.0 108.894 177.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.447 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 1.6 tp-100 -94.69 149.04 21.65 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.396 1.06 . . . . 0.0 112.072 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 73.3 m -104.89 122.62 46.18 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 119.984 -0.687 . . . . 0.0 109.88 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.5 mm? . . . . . 0 N--CA 1.5 2.061 0 CA-C-O 116.351 -1.785 . . . . 0.0 109.988 -179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 28.0 tp60 -91.72 159.06 16.03 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.84 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.33 171.84 7.72 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.179 -1.008 . . . . 0.0 110.774 -179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.634 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -56.65 158.18 4.76 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.634 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 78.1 m-85 48.89 18.21 0.19 Allowed 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 118.99 -1.084 . . . . 0.0 109.466 -178.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.456 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -89.64 153.73 23.47 Favored Glycine 0 N--CA 1.477 1.42 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.863 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -80.22 110.7 15.9 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 120.181 -0.608 . . . . 0.0 111.011 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.672 ' O ' HG22 ' A' ' 17' ' ' THR . 1.0 OUTLIER -94.65 -15.57 23.87 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 118.987 -1.085 . . . . 0.0 110.57 179.345 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.17 -176.46 26.53 Favored Glycine 0 N--CA 1.484 1.893 0 C-N-CA 118.429 -1.843 . . . . 0.0 112.14 -179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.25 143.21 5.33 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.024 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.88 142.65 16.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 118.117 -1.433 . . . . 0.0 110.215 -179.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.51 -5.84 63.01 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 119.711 -1.233 . . . . 0.0 111.497 -179.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 45.9 t80 -85.39 108.3 17.78 Favored 'General case' 0 N--CA 1.495 1.824 0 C-N-CA 119.336 -0.946 . . . . 0.0 110.498 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.4 p -101.88 46.68 0.92 Allowed 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 119.767 -0.773 . . . . 0.0 111.009 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.84 166.01 15.37 Favored Glycine 0 N--CA 1.494 2.543 0 C-N-CA 120.122 -1.037 . . . . 0.0 110.568 179.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -50.39 162.81 0.78 Allowed 'Trans proline' 0 C--O 1.207 -1.067 0 C-N-CA 121.265 1.31 . . . . 0.0 110.206 179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.672 HG22 ' O ' ' A' ' 8' ' ' CYS . 22.9 p -125.61 -3.72 7.22 Favored 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 119.467 -0.893 . . . . 0.0 111.683 -178.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.8 t -78.57 122.89 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 118.737 -1.185 . . . . 0.0 109.208 178.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 63.6 m -77.2 154.91 32.63 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.077 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -58.9 163.48 3.43 Favored 'General case' 0 N--CA 1.487 1.377 0 C-N-CA 119.588 -0.845 . . . . 0.0 109.916 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.6 m -60.27 155.74 17.05 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 118.92 -1.112 . . . . 0.0 109.605 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -6.86 24.73 Favored Glycine 0 N--CA 1.481 1.679 0 C-N-CA 119.372 -1.394 . . . . 0.0 111.452 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.467 HG21 ' CD2' ' A' ' 4' ' ' HIS . 0.8 OUTLIER -129.43 163.79 25.07 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.666 -179.892 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -132.63 176.74 8.19 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.788 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.4 t -96.43 141.65 29.48 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 118.944 -1.102 . . . . 0.0 110.931 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -135.85 112.21 9.86 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.671 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.405 HG13 ' OG ' ' A' ' 33' ' ' SER . 2.4 t -74.91 113.05 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 C-N-CA 119.804 -0.758 . . . . 0.0 111.057 -178.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.51 HD23 ' ND2' ' A' ' 29' ' ' ASN . 6.2 tp -78.21 -56.74 4.22 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 118.91 -1.116 . . . . 0.0 108.302 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.524 ' C ' ' H ' ' A' ' 31' ' ' TYR . 1.4 m-80 -150.09 174.19 3.69 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -71.2 23.63 0.22 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 120.493 0.795 . . . . 0.0 111.265 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.524 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -144.62 8.03 1.3 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.528 179.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -169.51 132.1 1.2 Allowed 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.644 -0.822 . . . . 0.0 111.104 -179.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.408 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 67.5 m -141.16 108.96 5.66 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.499 -0.88 . . . . 0.0 109.028 177.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -85.27 157.94 20.45 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 114.891 -1.05 . . . . 0.0 112.731 -177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.4 ' N ' ' O ' ' A' ' 6' ' ' GLY . 1.5 m -101.53 115.43 30.49 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.86 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.5 mt . . . . . 0 N--CA 1.497 1.916 0 CA-C-O 116.375 -1.774 . . . . 0.0 109.344 179.556 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.422 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 1.9 mp0 -121.9 -179.97 4.31 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.694 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.6 m -119.9 -176.55 3.21 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.914 -0.714 . . . . 0.0 110.028 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.647 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 20.9 t-160 -60.75 136.11 57.97 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 118.768 -1.173 . . . . 0.0 108.222 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.647 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 35.4 m-85 68.67 13.0 8.86 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 123.39 0.431 . . . . 0.0 110.127 -178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.65 154.95 34.9 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 119.435 -1.364 . . . . 0.0 111.797 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.8 tt0 -82.28 118.95 23.51 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.878 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 0.9 OUTLIER -111.05 -16.14 13.56 Favored 'General case' 0 C--N 1.31 -1.148 0 C-N-CA 119.739 -0.784 . . . . 0.0 110.484 179.321 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.69 -162.15 10.87 Favored Glycine 0 N--CA 1.495 2.572 0 C-N-CA 118.156 -1.973 . . . . 0.0 112.315 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.23 138.54 10.16 Favored Glycine 0 N--CA 1.482 1.743 0 C-N-CA 119.8 -1.19 . . . . 0.0 110.452 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.447 HD12 ' O ' ' A' ' 30' ' ' PRO . 53.8 mt -49.61 146.69 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 C-N-CA 118.884 -1.127 . . . . 0.0 110.027 -179.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 86.86 14.45 64.94 Favored Glycine 0 N--CA 1.483 1.817 0 C-N-CA 119.812 -1.185 . . . . 0.0 112.009 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -121.19 119.76 33.27 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.704 -0.798 . . . . 0.0 111.021 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.2 p -117.42 57.9 0.8 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.594 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -141.36 174.76 22.73 Favored Glycine 0 N--CA 1.484 1.849 0 C-N-CA 120.037 -1.078 . . . . 0.0 110.514 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -60.0 154.67 49.28 Favored 'Trans proline' 0 C--N 1.315 -1.218 0 C-N-CA 121.244 1.296 . . . . 0.0 110.137 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.1 p -112.64 5.23 17.66 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 115.506 -0.77 . . . . 0.0 110.709 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -77.69 116.29 20.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 C-N-CA 118.989 -1.085 . . . . 0.0 109.323 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 78.2 m -83.31 164.57 19.97 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 119.117 -1.033 . . . . 0.0 110.327 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -58.57 156.6 10.39 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.495 -0.882 . . . . 0.0 110.369 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 58.8 m -58.62 144.45 43.04 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.506 -0.878 . . . . 0.0 110.781 -179.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.03 -15.21 63.41 Favored Glycine 0 N--CA 1.484 1.888 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.928 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -117.84 -177.86 3.35 Favored 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.682 -179.368 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.609 ' C ' HE22 ' A' ' 26' ' ' GLN . 0.0 OUTLIER -146.17 171.29 15.15 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.767 -1.106 . . . . 0.0 108.855 179.263 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.3 t -100.61 114.15 27.58 Favored 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.122 -1.031 . . . . 0.0 112.094 -179.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.609 HE22 ' C ' ' A' ' 24' ' ' THR . 0.8 OUTLIER -105.58 118.36 36.39 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.862 178.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.2 t -68.66 130.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 C-N-CA 119.251 -0.98 . . . . 0.0 109.566 179.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -93.37 -56.43 2.94 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 118.146 -1.422 . . . . 0.0 109.144 -179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.519 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.2 p30 -154.39 176.53 2.44 Favored Pre-proline 0 C--N 1.299 -1.628 0 CA-C-N 114.676 -1.147 . . . . 0.0 108.131 -178.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.0 Cg_exo -65.98 25.05 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.688 0 C-N-CA 120.958 1.106 . . . . 0.0 112.812 -177.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 92.9 m-85 -152.68 15.85 0.58 Allowed 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.024 -1.07 . . . . 0.0 110.642 178.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -175.27 135.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 118.225 -1.39 . . . . 0.0 112.599 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.6 m -136.51 113.68 10.63 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -82.6 164.05 21.06 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 114.458 -1.246 . . . . 0.0 112.368 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.499 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 21.3 m -111.26 112.94 25.07 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.714 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.562 ' O ' HG22 ' A' ' 23' ' ' THR . 20.5 mt . . . . . 0 N--CA 1.502 2.165 0 CA-C-O 116.472 -1.728 . . . . 0.0 110.189 -179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -88.47 -162.51 0.85 Allowed 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 118.978 -1.089 . . . . 0.0 109.557 179.771 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.429 ' HA ' ' HB2' ' A' ' 20' ' ' ALA . 0.0 OUTLIER -127.61 174.68 8.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 115.605 -0.725 . . . . 0.0 109.9 179.535 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.636 ' ND1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -50.91 144.18 9.0 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 118.958 -1.097 . . . . 0.0 108.178 179.781 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CE2' ' ND1' ' A' ' 4' ' ' HIS . 25.7 m-85 62.65 15.41 7.99 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.177 -177.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -80.4 150.6 31.85 Favored Glycine 0 N--CA 1.483 1.818 0 C-N-CA 119.642 -1.266 . . . . 0.0 111.737 -179.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -85.3 103.8 14.57 Favored 'General case' 0 C--N 1.306 -1.314 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.847 179.759 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.755 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -90.05 -16.79 29.01 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.963 -1.095 . . . . 0.0 110.255 179.395 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -157.93 -176.34 29.87 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 118.305 -1.902 . . . . 0.0 112.359 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 128.54 130.57 3.31 Favored Glycine 0 N--CA 1.485 1.952 0 C-N-CA 120.056 -1.068 . . . . 0.0 110.959 179.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' O ' ' A' ' 30' ' ' PRO . 41.4 mt -46.9 148.68 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 118.785 -1.166 . . . . 0.0 109.252 179.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.2 -9.16 27.9 Favored Glycine 0 C--N 1.289 -2.05 0 C-N-CA 119.369 -1.396 . . . . 0.0 111.05 -178.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -88.78 130.32 35.39 Favored 'General case' 0 N--CA 1.503 2.183 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.331 179.874 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.7 p -130.19 62.35 1.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 119.995 -0.682 . . . . 0.0 109.38 179.263 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -140.3 173.41 23.04 Favored Glycine 0 N--CA 1.478 1.442 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.523 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -52.79 154.55 12.38 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 N-CA-C 109.473 -1.01 . . . . 0.0 109.473 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.0 p -122.06 18.14 10.84 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.817 -178.424 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.9 t -91.82 125.87 44.46 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 C-N-CA 119.424 -0.91 . . . . 0.0 108.904 178.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.479 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 67.2 m -80.87 157.14 25.76 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.034 -1.067 . . . . 0.0 111.392 -179.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.431 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.98 151.97 11.0 Favored 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.601 179.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.9 m -56.93 139.68 51.0 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.031 179.715 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.29 -20.1 39.29 Favored Glycine 0 N--CA 1.485 1.933 0 C-N-CA 119.437 -1.363 . . . . 0.0 111.28 -179.813 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.431 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.5 OUTLIER -112.21 161.59 16.4 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.685 -179.894 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -128.94 161.35 30.08 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.391 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 10.5 t -80.74 107.39 13.51 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 119.551 -0.86 . . . . 0.0 111.164 -179.251 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.5 mm-40 -106.84 108.88 20.6 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 115.186 -0.916 . . . . 0.0 109.274 179.364 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 73.1 t -49.65 141.37 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.639 -179.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.59 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -106.05 -57.82 1.99 Allowed 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.59 HD22 HD12 ' A' ' 28' ' ' LEU . 11.4 p30 -155.76 172.32 6.16 Favored Pre-proline 0 CA--C 1.576 1.979 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.121 -179.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.485 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.8 Cg_exo -68.94 23.76 0.15 Allowed 'Trans proline' 0 N--CA 1.485 1.011 0 C-N-CA 120.972 1.115 . . . . 0.0 113.127 -176.806 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' H ' ' C ' ' A' ' 29' ' ' ASN . 66.4 m-85 -154.16 18.07 0.49 Allowed 'General case' 0 C--N 1.29 -1.993 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.183 178.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.463 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 40.8 t80 -174.45 128.24 0.34 Allowed 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.354 -0.939 . . . . 0.0 110.399 -177.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.8 m -125.59 115.74 20.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.446 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.4 tp60 -93.32 150.62 20.34 Favored 'General case' 0 N--CA 1.504 2.245 0 O-C-N 124.198 0.937 . . . . 0.0 112.691 -177.028 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.554 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 47.7 m -102.24 116.26 32.27 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 15.8 mt . . . . . 0 N--CA 1.499 1.989 0 CA-C-O 116.235 -1.841 . . . . 0.0 110.133 -178.651 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.024 0.44 . . . . 0.0 109.847 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 tp60 -100.34 -165.79 1.25 Allowed 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.456 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.8 m -136.26 171.59 14.26 Favored 'General case' 0 N--CA 1.498 1.93 0 C-N-CA 119.204 -0.999 . . . . 0.0 111.044 179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.629 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.2 t-160 -57.15 149.37 19.74 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.629 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 50.0 m-85 53.72 26.74 6.19 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.856 -1.138 . . . . 0.0 109.221 -178.156 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -103.67 149.8 17.39 Favored Glycine 0 N--CA 1.492 2.414 0 C-N-CA 119.972 -1.108 . . . . 0.0 111.824 -178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.6 tt0 -76.7 117.61 18.5 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.562 -0.855 . . . . 0.0 110.83 179.873 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.435 ' O ' HG22 ' A' ' 17' ' ' THR . 1.3 p -105.81 -24.98 12.36 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.763 -0.775 . . . . 0.0 110.763 179.526 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.77 -154.09 6.56 Favored Glycine 0 N--CA 1.488 2.149 0 C-N-CA 118.592 -1.766 . . . . 0.0 112.23 -179.077 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.98 151.6 23.2 Favored Glycine 0 N--CA 1.48 1.607 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 -178.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -61.83 153.37 5.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 C-N-CA 118.967 -1.093 . . . . 0.0 109.945 -179.943 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.32 -10.54 35.27 Favored Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.408 -1.377 . . . . 0.0 110.801 -179.202 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -88.58 135.64 33.39 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.639 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -133.96 41.24 3.02 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.656 179.257 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.47 173.69 16.06 Favored Glycine 0 N--CA 1.486 2.025 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -58.37 158.33 23.19 Favored 'Trans proline' 0 C--N 1.316 -1.134 0 C-N-CA 121.379 1.386 . . . . 0.0 110.095 179.378 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' O ' ' A' ' 8' ' ' CYS . 11.9 p -127.36 29.4 5.55 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.976 -178.091 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.3 t -104.46 109.45 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.194 178.336 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.446 ' SG ' ' C ' ' A' ' 24' ' ' THR . 52.4 m -70.87 157.01 38.87 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.085 -178.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.56 169.49 0.2 Allowed 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 119.598 -0.841 . . . . 0.0 110.63 -179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.5 m -63.64 143.24 57.99 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.923 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 84.51 -15.47 40.75 Favored Glycine 0 N--CA 1.484 1.844 0 C-N-CA 119.719 -1.229 . . . . 0.0 111.429 179.627 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.34 169.27 8.99 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.709 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.446 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.6 OUTLIER -140.42 173.3 11.64 Favored 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.591 179.709 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 t -92.75 142.87 26.87 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.292 179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -139.31 123.98 18.46 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.578 -0.849 . . . . 0.0 110.906 -179.713 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.6 t -71.79 131.59 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 C-N-CA 119.537 -0.865 . . . . 0.0 109.988 179.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.502 HD23 HD21 ' A' ' 29' ' ' ASN . 5.0 tp -95.96 -57.26 2.4 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 179.305 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.534 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.7 m-80 -143.1 173.54 4.44 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.547 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.0 Cg_exo -70.1 25.11 0.18 Allowed 'Trans proline' 0 C--O 1.212 -0.787 0 CA-C-N 119.319 0.792 . . . . 0.0 111.107 -178.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.534 ' H ' ' C ' ' A' ' 29' ' ' ASN . 72.0 m-85 -152.06 20.87 0.67 Allowed 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 119.558 -0.857 . . . . 0.0 110.206 179.913 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.448 ' OH ' ' OE1' ' A' ' 34' ' ' GLN . 62.3 t80 -175.46 125.95 0.24 Allowed 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 119.242 -0.983 . . . . 0.0 111.71 -179.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.3 m -130.92 113.96 14.66 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.175 177.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.448 ' OE1' ' OH ' ' A' ' 32' ' ' TYR . 9.2 tt0 -101.36 159.53 15.19 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.914 -178.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 88.1 m -97.03 128.63 44.18 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.793 -0.763 . . . . 0.0 110.051 179.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 116.373 -1.775 . . . . 0.0 110.109 -178.501 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -120.0 -167.08 1.38 Allowed 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.781 179.662 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.89 162.77 25.93 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.897 -0.721 . . . . 0.0 110.212 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.484 ' NE2' ' CZ ' ' A' ' 5' ' ' TYR . 11.5 t-160 -51.3 128.69 22.99 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.213 -0.995 . . . . 0.0 108.371 -179.664 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.524 ' C ' HE21 ' A' ' 34' ' ' GLN . 54.8 m-85 72.22 20.31 4.21 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 123.912 0.758 . . . . 0.0 109.78 -178.202 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.55 154.98 22.45 Favored Glycine 0 N--CA 1.48 1.591 0 C-N-CA 119.729 -1.224 . . . . 0.0 110.595 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -80.92 117.13 21.28 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.505 -0.878 . . . . 0.0 111.125 -179.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.5 p -107.91 -15.91 14.43 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.867 -0.733 . . . . 0.0 109.96 178.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.27 -178.6 24.42 Favored Glycine 0 N--CA 1.486 2.007 0 C-N-CA 118.0 -2.047 . . . . 0.0 111.729 -179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.78 154.01 7.81 Favored Glycine 0 C--N 1.297 -1.598 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -178.919 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 20.1 mt -72.84 137.67 22.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.134 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.045 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.86 -20.6 11.77 Favored Glycine 0 C--N 1.291 -1.957 0 CA-C-N 114.574 -1.194 . . . . 0.0 110.572 -179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -69.26 100.37 1.31 Allowed 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.449 -0.901 . . . . 0.0 109.595 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.6 p -92.01 16.04 12.02 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.623 -0.831 . . . . 0.0 111.592 -178.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -85.41 177.46 50.28 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.221 -1.466 . . . . 0.0 110.729 179.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -61.41 153.98 62.14 Favored 'Trans proline' 0 C--N 1.32 -0.961 0 C-N-CA 121.578 1.519 . . . . 0.0 110.243 179.65 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 p -119.89 20.03 12.28 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.469 -0.893 . . . . 0.0 112.31 -177.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.4 t -105.51 112.22 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 C-N-CA 119.39 -0.924 . . . . 0.0 109.352 178.696 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 94.6 m -63.92 175.31 1.21 Allowed 'General case' 0 N--CA 1.494 1.77 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.73 -179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -75.27 173.72 10.48 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.115 178.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 71.4 m -66.52 143.74 56.89 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.917 -179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 81.09 -15.81 19.88 Favored Glycine 0 N--CA 1.482 1.724 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.972 179.666 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.32 162.43 13.69 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 119.839 -0.744 . . . . 0.0 110.494 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 166.81 22.02 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.867 179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.9 t -98.1 127.01 43.8 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 119.234 -0.987 . . . . 0.0 111.264 -179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -126.74 117.32 22.45 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.753 179.322 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 89.2 t -54.27 136.83 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.119 -1.032 . . . . 0.0 110.164 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -97.01 -53.46 3.5 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.704 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.54 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.3 OUTLIER -153.42 177.07 2.1 Favored Pre-proline 0 N--CA 1.5 2.04 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.44 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 5.7 Cg_exo -69.53 24.17 0.17 Allowed 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 120.534 0.822 . . . . 0.0 111.156 -178.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.54 ' H ' ' C ' ' A' ' 29' ' ' ASN . 37.1 m-85 -151.0 0.15 0.39 Allowed 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.756 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -159.83 138.21 10.41 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.796 -1.161 . . . . 0.0 111.426 -178.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 m -135.7 118.71 16.38 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.935 -0.706 . . . . 0.0 109.227 178.358 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.524 HE21 ' C ' ' A' ' 5' ' ' TYR . 1.2 tt0 -96.16 146.12 24.94 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.497 1.123 . . . . 0.0 113.16 -177.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 8.8 m -95.52 116.49 28.9 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.78 178.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.568 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.7 mm? . . . . . 0 N--CA 1.504 2.239 0 CA-C-O 116.413 -1.756 . . . . 0.0 110.055 -179.922 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.498 0 CA-C-O 121.042 0.449 . . . . 0.0 109.875 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.781 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 2.3 tp60 -92.12 -178.22 4.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.696 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -116.58 -179.61 3.73 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.426 -179.875 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.637 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.3 t-160 -66.99 142.37 57.26 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.637 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 72.9 m-85 59.65 27.84 17.15 Favored 'General case' 0 N--CA 1.5 2.027 0 C-N-CA 119.817 -0.753 . . . . 0.0 109.345 -178.153 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.62 156.37 20.64 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.999 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -86.87 117.09 25.38 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.285 -0.966 . . . . 0.0 111.157 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.421 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -102.32 -21.87 14.23 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 119.713 -0.795 . . . . 0.0 110.776 179.414 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.37 -169.13 15.51 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 118.243 -1.932 . . . . 0.0 112.473 -179.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.76 132.47 5.52 Favored Glycine 0 N--CA 1.477 1.412 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 -178.745 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.512 HD12 ' O ' ' A' ' 30' ' ' PRO . 97.7 mt -50.23 155.39 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 118.625 -1.23 . . . . 0.0 110.45 -179.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.452 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 82.17 -18.45 13.51 Favored Glycine 0 N--CA 1.485 1.912 0 C-N-CA 119.54 -1.314 . . . . 0.0 110.191 -178.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -82.7 148.11 28.09 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.978 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.6 p -141.1 11.07 2.17 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.571 -0.851 . . . . 0.0 109.514 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.66 -175.81 49.46 Favored Glycine 0 N--CA 1.478 1.473 0 C-N-CA 119.945 -1.122 . . . . 0.0 110.758 179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_endo -69.16 154.2 70.46 Favored 'Trans proline' 0 C--N 1.315 -1.202 0 C-N-CA 121.525 1.483 . . . . 0.0 109.866 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.421 HG22 ' O ' ' A' ' 8' ' ' CYS . 30.4 p -115.9 15.44 16.27 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.552 -0.859 . . . . 0.0 111.53 -178.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -100.41 115.37 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 C-N-CA 119.437 -0.905 . . . . 0.0 109.679 179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 60.7 m -73.62 149.58 41.94 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.562 -0.855 . . . . 0.0 111.547 -179.058 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.781 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -51.5 165.49 0.16 Allowed 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.683 -0.807 . . . . 0.0 110.306 179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 67.5 m -62.08 141.23 58.23 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 119.299 -0.96 . . . . 0.0 110.75 -179.705 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.09 -7.86 72.91 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.468 -1.348 . . . . 0.0 111.724 179.679 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.37 178.51 6.22 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.589 -0.844 . . . . 0.0 111.368 -179.762 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.63 173.98 11.36 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.754 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 t -100.08 129.91 46.18 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.194 -179.678 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -127.41 117.4 22.09 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.816 179.172 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.2 t -70.19 142.03 16.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 119.374 -0.93 . . . . 0.0 110.079 179.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.615 HD23 HD21 ' A' ' 29' ' ' ASN . 3.8 tp -105.5 -56.97 2.1 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.895 -1.122 . . . . 0.0 108.209 -179.512 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.615 HD21 HD23 ' A' ' 28' ' ' LEU . 2.3 m-80 -144.01 175.41 2.84 Favored Pre-proline 0 N--CA 1.492 1.654 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 178.781 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.512 ' O ' HD12 ' A' ' 11' ' ' ILE . 4.5 Cg_exo -69.36 24.64 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 CA-C-N 119.126 0.723 . . . . 0.0 111.356 -178.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.7 m-85 -148.24 6.15 0.76 Allowed 'General case' 0 C--N 1.309 -1.169 0 C-N-CA 119.338 -0.945 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -162.85 139.64 7.58 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 118.719 -1.192 . . . . 0.0 112.218 -179.258 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.4 m -143.97 114.39 7.53 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.416 -0.913 . . . . 0.0 109.474 176.817 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -88.07 164.07 15.93 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-N 115.053 -0.976 . . . . 0.0 112.101 -178.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.7 m -108.48 118.23 36.23 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.416 179.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 116.325 -1.798 . . . . 0.0 109.641 -179.889 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.536 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 4.1 tp60 -119.83 -164.34 1.07 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.165 179.077 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.504 ' H ' ' HG3' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -141.66 174.1 10.88 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.488 -0.885 . . . . 0.0 110.713 -179.735 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.457 ' NE2' ' CE2' ' A' ' 5' ' ' TYR . 20.4 t-160 -53.83 135.32 42.02 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.109 -179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.457 ' CE2' ' NE2' ' A' ' 4' ' ' HIS . 52.1 m-85 60.22 23.83 13.2 Favored 'General case' 0 N--CA 1.505 2.31 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.441 179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.17 143.47 16.17 Favored Glycine 0 N--CA 1.494 2.525 0 C-N-CA 119.74 -1.219 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.536 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 22.7 tt0 -67.43 111.62 4.18 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.374 -0.93 . . . . 0.0 111.347 179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.745 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -94.92 -21.84 18.38 Favored 'General case' 0 C--N 1.307 -1.242 0 C-N-CA 119.314 -0.954 . . . . 0.0 110.488 179.096 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -153.06 -175.14 24.17 Favored Glycine 0 N--CA 1.488 2.119 0 C-N-CA 118.321 -1.895 . . . . 0.0 112.342 -178.934 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.21 137.69 4.81 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 110.574 -1.01 . . . . 0.0 110.574 -179.768 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 30' ' ' PRO . 70.3 mt -47.9 151.31 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.167 -179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.08 7.36 66.68 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.794 -1.193 . . . . 0.0 111.957 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.54 128.0 44.7 Favored 'General case' 0 N--CA 1.496 1.863 0 C-N-CA 119.57 -0.852 . . . . 0.0 110.983 -179.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.7 p -119.87 56.56 0.95 Allowed 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.015 179.456 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -139.81 179.96 18.35 Favored Glycine 0 N--CA 1.487 2.081 0 C-N-CA 119.938 -1.125 . . . . 0.0 110.969 -179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -66.34 158.4 55.3 Favored 'Trans proline' 0 C--N 1.32 -0.923 0 C-N-CA 121.69 1.593 . . . . 0.0 110.785 -179.85 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.745 HG22 ' O ' ' A' ' 8' ' ' CYS . 21.7 p -121.96 11.75 10.35 Favored 'General case' 0 N--CA 1.499 1.982 0 C-N-CA 119.706 -0.798 . . . . 0.0 111.555 -178.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.3 t -93.27 117.2 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 C-N-CA 119.042 -1.063 . . . . 0.0 110.107 179.474 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.46 ' SG ' ' C ' ' A' ' 24' ' ' THR . 97.6 m -77.24 145.06 37.78 Favored 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.492 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.41 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.84 163.2 5.93 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.395 -0.922 . . . . 0.0 110.841 -179.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 28.8 m -54.44 147.28 14.16 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.551 -0.86 . . . . 0.0 110.398 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.25 -18.8 38.92 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 119.561 -1.304 . . . . 0.0 111.069 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.593 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.7 OUTLIER -122.3 172.44 8.31 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-O 121.493 0.663 . . . . 0.0 111.218 -179.881 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.46 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.0 OUTLIER -149.22 162.4 40.08 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.378 179.718 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.4 t -88.67 136.2 33.12 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 118.966 -1.094 . . . . 0.0 111.448 -178.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -130.22 116.54 18.55 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 115.438 -0.801 . . . . 0.0 110.172 179.593 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.4 t -59.23 118.44 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.561 179.681 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.466 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -84.6 -57.66 3.05 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 -179.151 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.542 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.16 178.37 1.64 Allowed Pre-proline 0 N--CA 1.495 1.797 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 178.476 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.581 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.1 Cg_exo -69.76 24.01 0.17 Allowed 'Trans proline' 0 C--O 1.214 -0.678 0 C-N-CA 120.734 0.956 . . . . 0.0 111.132 -179.185 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.542 ' H ' ' C ' ' A' ' 29' ' ' ASN . 76.7 m-85 -152.16 11.35 0.54 Allowed 'General case' 0 C--N 1.304 -1.398 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.294 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.428 ' CD1' ' N ' ' A' ' 33' ' ' SER . 4.7 t80 -173.15 138.56 0.75 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 118.46 -1.296 . . . . 0.0 111.682 -178.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.466 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 66.9 m -139.71 115.9 10.46 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 119.894 -0.722 . . . . 0.0 109.239 178.018 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.44 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.7 tt0 -90.77 152.5 20.77 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.916 -176.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.21 103.17 14.62 Favored 'General case' 0 N--CA 1.514 2.737 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.31 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.593 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.9 mm? . . . . . 0 N--CA 1.504 2.251 0 CA-C-O 116.364 -1.779 . . . . 0.0 109.562 179.301 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.036 0.446 . . . . 0.0 109.838 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -121.31 -169.23 1.81 Allowed 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 178.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.82 -179.48 5.11 Favored 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 119.491 -0.884 . . . . 0.0 111.153 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 19.0 t-160 -67.64 136.24 54.08 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 179.357 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 45.1 m-85 65.81 20.54 11.45 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -177.878 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.37 148.85 19.1 Favored Glycine 0 N--CA 1.485 1.966 0 C-N-CA 119.919 -1.134 . . . . 0.0 110.946 179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -76.44 115.28 16.03 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.531 -0.868 . . . . 0.0 111.258 -179.731 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' THR . 5.8 p -95.5 -19.06 20.14 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 119.589 -0.845 . . . . 0.0 110.379 179.127 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -162.55 -170.26 27.12 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 118.237 -1.935 . . . . 0.0 112.656 -179.677 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 121.66 134.41 4.53 Favored Glycine 0 N--CA 1.484 1.85 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 -179.467 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 30' ' ' PRO . 30.8 mt -43.88 142.8 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.156 -1.018 . . . . 0.0 110.667 -179.524 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 90.42 -17.54 53.69 Favored Glycine 0 N--CA 1.486 2.013 0 C-N-CA 119.687 -1.244 . . . . 0.0 111.922 179.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -82.7 159.82 22.51 Favored 'General case' 0 N--CA 1.499 2.019 0 C-N-CA 119.342 -0.943 . . . . 0.0 110.636 -179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.3 p -144.33 3.57 1.17 Allowed 'General case' 0 N--CA 1.492 1.656 0 C-N-CA 119.479 -0.888 . . . . 0.0 110.949 -179.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.0 173.34 39.5 Favored Glycine 0 N--CA 1.485 1.932 0 C-N-CA 119.458 -1.353 . . . . 0.0 111.624 -179.234 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.51 165.1 8.18 Favored 'Trans proline' 0 C--O 1.209 -0.959 0 C-N-CA 121.596 1.531 . . . . 0.0 110.215 179.083 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.648 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.1 p -128.17 14.45 6.73 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.14 -178.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -83.8 114.73 24.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 C-N-CA 119.379 -0.928 . . . . 0.0 108.662 178.386 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.443 ' SG ' ' C ' ' A' ' 24' ' ' THR . 64.2 m -77.28 147.43 36.29 Favored 'General case' 0 N--CA 1.495 1.798 0 C-N-CA 119.361 -0.936 . . . . 0.0 111.329 -178.555 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.23 170.34 0.22 Allowed 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 119.785 -0.766 . . . . 0.0 110.362 179.584 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 49.3 m -60.53 148.18 38.82 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.505 -0.878 . . . . 0.0 110.614 179.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.96 -10.97 44.49 Favored Glycine 0 N--CA 1.483 1.769 0 C-N-CA 119.452 -1.356 . . . . 0.0 111.379 179.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.19 165.45 17.57 Favored 'General case' 0 N--CA 1.492 1.639 0 C-N-CA 119.714 -0.794 . . . . 0.0 111.458 -179.908 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.443 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -143.49 165.91 26.26 Favored 'General case' 0 C--N 1.299 -1.608 0 CA-C-N 114.993 -1.003 . . . . 0.0 109.608 179.825 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.2 t -82.28 128.06 33.82 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.722 -1.191 . . . . 0.0 110.75 -179.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.9 mm-40 -120.72 115.51 23.46 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.094 179.89 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 69.2 t -70.93 121.41 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 C-N-CA 119.861 -0.736 . . . . 0.0 110.599 -179.7 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.3 tp -90.22 -57.35 2.87 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.753 -1.179 . . . . 0.0 109.427 179.635 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.8 p30 -157.49 176.84 2.37 Favored Pre-proline 0 C--N 1.297 -1.709 0 CA-C-N 114.465 -1.243 . . . . 0.0 108.032 -178.26 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.496 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 4.1 Cg_exo -66.58 27.6 0.11 Allowed 'Trans proline' 0 CA--C 1.537 0.625 0 C-N-CA 120.958 1.106 . . . . 0.0 112.989 -177.1 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 75.8 m-85 -154.75 14.84 0.42 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.947 179.018 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 59.5 t80 -174.87 140.7 0.57 Allowed 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.268 -1.373 . . . . 0.0 112.661 -178.228 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 66.4 m -143.9 113.25 6.92 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 176.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -90.11 158.27 17.37 Favored 'General case' 0 N--CA 1.503 2.186 0 C-N-CA 119.55 -0.86 . . . . 0.0 112.794 -177.783 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.6 m -99.77 112.82 25.04 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.007 178.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 84.0 mt . . . . . 0 N--CA 1.504 2.233 0 CA-C-O 116.312 -1.804 . . . . 0.0 110.236 179.669 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.154 0.502 . . . . 0.0 109.915 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -132.25 150.43 52.16 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.143 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -97.01 -174.92 3.1 Favored 'General case' 0 N--CA 1.5 2.067 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.743 -178.226 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.657 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 21.5 t-160 -61.65 158.07 16.18 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.079 -179.084 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.657 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.0 m-85 48.7 21.53 0.43 Allowed 'General case' 0 N--CA 1.503 2.203 0 C-N-CA 119.687 -0.805 . . . . 0.0 110.561 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -101.19 155.46 19.12 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.598 -1.287 . . . . 0.0 111.962 -179.186 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -83.66 121.02 26.7 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 119.967 -0.693 . . . . 0.0 111.163 -179.828 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.541 ' O ' HG22 ' A' ' 17' ' ' THR . 1.5 p -107.46 -27.96 10.11 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.673 -0.811 . . . . 0.0 110.656 179.125 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.38 -148.97 4.87 Favored Glycine 0 N--CA 1.486 1.978 0 C-N-CA 118.222 -1.942 . . . . 0.0 112.872 -178.515 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.04 134.25 7.58 Favored Glycine 0 N--CA 1.475 1.288 0 N-CA-C 109.307 -1.517 . . . . 0.0 109.307 -178.226 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.474 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.1 mt -51.37 152.44 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 118.547 -1.261 . . . . 0.0 109.976 -178.855 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -11.29 47.87 Favored Glycine 0 N--CA 1.485 1.922 0 C-N-CA 119.631 -1.271 . . . . 0.0 111.346 -179.616 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -86.26 130.5 34.5 Favored 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.386 -179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 58.6 p -121.09 62.32 0.89 Allowed 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.009 -0.677 . . . . 0.0 110.624 -179.833 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.84 -175.74 19.16 Favored Glycine 0 N--CA 1.484 1.854 0 C-N-CA 119.732 -1.223 . . . . 0.0 110.642 179.992 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.69 159.2 53.75 Favored 'Trans proline' 0 C--N 1.319 -1.017 0 C-N-CA 121.493 1.462 . . . . 0.0 109.909 179.05 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 8' ' ' CYS . 81.4 p -122.66 30.94 6.26 Favored 'General case' 0 N--CA 1.5 2.026 0 C-N-CA 119.455 -0.898 . . . . 0.0 111.581 -178.183 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 15.1 t -108.42 116.11 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 C-N-CA 119.927 -0.709 . . . . 0.0 109.394 178.699 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 82.2 m -82.01 155.79 24.98 Favored 'General case' 0 N--CA 1.497 1.886 0 C-N-CA 119.267 -0.973 . . . . 0.0 111.113 -179.328 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.09 151.66 30.39 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.684 -0.806 . . . . 0.0 110.341 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.2 m -49.56 141.77 9.02 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.503 -0.879 . . . . 0.0 111.077 -179.75 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.17 -26.44 21.1 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 119.714 -1.232 . . . . 0.0 111.093 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.51 165.81 12.36 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 119.826 -0.749 . . . . 0.0 111.102 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.91 160.16 39.45 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.764 179.779 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -76.42 102.31 5.92 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.229 -179.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -95.48 108.99 21.25 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.657 -0.817 . . . . 0.0 110.606 -179.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 92.2 t -50.7 135.62 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 118.882 -1.127 . . . . 0.0 109.412 179.275 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.402 ' HG ' ' CD2' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -102.19 -55.5 2.46 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -179.948 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.546 ' C ' ' H ' ' A' ' 31' ' ' TYR . 6.8 p30 -154.14 173.42 4.73 Favored Pre-proline 0 N--CA 1.49 1.53 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 179.965 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.474 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -66.87 24.99 0.11 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.504 0.859 . . . . 0.0 112.035 -177.879 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' H ' ' C ' ' A' ' 29' ' ' ASN . 47.4 m-85 -150.38 -5.65 0.32 Allowed 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 119.462 -0.895 . . . . 0.0 111.611 179.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' CD2' ' HG ' ' A' ' 28' ' ' LEU . 6.3 t80 -152.54 132.41 13.28 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 119.116 -1.034 . . . . 0.0 110.409 -178.282 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.8 m -127.79 112.28 14.6 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.925 177.841 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -89.83 155.33 19.23 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 115.065 -0.971 . . . . 0.0 112.121 -178.124 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 53.9 m -99.83 113.2 25.56 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.533 178.899 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 49.1 mt . . . . . 0 N--CA 1.5 2.074 0 CA-C-O 116.385 -1.769 . . . . 0.0 109.934 179.206 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -89.07 159.9 17.32 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 119.002 -1.079 . . . . 0.0 109.476 179.575 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -96.49 -177.42 3.93 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 119.262 -0.975 . . . . 0.0 110.88 -179.432 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.478 ' O ' ' HB2' ' A' ' 5' ' ' TYR . 14.0 t-160 -70.27 127.93 34.47 Favored 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.606 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 4' ' ' HIS . 68.5 m-85 79.87 18.32 0.7 Allowed 'General case' 0 N--CA 1.507 2.392 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.052 -178.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.1 154.46 20.5 Favored Glycine 0 N--CA 1.487 2.075 0 C-N-CA 119.786 -1.197 . . . . 0.0 110.869 179.624 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 59.6 tt0 -78.85 114.33 17.7 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.453 -179.621 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.2 p -99.26 -19.25 17.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.48 178.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.98 -167.02 13.51 Favored Glycine 0 N--CA 1.488 2.152 0 C-N-CA 118.325 -1.893 . . . . 0.0 112.276 -179.237 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 111.95 146.91 10.38 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 -179.198 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 38.6 mt -59.34 153.91 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.094 -179.758 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.8 -12.81 39.87 Favored Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.647 -1.263 . . . . 0.0 111.101 -179.999 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -88.19 152.97 21.6 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.836 -0.745 . . . . 0.0 110.642 -179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.4 p -148.59 13.32 0.93 Allowed 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.944 179.742 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.81 -172.73 43.97 Favored Glycine 0 N--CA 1.483 1.783 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.76 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -62.76 160.44 32.88 Favored 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.306 1.337 . . . . 0.0 110.252 179.814 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -128.96 27.62 5.41 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.059 -178.475 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 37.9 t -105.7 120.42 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.491 -0.777 . . . . 0.0 108.99 178.684 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 74.4 m -80.27 145.48 32.14 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.243 -0.983 . . . . 0.0 110.986 -179.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -50.1 145.24 6.05 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 118.806 -1.158 . . . . 0.0 108.74 178.757 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 m -50.01 141.67 10.46 Favored 'General case' 0 C--N 1.296 -1.723 0 C-N-CA 118.828 -1.149 . . . . 0.0 111.007 -179.281 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.45 -26.89 22.62 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.339 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.669 HG22 ' OXT' ' A' ' 36' ' ' LEU . 1.1 p -105.92 -173.46 2.3 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.845 -179.694 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -148.28 157.37 43.45 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.724 178.925 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -86.79 136.25 33.06 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.428 -1.309 . . . . 0.0 109.301 -179.466 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -136.53 120.62 17.73 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 119.532 -0.867 . . . . 0.0 111.392 -178.893 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.24 118.46 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 C-N-CA 119.042 -1.063 . . . . 0.0 108.639 178.635 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.534 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -84.28 -56.82 3.44 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 -178.674 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.534 HD22 HD12 ' A' ' 28' ' ' LEU . 4.3 p30 -149.06 171.59 6.13 Favored Pre-proline 0 C--N 1.299 -1.599 0 N-CA-C 106.708 -1.59 . . . . 0.0 106.708 179.346 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -69.08 26.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.622 0 CA-C-N 119.41 0.825 . . . . 0.0 111.95 -177.421 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.519 ' H ' ' C ' ' A' ' 29' ' ' ASN . 83.3 m-85 -154.39 14.97 0.45 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.528 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.416 ' HB3' HD21 ' A' ' 29' ' ' ASN . 74.6 t80 -173.8 126.37 0.38 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.403 -177.487 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 17.7 m -126.85 111.49 14.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.406 -0.917 . . . . 0.0 109.665 178.148 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.406 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 3.6 tp60 -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 124.767 1.292 . . . . 0.0 112.561 -176.939 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 1.9 m -99.66 105.94 17.83 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.998 179.331 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.669 ' OXT' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.505 2.292 0 CA-C-O 116.269 -1.824 . . . . 0.0 109.823 179.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -117.14 152.49 34.62 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.681 179.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.403 ' O ' ' C ' ' A' ' 4' ' ' HIS . 0.3 OUTLIER -109.69 170.45 8.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.694 -179.842 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.653 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 14.5 t-160 -40.98 130.29 2.65 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 115.406 -0.815 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.653 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 42.8 m-85 68.53 40.75 1.85 Allowed 'General case' 0 N--CA 1.511 2.605 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.26 -178.468 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.12 152.62 17.3 Favored Glycine 0 N--CA 1.486 2.011 0 C-N-CA 119.942 -1.123 . . . . 0.0 111.2 179.996 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -83.78 100.85 11.19 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 119.415 -0.914 . . . . 0.0 110.161 179.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.595 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -89.85 -17.51 27.96 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 118.845 -1.142 . . . . 0.0 110.802 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.43 -159.21 8.75 Favored Glycine 0 N--CA 1.487 2.095 0 C-N-CA 117.944 -2.074 . . . . 0.0 112.675 -179.679 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 106.09 124.57 5.33 Favored Glycine 0 N--CA 1.476 1.34 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 -178.571 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 ' C ' ' O ' ' A' ' 10' ' ' GLY . 96.4 mt -41.67 147.59 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.966 -178.891 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.06 -13.52 31.6 Favored Glycine 0 N--CA 1.485 1.917 0 C-N-CA 119.879 -1.153 . . . . 0.0 111.411 -179.247 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -84.32 114.11 21.63 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 119.567 -0.853 . . . . 0.0 110.489 -179.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 28.6 p -108.11 17.47 22.27 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.757 -0.777 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -89.78 176.73 42.96 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.301 -1.428 . . . . 0.0 110.594 179.732 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.64 158.65 44.96 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 121.453 1.435 . . . . 0.0 110.234 179.389 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.7 p -119.22 16.4 13.16 Favored 'General case' 0 N--CA 1.499 1.976 0 C-N-CA 119.778 -0.769 . . . . 0.0 111.582 -178.322 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 t -95.03 118.78 41.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 119.121 -1.032 . . . . 0.0 110.459 179.75 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 3.8 m -84.99 152.93 23.1 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.076 -1.049 . . . . 0.0 109.949 179.534 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -59.7 137.0 58.17 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.22 -0.992 . . . . 0.0 110.001 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.401 ' C ' ' O ' ' A' ' 20' ' ' ALA . 3.3 m -41.36 145.1 0.28 Allowed 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.639 -0.824 . . . . 0.0 110.826 -179.797 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.39 -24.02 30.06 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.727 HG22 ' O ' ' A' ' 36' ' ' LEU . 1.0 OUTLIER -120.98 -171.63 2.23 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-O 121.558 0.694 . . . . 0.0 110.473 179.69 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.88 162.12 41.48 Favored 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.821 -1.081 . . . . 0.0 108.969 179.323 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -83.92 136.53 34.05 Favored 'General case' 0 C--N 1.301 -1.503 0 C-N-CA 118.841 -1.144 . . . . 0.0 110.904 -179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 80.4 mt-30 -132.64 139.07 47.57 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.499 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 t -78.98 123.29 35.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.073 179.977 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -88.1 -56.39 3.35 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -154.87 174.78 3.57 Favored Pre-proline 0 N--CA 1.5 2.066 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 177.04 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.473 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 9.4 Cg_exo -64.78 24.12 0.08 OUTLIER 'Trans proline' 0 C--O 1.211 -0.825 0 C-N-CA 121.005 1.137 . . . . 0.0 112.769 -179.138 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.523 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.2 m-85 -154.9 14.03 0.4 Allowed 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.139 -1.024 . . . . 0.0 110.204 179.366 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 24.7 t80 -172.43 125.79 0.51 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 119.005 -1.078 . . . . 0.0 110.701 -178.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.467 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 72.2 m -126.84 115.43 19.31 Favored 'General case' 0 N--CA 1.503 2.208 0 C-N-CA 119.448 -0.901 . . . . 0.0 109.342 178.045 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG2' HD11 ' A' ' 36' ' ' LEU . 1.5 tt0 -93.92 149.32 21.34 Favored 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 114.585 -1.188 . . . . 0.0 112.669 -177.641 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.444 ' C ' HD22 ' A' ' 36' ' ' LEU . 55.0 m -103.42 117.2 33.91 Favored 'General case' 0 N--CA 1.514 2.726 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.066 179.125 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.727 ' O ' HG22 ' A' ' 23' ' ' THR . 2.2 mm? . . . . . 0 N--CA 1.499 2.023 0 CA-C-O 116.308 -1.805 . . . . 0.0 110.173 -178.944 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.048 0.451 . . . . 0.0 109.795 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.737 HE22 ' N ' ' A' ' 8' ' ' CYS . 3.1 tt0 -85.7 -168.45 2.23 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.546 -0.861 . . . . 0.0 109.305 179.339 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -128.56 160.28 32.86 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.956 -179.616 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.654 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 18.7 t-160 -46.62 132.67 10.81 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 119.909 -0.716 . . . . 0.0 109.37 -179.53 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.654 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 25.2 m-85 72.58 24.62 2.8 Favored 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -178.526 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.421 ' C ' ' NE2' ' A' ' 2' ' ' GLN . . . -92.44 144.54 17.16 Favored Glycine 0 C--N 1.302 -1.334 0 C-N-CA 119.614 -1.279 . . . . 0.0 111.111 -179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.541 ' C ' HE22 ' A' ' 2' ' ' GLN . 38.1 tt0 -76.13 96.37 3.85 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.543 -0.863 . . . . 0.0 109.614 179.264 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.847 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -88.56 -12.0 44.0 Favored 'General case' 0 C--N 1.309 -1.19 0 C-N-CA 118.623 -1.231 . . . . 0.0 110.663 -179.272 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.53 -160.96 10.17 Favored Glycine 0 N--CA 1.488 2.157 0 C-N-CA 118.047 -2.025 . . . . 0.0 112.181 179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 101.26 149.64 23.11 Favored Glycine 0 N--CA 1.48 1.601 0 C-N-CA 119.818 -1.182 . . . . 0.0 110.489 -179.367 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.585 HD12 ' O ' ' A' ' 30' ' ' PRO . 81.9 mt -69.73 157.41 6.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 C-N-CA 119.068 -1.053 . . . . 0.0 110.455 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 73.74 -3.29 35.91 Favored Glycine 0 N--CA 1.484 1.89 0 C-N-CA 119.597 -1.287 . . . . 0.0 111.338 -179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.485 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 16.7 t80 -85.1 154.24 22.18 Favored 'General case' 0 N--CA 1.496 1.854 0 C-N-CA 119.68 -0.808 . . . . 0.0 110.012 -179.841 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 59.0 p -146.8 57.26 1.16 Allowed 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.205 -0.998 . . . . 0.0 110.463 -179.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.64 177.26 24.15 Favored Glycine 0 CA--C 1.539 1.57 0 C-N-CA 119.802 -1.189 . . . . 0.0 110.331 179.951 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -57.48 164.64 6.92 Favored 'Trans proline' 0 C--N 1.316 -1.16 0 C-N-CA 121.13 1.22 . . . . 0.0 109.799 179.382 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.847 HG22 ' O ' ' A' ' 8' ' ' CYS . 29.8 p -127.15 29.33 5.61 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.37 -0.932 . . . . 0.0 111.326 -178.639 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.9 t -117.89 120.9 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.913 179.131 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' SG ' ' C ' ' A' ' 24' ' ' THR . 10.3 m -77.67 142.33 38.89 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 119.204 -0.998 . . . . 0.0 110.644 -179.748 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -45.6 168.76 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.04 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.11 149.99 46.49 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.798 -1.161 . . . . 0.0 110.512 -179.594 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.1 -15.14 57.07 Favored Glycine 0 CA--C 1.54 1.604 0 C-N-CA 119.482 -1.342 . . . . 0.0 111.497 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.437 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -114.9 -175.2 2.64 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 119.53 -0.868 . . . . 0.0 111.032 -179.715 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.451 ' C ' ' SG ' ' A' ' 19' ' ' CYS . 0.2 OUTLIER -150.96 162.46 40.77 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.53 179.631 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.2 t -92.37 124.61 36.55 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.494 -179.601 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.429 ' OE1' ' O ' ' A' ' 24' ' ' THR . 28.9 mp0 -125.42 128.52 48.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.787 -179.872 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.7 t -64.59 142.12 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.872 -179.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.506 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -108.42 -56.72 2.22 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 178.886 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.51 ' C ' ' H ' ' A' ' 31' ' ' TYR . 10.3 p30 -161.36 171.87 6.39 Favored Pre-proline 0 N--CA 1.495 1.802 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 179.519 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.585 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.9 Cg_exo -67.25 24.24 0.11 Allowed 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 120.601 0.867 . . . . 0.0 112.817 -176.789 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.51 ' H ' ' C ' ' A' ' 29' ' ' ASN . 62.3 m-85 -150.54 14.21 0.76 Allowed 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.548 -0.861 . . . . 0.0 110.002 178.722 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' HB3' HD21 ' A' ' 29' ' ' ASN . 6.0 t80 -175.34 134.97 0.32 Allowed 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 119.344 -0.942 . . . . 0.0 110.46 -179.27 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.4 m -132.74 114.33 14.02 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 177.05 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -90.62 156.08 18.38 Favored 'General case' 0 N--CA 1.503 2.21 0 C-N-CA 119.407 -0.917 . . . . 0.0 112.986 -176.974 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.571 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 6.2 m -104.04 131.03 51.71 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.048 178.969 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.403 ' N ' ' OE1' ' A' ' 26' ' ' GLN . 70.6 mt . . . . . 0 N--CA 1.498 1.931 0 CA-C-O 116.404 -1.76 . . . . 0.0 109.875 179.667 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.827 -0.435 . . . . 0.0 109.827 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.734 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.9 OUTLIER -131.23 166.5 21.04 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.48 179.499 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.59 -175.71 3.16 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.322 -0.951 . . . . 0.0 111.123 -179.452 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.635 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 23.1 t-160 -68.06 147.51 52.26 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.987 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.635 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 54.4 m-85 55.52 26.13 8.67 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 119.322 -0.951 . . . . 0.0 108.444 -177.975 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -96.93 145.92 18.07 Favored Glycine 0 N--CA 1.483 1.791 0 C-N-CA 119.956 -1.116 . . . . 0.0 111.342 -179.509 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -77.05 116.94 18.14 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.599 -0.84 . . . . 0.0 110.598 179.917 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -105.23 -17.37 14.49 Favored 'General case' 0 C--N 1.307 -1.282 0 C-N-CA 119.969 -0.692 . . . . 0.0 110.816 179.715 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -150.48 -168.54 15.51 Favored Glycine 0 N--CA 1.486 2.032 0 C-N-CA 118.641 -1.743 . . . . 0.0 111.873 -179.308 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.81 133.91 5.59 Favored Glycine 0 N--CA 1.484 1.837 0 N-CA-C 110.131 -1.188 . . . . 0.0 110.131 -179.233 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 30' ' ' PRO . 63.0 mt -46.55 147.41 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.772 -1.171 . . . . 0.0 110.01 -179.661 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.41 -11.42 24.71 Favored Glycine 0 C--N 1.298 -1.548 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.816 -179.275 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -82.37 110.65 17.7 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.228 -0.989 . . . . 0.0 110.813 -179.829 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 72.6 p -111.43 59.1 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.432 179.235 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -137.81 179.46 18.2 Favored Glycine 0 N--CA 1.484 1.84 0 C-N-CA 120.198 -1.001 . . . . 0.0 110.713 -179.579 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -62.18 149.06 91.96 Favored 'Trans proline' 0 C--N 1.318 -1.076 0 C-N-CA 121.432 1.421 . . . . 0.0 110.671 179.757 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.2 p -110.61 -12.6 14.32 Favored 'General case' 0 C--N 1.29 -2.004 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.536 -178.705 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 35.1 t -76.77 108.98 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.375 0 C-N-CA 119.157 -1.017 . . . . 0.0 109.43 179.104 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.2 m -70.65 156.86 38.93 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.664 -179.301 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.734 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -52.92 152.3 4.06 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 119.146 -1.022 . . . . 0.0 109.224 179.276 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.11 152.24 4.38 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 118.225 -1.39 . . . . 0.0 109.981 179.821 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.94 -17.04 55.36 Favored Glycine 0 C--N 1.295 -1.709 0 C-N-CA 119.389 -1.386 . . . . 0.0 111.745 179.905 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.8 OUTLIER -120.77 -179.94 4.16 Favored 'General case' 0 N--CA 1.501 2.113 0 C-N-CA 119.704 -0.799 . . . . 0.0 111.227 -179.761 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 163.25 37.4 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.856 -1.065 . . . . 0.0 109.085 179.549 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.9 t -89.72 138.37 31.54 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 118.466 -1.294 . . . . 0.0 110.534 -179.449 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -130.96 106.08 8.17 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.074 179.882 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.3 t -61.36 114.8 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.087 179.945 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.8 tp -79.09 -51.82 9.04 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 118.275 -1.37 . . . . 0.0 108.51 -179.564 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.9 p30 -158.68 174.78 3.73 Favored Pre-proline 0 C--N 1.298 -1.653 0 CA-C-N 114.414 -1.266 . . . . 0.0 108.202 -179.051 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' O ' HD12 ' A' ' 11' ' ' ILE . 2.8 Cg_exo -65.57 24.87 0.09 OUTLIER 'Trans proline' 0 C--O 1.215 -0.655 0 C-N-CA 121.01 1.14 . . . . 0.0 113.213 -176.87 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 93.5 m-85 -152.33 10.2 0.5 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.076 -1.05 . . . . 0.0 110.703 179.023 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.402 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.8 t80 -169.67 134.4 1.38 Allowed 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 118.851 -1.14 . . . . 0.0 112.053 -178.843 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.6 m -138.07 113.73 9.7 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.696 -0.802 . . . . 0.0 109.452 177.295 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -88.61 163.54 15.78 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.507 -0.877 . . . . 0.0 111.862 -178.415 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.1 m -107.35 115.02 29.43 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.363 179.609 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 116.319 -1.8 . . . . 0.0 110.198 -179.804 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ALA . 3.4 tp60 -98.58 153.02 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 119.802 -0.759 . . . . 0.0 109.858 179.913 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.24 179.07 5.43 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.172 -1.011 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.617 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 22.6 t-160 -55.42 145.47 22.41 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.336 -0.946 . . . . 0.0 108.8 -179.633 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.617 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 48.7 m-85 60.46 29.59 19.12 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.261 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.61 155.11 20.46 Favored Glycine 0 N--CA 1.479 1.555 0 C-N-CA 119.925 -1.131 . . . . 0.0 111.81 -179.064 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.509 ' O ' ' CZ ' ' A' ' 13' ' ' TYR . 57.5 tt0 -89.82 104.54 17.1 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 119.664 -0.814 . . . . 0.0 110.357 179.455 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.1 p -90.11 -22.67 21.66 Favored 'General case' 0 C--N 1.295 -1.763 0 C-N-CA 118.868 -1.133 . . . . 0.0 110.132 179.557 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -149.35 -172.65 19.19 Favored Glycine 0 N--CA 1.486 1.984 0 C-N-CA 118.241 -1.933 . . . . 0.0 112.323 -178.783 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.52 136.49 4.64 Favored Glycine 0 C--O 1.211 -1.313 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.157 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.471 HD12 ' O ' ' A' ' 30' ' ' PRO . 29.6 mt -48.06 142.03 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.421 -1.312 . . . . 0.0 110.554 -179.408 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.44 3.2 65.5 Favored Glycine 0 N--CA 1.489 2.19 0 C-N-CA 119.874 -1.155 . . . . 0.0 112.844 179.606 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.509 ' CZ ' ' O ' ' A' ' 7' ' ' GLN . 87.9 t80 -95.97 100.45 12.12 Favored 'General case' 0 N--CA 1.504 2.259 0 C-N-CA 119.09 -1.044 . . . . 0.0 110.531 179.767 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 73.1 p -97.43 40.75 1.14 Allowed 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 119.493 -0.883 . . . . 0.0 111.254 -179.547 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.03 169.88 13.53 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 179.27 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -51.05 149.78 14.71 Favored 'Trans proline' 0 C--N 1.316 -1.182 0 C-N-CA 121.199 1.266 . . . . 0.0 109.899 179.482 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.3 p -111.84 -12.13 13.84 Favored 'General case' 0 C--N 1.288 -2.101 0 C-N-CA 119.585 -0.846 . . . . 0.0 112.337 -177.04 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 26.2 t -82.28 125.72 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 118.776 -1.169 . . . . 0.0 109.666 179.161 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 5.7 m -80.34 160.49 25.42 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 119.022 -1.071 . . . . 0.0 110.076 179.611 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -62.09 175.06 0.76 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.357 -0.937 . . . . 0.0 110.508 -179.926 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 64.6 m -62.63 144.79 55.85 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.724 -0.791 . . . . 0.0 111.251 -179.453 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.83 -12.27 60.03 Favored Glycine 0 N--CA 1.483 1.821 0 C-N-CA 119.667 -1.254 . . . . 0.0 112.435 178.684 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -120.35 166.47 13.49 Favored 'General case' 0 N--CA 1.498 1.942 0 C-N-CA 119.356 -0.937 . . . . 0.0 111.603 -179.655 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -139.36 158.52 44.0 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 114.414 -1.266 . . . . 0.0 109.717 179.776 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 15.7 t -82.14 132.16 35.24 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 119.49 -0.884 . . . . 0.0 111.274 -179.012 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -127.57 119.25 25.58 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.104 179.46 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 87.1 t -61.67 122.3 11.98 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 C-N-CA 119.227 -0.989 . . . . 0.0 109.595 179.434 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.442 HD12 HD21 ' A' ' 29' ' ' ASN . 0.0 OUTLIER -93.46 -53.28 4.13 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -179.459 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.525 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -154.23 175.02 3.3 Favored Pre-proline 0 N--CA 1.498 1.926 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 178.754 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.471 ' O ' HD12 ' A' ' 11' ' ' ILE . 6.0 Cg_exo -72.75 23.27 0.29 Allowed 'Trans proline' 0 C--O 1.217 -0.545 0 C-N-CA 120.512 0.808 . . . . 0.0 110.716 -179.673 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.525 ' H ' ' C ' ' A' ' 29' ' ' ASN . 94.1 m-85 -150.63 13.09 0.72 Allowed 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.877 -0.729 . . . . 0.0 109.867 -179.911 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.437 ' HB3' HD22 ' A' ' 29' ' ' ASN . 42.1 t80 -174.16 126.65 0.35 Allowed 'General case' 0 C--N 1.306 -1.303 0 C-N-CA 119.284 -0.966 . . . . 0.0 110.836 -178.84 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.433 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 38.4 m -128.68 112.66 14.48 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 177.103 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.449 ' HG2' HD21 ' A' ' 36' ' ' LEU . 1.6 tt0 -90.13 149.82 22.3 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.569 -1.196 . . . . 0.0 112.597 -176.973 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.577 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 40.7 m -105.51 110.59 22.98 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.409 179.566 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.574 HD22 ' N ' ' A' ' 36' ' ' LEU . 2.1 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.388 -1.768 . . . . 0.0 109.857 -179.359 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 N-CA-C 109.805 -0.443 . . . . 0.0 109.805 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -120.45 151.33 39.47 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.239 179.467 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.53 175.95 5.83 Favored 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 119.275 -0.97 . . . . 0.0 111.662 -178.848 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.579 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.7 t-160 -52.01 136.12 29.69 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.464 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.9 m-85 70.53 25.03 4.33 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 120.591 -0.444 . . . . 0.0 109.885 -178.992 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.51 149.13 19.06 Favored Glycine 0 N--CA 1.486 1.989 0 C-N-CA 119.821 -1.181 . . . . 0.0 111.441 -179.856 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -81.62 111.27 17.76 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.629 179.698 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.843 ' O ' HG22 ' A' ' 17' ' ' THR . 1.4 p -103.45 -12.76 16.95 Favored 'General case' 0 C--N 1.303 -1.456 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.415 179.723 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.08 -163.55 14.31 Favored Glycine 0 N--CA 1.488 2.141 0 C-N-CA 118.451 -1.833 . . . . 0.0 112.083 -179.761 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.0 133.35 8.04 Favored Glycine 0 N--CA 1.48 1.628 0 C-N-CA 119.813 -1.184 . . . . 0.0 110.54 -179.634 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 41.5 mt -50.6 154.12 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.014 -1.074 . . . . 0.0 109.696 -179.765 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.16 15.04 81.34 Favored Glycine 0 N--CA 1.488 2.127 0 C-N-CA 119.646 -1.264 . . . . 0.0 112.148 -179.827 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.447 ' CZ ' ' CA ' ' A' ' 15' ' ' GLY . 21.2 t80 -105.63 153.29 22.01 Favored 'General case' 0 N--CA 1.505 2.313 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.148 -179.882 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 62.9 p -136.42 2.06 2.69 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.604 -0.838 . . . . 0.0 111.479 -179.058 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.447 ' CA ' ' CZ ' ' A' ' 13' ' ' TYR . . . -93.97 178.59 37.67 Favored Glycine 0 CA--C 1.551 2.294 0 C-N-CA 119.338 -1.411 . . . . 0.0 111.584 -179.459 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.41 161.78 29.84 Favored 'Trans proline' 0 C--O 1.211 -0.87 0 C-N-CA 122.189 1.926 . . . . 0.0 111.881 -179.683 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.843 HG22 ' O ' ' A' ' 8' ' ' CYS . 33.7 p -116.44 25.46 10.6 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.846 -178.653 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 21.7 t -105.07 116.63 49.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 119.436 -0.906 . . . . 0.0 109.875 179.407 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 72.4 m -85.22 149.44 25.5 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.501 -0.88 . . . . 0.0 110.42 -179.905 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.424 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -55.56 150.51 12.03 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.268 -0.973 . . . . 0.0 110.013 179.58 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -53.46 160.24 1.26 Allowed 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 118.559 -1.256 . . . . 0.0 109.481 179.467 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.7 -20.15 9.93 Favored Glycine 0 N--CA 1.478 1.435 0 C-N-CA 119.205 -1.474 . . . . 0.0 110.069 -179.378 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -126.83 163.43 23.61 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.668 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.423 ' O ' ' OE1' ' A' ' 26' ' ' GLN . 0.0 OUTLIER -135.84 173.82 11.29 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.821 179.214 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.8 t -87.09 148.81 25.08 Favored 'General case' 0 C--N 1.295 -1.772 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.371 -179.393 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.448 ' OE1' ' N ' ' A' ' 26' ' ' GLN . 29.5 mp0 -143.64 124.54 14.3 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 119.506 -0.877 . . . . 0.0 110.558 179.969 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 38.7 t -61.56 113.6 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 C-N-CA 119.114 -1.034 . . . . 0.0 109.167 179.04 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.507 HD12 HD22 ' A' ' 29' ' ' ASN . 0.1 OUTLIER -81.97 -57.05 3.58 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 -179.797 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.52 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.7 p30 -150.69 171.86 5.95 Favored Pre-proline 0 CA--C 1.566 1.566 0 CA-C-N 114.053 -1.431 . . . . 0.0 107.346 179.579 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -66.07 24.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.214 -0.69 0 C-N-CA 120.739 0.959 . . . . 0.0 113.123 -177.028 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.52 ' H ' ' C ' ' A' ' 29' ' ' ASN . 86.3 m-85 -155.58 16.63 0.39 Allowed 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.697 -0.801 . . . . 0.0 109.903 178.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.4 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 52.9 t80 -171.65 121.8 0.5 Allowed 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.571 -176.414 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.44 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 13.8 m -118.44 111.81 19.15 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 176.656 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.426 ' HG2' HD21 ' A' ' 36' ' ' LEU . 6.0 tp60 -90.51 144.02 26.19 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.473 -1.24 . . . . 0.0 112.448 -177.559 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.412 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 94.6 m -87.85 115.13 25.09 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.822 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.426 HD21 ' HG2' ' A' ' 34' ' ' GLN . 33.0 mt . . . . . 0 N--CA 1.497 1.902 0 CA-C-O 116.391 -1.766 . . . . 0.0 110.197 -178.356 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -106.87 148.25 28.79 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.884 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.6 m -93.46 -167.43 1.7 Allowed 'General case' 0 N--CA 1.489 1.512 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.153 -179.709 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.636 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 16.4 t-160 -66.71 132.12 47.43 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.934 -1.107 . . . . 0.0 108.649 -179.466 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.636 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 28.5 m-85 71.35 29.35 2.77 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -178.518 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.01 154.62 20.25 Favored Glycine 0 N--CA 1.481 1.693 0 C-N-CA 119.896 -1.145 . . . . 0.0 110.935 179.942 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -86.54 117.3 25.23 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.496 -0.882 . . . . 0.0 110.416 179.984 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.886 ' O ' HG22 ' A' ' 17' ' ' THR . 1.2 p -102.7 -33.16 9.52 Favored 'General case' 0 C--N 1.309 -1.154 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.624 179.949 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 33' ' ' SER . . . -152.42 -178.75 27.4 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 117.433 -2.318 . . . . 0.0 113.828 -177.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 123.81 151.57 8.23 Favored Glycine 0 N--CA 1.481 1.635 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.392 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.411 HG21 HD13 ' A' ' 11' ' ' ILE . 12.3 mt -59.32 149.06 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 C-N-CA 118.562 -1.255 . . . . 0.0 109.915 179.997 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.74 -24.07 8.13 Favored Glycine 0 C--N 1.296 -1.663 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.211 -179.559 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -82.38 138.17 34.54 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.44 -0.904 . . . . 0.0 109.561 179.578 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 3.1 p -136.53 40.13 2.61 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 119.517 -0.873 . . . . 0.0 110.462 -179.759 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.44 176.3 16.27 Favored Glycine 0 N--CA 1.485 1.916 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 179.151 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.9 155.95 35.8 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 N-CA-C 109.407 -1.036 . . . . 0.0 109.407 179.132 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.886 HG22 ' O ' ' A' ' 8' ' ' CYS . 38.8 p -117.89 32.64 6.04 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 119.642 -0.823 . . . . 0.0 110.869 -178.652 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.7 t -117.96 119.13 60.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.843 179.347 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.7 m -80.02 171.31 15.26 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 119.307 -0.957 . . . . 0.0 110.641 -179.707 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 2' ' ' GLN . . . -74.16 147.32 42.72 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 119.326 -0.95 . . . . 0.0 109.236 179.345 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.1 m -43.05 139.26 1.82 Allowed 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.305 -0.958 . . . . 0.0 110.677 -179.579 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.43 -26.8 22.92 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 119.861 -1.162 . . . . 0.0 111.248 -179.906 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.613 HG22 ' OXT' ' A' ' 36' ' ' LEU . 0.8 OUTLIER -114.01 171.46 7.59 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.183 -179.93 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.65 161.57 37.62 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.709 -1.132 . . . . 0.0 109.973 -179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.0 t -85.69 140.39 30.56 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.02 -1.072 . . . . 0.0 110.864 -179.383 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 -137.19 117.47 13.59 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 119.845 -0.742 . . . . 0.0 110.399 179.776 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -54.56 126.33 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 C-N-CA 119.494 -0.882 . . . . 0.0 109.568 179.489 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -95.94 -57.64 2.3 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 179.802 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.03 177.03 2.05 Favored Pre-proline 0 N--CA 1.502 2.134 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.065 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -67.43 24.08 0.12 Allowed 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 120.774 0.983 . . . . 0.0 111.716 -178.985 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' ASN . 98.3 m-85 -154.38 12.82 0.42 Allowed 'General case' 0 C--N 1.305 -1.357 0 C-N-CA 119.586 -0.846 . . . . 0.0 110.034 179.522 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.412 ' HB3' HD22 ' A' ' 29' ' ' ASN . 11.6 t80 -171.98 137.16 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.169 -1.412 . . . . 0.0 112.435 -178.137 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 9' ' ' GLY . 50.8 m -136.88 115.98 12.45 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 177.402 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.429 ' HG3' ' N ' ' A' ' 35' ' ' CYS . 4.8 tp60 -89.64 155.69 19.07 Favored 'General case' 0 N--CA 1.51 2.563 0 O-C-N 124.119 0.887 . . . . 0.0 113.062 -176.795 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.429 ' N ' ' HG3' ' A' ' 34' ' ' GLN . 8.6 m -105.85 106.09 16.44 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 114.844 -1.071 . . . . 0.0 110.459 179.035 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.613 ' OXT' HG22 ' A' ' 23' ' ' THR . 1.7 mm? . . . . . 0 N--CA 1.502 2.155 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.705 179.918 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.51 ' NE2' ' O ' ' A' ' 7' ' ' GLN . 0.2 OUTLIER -101.97 151.65 21.88 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.666 -0.814 . . . . 0.0 110.053 179.797 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.67 179.87 4.53 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 119.6 -0.84 . . . . 0.0 110.756 -179.706 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.642 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 22.7 t-160 -57.85 147.5 28.28 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 -179.949 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.642 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 86.8 m-85 58.12 23.75 10.5 Favored 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 120.186 -0.606 . . . . 0.0 110.007 -178.884 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.401 ' H ' ' HB2' ' A' ' 35' ' ' CYS . . . -99.67 156.11 19.77 Favored Glycine 0 N--CA 1.498 2.785 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.898 -179.341 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.51 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 58.3 tt0 -83.85 110.06 18.06 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.416 -179.837 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.846 ' O ' HG22 ' A' ' 17' ' ' THR . 3.4 p -96.24 -19.61 19.18 Favored 'General case' 0 C--N 1.307 -1.251 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.207 179.046 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.84 -149.96 5.28 Favored Glycine 0 C--N 1.302 -1.35 0 C-N-CA 118.887 -1.625 . . . . 0.0 111.47 -179.565 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.11 126.09 5.79 Favored Glycine 0 N--CA 1.477 1.375 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -178.872 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 30' ' ' PRO . 54.3 mt -48.61 149.6 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 C-N-CA 118.543 -1.263 . . . . 0.0 110.526 -179.291 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.28 -13.55 20.38 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.106 -179.754 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -70.46 153.5 42.89 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.467 -0.893 . . . . 0.0 110.231 -179.934 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -143.47 52.89 1.33 Allowed 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 119.321 -0.952 . . . . 0.0 110.687 -179.573 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -143.01 174.3 23.72 Favored Glycine 0 N--CA 1.486 1.972 0 C-N-CA 119.851 -1.166 . . . . 0.0 110.442 179.657 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.12 163.64 5.92 Favored 'Trans proline' 0 C--N 1.315 -1.195 0 C-N-CA 121.072 1.181 . . . . 0.0 109.795 179.073 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.846 HG22 ' O ' ' A' ' 8' ' ' CYS . 74.9 p -127.4 15.65 7.14 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.257 -0.977 . . . . 0.0 111.971 -178.332 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 90.8 t -91.21 115.61 30.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.926 178.291 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 20' ' ' ALA . 54.0 m -79.99 130.13 35.03 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.175 -1.01 . . . . 0.0 110.537 -179.217 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.453 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -41.12 132.01 2.54 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.978 179.625 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.428 ' C ' ' O ' ' A' ' 20' ' ' ALA . 0.4 OUTLIER -40.07 144.85 0.18 Allowed 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.393 -0.923 . . . . 0.0 110.57 -179.683 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 104.13 -23.88 30.78 Favored Glycine 0 N--CA 1.482 1.746 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.72 -179.177 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -122.82 176.96 5.69 Favored 'General case' 0 N--CA 1.495 1.791 0 C-N-CA 120.152 -0.619 . . . . 0.0 110.765 179.818 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -136.2 167.84 20.52 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 119.882 -0.727 . . . . 0.0 109.675 179.209 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.3 t -93.65 106.32 18.3 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.854 -1.139 . . . . 0.0 110.653 -179.117 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -106.77 136.68 46.18 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 119.945 -0.702 . . . . 0.0 110.264 179.897 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.4 t -83.77 104.2 11.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 C-N-CA 119.527 -0.869 . . . . 0.0 110.926 -179.473 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.529 HD23 HD21 ' A' ' 29' ' ' ASN . 7.5 tp -62.06 -57.86 10.0 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.321 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.529 HD21 HD23 ' A' ' 28' ' ' LEU . 0.8 OUTLIER -146.03 173.42 4.27 Favored Pre-proline 0 C--N 1.303 -1.422 0 CA-C-N 113.951 -1.477 . . . . 0.0 107.073 178.31 . . . . . . . . 3 3 . 1 . 035 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.495 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.7 Cg_exo -69.41 23.57 0.16 Allowed 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 120.413 0.742 . . . . 0.0 111.99 -177.972 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.493 ' H ' ' C ' ' A' ' 29' ' ' ASN . 34.2 m-85 -147.56 7.62 0.87 Allowed 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.239 179.396 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -163.62 112.76 1.26 Allowed 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.163 -178.949 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.1 m -115.87 114.29 24.51 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 119.243 -0.983 . . . . 0.0 108.982 177.647 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 18.0 tt0 -94.65 166.95 11.76 Favored 'General case' 0 C--N 1.287 -2.118 0 C-N-CA 119.329 -0.948 . . . . 0.0 112.488 -177.792 . . . . . . . . 1 1 . 1 . 035 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.401 ' HB2' ' H ' ' A' ' 6' ' ' GLY . 13.9 m -100.44 108.31 20.27 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 114.883 -1.053 . . . . 0.0 109.826 179.722 . . . . . . . . 2 2 . 1 . 035 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 11.6 mt . . . . . 0 N--CA 1.497 1.914 0 CA-C-O 116.229 -1.844 . . . . 0.0 109.951 -179.634 . . . . . . . . 0 0 . 1 . 036 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 . . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -94.64 -166.69 1.52 Allowed 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 119.454 -0.898 . . . . 0.0 110.096 179.871 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -134.69 -175.42 3.89 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.91 -0.716 . . . . 0.0 110.408 179.943 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.631 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.5 t-160 -71.39 154.38 41.61 Favored 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 119.201 -1.0 . . . . 0.0 109.056 179.725 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.631 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 63.4 m-85 51.18 18.04 0.54 Allowed 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.697 -178.338 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -93.66 155.67 22.21 Favored Glycine 0 N--CA 1.488 2.15 0 C-N-CA 119.65 -1.262 . . . . 0.0 112.165 -178.857 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -83.27 110.86 18.44 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.644 179.666 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.848 ' O ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -93.78 -26.23 17.06 Favored 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 118.819 -1.152 . . . . 0.0 110.868 179.495 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -152.14 -151.36 5.62 Favored Glycine 0 N--CA 1.48 1.614 0 C-N-CA 118.343 -1.884 . . . . 0.0 112.601 -178.972 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 150.42 18.78 Favored Glycine 0 N--CA 1.478 1.465 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -178.289 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.456 HD12 ' O ' ' A' ' 30' ' ' PRO . 77.3 mt -62.16 149.73 9.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 C-N-CA 118.508 -1.277 . . . . 0.0 110.33 -179.439 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.18 -4.09 42.41 Favored Glycine 0 N--CA 1.488 2.117 0 C-N-CA 119.676 -1.249 . . . . 0.0 111.313 -179.144 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.3 t80 -80.44 125.56 30.09 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.85 -0.74 . . . . 0.0 110.959 -179.819 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 74.1 p -117.53 58.91 0.79 Allowed 'General case' 0 N--CA 1.499 1.997 0 C-N-CA 120.095 -0.642 . . . . 0.0 110.149 179.678 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.03 21.42 Favored Glycine 0 N--CA 1.486 1.982 0 C-N-CA 119.591 -1.29 . . . . 0.0 111.322 -179.562 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -68.44 159.77 51.99 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 C-N-CA 121.758 1.638 . . . . 0.0 110.506 179.458 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.848 HG22 ' O ' ' A' ' 8' ' ' CYS . 15.0 p -120.23 12.63 11.83 Favored 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.569 -178.661 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 2.3 t -96.62 116.54 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 C-N-CA 119.248 -0.981 . . . . 0.0 110.116 179.653 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 36.4 m -79.11 149.41 32.07 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.191 -1.004 . . . . 0.0 110.199 -179.765 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.436 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -60.0 146.69 41.71 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.058 -1.057 . . . . 0.0 110.09 179.757 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 p -43.09 149.66 0.21 Allowed 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.599 179.524 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.19 -12.89 68.46 Favored Glycine 0 N--CA 1.484 1.894 0 C-N-CA 119.368 -1.396 . . . . 0.0 111.298 -179.849 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 1.0 OUTLIER -134.04 178.83 6.65 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 119.874 -0.73 . . . . 0.0 111.095 -179.971 . . . . . . . . 3 3 . 1 . 036 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.63 168.69 19.55 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.677 179.845 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 25.1 t -89.87 136.44 33.04 Favored 'General case' 0 N--CA 1.503 2.2 0 C-N-CA 118.776 -1.17 . . . . 0.0 110.914 -179.535 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.0 mm-40 -128.27 133.1 48.71 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.147 -179.661 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 t -88.11 108.32 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 119.132 -1.027 . . . . 0.0 109.633 179.041 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.3 tp -69.69 -51.03 38.19 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 118.495 -1.282 . . . . 0.0 108.557 -179.359 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.491 ' C ' ' H ' ' A' ' 31' ' ' TYR . 8.4 p30 -159.54 173.87 4.52 Favored Pre-proline 0 C--N 1.3 -1.57 0 CA-C-N 114.115 -1.402 . . . . 0.0 107.843 -179.122 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.1 Cg_exo -66.34 24.93 0.1 OUTLIER 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 120.909 1.073 . . . . 0.0 113.106 -176.713 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' H ' ' C ' ' A' ' 29' ' ' ASN . 99.3 m-85 -152.75 19.37 0.61 Allowed 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 118.792 -1.163 . . . . 0.0 110.468 179.287 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' ' ND2' ' A' ' 29' ' ' ASN . 48.3 t80 -175.99 130.66 0.24 Allowed 'General case' 0 N--CA 1.492 1.625 0 C-N-CA 119.325 -0.95 . . . . 0.0 111.094 -179.452 . . . . . . . . 2 2 . 1 . 036 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 56.1 m -132.57 112.04 11.74 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 119.139 -1.024 . . . . 0.0 109.834 177.166 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -93.73 157.77 15.99 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.071 -178.773 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.3 m -102.39 121.14 41.73 Favored 'General case' 0 N--CA 1.499 1.991 0 C-N-CA 119.801 -0.76 . . . . 0.0 110.145 179.36 . . . . . . . . 1 1 . 1 . 036 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.9 mt . . . . . 0 N--CA 1.504 2.243 0 CA-C-O 116.132 -1.89 . . . . 0.0 109.567 -179.949 . . . . . . . . 0 0 . 1 . 037 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 7' ' ' GLN . 11.7 tp60 -113.51 147.54 37.73 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.563 179.604 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.77 164.71 12.82 Favored 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 119.251 -0.98 . . . . 0.0 111.937 -178.944 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.621 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.8 t-160 -44.73 159.41 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.159 179.708 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.621 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 67.3 m-85 47.57 19.37 0.14 Allowed 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.545 -0.862 . . . . 0.0 110.727 -179.511 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.25 154.39 20.44 Favored Glycine 0 N--CA 1.5 2.906 0 C-N-CA 119.518 -1.325 . . . . 0.0 112.736 -178.707 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.449 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 39.7 tt0 -78.17 108.49 11.51 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.367 179.755 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.667 ' O ' HG22 ' A' ' 17' ' ' THR . 2.0 p -92.61 -24.72 18.6 Favored 'General case' 0 C--O 1.208 -1.103 0 C-N-CA 119.008 -1.077 . . . . 0.0 110.794 179.386 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -151.26 -157.03 7.66 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 118.614 -1.755 . . . . 0.0 112.253 -178.763 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.433 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 113.94 126.38 4.35 Favored Glycine 0 N--CA 1.476 1.339 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -178.876 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 30' ' ' PRO . 17.4 mt -40.41 145.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.428 -0.909 . . . . 0.0 110.62 -179.471 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.9 -1.04 56.29 Favored Glycine 0 CA--C 1.544 1.903 0 C-N-CA 119.679 -1.248 . . . . 0.0 111.795 -179.405 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -91.43 101.3 13.97 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.424 179.693 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.6 p -95.1 55.95 1.86 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.764 -0.774 . . . . 0.0 110.426 -179.651 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.07 171.76 22.0 Favored Glycine 0 N--CA 1.491 2.319 0 C-N-CA 120.021 -1.085 . . . . 0.0 111.228 179.99 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -58.68 161.9 13.97 Favored 'Trans proline' 0 C--O 1.205 -1.162 0 C-N-CA 121.756 1.637 . . . . 0.0 110.415 179.593 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.667 HG22 ' O ' ' A' ' 8' ' ' CYS . 73.0 p -131.33 20.14 4.81 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.712 -178.813 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.8 t -85.21 116.11 28.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 C-N-CA 119.444 -0.902 . . . . 0.0 109.379 178.694 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.06 144.07 29.31 Favored 'General case' 0 N--CA 1.494 1.73 0 C-N-CA 119.221 -0.992 . . . . 0.0 110.149 -179.529 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.34 169.1 0.08 Allowed 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.198 -179.969 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.5 p -67.07 143.45 56.7 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.561 -0.856 . . . . 0.0 110.474 -179.934 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 87.79 -17.36 45.83 Favored Glycine 0 N--CA 1.482 1.757 0 C-N-CA 119.464 -1.35 . . . . 0.0 111.153 179.897 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -114.39 169.9 8.7 Favored 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 119.873 -0.731 . . . . 0.0 110.515 -179.916 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.53 160.03 41.8 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.223 -179.992 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 16.3 t -79.97 116.73 20.27 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.111 -1.036 . . . . 0.0 111.114 -179.269 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -113.99 136.16 53.21 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.394 179.19 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 80.6 t -83.43 132.09 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 119.402 -0.919 . . . . 0.0 110.871 -179.145 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.468 HD23 HD21 ' A' ' 29' ' ' ASN . 5.0 tp -95.73 -53.87 3.55 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.399 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' TYR . 2.2 m-80 -149.74 173.33 4.36 Favored Pre-proline 0 N--CA 1.495 1.811 0 CA-C-N 114.55 -1.205 . . . . 0.0 107.876 178.905 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.694 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.7 Cg_exo -70.42 23.88 0.19 Allowed 'Trans proline' 0 C--O 1.216 -0.597 0 C-N-CA 120.539 0.826 . . . . 0.0 111.39 -179.199 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' ASN . 67.0 m-85 -152.88 20.17 0.59 Allowed 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.875 -0.73 . . . . 0.0 109.661 179.305 . . . . . . . . 2 2 . 1 . 037 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -173.96 129.76 0.4 Allowed 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 119.28 -0.968 . . . . 0.0 111.35 -179.395 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 62.6 m -136.79 119.45 16.07 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.606 -0.838 . . . . 0.0 109.549 177.927 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -99.81 158.28 15.91 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 119.727 -0.789 . . . . 0.0 112.431 -178.464 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.6 m -92.1 110.83 22.21 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 178.795 . . . . . . . . 1 1 . 1 . 037 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 85.4 mt . . . . . 0 N--CA 1.496 1.864 0 CA-C-O 116.415 -1.755 . . . . 0.0 110.066 -178.681 . . . . . . . . 0 0 . 1 . 038 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.686 -0.487 . . . . 0.0 109.686 . . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 3.7 tp60 -127.8 -176.89 3.91 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.953 -0.699 . . . . 0.0 110.177 179.771 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.42 174.77 8.74 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.415 -179.87 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.615 ' CE1' ' CZ ' ' A' ' 5' ' ' TYR . 17.3 t-160 -55.17 134.08 49.37 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.801 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.615 ' CZ ' ' CE1' ' A' ' 4' ' ' HIS . 42.2 m-85 69.23 -3.48 1.54 Allowed 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.528 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.467 ' H ' ' C ' ' A' ' 4' ' ' HIS . . . -61.45 152.75 41.02 Favored Glycine 0 C--N 1.298 -1.536 0 C-N-CA 119.681 -1.247 . . . . 0.0 110.765 179.715 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -84.61 111.93 19.98 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.72 -179.952 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.904 ' O ' HG22 ' A' ' 17' ' ' THR . 1.7 p -89.69 -34.42 16.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 118.98 -1.088 . . . . 0.0 109.937 179.123 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -148.8 -155.54 6.75 Favored Glycine 0 N--CA 1.48 1.569 0 C-N-CA 118.303 -1.903 . . . . 0.0 112.395 -178.797 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.31 152.52 14.67 Favored Glycine 0 C--N 1.3 -1.423 0 N-CA-C 109.208 -1.557 . . . . 0.0 109.208 -178.456 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.403 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 11.0 mt -60.87 146.9 10.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 C-N-CA 119.027 -1.069 . . . . 0.0 110.917 -179.309 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 80.48 -8.76 52.85 Favored Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.85 -1.167 . . . . 0.0 111.736 -179.909 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.479 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 52.2 t80 -82.64 119.21 23.99 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.417 -0.913 . . . . 0.0 110.865 -179.652 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 6.4 p -113.04 57.62 0.66 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.329 179.791 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -145.43 -179.27 21.6 Favored Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.663 -1.256 . . . . 0.0 111.056 -179.911 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -69.19 157.14 62.62 Favored 'Trans proline' 0 C--O 1.21 -0.907 0 C-N-CA 121.818 1.679 . . . . 0.0 110.596 179.55 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.904 HG22 ' O ' ' A' ' 8' ' ' CYS . 47.7 p -115.87 13.31 16.01 Favored 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.703 -0.799 . . . . 0.0 111.716 -178.281 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.5 t -84.31 110.27 18.64 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.948 -1.101 . . . . 0.0 109.663 179.322 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 73.4 m -77.01 149.56 35.88 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 119.253 -0.979 . . . . 0.0 110.877 -179.067 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -47.63 155.98 0.34 Allowed 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 119.24 -0.984 . . . . 0.0 110.239 179.804 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -52.64 144.8 13.13 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 119.773 -0.771 . . . . 0.0 111.428 -179.84 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.06 -25.15 10.52 Favored Glycine 0 N--CA 1.484 1.858 0 C-N-CA 119.968 -1.11 . . . . 0.0 111.673 178.718 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.46 173.86 6.14 Favored 'General case' 0 N--CA 1.498 1.927 0 C-N-CA 119.65 -0.82 . . . . 0.0 110.726 -179.462 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.64 170.14 17.05 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.592 -0.843 . . . . 0.0 110.283 -179.518 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.5 t -87.65 140.99 28.96 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.12 -1.032 . . . . 0.0 111.114 -179.417 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -141.9 113.88 8.03 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.43 179.841 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.6 t -62.86 111.44 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 119.585 -0.846 . . . . 0.0 110.332 179.901 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.6 tp -70.87 -48.97 50.96 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 118.021 -1.471 . . . . 0.0 107.651 179.299 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.471 ' C ' ' H ' ' A' ' 31' ' ' TYR . 7.6 p30 -163.27 175.09 3.0 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 113.728 -1.578 . . . . 0.0 107.655 -179.554 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' O ' ' CD1' ' A' ' 31' ' ' TYR . 6.3 Cg_exo -65.93 28.9 0.1 OUTLIER 'Trans proline' 0 N--CA 1.48 0.733 0 C-N-CA 121.001 1.134 . . . . 0.0 113.6 -177.278 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' CD1' ' O ' ' A' ' 30' ' ' PRO . 70.7 m-85 -154.48 13.78 0.43 Allowed 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.079 -1.048 . . . . 0.0 110.144 178.425 . . . . . . . . 2 2 . 1 . 038 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -175.35 133.93 0.31 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.734 -1.186 . . . . 0.0 111.747 -178.544 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.7 m -131.54 109.07 9.99 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.54 -0.864 . . . . 0.0 109.487 177.286 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -86.82 153.18 21.85 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.315 -1.311 . . . . 0.0 112.72 -177.85 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 21.4 m -97.4 115.33 27.54 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.847 178.961 . . . . . . . . 1 1 . 1 . 038 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 31.8 mt . . . . . 0 N--CA 1.502 2.15 0 CA-C-O 116.403 -1.76 . . . . 0.0 110.329 -179.879 . . . . . . . . 0 0 . 1 . 039 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 . . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' NE2' ' OH ' ' A' ' 13' ' ' TYR . 1.3 tp60 -118.15 169.22 9.87 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.642 179.647 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -113.37 166.34 11.58 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.405 -179.214 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.622 ' CE1' ' CE2' ' A' ' 5' ' ' TYR . 21.0 t-160 -48.56 139.67 9.02 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.56 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.622 ' CE2' ' CE1' ' A' ' 4' ' ' HIS . 79.8 m-85 58.21 30.13 18.98 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.297 -178.491 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.59 148.34 18.59 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 119.835 -1.174 . . . . 0.0 111.976 -178.98 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 33.3 tt0 -75.81 102.39 5.46 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 119.771 -0.772 . . . . 0.0 110.694 179.643 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.439 ' O ' HG22 ' A' ' 17' ' ' THR . 1.1 p -91.21 -14.25 31.34 Favored 'General case' 0 C--N 1.307 -1.265 0 C-N-CA 118.768 -1.173 . . . . 0.0 110.054 179.389 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -156.08 -154.29 6.92 Favored Glycine 0 N--CA 1.485 1.938 0 C-N-CA 118.423 -1.846 . . . . 0.0 112.378 -179.492 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.13 137.23 8.69 Favored Glycine 0 N--CA 1.483 1.79 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -178.813 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 31.6 mt -49.04 145.21 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 118.327 -1.349 . . . . 0.0 110.076 -179.565 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.79 4.72 89.52 Favored Glycine 0 N--CA 1.484 1.846 0 C-N-CA 119.425 -1.369 . . . . 0.0 111.594 -179.575 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' OH ' ' NE2' ' A' ' 2' ' ' GLN . 87.4 t80 -100.25 113.64 26.49 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.649 -0.82 . . . . 0.0 110.222 179.979 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.1 p -111.05 46.5 1.07 Allowed 'General case' 0 N--CA 1.499 2.004 0 C-N-CA 119.849 -0.741 . . . . 0.0 110.718 -179.707 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -123.79 172.89 16.49 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 179.419 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -62.31 155.89 54.36 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 N-CA-C 109.141 -1.138 . . . . 0.0 109.141 178.837 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.439 HG22 ' O ' ' A' ' 8' ' ' CYS . 32.8 p -117.01 20.34 13.86 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.647 -178.536 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.6 t -89.46 120.82 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 C-N-CA 119.385 -0.926 . . . . 0.0 109.305 178.718 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 86.0 m -83.19 156.47 23.19 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 119.14 -1.024 . . . . 0.0 110.774 -179.345 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -59.47 152.95 20.46 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 119.324 -0.951 . . . . 0.0 109.706 179.395 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -50.72 144.98 7.43 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 118.79 -1.164 . . . . 0.0 110.196 179.957 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.72 -12.02 69.97 Favored Glycine 0 CA--C 1.544 1.886 0 C-N-CA 119.479 -1.344 . . . . 0.0 112.373 179.58 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.03 163.68 23.21 Favored 'General case' 0 N--CA 1.504 2.234 0 C-N-CA 119.61 -0.836 . . . . 0.0 111.722 -179.699 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.22 158.92 39.27 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.179 -179.906 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.5 t -89.53 131.87 35.35 Favored 'General case' 0 N--CA 1.494 1.725 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.775 -179.519 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -131.48 119.05 21.03 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.159 179.663 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.3 t -54.29 117.23 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.664 179.668 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.489 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.0 OUTLIER -82.3 -58.01 3.12 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 -179.923 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.521 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -152.16 176.75 2.2 Favored Pre-proline 0 N--CA 1.494 1.759 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 177.327 . . . . . . . . 3 3 . 1 . 039 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' C ' ' CD1' ' A' ' 31' ' ' TYR . 5.9 Cg_exo -67.99 24.56 0.13 Allowed 'Trans proline' 0 C--O 1.215 -0.645 0 C-N-CA 121.056 1.171 . . . . 0.0 112.047 -178.636 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.521 ' H ' ' C ' ' A' ' 29' ' ' ASN . 88.9 m-85 -155.01 15.03 0.41 Allowed 'General case' 0 C--N 1.303 -1.431 0 C-N-CA 119.541 -0.864 . . . . 0.0 110.043 179.877 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' OH ' ' CD ' ' A' ' 34' ' ' GLN . 21.2 t80 -174.17 124.42 0.33 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 118.83 -1.148 . . . . 0.0 111.062 -177.746 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.489 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 22.3 m -124.98 115.44 20.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 176.948 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 5.4 tp60 -94.34 151.69 19.22 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.834 -1.075 . . . . 0.0 112.733 -176.251 . . . . . . . . 2 2 . 1 . 039 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 48.3 m -100.98 107.21 18.62 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.515 179.061 . . . . . . . . 1 1 . 1 . 039 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 N--CA 1.501 2.078 0 CA-C-O 116.413 -1.755 . . . . 0.0 109.943 -179.615 . . . . . . . . 0 0 . 1 . 040 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.67 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 . . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -97.57 154.39 17.56 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 119.449 -0.901 . . . . 0.0 110.149 179.877 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.6 p -99.73 -172.95 2.34 Favored 'General case' 0 C--N 1.311 -1.099 0 C-N-CA 119.792 -0.763 . . . . 0.0 110.867 -179.617 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.59 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 22.8 t-160 -61.8 160.71 11.43 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.312 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.59 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 81.9 m-85 47.09 19.33 0.1 Allowed 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.631 -1.227 . . . . 0.0 109.125 -178.046 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.486 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -87.09 154.06 26.11 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.511 -1.328 . . . . 0.0 112.62 -178.138 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -89.13 114.72 26.02 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.381 179.577 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.861 ' O ' HG22 ' A' ' 17' ' ' THR . 1.8 p -103.05 -21.51 13.91 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 119.567 -0.853 . . . . 0.0 111.093 -179.945 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' N ' ' HB2' ' A' ' 33' ' ' SER . . . -155.32 -153.32 6.49 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 118.175 -1.964 . . . . 0.0 112.765 -179.145 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 102.6 139.3 10.41 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -178.948 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.554 HD12 ' O ' ' A' ' 30' ' ' PRO . 90.9 mt -51.32 151.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 C-N-CA 117.997 -1.481 . . . . 0.0 110.069 -179.437 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' N ' HG22 ' A' ' 11' ' ' ILE . . . 80.68 -15.98 16.97 Favored Glycine 0 C--N 1.296 -1.676 0 C-N-CA 119.508 -1.329 . . . . 0.0 111.032 -179.701 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -82.06 124.5 29.88 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.534 -0.866 . . . . 0.0 110.394 -179.838 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -120.55 37.29 4.32 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.309 -179.933 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -116.12 -175.5 17.94 Favored Glycine 0 N--CA 1.491 2.356 0 C-N-CA 120.298 -0.953 . . . . 0.0 111.133 -179.657 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_endo -68.28 158.71 56.38 Favored 'Trans proline' 0 C--N 1.323 -0.805 0 C-N-CA 121.798 1.665 . . . . 0.0 110.493 179.634 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.861 HG22 ' O ' ' A' ' 8' ' ' CYS . 41.7 p -122.23 31.09 6.29 Favored 'General case' 0 N--CA 1.499 2.011 0 C-N-CA 119.544 -0.863 . . . . 0.0 112.012 -178.184 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 t -111.52 117.07 54.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.954 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.733 178.707 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.427 ' SG ' ' N ' ' A' ' 25' ' ' CYS . 4.3 m -85.32 142.17 29.53 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 119.224 -0.991 . . . . 0.0 110.808 -179.598 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.404 ' O ' ' OG1' ' A' ' 23' ' ' THR . . . -49.13 146.93 3.22 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.576 -0.849 . . . . 0.0 110.358 179.851 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.1 m -47.3 153.84 0.46 Allowed 'General case' 0 N--CA 1.495 1.814 0 C-N-CA 119.343 -0.943 . . . . 0.0 110.733 -179.853 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.3 -26.11 12.77 Favored Glycine 0 N--CA 1.48 1.57 0 C-N-CA 119.668 -1.253 . . . . 0.0 110.308 179.826 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.404 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.7 OUTLIER -119.59 171.97 7.99 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.245 -0.582 . . . . 0.0 110.129 179.779 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.67 155.91 43.31 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.248 -0.981 . . . . 0.0 109.88 179.265 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.427 ' N ' ' SG ' ' A' ' 19' ' ' CYS . 14.8 t -70.71 130.33 41.46 Favored 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.412 -0.915 . . . . 0.0 110.733 -178.801 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -128.43 103.07 6.93 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 115.129 -0.942 . . . . 0.0 110.228 -179.881 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 42.9 t -51.02 128.14 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 C-N-CA 118.635 -1.226 . . . . 0.0 108.673 179.166 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.48 ' H ' ' HA ' ' A' ' 33' ' ' SER . 0.1 OUTLIER -92.78 -56.45 3.0 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 -178.337 . . . . . . . . 3 3 . 1 . 040 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' C ' ' H ' ' A' ' 31' ' ' TYR . 5.4 p30 -153.28 171.44 6.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.256 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.554 ' O ' HD12 ' A' ' 11' ' ' ILE . 3.4 Cg_exo -67.81 24.79 0.13 Allowed 'Trans proline' 0 CA--C 1.539 0.739 0 CA-C-N 119.36 0.807 . . . . 0.0 112.26 -177.341 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 29' ' ' ASN . 84.9 m-85 -151.27 11.91 0.63 Allowed 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 119.906 -0.718 . . . . 0.0 109.87 178.861 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -171.88 131.18 0.67 Allowed 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 119.092 -1.043 . . . . 0.0 110.649 -178.619 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.48 ' HA ' ' H ' ' A' ' 28' ' ' LEU . 55.0 m -131.7 113.49 13.62 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 119.496 -0.882 . . . . 0.0 109.656 178.153 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -98.45 161.07 13.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 124.482 1.113 . . . . 0.0 111.464 -178.001 . . . . . . . . 1 1 . 1 . 040 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.483 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 71.3 m -111.94 121.54 45.3 Favored 'General case' 0 N--CA 1.498 1.944 0 C-N-CA 119.832 -0.747 . . . . 0.0 110.073 179.311 . . . . . . . . 2 2 . 1 . 040 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 N--CA 1.503 2.207 0 CA-C-O 116.236 -1.84 . . . . 0.0 109.872 -179.684 . . . . . . . . 0 0 . 1 . 041 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.763 -0.458 . . . . 0.0 109.763 . . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.586 ' O ' ' HB2' ' A' ' 20' ' ' ALA . 0.3 OUTLIER -136.81 -166.13 1.85 Allowed 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.207 179.774 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -171.32 1.96 Allowed 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.905 -179.45 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.666 ' CD2' ' H ' ' A' ' 5' ' ' TYR . 23.0 t-160 -59.11 164.87 2.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.01 -1.108 . . . . 0.0 108.01 179.553 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.666 ' H ' ' CD2' ' A' ' 4' ' ' HIS . 30.7 m-85 47.82 23.64 0.48 Allowed 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 118.442 -1.303 . . . . 0.0 108.538 -178.272 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 4' ' ' HIS . . . -86.01 157.58 30.95 Favored Glycine 0 N--CA 1.484 1.874 0 CA-C-N 115.095 -0.957 . . . . 0.0 112.069 -179.06 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' C ' ' OE1' ' A' ' 2' ' ' GLN . 50.8 tt0 -93.69 106.07 18.06 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.066 -0.654 . . . . 0.0 111.147 -179.049 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 35' ' ' CYS . 1.0 OUTLIER -91.9 -19.04 22.9 Favored 'General case' 0 C--N 1.31 -1.135 0 C-N-CA 118.735 -1.186 . . . . 0.0 110.777 179.997 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -154.45 -161.63 10.62 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.174 -1.965 . . . . 0.0 112.288 -179.381 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' ILE . . . 110.35 127.32 5.24 Favored Glycine 0 N--CA 1.481 1.7 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.317 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.538 HD12 ' O ' ' A' ' 30' ' ' PRO . 78.5 mt -44.96 154.02 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.028 -179.379 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 79.48 -12.84 25.17 Favored Glycine 0 C--N 1.296 -1.69 0 C-N-CA 119.315 -1.422 . . . . 0.0 110.037 -178.187 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -89.46 110.03 20.9 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.916 -0.714 . . . . 0.0 110.785 -179.982 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 52.5 p -109.86 30.65 6.5 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.553 179.233 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -104.4 -179.05 24.98 Favored Glycine 0 N--CA 1.482 1.753 0 N-CA-C 110.592 -1.003 . . . . 0.0 110.592 -179.93 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -70.5 150.12 63.22 Favored 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.487 1.458 . . . . 0.0 109.761 179.422 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.404 HG22 ' O ' ' A' ' 8' ' ' CYS . 45.5 p -106.92 11.62 29.72 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 119.509 -0.877 . . . . 0.0 111.926 -178.001 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.1 t -86.53 116.28 28.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 C-N-CA 118.458 -1.297 . . . . 0.0 110.265 179.686 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' O ' ' C ' ' A' ' 20' ' ' ALA . 16.4 m -83.1 139.23 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.287 -0.965 . . . . 0.0 110.094 179.847 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 2' ' ' GLN . . . -40.73 147.77 0.11 Allowed 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.249 -0.98 . . . . 0.0 110.604 179.49 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -51.19 153.65 1.91 Allowed 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.301 -179.479 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.36 -20.66 32.8 Favored Glycine 0 N--CA 1.483 1.829 0 C-N-CA 119.81 -1.186 . . . . 0.0 111.429 179.197 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.423 ' OG1' ' O ' ' A' ' 20' ' ' ALA . 0.6 OUTLIER -118.18 174.21 6.35 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 119.946 -0.701 . . . . 0.0 111.004 -179.609 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.0 -179.59 5.76 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.443 179.933 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.0 t -99.85 139.43 35.54 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.264 -0.974 . . . . 0.0 111.206 -179.356 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -140.18 113.38 8.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 119.896 -0.721 . . . . 0.0 110.217 179.531 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.2 t -55.07 138.37 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 C-N-CA 119.166 -1.013 . . . . 0.0 110.115 -179.978 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.449 HD12 ' ND2' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -107.3 -60.87 1.63 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 -179.511 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -145.5 175.42 2.76 Favored Pre-proline 0 N--CA 1.505 2.275 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 178.63 . . . . . . . . 3 3 . 1 . 041 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.538 ' O ' HD12 ' A' ' 11' ' ' ILE . 5.9 Cg_exo -70.08 22.35 0.18 Allowed 'Trans proline' 0 C--O 1.215 -0.654 0 C-N-CA 120.616 0.877 . . . . 0.0 111.851 -178.413 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' ASN . 95.9 m-85 -155.81 19.11 0.38 Allowed 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 119.71 -0.796 . . . . 0.0 109.549 179.229 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.459 ' HB3' HD22 ' A' ' 29' ' ' ASN . 47.1 t80 -172.8 127.54 0.49 Allowed 'General case' 0 C--N 1.305 -1.36 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.816 -178.505 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 63.3 m -130.46 113.0 13.76 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.574 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 46.1 tt0 -93.11 156.88 16.59 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 124.06 0.85 . . . . 0.0 112.224 -176.84 . . . . . . . . 1 1 . 1 . 041 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.573 ' SG ' ' SG ' ' A' ' 8' ' ' CYS . 86.4 m -106.19 130.92 53.97 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.545 179.851 . . . . . . . . 2 2 . 1 . 041 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 19.7 mt . . . . . 0 N--CA 1.499 1.993 0 CA-C-O 116.358 -1.782 . . . . 0.0 109.76 -179.886 . . . . . . . . 0 0 . 1 stop_ save_